From: <Salvato da Windows Internet Explorer 7>
Subject: MicroRNA signatures in human cancers : Article : Nature Reviews Cancer
Date: Thu, 8 May 2008 13:49:51 +0200
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----=_NextPart_000_01AB_01C8B112.634FA1F0"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.5512

This is a multi-part message in MIME format.

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" =
"http://www.w3c.org/TR/1999/REC-html401-19991224/loose.dtd">
<HTML lang=3Den xml:lang=3D"en" =
xmlns=3D"http://www.w3.org/1999/xhtml"><HEAD><TITLE>MicroRNA signatures =
in human cancers : Article : Nature Reviews Cancer</TITLE>
<META http-equiv=3DContent-Style-Type content=3Dtext/css>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Diso-8859-1">
<META content=3Dnoarchive name=3Drobots><LINK=20
href=3D"http://www.nature.com/favicon.ico" rel=3D"shortcut icon"><LINK =
title=3Dhome=20
href=3D"/nrc/index.html" rel=3Dhome><LINK title=3Dcopyright=20
href=3D"/common/copyright_statement.html" rel=3Dcopyright><LINK =
title=3Dhelp=20
href=3D"/common/accessibility_statement.html" rel=3Dhelp>
<STYLE type=3Dtext/css media=3D"screen, projection, print">@import url( =
/common/style/null.css?"{ );
@import url( /common/includes/header/03/style/header.css );
@import url( /common/includes/footer/03/style/footer.css );
@import url( /common/style/layout.css );
@import url( /reviews/style/layout.css );
@import url( /common/style/main.css );
@import url( /reviews/style/group.css );
@import url( /nrc/style/site.css );
@import url( /common/style/restrict_width/966px.css );
#hdr .login-nav {
	BACKGROUND-IMAGE: url(/nrc/images/journal_header_v3.gif)
}
</STYLE>
<LINK title=3D"Print Stylesheet" media=3Dprint=20
href=3D"http://www.nature.com/common/style/print.css" type=3Dtext/css=20
rel=3Dstylesheet><!--[if lte IE 7]>
<STYLE type=3Dtext/css media=3D"screen, projection">@import url( =
/common/style/null.css?"{ );
@import url( /common/includes/header/03/style/ie-specific/lte-ie-7.css =
);
@import url( /reviews/style/ie-specific/lte-ie-7.css );
</STYLE>
<![endif]--><!--[if IE 7]>
<STYLE type=3Dtext/css media=3D"screen, projection">@import url( =
/common/includes/header/03/style/ie-specific/ie-7.css );
@import url( /common/style/ie-specific/ie-7.css );
@import url( /reviews/style/ie-specific/ie-7.css );
</STYLE>
<![endif]--><!--[if IE 6]>
<script type=3D"text/javascript" =
src=3D"/common/scripts/ie-specific/ie-6.js"></script>
<style type=3D"text/css" media=3D"screen, projection">
	@import "/common/includes/header/03/style/ie-specific/ie-6.css";
	@import "/common/includes/footer/03/style/ie-specific/ie-6.css";
	@import "/common/style/ie-specific/ie-6.css";
	@import "/reviews/style/ie-specific/ie-6.css";
	@import "/nrc/style/ie-specific/ie-6.css";
</style>
<![endif]-->
<META content=3D"MSHTML 6.00.6000.16640" name=3DGENERATOR></HEAD>
<BODY class=3Dwww-nature-com-nrc id=3Darticle>
<DIV id=3Dconstrain>
<DIV class=3Dconstrain>
<DIV id=3Dhdr>
<DIV class=3Dpublications-search id=3Dtop>
<DIV class=3Dpublications>
<UL>
  <LI class=3D"first jumplink"><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#conten=
t">Jump&nbsp;to&nbsp;main&nbsp;content</A>=20
  </LI>
  <LI class=3Djumplink><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#journa=
lnav">Jump&nbsp;to&nbsp;navigation</A>=20
  </LI>
  <LI class=3Dnature-link><A =
href=3D"http://www.nature.com/">nature.com<SPAN=20
  class=3Dhidden> homepage</SPAN></A> </LI>
  <LI class=3Dpub1><A=20
  =
href=3D"http://www.nature.com/siteindex/">Publications&nbsp;A-Z&nbsp;inde=
x</A></LI>
  <LI><A =
href=3D"http://www.nature.com/browse/">Browse&nbsp;by&nbsp;subject</A>=20
  </LI></UL></DIV></DIV><SPAN class=3Dcleardiv><!-- --></SPAN>
<DIV class=3Dleaderboard-links>
<DIV class=3Duser-services>
<UL class=3Dlist>
  <LI class=3D"us-link li1"><A =
href=3D"http://www.nature.com/myaccount/">My=20
  account</A>
  <LI class=3D"us-link li2"><A=20
  title=3D"sign up to receive Nature Reviews Cancer email alerts"=20
  =
href=3D"http://www.nature.com/nams/svc/myaccount/save/ealert?list_id=3D19=
">E-alert=20
  sign up</A>=20
  <LI class=3D"us-link li3"><A title=3D"Subscribe to Nature Reviews =
Cancer"=20
  href=3D"https://secure.nature.com/subscribe/nrc">Subscribe</A>
  <LI class=3D"us-link li4"><A title=3D"Register with Nature.com"=20
  href=3D"http://www.nature.com/register/">Register</A> </LI></UL><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV><!-- leaderboard ad -->
<DIV class=3Dleaderboard>
<DIV class=3Dpadder>
<SCRIPT type=3Dtext/javascript><!--//--><![CDATA[//><!--
	var include =3D '';

	var wp =3D '';
	if (wp !=3D '') include +=3D 'wp=3D'+wp;
	include +=3D ';';

	var rf =3D '';
	if (rf !=3D '') include +=3D "rf=3D"+rf;
	include +=3D ';';
=09
	var sp =3D '75';
	if (sp !=3D '') include +=3D "sp=3D"+sp;
	include +=3D ";";
=09
	var ps =3D '';
	if (ps !=3D '') include +=3D "ps=3D"+ps;
	include +=3D ";";
=09
	var adinf =3D "lg=3Dno;";

	if(include !=3D ";;;;")
	{
		adinf =3D include;
	}

	var time =3D new Date();
	ordval=3D (time.getTime());
=09
		ord=3DMath.random()*10000000000000000;
//--><!]]></SCRIPT>

<SCRIPT type=3Dtext/javascript><!--//--><![CDATA[//><!--=0A=
		document.write('<script type=3D"text/javascript" =
src=3D"http://ad.doubleclick.net/adj/naturereviews.cancer/article;abr=3D!=
webtv;type=3Drv;artid=3Dnrc1997;date=3D200611;issue=3D11;subco=3D;chaco=3D=
;keywd=3D;njdis=3D;njreg=3D;crstg=3D;pos=3Dtop;sz=3D728x90;ptile=3D1;ord=3D=
' + ord + '?" ><\/script>');=0A=
=0A=
	if ((!document.images && navigator.userAgent.indexOf('Mozilla/2.') >=3D =
0) || (navigator.userAgent.indexOf("WebTV") >=3D 0)) {=0A=
		document.write('<a =
href=3D"http://ad.doubleclick.net/jump/naturereviews.cancer/article;keywd=
=3D;sz=3D728x90;ord=3D' + ord + '?">');=0A=
		document.write('<img =
src=3D"http://ad.doubleclick.net/ad/naturereviews.cancer/article;keywd=3D=
;sz=3D728x90;ord=3D' + ord + '?" width=3D"728" height=3D"90" =
border=3D"0"></a>');=0A=
	}=0A=
//--><!]]></SCRIPT>
<NOSCRIPT>
<DIV><A=20
href=3D"http://ad.doubleclick.net/jump/naturereviews.cancer/article;abr=3D=
!NN2;type=3Drv;artid=3Dnrc1997;date=3D200611;issue=3D11;subco=3D;chaco=3D=
;keywd=3D;njdis=3D;njreg=3D;crstg=3D;pos=3Dtop;sz=3D728x90;ptile=3D1;ord=3D=
123456789?"><IMG=20
style=3D"BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; =
BORDER-BOTTOM-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px"=20
alt=3DAdvertisement=20
src=3D"http://ad.doubleclick.net/ad/naturereviews.cancer/article;abr=3D!N=
N2;tile=3D1;type=3Drv;artid=3Dnrc1997;date=3D200611;issue=3D11;subco=3D;c=
haco=3D;keywd=3D;njdis=3D;njreg=3D;crstg=3D;pos=3Dtop;sz=3D728x90;ptile=3D=
1;ord=3D123456789?"></A></DIV></NOSCRIPT></DIV></DIV><!-- end =
leaderboard ad --></DIV><SPAN=20
class=3Dcleardiv><!-- --></SPAN>
<DIV class=3Dlogin-nav>
<DIV class=3Dlogon>
<P>Welcome back: Giovanni Camporeale<BR><A class=3Dlogoff=20
title=3D"log out of Nature.com"=20
href=3D"http://www.nature.com/foxtrot/svc/logout">Logout<SPAN =
class=3Dhidden> of=20
nature.com </SPAN></A></P></DIV><A class=3Djournal-header=20
title=3D"Nature Reviews Cancer homepage"=20
href=3D"http://www.nature.com/nrc/index.html"><IMG =
class=3Djournal-header-image=20
style=3D"DISPLAY: block" alt=3D"Nature Reviews Cancer homepage"=20
src=3D"http://www.nature.com/nrc/images/journal_header_v3.gif"></A>=20
<FORM class=3Dsearch action=3D/search/executeSearch? method=3Dget>
<DIV><LABEL for=3Dsearchtext>Search</LABEL> <SELECT name=3Dsp-q-9> =
<OPTION=20
  value=3DNRC selected>This journal</OPTION> <OPTION value=3D"">All of=20
  nature.com</OPTION></SELECT> <INPUT id=3Dsearchtext name=3Dsp-q> =
<INPUT type=3Dhidden=20
value=3D10 name=3Dsp-c> <INPUT type=3Dhidden value=3Dcat name=3Dsp-x-9> =
<INPUT type=3Dhidden=20
value=3Ddate name=3Dsp-s> <INPUT class=3Dbutton title=3D"search now" =
type=3Dsubmit value=3Dgo name=3Dsubmit> <A=20
href=3D"http://www.nature.com/search/adv_search?sp-a=3Dsp1001702d&amp;sp-=
x-1=3Dujournal&amp;sp-q-1=3DNature Reviews =
Cancer">Advanced&nbsp;search</A>=20
<INPUT type=3Dhidden value=3Dsp1001702d name=3Dsp-a> <INPUT =
type=3Dhidden=20
value=3Dsubject|ujournal name=3Dsp-sfvl-field> <INPUT type=3Dhidden =
value=3Dujournal=20
name=3Dsp-x-1> <INPUT type=3Dhidden value=3Dphrase name=3Dsp-p-1> <INPUT =
type=3Dhidden=20
value=3Dall name=3Dsp-p> </DIV></FORM><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV></DIV>
<DIV id=3Dbreadcrumb>
<DIV><A href=3D"http://www.nature.com/nrc/index.html">Journal =
home</A><SPAN=20
class=3Ddivider> &gt; </SPAN><A=20
href=3D"http://www.nature.com/nrc/archive/">Archive</A><SPAN =
class=3Ddivider> &gt;=20
</SPAN><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/index.html#rv">Review</A=
><SPAN=20
class=3Ddivider> &gt; </SPAN><SPAN class=3Dthisitem>Full =
Text</SPAN></DIV></DIV>
<DIV id=3Dcontent-journalnav>
<DIV id=3Dcontent>
<DIV class=3Dpage-heading>
<H1 class=3Dpage-header>Review</H1></DIV>
<DIV class=3Dbox>
<P id=3Dcite><SPAN class=3Djournalname>Nature Reviews Cancer</SPAN> =
<SPAN=20
class=3Djournalnumber>6</SPAN>, <SPAN class=3Dcite-pages>857-866</SPAN> =
<SPAN=20
class=3Dcite-month-year>(November 2006)</SPAN><SPAN class=3Ddivider> | =
</SPAN><SPAN=20
class=3Dcite-doi><SPAN class=3Ddoi><ABBR=20
title=3D"Digital Object =
Identifier">doi</ABBR>:10.1038/nrc1997</SPAN></SPAN></P>
<P id=3Derrorcor></P>
<H2 id=3Datl>MicroRNA signatures in human cancers</H2>
<P id=3Daug>George A. Calin<SUP><A title=3D"affiliated with "=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#a1">1<=
/A></SUP>=20
&amp; Carlo M. Croce<SUP><A title=3D"affiliated with "=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#a1">1<=
/A></SUP>&nbsp;=20
<A title=3D"More information about the author"=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/authors/nrc1997.html">Ab=
out the=20
authors</A></P>
<DIV id=3Dabs><A class=3Dbacktotop=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#top">T=
op<SPAN=20
class=3Dhidden> of page</SPAN></A>
<H3 class=3Dhidden>Abstract</H3>
<P class=3Dlead>MicroRNA (miRNA) alterations are involved in the =
initiation and=20
progression of human cancer. The causes of the widespread differential=20
expression of miRNA genes in malignant compared with normal cells can be =

explained by the location of these genes in cancer-associated genomic =
regions,=20
by epigenetic mechanisms and by alterations in the miRNA processing =
machinery.=20
MiRNA-expression profiling of human tumours has identified signatures =
associated=20
with diagnosis, staging, progression, prognosis and response to =
treatment. In=20
addition, profiling has been exploited to identify miRNA genes that =
might=20
represent downstream targets of activated oncogenic pathways, or that =
target=20
protein-coding genes involved in cancer.</P></DIV>
<UL class=3Dswitch-article-view>
  <LI>View <A title=3D""=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/execsumm/nrc1997.html">A=
t a=20
  Glance</A></LI></UL>
<DIV id=3Darticlebody>
<P class=3Dnorm>Cancer is a complex genetic disease involving structural =
and=20
expression abnormalities of both coding and non-coding genes. For almost =
three=20
decades, the alteration of protein-coding oncogenes and/or =
tumour-suppressor=20
genes (for reviews see Refs <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B1">1=96=
3</A>)=20
have been thought to be the causes of tumorigenesis. With the discovery =
in the=20
past few years of thousands of genes that produce non-coding RNA (ncRNA) =

transcripts with no significant open reading frame, it has become =
evident that=20
the genomic complexity of the cancer cell is far greater than expected. =
Although=20
the identification of long ncRNAs was quite a slow process owing to the=20
difficulties of experimentally cloning non-coding cDNAs of tens or =
hundreds of=20
thousands of bases<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B4">4<=
/A></SUP>,=20
the cloning of small members of the ncRNA class was recently extremely=20
successful<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B5">5,=
=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B6">6,=
=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B7">7,=
=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B8">8,=
=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B9">9<=
/A></SUP>.</P>
<P class=3Dnorm>These microRNAs (miRNAs) are small non-coding RNAs of =
20=9622=20
nucleotides, typically excised from 60=96110 nucleotide foldback RNA =
precursor=20
structures (for reviews see Refs <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B10">1=
0=9612</A>).=20
The biogenesis of miRNAs involves a complex protein system, including =
members of=20
the Argonaute family, Pol II-dependent transcription and the RNase IIIs =
<A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D29102">Drosh=
a</A>=20
and <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D23405">Dicer=
</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B13">1=
3</A></SUP>.=20
MiRNAs are involved in crucial biological processes, including =
development,=20
differentiation, apoptosis and proliferation<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B11">1=
1,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B14">1=
4</A></SUP>,=20
through imperfect pairing with target messenger RNAs (mRNAs) of =
protein-coding=20
genes and the transcriptional or post-transcriptional regulation of =
their=20
expression<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B15">1=
5,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B16">1=
6,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B17">1=
7</A></SUP>.=20
The number of human miRNAs reported so far (the July 2006 release of <A=20
href=3D"http://microrna.sanger.ac.uk/sequences/">miRBase</A>, at the =
Sanger=20
Institute<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B18">1=
8</A></SUP>)=20
is in excess of 450, twice as many as initial calculations =
indicated<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B19">1=
9</A></SUP>,=20
and more than1,000 predicted miRNA genes<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B20">2=
0,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B21">2=
1,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B22">2=
2</A></SUP>=20
are awaiting experimental confirmation.</P>
<P class=3Dnorm>Initially identified in B-cell chronic lymphocytic =
leukaemia (<A=20
href=3D"http://www.cancer.gov/cancertopics/types/leukemia">CLL</A>)<SUP><=
A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B23">2=
3</A></SUP>,=20
changes in the expression level of miRNAs have subsequently been =
detected by=20
different groups in many types of human tumours (several reviews give =
various=20
details of the link between miRNAs and cancer, such as Refs <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B24">2=
4=9634</A>).=20
MiRNAs have been proposed to contribute to oncogenesis because they can =
function=20
either as tumour suppressors (as is the case for <SPAN =
class=3Di>miR-15</SPAN>a=20
and <SPAN class=3Di>miR-16-1</SPAN>) or oncogenes (as is the case for =
<SPAN=20
class=3Di>miR -155</SPAN>or members of the <SPAN =
class=3Di>miR-17=9692</SPAN>=20
cluster). The genomic abnormalities found to influence the activity of =
miRNAs=20
are the same as those previously described for protein-coding genes, =
such as=20
chromosomal rearrangements, genomic amplifications or deletions and =
mutations.=20
In a specific tumour, abnormalities both in protein-coding genes and =
miRNAs can=20
be identified<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B29">2=
9</A></SUP>.=20
Homozygous mutations or the combination of deletion plus mutation in =
miRNA genes=20
are rare events<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B35">3=
5</A></SUP>,=20
and the functional consequences of heterozygous sequence variations of =
miRNAs in=20
human cancers have not been identified<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B36">3=
6</A></SUP>.=20
Furthermore, the role of polymorphisms in the complementary sites of =
target=20
mRNAs in cancer patients<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B37">3=
7</A></SUP>=20
or individuals with a predisposition to other hereditary diseases<SUP><A =

href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B38">3=
8</A></SUP>=20
have just started to be understood. Therefore, at the present time, the =
main=20
mechanism that underlies changes in the function of miRNAs in cancer =
cells seems=20
to be aberrant gene expression, characterized by abnormal levels of =
expression=20
for mature and/or precursor miRNA sequences compared with the =
corresponding=20
normal tissues.</P>
<H4 class=3Dnorm =
id=3DMiRNA-profiling-of-tumour-versus-normal-tissues>MiRNA=20
profiling of tumour versus normal tissues</H4>
<P class=3Dnorm>Oligonucleotide miRNA microarray analysis is the most =
commonly=20
used high-throughput technique for the assessment of cancer-specific =
expression=20
levels for hundreds of miRNAs in a large number of samples (for reviews =
see Refs=20
<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B13">1=
3</A>,<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B39">3=
9</A>,<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B40">4=
0</A>).=20
Another method to determine miRNA expression levels involves the use of =
a <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html#df=
1">bead-based=20
flow-cytometric technique</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B41">4=
1</A></SUP>=20
(<A =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#f1">Fi=
g.=20
1</A>). Other developments include quantitative real-time PCR for =
precursor=20
miRNAs<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B42">4=
2</A></SUP>=20
or active miRNAs<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B43">4=
3,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B44">4=
4</A></SUP>,=20
miRAGE =97 a genome-wide miRNA analysis with serial analysis of gene =
expression=20
(SAGE)<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B45">4=
5</A></SUP>=20
=97 or the high-throughput array-based Klenow enzyme (RAKE) assay<SUP><A =

href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B46">4=
6</A></SUP>.=20
Each of these techniques has its strengths and weaknesses, but after =
several=20
years of study using these technologies, and the analysis of more than =
1,000=20
primary tumours, common characteristics of miRNA deregulation in human =
tumours=20
have emerged.</P>
<DIV class=3Dfigure-table id=3Df1>
<H5 class=3Dnorm><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F1.html"=
>Figure=20
1<SPAN class=3Ddivider> | </SPAN>Principles of microarray technology and =

bead-based flow cytometry used for microRNA profiling.</A></H5><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F1.html"=
><IMG=20
class=3Dthumb=20
alt=3D"Figure 1 : Principles of microarray technology and bead-based =
flow cytometry used for microRNA profiling. Unfortunately we are unable =
to provide accessible alternative text for this. If you require =
assistance to access this image, or to obtain a text description, please =
contact npg@nature.com"=20
src=3D"http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f1.jpg"></=
A>
<P>The process of microarray-based microRNA (miRNA) profiling, which was =

initially developed by Liu <SPAN class=3Di>et al</SPAN>.<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B39">3=
9</A></SUP>,=20
is shown as described in most profiling studies on primary tumours. The=20
bead-based miRNA profiling technique was developed by Lu <SPAN =
class=3Di>et=20
al</SPAN><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B41">4=
1</A></SUP>.=20
Both strategies involve four main steps (shown on the left side): target =

labelling, DNA=96DNA hybridization, staining and signal detection. The =
different=20
replicates of the spots on the glass slide represent different =
oligonucleotide=20
sequences corresponding to sequences from the precursor miRNA or active =
miRNA=20
molecule, whereas the different beads are marked with different =
fluorescent tags=20
(each colour represents a specific miRNA using up to 100 different =
colours). The=20
main advantage of the microarray-based miRNA profiling technique is the =
high=20
standardization of the procedure (which enables tens of samples to be =
processed=20
in parallel), whereas the main advantage of the bead-based miRNA =
profiling is=20
that, because hybridization takes place in solution (instead of a glass=20
surface), it offers a higher specificity for closely related miRNAs. The =

described polyacrylamide gel (PAA) fractionation is an additional =
processing=20
step in the bead-based system. This figure is modified with permission =
from Ref.=20
<A =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B49">4=
9</A>=20
=A9 (2004) National Academy of Science, USA.</P>
<UL class=3Doptions>
  <LI class=3Dhigh-res><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F1.html"=
>High=20
  resolution image and legend (56 <ABBR title=3DKilobyte>KB</ABBR>) </A>
  <LI class=3Dfti><A title=3D"View a list of all figures and tables in =
this article"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_ft.html"=
>Figures=20
  and tables index</A>
  <LI class=3Dpowerpoint><A class=3Ddownload-pp=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/slides/nrc1997-pf1.ppt">=
Download=20
  Power<SPAN class=3Dhidden> </SPAN>Point slide (264 <ABBR=20
  title=3DKilobyte>KB</ABBR>) </A></LI></UL><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV><BR class=3Dclear>
<P class=3Dnorm><B><I>MiRNA-expression profiles classify human =
cancers</I></B>. To=20
date, every type of tumour analysed by miRNA profiling has shown =
significantly=20
different miRNA profiles (for mature and/or precursor miRNAs) compared =
with=20
normal cells from the same tissue (<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#t1">Ta=
ble=20
1</A>, <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#f2">Fi=
g.=20
2</A>). Two large profiling studies using various tumours and two =
distinct=20
technologies to investigate genome-wide miRNA expression have been=20
published<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B41">4=
1,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7</A></SUP>.=20
Lu <SPAN class=3Di>et al</SPAN>. developed a bead-based flow-cytometric =
profiling=20
technology that is highly specific. They performed a systematic analysis =
of 334=20
leukaemias and solid cancers, and found that miRNA-expression profiles =
classify=20
human cancers according to the developmental lineage and differentiation =
state=20
of the tumours. Furthermore, they observed patterns of gene expression =
for each=20
type of tumour that reflected distinct mechanisms of transformation. For =

example, the acute leukaemia samples were divided into three clusters =
that=20
corresponded to the <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D613"><SPAN=20
class=3Di>BCR</SPAN></A>=96<A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D25"><SPAN=20
class=3Di>ABL</SPAN></A>, <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D2120"><SPAN =

class=3Di>TEL</SPAN></A>-<A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D861"><SPAN=20
class=3Di>AML1</SPAN></A> (acute myeloid leukeamia 1, also known as =
runt-related=20
transcription factor 1; <SPAN class=3Di>RUNX1</SPAN>) and <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D4297"><SPAN =

class=3Di>MLL</SPAN></A> (mixed lineage leukaemia) rearrangements, =
respectively.=20
An interesting observation was that miRNA expression in tumour samples =
seems=20
globally lower than in normal tissue, as 129 out of 217 measured miRNAs =
showed=20
this pattern of expression. One explanation could be that global miRNA =
levels=20
reflect the state of cellular differentiation. In fact, several =
profiling=20
studies, including those by Lu <SPAN class=3Di>et al</SPAN>.<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B41">4=
1</A></SUP>=20
and by Garzon <SPAN class=3Di>et al</SPAN>.<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B48">4=
8</A></SUP>,=20
showed that distinct miRNA profiles characterize different =
haematopoietic=20
differentiation stages.</P>
<DIV class=3Dfigure-table id=3Df2>
<H5 class=3Dnorm><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F2.html"=
>Figure=20
2<SPAN class=3Ddivider> | </SPAN>Examples of microRNA profiles in human =
solid and=20
liquid cancers.</A></H5><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F2.html"=
><IMG=20
class=3Dthumb=20
alt=3D"Figure 2 : Examples of microRNA profiles in human solid and =
liquid cancers. Unfortunately we are unable to provide accessible =
alternative text for this. If you require assistance to access this =
image, or to obtain a text description, please contact npg@nature.com"=20
src=3D"http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f2.jpg"></=
A>
<P>The general consensus is that profiling enabled the signatures that =
are=20
associated with diagnosis =97 the process of identifying the nature of a =
disease =97=20
and prognosis =97 a prediction of the probable course and outcome of a =
disease =97=20
to be defined. <SPAN class=3Db>a</SPAN> | The profiling of 836 solid =
tissue and=20
haematological primary cancers (and corresponding normal tissues =
samples) using=20
the microarray technology (as described in Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B39">3=
9</A>)=20
and reported to date is shown. The exact number of analysed samples from =
each=20
tumour type (corresponding normal controls included) is shown. The data =
were=20
collected from the references cited in the text. <SPAN =
class=3Db>b</SPAN> | The=20
common expression signature in six solid cancers indicates common =
altered=20
regulatory pathways involving the same microRNA (miRNA) genes (named on =
the=20
right side of the dendrogram)<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7</A></SUP>.=20
These miRNAs could be considered as 'cancer markers', because variations =
of=20
their expression could identify the cancerous state. <SPAN =
class=3Db>c</SPAN> |=20
The distinct clusters identified by miRNA profiles in chronic =
lymphocytic=20
leukaemia (CLL)<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B49">4=
9</A></SUP>=20
were further confirmed to be associated with prognostic factors and =
disease=20
progression<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B35">3=
5</A></SUP>.=20
Note also that various normal haematopoietic samples cluster in a group =
that is=20
distinct from all CLL samples. MNC, mononuclear cells; Ly, B =
lymphocytes; CD5, a=20
subset of B lymphocytes largely accepted to represent the equivalent of=20
malignant cells in CLL<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B93">9=
3</A></SUP>.=20
Panel b is modified with permission from Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7</A> =A9=20
(2006) National Academy of Science, USA.</P>
<UL class=3Doptions>
  <LI class=3Dhigh-res><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F2.html"=
>High=20
  resolution image and legend (71 <ABBR title=3DKilobyte>KB</ABBR>) </A>
  <LI class=3Dfti><A title=3D"View a list of all figures and tables in =
this article"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_ft.html"=
>Figures=20
  and tables index</A>
  <LI class=3Dpowerpoint><A class=3Ddownload-pp=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/slides/nrc1997-pf2.ppt">=
Download=20
  Power<SPAN class=3Dhidden> </SPAN>Point slide (280 <ABBR=20
  title=3DKilobyte>KB</ABBR>) </A></LI></UL><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV><BR class=3Dclear>
<DIV class=3Dfigure-table id=3Dt1>
<H5 class=3Dnorm><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_T1.html"=
>Table=20
1<SPAN class=3Ddivider> | </SPAN>Facts about microRNA-expression =
profiling in=20
human cancers</A></H5><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_T1.html"=
><IMG=20
class=3Dthumb=20
alt=3D"Table 1 - Facts about microRNA-expression profiling in human =
cancers"=20
src=3D"http://www.nature.com/common/images/table_thumb.gif"></A>
<UL class=3Doptions>
  <LI class=3Dfull><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_T1.html"=
>Full=20
  table</A>=20
  <LI class=3Dfti><A title=3D"View a list of all figures and tables in =
this article"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_ft.html"=
>Figures=20
  and tables index</A>
  <LI class=3Dpowerpoint><A class=3Ddownload-pp=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/slides/nrc1997-pt1.ppt">=
Download=20
  Power<SPAN class=3Dhidden> </SPAN>Point slide (277 <ABBR=20
  title=3DKilobyte>KB</ABBR>) </A></LI></UL><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV><BR class=3Dclear>
<P class=3Dnorm>Using a large-scale microarray analysis of 540 samples, =
including=20
363 from six of the most frequent human solid tumour types and 177 =
normal=20
controls, Volinia <SPAN class=3Di>et al</SPAN>. also found that cancer =
cells=20
showed distinct miRNA profiles compared with normal cells<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7</A></SUP>=20
(<A =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#f2">Fi=
g.=20
2</A>). Out of the 228 miRNA genes analysed, 36 were overexpressed and =
21 were=20
downregulated in cancer cells versus normal cells. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html#df=
2">Hierarchical=20
clustering analyses</A> showed that this miRNA signature enabled the =
tumour=20
samples to be grouped on the basis of their tissue of origin. Several =
other=20
genome-wide profiling studies have been performed on various cancer =
types,=20
including CLL<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B49">4=
9</A></SUP>,=20
<A href=3D"http://www.cancer.gov/cancertopics/types/breast">breast=20
cancer</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B50">5=
0</A></SUP>,=20
glioblastoma<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B51">5=
1</A></SUP>,=20
<A href=3D"http://www.cancer.gov/cancertopics/types/thyroid">thyroid =
papillary=20
carcinoma</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B37">3=
7</A></SUP>,=20
<A =
href=3D"http://www.cancer.gov/cancertopics/types/liver">hepatocellular=20
carcinoma</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B52">5=
2</A></SUP>,=20
<A href=3D"http://www.cancer.gov/cancertopics/types/lung">lung =
cancer</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B53">5=
3</A></SUP>,=20
<A =
href=3D"http://www.cancer.gov/cancertopics/types/colon-and-rectal">colon =

cancer</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B45">4=
5</A></SUP>=20
and <A =
href=3D"http://www.cancer.gov/cancertopics/types/isletcell">endocrine=20
pancreatic tumours</A><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B54">5=
4</A></SUP>.=20
For example, in a study of 104 matched pairs of primary cancerous and=20
non-cancerous lung tissue, Yanaihara <SPAN class=3Di>et al</SPAN>. found =
a set of=20
43 differentially expressed miRNAs; 28 were downregulated and 15 were=20
overexpressed in the tumour cells<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B53">5=
3</A></SUP>.=20
Murakami <SPAN class=3Di>et al</SPAN>., using a microarray platform, =
found that in=20
hepatocellular carcinoma five out of eight differentially expressed =
miRNAs were=20
downregulated in cancer cells<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B52">5=
2</A></SUP>.=20
All these studies support the same view: the alterations seen in cancer =
cells=20
that express miRNAs consist of both overexpressed and downregulated=20
microRNAs.</P>
<P class=3Dnorm>One key issue is the level of differential expression =
that can be=20
considered biologically significant. 10=9620-fold differences in miRNA =
expression=20
levels have been found to be important in papillary thyroid =
carcinomas<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B37">3=
7</A></SUP>,=20
however, we share the view that much smaller changes (less than twofold) =
could=20
also be significant<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B35">3=
5,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B49">4=
9,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B50">5=
0,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B51">5=
1</A></SUP>.=20
This reflects the fact that specific miRNAs target many genes and, as a =
large=20
number of miRNAs seem to be altered in human tumours, one can postulate =
that the=20
disruption of two or more cooperating oncogenes and/or tumour =
suppressors is a=20
likely event<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B29">2=
9</A></SUP>.=20
An opposite view is that in some cases the described changes in miRNA =
expression=20
between normal and tumour cells could be biologically irrelevant: the =
main=20
interactions with various targets could have antagonistic rather than=20
accumulating biological consequences (for example, the repression of =
both=20
pro-apoptotic and anti-apoptotic genes).</P>
<P class=3Dnorm><B><I>Common miRNA genes are differentially expressed in =
various=20
cancers, suggesting common altered regulatory pathways</I></B>. =
Assembling the=20
statistical analyses of microarray data obtained by two different =
methods, <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html#df=
3">significance=20
analysis of microarrays</A> (SAM) and <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html#df=
4">prediction=20
analysis of microarrays</A> (PAM) from six solid tumours (lung, breast, =
colon,=20
gastric and prostate carcinomas and endocrine pancreatic tumours), =
Volinia <SPAN=20
class=3Di>et al</SPAN>. described a common signature composed of 21 =
miRNAs=20
differentially expressed in at least three tumour types<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7</A></SUP>.=20
At the top of the list were <SPAN class=3Di>miR-21</SPAN>, which was =
overexpressed=20
in six types of cancer cells, and <SPAN class=3Di>miR-17-5p</SPAN> and =
<SPAN=20
class=3Di>miR-191</SPAN>, which were overexpressed in five. As the =
embryological=20
origin of the analysed tumours was different, the significance of such =
findings=20
could be that these common miRNAs participate in fundamental signalling =
pathways=20
altered in many types of tumour. Supporting the function of these genes =
in=20
tumorigenesis, it was found that the predicted targets for the =
differentially=20
expressed miRNAs are significantly enriched for those that target known =
tumour=20
suppressors and oncogenes<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7</A></SUP>.=20
Furthermore, <SPAN class=3Di>miR-21</SPAN>, the only miRNA overexpressed =
in all=20
six types of cancer analysed, and which is also overexpressed in=20
glioblastomas<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B55">5=
5,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B51">5=
1</A></SUP>=20
and cholangiocarcinomas<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B56">5=
6</A></SUP>,=20
was shown by Meng <SPAN class=3Di>et al</SPAN>. to directly target the =
tumour=20
suppressor <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D5728"><SPAN =

class=3Di>PTEN</SPAN></A> in cholangiocarcinoma cells. <SPAN =
class=3Di>PTEN</SPAN>=20
encodes a phosphatase that can inhibit growth and/or survival pathways, =
and its=20
function is altered in advanced tumours of various types, including =
breast,=20
lung, gastric and prostate<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B57">5=
7</A></SUP>.=20
In all these tumours, the frequency of loss-of-heterozygosity (LOH) at =
the <SPAN=20
class=3Di>PTEN</SPAN> locus is relatively small (less than 10%), leading =
to the=20
speculation that if <SPAN class=3Di>PTEN</SPAN> is shown to be a target =
of <SPAN=20
class=3Di>miR-21</SPAN> in the other tumour types then this could be the =
main=20
mechanism of <SPAN class=3Di>PTEN</SPAN> inactivation. Furthermore, =
knockdown of=20
<SPAN class=3Di>miR-21</SPAN> in cultured glioblastoma cells triggers =
apoptosis by=20
a caspase-dependent mechanism<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B55">5=
5</A></SUP>.=20
All these data suggest that <SPAN class=3Di>miR-21</SPAN> is an =
anti-apoptotic and=20
pro-survival factor.</P>
<P class=3Dnorm>Further examples of miRNAs that are frequently =
deregulated in=20
cancer and target tumour suppressors and/or oncogenes come from an =
elegant study=20
performed in the laboratory of F. Slack, which clearly showed that Ras =
oncogenes=20
are regulated by the <SPAN class=3Di>let-7</SPAN> miRNA family<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B58">5=
8</A></SUP>.=20
Another example of fine functional dissection of a miRNA pathway comes =
from the=20
study of Voorhoeve <SPAN class=3Di>et al</SPAN>., which shows the =
oncogenic=20
function of <SPAN class=3Di>miR-372</SPAN> and <SPAN =
class=3Di>miR-373</SPAN> in=20
testicular germ-cell tumours of adolescents and adults. These miRNAs =
facilitate=20
the proliferation and transformation of cells that harbour both =
oncogenic <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D3265"><SPAN =

class=3Di>HRAS</SPAN></A> and functional wild-type <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D7157"><SPAN =

class=3Di>TP53</SPAN></A> (Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B59">5=
9</A>).</P>
<P class=3Dnorm>Additional support for the function of miRNAs in human =
cancers has=20
come from transgenic and knockout mouse models, which have been =
important for=20
understanding the tumorigenic pathways in which deregulated miRNAs are =
involved.=20
He <SPAN class=3Di>et al</SPAN>. showed that enforced expression of the =
<SPAN=20
class=3Di>miR-17-92</SPAN> cluster accelerated <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D4609">MYC</A=
>-induced=20
lymphomagenesis<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B60">6=
0</A></SUP>,=20
suggesting the oncogenic potential of some of the miRNAs that are =
overexpressed=20
in B-cell lymphoma samples owing to genomic amplification. Recently, =
Costinean=20
<SPAN class=3Di>et al</SPAN>. produced the first transgenic mouse that=20
specifically overexpresses a miRNA gene, <SPAN class=3Di>miR-155</SPAN>, =
in B=20
cells<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B61">6=
1</A></SUP>.=20
This gene is overexpressed in various types of B-cell malignancy<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B62">6=
2,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B63">6=
3,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B64">6=
4</A></SUP>.=20
The transgenic mice developed polyclonal pre-leukaemic pre-B-cell =
proliferation=20
followed by B-cell malignancy. These findings suggest that <SPAN=20
class=3Di>miR-155</SPAN> deregulation could be an early event in =
oncogenesis that=20
needs additional genetic alterations for the development of the fully =
malignant=20
phenotype<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B61">6=
1</A></SUP>.=20
The same was also shown for the <SPAN class=3Di>MYC</SPAN> oncogene, =
which is=20
activated by chromosomal translocation in human B-cell neoplasia<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B65">6=
5</A></SUP>.=20
In an avian model, oncogenic cooperation in lymphomagenesis and=20
erythroleukaemogenesis between the non-protein-coding <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D114614"><SPA=
N=20
class=3Di>BIC</SPAN></A> gene, which was later shown to include the =
<SPAN=20
class=3Di>miR-155</SPAN> sequence, and MYC has been observed<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B66">6=
6</A></SUP>,=20
indicating that MYC and <SPAN class=3Di>BIC</SPAN> might cooperate in =
human=20
tumours. A microarray study of the malignant B cells isolated from <SPAN =

class=3Di>miR-155</SPAN> transgenic mice compared with non-transgenic =
controls=20
resulted in a complete list of the deregulated protein-coding genes in =
these=20
cells, and therefore potentially identified direct and indirect targets =
of <SPAN=20
class=3Di>miR-155</SPAN>. Of particular note, the expression of 16 =
different=20
miRNAs was altered in pre-malignant cells from the transgenic =
mice<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B61">6=
1</A></SUP>,=20
supporting the view that complex relationships exist between =
protein-coding=20
genes and miRNAs that affect specific signalling pathways and, probably, =
direct=20
or indirect interactions exist between <SPAN class=3Di>miR-155</SPAN> =
and some of=20
the other deregulated miRNAs.</P>
<P class=3Dnorm><B><I>Onco-miRNAs and tumour-suppressor-miRNAs: two =
different=20
views of the same gene?</I></B> Genome-wide expression studies also =
offer=20
intriguing new perspectives on the involvement of miRNAs in human =
cancer. The=20
first perspective comes from the studies performed by O'Donnell <SPAN =
class=3Di>et=20
al</SPAN>. on cell models, which showed that in the human B-cell line =
P493-6,=20
which overexpresses <SPAN class=3Di>MYC</SPAN>, miRNA members of the =
<SPAN=20
class=3Di>miR-17=9692</SPAN> locus have tumour-suppressor activity =
because their=20
expression decreases the expression of E2F1, and so inhibits =
MYC-mediated=20
cellular proliferation<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B67">6=
7</A></SUP>.=20
However, a different perspective is offered by the results from B-cell=20
lymphomas. The same cluster of miRNAs function as a potential oncogene =
by=20
cooperating with <SPAN class=3Di>MYC</SPAN> and blocking =
apoptosis<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B60">6=
0</A></SUP>.=20
One possible explanation is that the same miRNA can participate in =
distinct=20
pathways, having different effects on cell survival, growth and =
proliferation=20
that are dependent on the cell type and the pattern of gene expression. =
The=20
combinatorial nature of miRNA=96mRNA interactions means that the same =
miRNA could=20
have different targets and the same mRNA could be targeted by different =
miRNAs=20
in different cell types. For example, Cimmino <SPAN class=3Di>et =
al</SPAN>. found=20
that in leukaemic cells with a deletion of the locus on chromosome 13 =
that=20
contains <SPAN class=3Di>miR-15a</SPAN> and <SPAN =
class=3Di>miR-16-1</SPAN> miRNA=20
genes, apoptosis is induced as a result of the exogenous re-expression =
of these=20
miRNAs. <SPAN class=3Di>MiR-15a</SPAN> and <SPAN =
class=3Di>miR-16-1</SPAN> interact=20
with the anti-apoptotic gene <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D596"><SPAN=20
class=3Di>BCL2</SPAN></A> when added back to these cells, however, a =
similar=20
response is not seen in 293 fetal kidney cells, which normally express =
<SPAN=20
class=3Di>miR-15a</SPAN>, <SPAN class=3Di>miR-16-1</SPAN> and BCL2 (Ref. =
<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B68">6=
8</A>).=20
Therefore, it is probable that the loss of <SPAN =
class=3Di>miR-15a</SPAN> and=20
<SPAN class=3Di>miR-16-1</SPAN> induces the overexpression of BCL2 in B =
cells,=20
giving rise to B-cell malignancies. In a different tissue, the =
overexpression of=20
<SPAN class=3Di>miR-15a</SPAN> and <SPAN class=3Di>miR-16-1</SPAN> might =
cause the=20
loss of expression of a tumour suppressor that is important for growth =
control=20
and/or apoptosis. In support of this hypothesis are reports that show =
that,=20
although<SPAN class=3Di>miR-15a</SPAN> and <SPAN =
class=3Di>miR-16-1</SPAN> are=20
downregulated in B lymphocytes from patients with CLL<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B23">2=
3</A></SUP>,=20
the same miRNAs are overexpressed in endocrine pancreatic tumours of=20
neuroectodermal origin<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B54">5=
4</A></SUP>.</P>
<P class=3Dnorm>The second perspective comes from the finding that the =
consistent=20
abnormal expression of the precursor miRNAs, but not the active =
molecules, can=20
be identified in various types of cancer<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B42">4=
2,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B47">4=
7,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B49">4=
9,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B52">5=
2,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B53">5=
3</A></SUP>.=20
Yanaihara <SPAN class=3Di>et al</SPAN>. found that in their 43 miRNA =
gene=20
signature, seven precursor miRNAs were differentially expressed in =
matched lung=20
cancer versus normal lung tissue. In addition, Jiang <SPAN class=3Di>et=20
al</SPAN>., using a real-time PCR method specifically designed for =
precursor=20
profiling<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B42">4=
2</A></SUP>,=20
found significant variations in the expression of nine precursors in a =
panel of=20
32 cancer cell lines<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B69">6=
9</A></SUP>.=20
These data raise the possibility that the 'non-active' part of the miRNA =

molecule could have 'independent' and as yet unknown functions that =
could be=20
important in tumorigenesis. Putative interaction partners might be the=20
RNA-binding proteins (such as the heterogenous nuclear =
ribonucleoproteins,=20
hnRNPs), a class of proteins that are abnormally expressed in all types =
of human=20
cancers<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B70">7=
0</A></SUP>.=20
These proteins bind RNA molecules to regulate their stability, and =
therefore it=20
is possible that in the sequence of several precursor miRNAs such=20
hnRNP-interacting motifs exist. However, there are no data so far that =
directly=20
attribute regulatory function to a miRNA precursor.</P>
<H4 class=3Dnorm id=3DCauses-of-abnormal-miRNA-expression>Causes of =
abnormal miRNA=20
expression</H4>
<P class=3Dnorm>The causes of the widespread disruption of miRNA =
expression in=20
tumour cells are only partially known and, very probably, various =
abnormalities=20
in each tumour could contribute to the global miRNA-expression profile. =
So far,=20
at least three different mechanisms (that could function independently =
or=20
together) have been described. Such alterations correlate with and could =
explain=20
the abnormal expression of specific miRNA genes.</P>
<P class=3Dnorm><B><I>The location of miRNAs at cancer-associated =
genomic regions=20
(CAGRs)</I></B>. Soon after the identification of hundreds of new =
members of the=20
miRNA family, it was shown that more than half of the known human miRNAs =
reside=20
in particular genomic regions that are prone to alteration in cancer=20
cells<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B71">7=
1</A></SUP>.=20
Such regions include minimal regions of LOH, which are thought to =
harbour=20
tumour-suppressor genes, minimal regions of amplification, which might =
contain=20
oncogenes, common breakpoint regions in or near possible oncogenes or=20
tumour-suppressor genes and fragile sites (FRA). FRA are preferential =
sites of=20
sister-chromatid exchange, translocation, deletion, amplification or =
integration=20
of plasmid DNA, and tumour-associated viruses such as human papilloma =
virus=20
(HPV). Of note, miRNA loci were significantly associated with insertion =
sites of=20
tumorigenic HPV strains linked to endometrial cancers, leading to the=20
possibility that viral insertions in the human genome might disturb =
small=20
ncRNAs<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B71">7=
1</A></SUP>.</P>
<P class=3Dnorm>Several reports show that this computationally =
identified=20
association is significant for miRNA expression. Zhang <SPAN =
class=3Di>et=20
al</SPAN>. showed, by using high-resolution array comparative genomic=20
hybridization (aCGH), that the miRNA loci have a high frequency of =
genomic=20
alteration in human cancers<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B72">7=
2</A></SUP>.=20
Furthermore, about 75% of the miRNAs analysed showed concordance between =
mature=20
miRNA levels and DNA copy number, and, importantly, their genomic data =
were in=20
agreement (81% concordance for amplified and/or overexpressed miRNAs, =
and 60%=20
concordance for deleted and/or downregulated miRNAs, respectively) with =
the=20
expression data published with an independent set of breast cancers by =
Iorio=20
<SPAN class=3Di>et al</SPAN><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B50">5=
0</A></SUP>.=20
Other examples of concordance by two independent reports, involve two =
miRNA=20
clusters located at chromosome 13 (<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#f3">Fi=
g.=20
3</A>). The cluster <SPAN class=3Di>miR-15a=96miR-16-1</SPAN>, located =
at 13q14.3 in=20
a region deleted in B-cell chronic lymphocytic leukaemia and pituitary =
adenomas=20
was shown by northern blots to be downregulated in most patients with =
these=20
tumours<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B23">2=
3,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B73">7=
3</A></SUP>.=20
The cluster <SPAN class=3Di>miR-17=9692</SPAN>, located at chromosome =
13q31, in a=20
region amplified in B-cell lymphomas and lung cancers, was found to be=20
overexpressed using microarray studies by He <SPAN class=3Di>et =
al</SPAN>.<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B59">5=
9</A></SUP>,=20
and by Hayashita and colleagues and Tagawa and Seto using northern blot =
analyses=20
in lung cancers and malignant lymphomas, respectively<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B74">7=
4,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B75">7=
5</A></SUP>.</P>
<DIV class=3Dfigure-table id=3Df3>
<H5 class=3Dnorm><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F3.html"=
>Figure=20
3<SPAN class=3Ddivider> | </SPAN>Chromosomal alterations at microRNA=20
loci.</A></H5><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F3.html"=
><IMG=20
class=3Dthumb=20
alt=3D"Figure 3 : Chromosomal alterations at microRNA loci. =
Unfortunately we are unable to provide accessible alternative text for =
this. If you require assistance to access this image, or to obtain a =
text description, please contact npg@nature.com"=20
src=3D"http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f3.jpg"></=
A>
<P>The main chromosomal alterations at microRNA (miRNA) loci, loss of=20
heterozygosity and amplification, are identified at two separate regions =
of=20
chromosome 13. <SPAN class=3Db>a</SPAN> | Shows the 13q14.3 deletion =
found in=20
chronic lymphocytic leukaemia (CLL) as described in Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B23">2=
3</A>.=20
The downregulation of <SPAN class=3Di>miR-15a</SPAN> and <SPAN=20
class=3Di>miR-16-1</SPAN> induces overexpression of the anti-apoptotic =
BCL2=20
protein in leukaemia cells<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B68">6=
8</A></SUP>.=20
The genomic regions are not drawn to scale, and the cluster on 13q13 is=20
simplified. The functional consequences are shown on the right of the =
figure.=20
<SPAN class=3Db>b</SPAN> | Shows the 13q13 amplification identified in =
high-grade=20
lymphomas, as described in Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B74">7=
4</A>.=20
The functional consequences are presented on the right side of the =
figure.The=20
overexpression of <SPAN class=3Di>miR-17-5p</SPAN> and <SPAN=20
class=3Di>miR-20a</SPAN> from the same cluster induces the =
downregulation of the=20
transcription factor E2F1. It was also shown that the <SPAN =
class=3Di>MYC</SPAN>=20
oncogene increases the expression of the <SPAN =
class=3Di>miR-17=9692</SPAN> cluster=20
and activates E2F1 (Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B67">6=
7</A>),=20
and that the MYC-activated cluster increases tumour angiogenesis<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B113">=
113</A></SUP>.=20
Therefore, the overexpression of the <SPAN class=3Di>miR-17=9692</SPAN> =
cluster is=20
correlated with hyperproliferation, the blocking of apoptosis and=20
neovascularisation. The arrows and the bars represent stimulatory and =
inhibitory=20
signals, respectively. Orf, open reading frame.</P>
<UL class=3Doptions>
  <LI class=3Dhigh-res><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F3.html"=
>High=20
  resolution image and legend (32 <ABBR title=3DKilobyte>KB</ABBR>) </A>
  <LI class=3Dfti><A title=3D"View a list of all figures and tables in =
this article"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_ft.html"=
>Figures=20
  and tables index</A>
  <LI class=3Dpowerpoint><A class=3Ddownload-pp=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/slides/nrc1997-pf3.ppt">=
Download=20
  Power<SPAN class=3Dhidden> </SPAN>Point slide (240 <ABBR=20
  title=3DKilobyte>KB</ABBR>) </A></LI></UL><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV><BR class=3Dclear>
<P class=3Dnorm><B><I>Epigenetic regulation of miRNA expression</I></B>. =
DNA=20
hypomethylation, CpG island hypermethylation and histone-modification =
losses=20
represent epigenetic markers of malignant transformation<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B76">7=
6</A></SUP>.=20
Therefore, several groups have investigated whether such events also =
affect=20
miRNA expression. Scott <SPAN class=3Di>et al</SPAN>. showed that in =
breast cancer=20
cells histone deacetylase inhibition is followed by the extensive and =
rapid=20
alteration of miRNA levels<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B77">7=
7</A></SUP>.=20
Furthermore, Saito <SPAN class=3Di>et al</SPAN>. found that the combined =
treatment=20
of human bladder cancer cells with 5-aza-2'-deoxycytidine (5-Aza-CdR) =
and the=20
histone deacetylase (HDAC) inhibitor 4-phenylbutyric acid (PBA) has a=20
significant effect on the expression of miRNAs<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B78">7=
8</A></SUP>.=20
Seventeen miRNAs (out of 313 screened by a microarray assay) were =
upregulated=20
more than threefold, and <SPAN class=3Di>miR-127</SPAN> was the most=20
differentially expressed. This miRNA is located in a CpG island at =
chromosome=20
14q32, a region that is involved in several types of translocations =
identified=20
in haematological cancers and deleted by LOH in solid tumours<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B71">7=
1</A></SUP>.=20
Furthermore, the combined treatment was accompanied by a decrease in DNA =

methylation and an increase in active histone markers around the =
transcription=20
start site of <SPAN class=3Di>miR-127</SPAN>. The investigators showed =
that <SPAN=20
class=3Di>miR-127</SPAN> can translationally repress the transcription =
of the=20
zinc-finger repressor <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D604"><SPAN=20
class=3Di>BCL6</SPAN></A> (Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B78">7=
8</A>).=20
Therefore, the induction of <SPAN class=3Di>miR-127</SPAN> by 5-Aza-CdR =
and PBA=20
treatment in cancer cells might have an anticancer effect by =
downregulating=20
anti-apoptotic factors, such as <SPAN class=3Di>BCL6</SPAN>, and =
inducing=20
apoptosis<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B78">7=
8</A></SUP>.</P>
<P class=3Dnorm>The effects of DNA demethylation and histone =
deacetylation on=20
miRNA expression could be tissue-specific, as the treatment of non-small =
cell=20
lung cancer (NSCLC) cells with demethylating agents and/or HDAC =
inhibitors does=20
not have a significant influence on miRNA expression<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B36">3=
6,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B53">5=
3</A></SUP>.=20
Supporting this assumption is the fact that <SPAN =
class=3Di>miR-127</SPAN> was not=20
found to be expressed in normal lung cells by microarray analysis<SUP><A =

href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B39">3=
9</A></SUP>,=20
and was not differentially expressed between cancerous and non-cancerous =
lung=20
tissue<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B53">5=
3</A></SUP>.</P>
<P class=3Dnorm><B><I>Abnormalities in miRNA-processing genes and=20
proteins</I></B>. The protein machinery that is involved in the =
biogenesis of=20
miRNAs is complex. Theoretically, alterations of these proteins (for a=20
comprehensive description see Ref. <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B34">3=
4</A>)=20
should have dramatic effects on miRNA expression. In fact, it was shown =
that a=20
failure of the Drosha processing step could explain the downregulation =
of miRNAs=20
observed in primary tumours<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B79">7=
9</A></SUP>.=20
Furthermore, in a large study of patients with NSCLC, Karube <SPAN =
class=3Di>et=20
al</SPAN>. found that the expression levels of Dicer, but not Drosha, =
were=20
reduced in a fraction of lung cancers. This correlated with reduced=20
post-operative survival and poor tumour differentiation status, both of =
which=20
are associated with a poor prognosis<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B80">8=
0,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B81">8=
1</A></SUP>.=20
A similar correlation with reduced survival in patients with NSCLC was =
found for=20
the expression of <SPAN class=3Di>miR-155</SPAN> and <SPAN =
class=3Di>let-7</SPAN>=20
(Refs <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B53">5=
3</A>,<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B82">8=
2</A>).=20
These results suggest that patient survival could be a consequence of =
both=20
aberrant miRNA processing and aberrant expression. The conditional =
knockout=20
Dicer mouse has developmental defects, including lung epithelium=20
abnormalities<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B81">8=
1,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B83">8=
3</A></SUP>,=20
but no reports on tumour formation are available, and Dicer-deficient =
embryonic=20
stem cells injected into nude mice do not form tumours<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B84">8=
4</A></SUP>.</P>
<P class=3Dnorm>The influence of genetic abnormalities in =
small-RNA-processing=20
proteins could have a more significant influence than is recognized at =
present.=20
Recently, a new class of germline-specific small ncRNAs (26=9631 =
nucleotides=20
long), named PIWI-interacting RNAs (piRNAs), was discovered and found to =
bind=20
the testis-specific murine PIWI protein orthologues<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B85">8=
5,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B86">8=
6,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B87">8=
7,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B88">8=
8,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B89">8=
9</A></SUP>.=20
Intriguingly, the human homologue of this subgroup of the Argonaute =
proteins,=20
named <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D9271">HIWI</=
A>,=20
is located in the genomic region 12q24.33 that is genetically linked =
with the=20
development of testicular germ-cell tumours in adolescents and adults. =
In=20
addition, <SPAN class=3Di>HIWI</SPAN> is overexpressed in most =
testicular=20
seminomas analysed so far<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B90">9=
0</A></SUP>.=20
The expression of <SPAN class=3Di>HIWI</SPAN> in human gastric cancer is =

associated with proliferating cells<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B91">9=
1</A></SUP>.=20
These correlations raise the possibility that piRNAs could represent =
another=20
example of cancer-altered small ncRNAs, specifically in relation to PIWI =

overexpression.</P>
<H4 class=3Dnorm id=3DMiRNA-profiling-as-a-new-clinical-tool>MiRNA =
profiling as a=20
new clinical tool</H4>
<P class=3Dnorm>As active players in important human oncogenic =
signalling=20
pathways, miRNAs should affect cancer diagnosis and prognosis (<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#t1">Ta=
ble=20
1</A>). As discussed above, several reports have already shown this for =
several=20
tumour types<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B49">4=
9,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B50">5=
0,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B62">6=
2</A></SUP>.=20
But other reports indicate that miRNA profiles can be used to diagnose =
tumour=20
types that cannot be determined on the basis of tumour biopsy =
samples.</P>
<P class=3Dnorm><B><I>MiRNA profiling as a diagnostic tool</I></B>. =
Metastatic=20
cancer of unknown primary site (CUP) is one of the 10 most frequent =
cancer=20
diagnoses worldwide, and constitutes 3=965% of all human =
malignancies<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B92">9=
2</A></SUP>.=20
Patients with CUP present with metastases (late-stage disease) without =
an=20
established primary tumour (that is, a site at which the tumour has =
initially=20
developed and from which it has metastasized). The study of Lu <SPAN =
class=3Di>et=20
al</SPAN>. produces an important advance in the diagnosis of this =
peculiar type=20
of cancer. Analysing 17 poorly differentiated tumours with =
non-diagnostic=20
histological appearance, they showed that the miRNA-based classifier was =
much=20
better at establishing the correct diagnosis of the samples than the =
mRNA=20
classifier<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B41">4=
1</A></SUP>.=20
This result is exciting =97 profiling a few hundred miRNAs has a much =
better=20
predictive power for CUP diagnosis than profiling several tens of =
thousands of=20
mRNAs. As miRNA expression changes with differentiation, the poorly=20
differentiated tumours have lower global expression levels of miRNAs =
compared=20
with well-differentiated tumours from control groups<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B41">4=
1</A></SUP>.=20
The reduced expression levels of miRNAs in poorly differentiated tumours =
is=20
probably why miRNA profiling is effective in the diagnosis of CUP.</P>
<P class=3Dnorm>CLL is the most common adult leukaemia in the Western =
world<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B93">9=
3,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B94">9=
4</A></SUP>.=20
During its natural history, this indolent disease can evolve into an =
aggressive=20
type of lymphoma and/or leukaemia, including <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html#df=
5">Richter</A>=20
syndrome<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B95">9=
5</A></SUP>.=20
Furthermore, as the prognosis of most cases of CLL is relatively good, =
treatment=20
after diagnosis is started only if poor prognostic markers are =
evident<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B96">9=
6</A></SUP>.=20
Few such markers have been found, but those that have include high =
expression=20
levels of the 70 kDa zeta-associated protein (<A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D7535">ZAP70<=
/A>)=20
and an absence of mutations in the immunoglobulin heavy-chain =
variable-region=20
gene (<SPAN class=3Di>IgV<SUB>H</SUB></SPAN>). By performing a =
miRNA-profiling=20
screen on 144 patients with CLL, a unique signature of 13 miRNAs (out of =
the 190=20
analysed) was shown to differentiate cases on the basis of a good or bad =

prognosis, or on the presence or absence of disease progression<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B35">3=
5</A></SUP>.=20
Among them, <SPAN class=3Di>miR-16-1</SPAN> and <SPAN =
class=3Di>miR-15a</SPAN> were=20
expressed at lower levels in patients with a good prognosis, in =
agreement with=20
early reports that 13q14.3 genomic deletions at the locus that harbours =
these=20
genes correlate with a favourable course of the disease<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B97">9=
7</A></SUP>.=20
Among the genes found to be downregulated in the group of patients with =
a bad=20
prognosis were members of the <SPAN class=3Di>miR-29</SPAN> family. This =
could be=20
explained by the recent findings that <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D8115"><SPAN =

class=3Di>TCL1</SPAN></A>, an oncogene that is overexpressed in CLL =
cells from=20
patients with aggressive disease<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B98">9=
8</A></SUP>,=20
is a target of <SPAN class=3Di>miR-29</SPAN> genes (Y. Pekarsky, =
unpublished=20
observations). Therefore, these findings support a model in which two =
different=20
molecular types of CLL with opposite clinical behaviours exist: one with =
a good=20
prognosis and slow disease progression characterized by deletions of =
chromosome=20
13q14.3 and low levels of <SPAN class=3Di>miR-15a</SPAN> and <SPAN=20
class=3Di>miR-16-1</SPAN>, and a second that is aggressive and prone to =
develop=20
Richter syndrome, characterized by low levels of expression of <SPAN=20
class=3Di>miR-29</SPAN> genes and high expression levels of TCL1 =
protein. As <SPAN=20
class=3Di>BCL2</SPAN> is consistently overexpressed in CLL =
samples<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B99">9=
9</A></SUP>,=20
<SPAN class=3Di>miR-15a</SPAN> and <SPAN class=3Di>miR-16-1</SPAN> might =
have=20
additional targets important for progression; furthermore, other =
mechanisms of=20
BCL2 deregulation (such as the minority of cases that have a BCL2=20
translocation<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B100">=
100</A></SUP>),=20
and other interacting miRNAs might be involved.</P>
<P class=3Dnorm><B><I>MiRNA profiling as a prognostic tool</I></B>. Lung =
cancer is=20
the leading cause of death from cancer in males worldwide<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B101">=
101</A></SUP>.=20
Therefore, the identification of new prognostic markers (markers that =
correlate=20
with disease evolution) could be a significant advance for the =
identification of=20
patients that would benefit from more aggressive therapy. In <A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html#df=
6">univariate=20
analyses</A>, the expression of both <SPAN class=3Di>miR-155</SPAN> =
(high levels)=20
and <SPAN class=3Di>let-7a-2</SPAN> (low levels)has been shown to =
correlate with=20
poor survival in 104 United States patients with lung cancer; by =
multivariate=20
analyses the expression of <SPAN class=3Di>miR-155</SPAN> also =
correlated with a=20
poor prognosis when all clinical variables were considered =
together<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B53">5=
3</A></SUP>.=20
In an independent study of 143 Japanese patients with lung cancer, =
reduced <SPAN=20
class=3Di>let-7</SPAN> expression was found to significantly correlate =
with a=20
shorter survival time after potentially curative surgery<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B82">8=
2</A></SUP>.=20
In both studies, about two thirds of the cases were adenocarcinomas (a =
type of=20
NSCLC). By multivariate analyses, a low expression level of <SPAN=20
class=3Di>let-7</SPAN> was an independent prognostic factor for the =
stage of the=20
disease, and correlated with significantly shorter survival<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B82">8=
2</A></SUP>.=20
In a meta-analysis of 29 studies that investigated the role of Ras =
oncogenes in=20
the survival of patients with NSCLC cancers, Ras overexpression was =
associated=20
with a reduced survival time<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B102">=
102</A></SUP>.=20
As <SPAN class=3Di>let-7</SPAN> negatively regulates Ras<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B58">5=
8</A></SUP>,=20
these results show the existence of a link between <SPAN =
class=3Di>let-7</SPAN>,=20
Ras expression and the life expectancy of patients with lung cancer.</P>
<H4 class=3Dnorm id=3DA-miRNA-perspective-in-cancer-therapy>A miRNA =
perspective in=20
cancer therapy</H4>
<P class=3Dnorm>The potential for using miRNAs in cancer is now being =
explored.=20
The theoretical rationale is based on the fact that miRNAs are natural =
antisense=20
interactors that regulate many genes involved in eukaryotic survival and =

proliferation. Also, miRNA-expression profiles have been shown to change =
during=20
treatment with gemcitabine, and the modulation of some miRNAs (including =
the=20
overexpression of <SPAN class=3Di>miR-21</SPAN>) increases the =
sensitivity of=20
cholangiocarcinoma tumour cells to this chemotherapeutic agent <SPAN =
class=3Di>in=20
vitro</SPAN><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B56">5=
6</A></SUP>.=20
Such results offer the experimental bases for the use of miRNAs as =
therapeutic=20
targets. The development of modified miRNA molecules with longer <SPAN=20
class=3Di>in vivo</SPAN> half lives and efficiency, such as the locked =
nucleic=20
acid (LNA)-modified oligonucleotides<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B103">=
103</A></SUP>,=20
the anti-miRNA oligonucleotides (AMOs)<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B104">=
104</A></SUP>=20
and the '<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html#df=
7">antagomirs</A>'<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B105">=
105</A></SUP>=20
is the first step towards bringing these fundamental research advances =
into=20
medical practice. Future <SPAN class=3Di>in vivo</SPAN> experiments of =
miRNA=20
transgenics and knockouts will offer valuable information about safety =
and=20
efficacy.</P>
<H4 class=3Dnorm id=3DA-new-form-of-cancer-predisposition>A new form of =
cancer=20
predisposition?</H4>
<P class=3Dnorm>The expression levels of many genes show abundant =
natural=20
variation in species that range from yeasts to humans. This trait, =
termed 'gene=20
expression phenotype' has an inherited component, which was shown to be =
present=20
through familial aggregation studies in humans and simple segregation =
studies in=20
yeast<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B106">=
106,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B107">=
107</A></SUP>.=20
Cheung <SPAN class=3Di>et al</SPAN>., using microarray studies of human=20
lymphoblastoid cells, identified a set of genes with a high degree of =
variation=20
in expression levels between individuals<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B106">=
106</A></SUP>.=20
The variation in expression among unrelated individuals was 3=9611 times =
greater=20
than between monozygotic twins, and the variance among siblings was =
2=965 times=20
greater than that between twins. These data suggest that genetic =
differences=20
among individuals contribute to the variation in expression phenotype =
for some=20
genes<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B106">=
106</A></SUP>.=20
Because of the particular way in which miRNAs function =97 by targeting =
a number=20
of functionally important protein-coding genes =97 we propose that =
variations in=20
the expression and/or sequence of miRNAs, if inherited in the germline, =
could be=20
important in cancer predisposition by affecting the levels of expression =
of=20
tumour-suppressor genes or oncogenes (<A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/box/nrc1997_BX1.html">Bo=
x1</A>,=20
<A =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#f4">Fi=
g.=20
4</A>).</P>
<DIV class=3Dfigure-table id=3Df4>
<H5 class=3Dnorm><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F4.html"=
>Figure=20
4<SPAN class=3Ddivider> | </SPAN>The involvement of microRNAs in cancer=20
predisposition.</A></H5><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F4.html"=
><IMG=20
class=3Dthumb=20
alt=3D"Figure 4 : The involvement of microRNAs in cancer predisposition. =
Unfortunately we are unable to provide accessible alternative text for =
this. If you require assistance to access this image, or to obtain a =
text description, please contact npg@nature.com"=20
src=3D"http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f4.jpg"></=
A>
<P>MicroRNA (miRNA) alterations could predispose to cancer development. =
Here we=20
propose a model in which structural and/or expression abnormalities of =
miRNAs in=20
the germline could represent an inherited predisposing event (blue =
person). For=20
simplicity, we present only the situation of gene deletion, but all =
other types=20
of loss-of-function or gain-of-function mutations described for =
protein-coding=20
genes can be involved in the disruption of miRNA expression. To develop =
a=20
malignant tumour, a second genetic event has to occur in a somatic cell =
(green=20
people): this can be an alteration in a protein-coding gene, or a 'hit' =
in=20
another miRNA (shown here as amplification). The consequences are on the =
levels=20
of expression of various target mRNAs: the overexpression of target =
oncogenes=20
(red protein) in the case of miRNA deletion, and the downregulation of =
target=20
tumour-suppressor genes in the case of miRNA amplification (purple =
protein).</P>
<UL class=3Doptions>
  <LI class=3Dhigh-res><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_F4.html"=
>High=20
  resolution image and legend (44 <ABBR title=3DKilobyte>KB</ABBR>) </A>
  <LI class=3Dfti><A title=3D"View a list of all figures and tables in =
this article"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_ft.html"=
>Figures=20
  and tables index</A>
  <LI class=3Dpowerpoint><A class=3Ddownload-pp=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/slides/nrc1997-pf4.ppt">=
Download=20
  Power<SPAN class=3Dhidden> </SPAN>Point slide (251 <ABBR=20
  title=3DKilobyte>KB</ABBR>) </A></LI></UL><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV><BR class=3Dclear>
<DIV class=3D"figure-table box" id=3Dbx1>
<H5 class=3Dnorm><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/box/nrc1997_BX1.html">Bo=
x 1 |=20
Putative mechanisms of cancer predisposition by microRNA =
alterations</A></H5>
<UL class=3Doptions>
  <LI class=3Dfti><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/box/nrc1997_BX1.html">Fu=
ll box=20
  </A></LI></UL></DIV>
<P class=3Dnorm>A significant proportion of patients with cancer are =
members of=20
kindreds that develop the same type of cancer without a specific =
Mendelian=20
inheritance, or that develop different types of cancers. This type of =
familial=20
predisposition represents an important medical problem, and the =
identification=20
of the predisposing gene(s) could offer early diagnosis and potential =
cancer=20
prevention. Despite various efforts, the basis of this type of =
predisposition is=20
largely unknown. A clear example comes from cases of familial CLL: =
although rare=20
mutations in the ataxia telangiectasia mutated (<A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D472"><SPAN=20
class=3Di>ATM</SPAN></A>)<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B108">=
108,=20
</A></SUP><SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B109">=
109</A></SUP>=20
or <A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D115761"><SPA=
N=20
class=3Di>ARLTS1</SPAN></A> genes<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B110">=
110</A></SUP>,=20
as well as in the <SPAN class=3Di>miR-15a</SPAN> and <SPAN =
class=3Di>miR-16-1</SPAN>=20
transcripts<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B35">3=
5</A></SUP>,=20
have been identified in families with two or more members with CLL, the =
culprit=20
genes are still unknown for most cases.</P>
<P class=3Dnorm>In the United States, prostate cancer affects =
African-American=20
males at a rate that is disproportionate with the number of White males=20
diagnosed with the disease, and genetics could have an important role, =
but no=20
target genes have been identified after decades of research<SUP><A=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#B111">=
111</A></SUP>.=20
We analysed miRNA expression levels in a pilot set of 18 samples of =
normal=20
prostate tissue derived from two distinct human populations, 10 =
Caucasians from=20
the United States and 8 African-Americans collected by the US National =
Cancer=20
Institute Cooperative Prostate Cancer Tissue Resources. Using two =
different=20
methods of microarray analyses, PAM and SAM, we identified both =
significantly=20
overexpressed and downregulated miRNAs in the African-American =
individuals=20
compared with the Caucasian individuals (G.A.C., C.M.C., S. Volinia and =
S. Ambs,=20
unpublished data). The list of miRNAs that are at least three times=20
differentially expressed includes <SPAN class=3Di>miR-301</SPAN>, <SPAN=20
class=3Di>miR-219</SPAN>, <SPAN class=3Di>miR-26a</SPAN>, <SPAN=20
class=3Di>miR-1b-1</SPAN> and <SPAN class=3Di>miR-30c-1</SPAN>. =
Therefore, different=20
human populations show variations in the global expression pattern of =
miRNAs=20
expressed in a specific tissue. Whether such variations represent an =
inherited=20
family trait remains an open question that should be solved by future =
large=20
studies aimed at assessing the global miRNA expression profiles in =
cancers with=20
high heritability, such as familial breast cancers or familial CLLs.</P>
<H4 class=3Dnorm id=3DIn-conclusion>In conclusion</H4>
<P class=3Dnorm>The question of whether miRNAs represent the 'dark side' =
of cancer=20
predisposition remains to be answered, but there is no doubt that these=20
'strangers' in the genomic galaxy are involved in the regulation of =
pathways=20
that are involved in the development and progression of many types of=20
tumour.</P></DIV>
<DIV id=3Dlinks>
<H4>Links</H4>
<H5>DATABASES</H5>
<H6><A href=3D"http://www.cancer.gov/">National Cancer =
Institute</A></H6>
<UL>
  <LI class=3Dfirst><A=20
  href=3D"http://www.cancer.gov/cancertopics/types/breast">breast =
cancer</A>=20
  <LI><A =
href=3D"http://www.cancer.gov/cancertopics/types/colon-and-rectal">colon =

  cancer</A>=20
  <LI><A =
href=3D"http://www.cancer.gov/cancertopics/types/leukemia">CLL</A>=20
  <LI><A =
href=3D"http://www.cancer.gov/cancertopics/types/isletcell">endocrine=20
  pancreatic cancer</A>=20
  <LI><A =
href=3D"http://www.cancer.gov/cancertopics/types/liver">hepatocellular=20
  carcinoma</A>=20
  <LI><A href=3D"http://www.cancer.gov/cancertopics/types/lung">lung =
cancer</A>=20
  <LI><A =
href=3D"http://www.cancer.gov/cancertopics/types/thyroid">thyroid=20
  papillary carcinoma</A> </LI></UL>
<H6><A=20
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene">Entrez-G=
ene</A></H6>
<UL>
  <LI class=3Dfirst><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D29102">Drosh=
a</A>=20

  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D23405">Dicer=
</A>=20

  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D613"><SPAN=20
  class=3Di>BCR</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D25"><SPAN=20
  class=3Di>ABL</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D2120"><SPAN =

  class=3Di>TEL</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D861"><SPAN=20
  class=3Di>AML1</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D4297"><SPAN =

  class=3Di>MLL</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D5728"><SPAN =

  class=3Di>PTEN</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D3265"><SPAN =

  class=3Di>HRAS</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D7157"><SPAN =

  class=3Di>TP53</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D4609">MYC</A=
>=20

  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D114614"><SPA=
N=20
  class=3Di>BIC</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D596"><SPAN=20
  class=3Di>BCL2</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D604"><SPAN=20
  class=3Di>BCL6</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D9271">HIWI</=
A>=20

  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D7535">ZAP70<=
/A>=20

  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D8115"><SPAN =

  class=3Di>TCL1</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D472"><SPAN=20
  class=3Di>ATM</SPAN></A>=20
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=3Dgene&amp;amp;c=
md=3DRetrieve&amp;amp;dopt=3Dfull_report&amp;amp;list_uids=3D115761"><SPA=
N=20
  class=3Di>ARLTS1</SPAN></A> </LI></UL>
<H5>FURTHER INFORMATION</H5>
<UL>
  <LI class=3Dfirst><A =
href=3D"http://microrna.sanger.ac.uk/sequences/">miRBase</A>=20
  <LI><A href=3D"http://www.diana.pcbi.upenn.edu/tarbase.html">DIANA =
Tarbase</A>=20
  <LI><A href=3D"http://www.ebi.ac.uk/miamexpress/">MIAME</A> =
</LI></UL></DIV>
<DIV id=3Dacknowledgements><A class=3Dbacktotop=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#top">T=
op<SPAN=20
class=3Dhidden> of page</SPAN></A>
<H3>Acknowledgements</H3>
<P class=3Dnorm>We want to thank the collaborators and young =
investigators who=20
contributed to the microRNA work done in our laboratories. C.M.C. is =
supported=20
by Program Project grants from the US National Cancer Institute, and =
G.A.C. is=20
supported by a Kimmel Foundation Scholar award and by the CLL Global =
Research=20
Foundation. We thank M. Negrini and M. Fabbri for their critical reading =
of the=20
manuscript, and thank A. Cimmino for assistance with the figures. We =
apologize=20
to many colleagues whose work was not cited owing to space =
limitations.</P>
<H4 class=3Dinline>Competing interests statement </H4>
<P class=3Dfollows-h4>The authors declare no competing financial=20
interests.</P></DIV>
<DIV id=3DReferences><A class=3Dbacktotop=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#top">T=
op<SPAN=20
class=3Dhidden> of page</SPAN></A>
<H3 class=3Dsectitle1>References</H3>
<OL class=3Dreferences>
  <LI id=3DB1>
  <P class=3Ddetails>Bishop, J. M. <SPAN class=3Datl>Molecular themes in =

  oncogenesis</SPAN>. <SPAN class=3Djtl>Cell</SPAN> <SPAN =
class=3Dvid>64</SPAN>,=20
  235=96248 (<SPAN class=3Dcite-month-year>1991</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/0092-8674(91)90636-D">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D1988146&amp;dopt=3DAbstract=
">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3DA1991EV33600004&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK3MXpvF=
WksQ%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D21136a86739aa=
5b81e328c779d6cabef">ChemPort</A></LI></UL>
  <LI id=3DB2>
  <P class=3Ddetails>Hunter, T. <SPAN class=3Datl>Cooperation between=20
  oncogenes</SPAN>. <SPAN class=3Djtl>Cell</SPAN> <SPAN =
class=3Dvid>64</SPAN>,=20
  249=96270 (<SPAN class=3Dcite-month-year>1991</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/0092-8674(91)90637-E">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D1988147&amp;dopt=3DAbstract=
">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3DA1991EV33600005&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK3MXpvF=
Wktg%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D8aff36e5f3cbb=
07cbda1961e9ea49e12">ChemPort</A></LI></UL>
  <LI id=3DB3>
  <P class=3Ddetails>Weinberg, R. A. <SPAN class=3Datl>Tumor suppressor=20
  genes</SPAN>. <SPAN class=3Djtl>Science</SPAN> <SPAN =
class=3Dvid>254</SPAN>,=20
  1138=961146 (<SPAN class=3Dcite-month-year>1991</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1126/science.1659741">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D1659741&amp;dopt=3DAbstract=
">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3DA1991GQ83400032&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK38Xls1=
CjsA%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dfcd2bee4f5898=
07035742f99fdea0fb1">ChemPort</A></LI></UL>
  <LI id=3DB4>
  <P class=3Ddetails>Furuno, M. <I>et al</I>. <SPAN class=3Datl>Clusters =
of=20
  internally primed transcripts reveal novel long noncoding RNAs</SPAN>. =
<SPAN=20
  class=3Djtl>PLoS Genet.</SPAN> <SPAN class=3Dvid>2</SPAN>, e37 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1371/journal.pgen.0020037">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16683026&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xk=
tFahtb4%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dc10c64ec19536=
34e754313586fd77794">ChemPort</A></LI></UL>
  <LI id=3DB5>
  <P class=3Ddetails>Lee, R. C., Feinbaum, R. L. &amp; Ambros, V. <SPAN=20
  class=3Datl>A short history of a short RNA</SPAN>. <SPAN =
class=3Djtl>Cell</SPAN>=20
  <SPAN class=3Dvid>S116</SPAN>, S89=96S92 (<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).<BR><B>The history of the first =
ever miRNA=20
  identification by Ambros's group.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/S0092-8674(04)00035-2">Article</A></LI>=
</UL>
  <LI id=3DB6>
  <P class=3Ddetails>Berezikov, E., Cuppen, E. &amp; Plasterk, R. H. =
<SPAN=20
  class=3Datl>Approaches to microRNA discovery</SPAN>. <SPAN =
class=3Djtl>Nature=20
  Genet.</SPAN> <SPAN class=3Dvid>38</SPAN>, (Suppl.) S2=96S7 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1038/ng1794">Article</A></LI></UL>
  <LI id=3DB7>
  <P class=3Ddetails>Lagos-Quintana, M., Rauhut, R., Lendeckel, W. &amp; =
Tuschl,=20
  T. <SPAN class=3Datl>Identification of novel genes coding for small =
expressed=20
  RNA</SPAN>. <SPAN class=3Djtl>Science</SPAN> <SPAN =
class=3Dvid>294</SPAN>, 853=96858=20
  (<SPAN class=3Dcite-month-year>2001</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1126/science.1064921">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D11679670&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000171851800047&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3MXo=
tVChtb8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D18bd99bcdb3df=
c3c0925bfbf907c102a">ChemPort</A></LI></UL>
  <LI id=3DB8>
  <P class=3Ddetails>Lau, N. C., Lim, L. P., Weinstein, E. G. &amp; =
Bartel, D. P.=20
  <SPAN class=3Datl>An abundant class of tiny RNAs with probable =
regulatory roles=20
  in <I>Caenorhabditis elegans</I></SPAN>. <SPAN =
class=3Djtl>Science</SPAN> <SPAN=20
  class=3Dvid>294</SPAN>, 858=96862 (<SPAN =
class=3Dcite-month-year>2001</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1126/science.1065062">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D11679671&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000171851800048&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3MXo=
tVChurw%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Db98d2023eb0fd=
6efe7243863af7c78dc">ChemPort</A></LI></UL>
  <LI id=3DB9>
  <P class=3Ddetails>Lee, R. C. &amp; Ambros, V. <SPAN class=3Datl>An =
extensive=20
  class of small RNAs in <I>Caenorhabditis elegans</I></SPAN>. <SPAN=20
  class=3Djtl>Science</SPAN> <SPAN class=3Dvid>294</SPAN>, 862=96864 =
(<SPAN=20
  class=3Dcite-month-year>2001</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1126/science.1065329">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D11679672&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000171851800049&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3MXo=
tVChu70%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dcf65ffd51f854=
75874e97908c893d148">ChemPort</A></LI></UL>
  <LI id=3DB10>
  <P class=3Ddetails>Ambros, V. <SPAN class=3Datl>The functions of =
animal=20
  microRNAs</SPAN>. <SPAN class=3Djtl>Nature</SPAN> <SPAN =
class=3Dvid>431</SPAN>,=20
  350=96355 (<SPAN class=3Dcite-month-year>2004</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature02871">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15372042&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000223864000051&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXn=
sFaiu7g%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D94e15bbc288bd=
8552fba2ed554ff8a09">ChemPort</A></LI></UL>
  <LI id=3DB11>
  <P class=3Ddetails>Bartel, D. P. <SPAN class=3Datl>MicroRNAs: =
genomics,=20
  biogenesis, mechanism, and function</SPAN>. <SPAN =
class=3Djtl>Cell</SPAN> <SPAN=20
  class=3Dvid>116</SPAN>, 281=96297 (<SPAN =
class=3Dcite-month-year>2004</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/S0092-8674(04)00045-5">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D14744438&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000188541700017&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXh=
tVals7o%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D4521b6b5e3402=
0d0bbfb5945b34f7bd9">ChemPort</A></LI></UL>
  <LI id=3DB12>
  <P class=3Ddetails>Pasquinelli, A. E., Hunter, S. &amp; Bracht, J. =
<SPAN=20
  class=3Datl>MicroRNAs: a developing story</SPAN>. <SPAN =
class=3Djtl>Curr. Opin.=20
  Genet. Dev.</SPAN> <SPAN class=3Dvid>15</SPAN>, 200=96205 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.gde.2005.01.002">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15797203&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000228496100011&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXi=
s1Klsr0%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D4b0535ff79112=
05e01627766a14d3947">ChemPort</A></LI></UL>
  <LI id=3DB13>
  <P class=3Ddetails>Kim, V. N. &amp; Nam, J. W. <SPAN =
class=3Datl>Genomics of=20
  microRNA</SPAN>. <SPAN class=3Djtl>Trends Genet.</SPAN> <SPAN=20
  class=3Dvid>22</SPAN>, 165=96173 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.tig.2006.01.003">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16446010&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000236534100007&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xh=
vVWitLw%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dd129816431a3f=
bda262df216e442efd4">ChemPort</A></LI></UL>
  <LI id=3DB14>
  <P class=3Ddetails>Harfe, B. D. <SPAN class=3Datl>MicroRNAs in =
vertebrate=20
  development</SPAN>. <SPAN class=3Djtl>Curr. Opin. Genet. Dev.</SPAN> =
<SPAN=20
  class=3Dvid>15</SPAN>, 410=96415 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.gde.2005.06.012">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15979303&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXm=
sVWnsLc%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D119e9cb9c8bc7=
c70b55d1b9cd1abecf9">ChemPort</A></LI></UL>
  <LI id=3DB15>
  <P class=3Ddetails>Bartel, D. P. &amp; Chen, C. Z. <SPAN =
class=3Datl>Micromanagers=20
  of gene expression: the potentially widespread influence of metazoan=20
  microRNAs</SPAN>. <SPAN class=3Djtl>Nature Rev. Genet.</SPAN> <SPAN=20
  class=3Dvid>5</SPAN>, 396=96400 (<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).<BR><B>An interesting perspective =
on how=20
  miRNAs influence gene expression.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nrg1328">Article</A></LI>=
</UL>
  <LI id=3DB16>
  <P class=3Ddetails>Rajewsky, N. <SPAN class=3Datl>MicroRNA target =
predictions in=20
  animals</SPAN>. <SPAN class=3Djtl>Nature Genet.</SPAN> (Suppl.), =
S8=96S13 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1038/ng1798">Article</A></LI></UL>
  <LI id=3DB17>
  <P class=3Ddetails>Lim, L. P. <I>et al</I>. <SPAN =
class=3Datl>Microarray analysis=20
  shows that some microRNAs downregulate large numbers of target =
mRNAs</SPAN>.=20
  <SPAN class=3Djtl>Nature</SPAN> <SPAN class=3Dvid>433</SPAN>, =
769=96773 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature03315">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15685193&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000227039200045&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tleqsLs%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Def6a22a5f8b7e=
967313cd37d5d945068">ChemPort</A></LI></UL>
  <LI id=3DB18>
  <P class=3Ddetails>Griffiths-Jones, S., Grocock, R. J., van Dongen, =
S., Bateman,=20
  A. &amp; Enright, A. J. <SPAN class=3Datl>miRBase: microRNA sequences, =
targets=20
  and gene nomenclature</SPAN>. <SPAN class=3Djtl>NAR</SPAN> Database =
Issue,=20
  D140=96D144 (<SPAN class=3Dcite-month-year>2006</SPAN>).<BR><B>A =
description of=20
  miRBase, the extensive database of all annotated miRNAs.</B></P>
  <LI id=3DB19>
  <P class=3Ddetails>Lim, L. P., Glasner, M. E., Yekta, S., Burge, C. B. =
&amp;=20
  Bartel, D. P. <SPAN class=3Datl>Vertebrate microRNA genes</SPAN>. =
<SPAN=20
  class=3Djtl>Science</SPAN> <SPAN class=3Dvid>299</SPAN>, 1540 (<SPAN=20
  class=3Dcite-month-year>2003</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1126/science.1080372">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D12624257&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000181367900027&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3sXj=
tFahtr8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D856e2d95cfb3b=
4003bab5b36f6862752">ChemPort</A></LI></UL>
  <LI id=3DB20>
  <P class=3Ddetails>Xie, X. <I>et al</I>. <SPAN class=3Datl>Systematic =
discovery of=20
  regulatory motifs in human promoters and 3' UTRs by comparison of =
several=20
  mammals</SPAN>. <SPAN class=3Djtl>Nature</SPAN> <SPAN =
class=3Dvid>434</SPAN>,=20
  338=96345 (<SPAN class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature03441">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15735639&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000227715100041&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXi=
t1yqsrk%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D9d23d18436e46=
0621e9b36a7f276bd30">ChemPort</A></LI></UL>
  <LI id=3DB21>
  <P class=3Ddetails>Berezikov, E. <I>et al</I>. <SPAN =
class=3Datl>Phylogenetic=20
  shadowing and computational identification of human microRNA =
genes</SPAN>.=20
  <SPAN class=3Djtl>Cell</SPAN> <SPAN class=3Dvid>120</SPAN>, 21=9624 =
(<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.cell.2004.12.031">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15652478&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000226365400007&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXo=
t1ChsQ%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Da4c653a5127=
9569bf1f8eb039f3abb92">ChemPort</A></LI></UL>
  <LI id=3DB22>
  <P class=3Ddetails>Bentwich, I. <I>et al</I>. <SPAN =
class=3Datl>Identification of=20
  hundreds of conserved and nonconserved human microRNAs</SPAN>. <SPAN=20
  class=3Djtl>Nature Genet.</SPAN> <SPAN class=3Dvid>37</SPAN>, =
766=96770 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/ng1590">Article</A></LI><=
/UL>
  <LI id=3DB23>
  <P class=3Ddetails>Calin, G. A. <I>et al</I>. <SPAN =
class=3Datl>Frequent deletions=20
  and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in =
chronic=20
  lymphocytic leukemia</SPAN>. <SPAN class=3Djtl>Proc. Natl Acad. Sci. =
USA</SPAN>=20
  <SPAN class=3Dvid>99</SPAN>, 15524=9615529 (<SPAN=20
  class=3Dcite-month-year>2002</SPAN>).<BR><B>The first demonstration of =
a link=20
  between miRNA genes and cancer.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.242606799">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D12434020&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3sXj=
vVOl&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D9c05d0211223de64483=
1cdcc411efd67">ChemPort</A></LI></UL>
  <LI id=3DB24>
  <P class=3Ddetails>McManus, M. T. <SPAN class=3Datl>MicroRNAs and =
cancer</SPAN>.=20
  <SPAN class=3Djtl>Semin. Cancer Biol.</SPAN> <SPAN =
class=3Dvid>13</SPAN>, 253=96258=20
  (<SPAN class=3Dcite-month-year>2003</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/S1044-579X(03)00038-5">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D14563119&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000184953400002&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3sXn=
tFykurY%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D17e7f8fd18ac6=
a322665f054d08286b1">ChemPort</A></LI></UL>
  <LI id=3DB25>
  <P class=3Ddetails>Berezikov, E. &amp; Plasterk, R. H. <SPAN =
class=3Datl>Camels=20
  and zebrafish, viruses and cancer: a microRNA update</SPAN>. <SPAN=20
  class=3Djtl>Hum. Mol. Genet.</SPAN> <SPAN class=3Dvid>14</SPAN>, =
R183=96R190 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1093/hmg/ddi271">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16244316&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000233006400004&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tFCjtL3L&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D62c91738211b475=
f95ff70ebdef23613">ChemPort</A></LI></UL>
  <LI id=3DB26>
  <P class=3Ddetails>Gregory, R. I. &amp; Shiekhattar, R. <SPAN =
class=3Datl>MicroRNA=20
  biogenesis and cancer</SPAN>. <SPAN class=3Djtl>Cancer Res.</SPAN> =
<SPAN=20
  class=3Dvid>65</SPAN>, 3509=963512 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-05-0298">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15867338&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000228656000002&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXj=
slGltb4%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Ddc3b030b7820d=
7fe1e6aba7ea2d3b3e8">ChemPort</A></LI></UL>
  <LI id=3DB27>
  <P class=3Ddetails>Croce, C. M. &amp; Calin, G. A. <SPAN =
class=3Datl>miRNAs,=20
  cancer, and stem cell division</SPAN>. <SPAN class=3Djtl>Cell</SPAN> =
<SPAN=20
  class=3Dvid>122</SPAN>, 6=967 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.cell.2005.06.036">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16009126&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000230839400004&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXm=
sFeitb8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D4773330edb0f0=
46048cdc9ee1649eafb">ChemPort</A></LI></UL>
  <LI id=3DB28>
  <P class=3Ddetails>Caldas, C. &amp; Brenton, J. D. <SPAN =
class=3Datl>Sizing up=20
  miRNAs as cancer genes</SPAN>. <SPAN class=3Djtl>Nature Med.</SPAN> =
<SPAN=20
  class=3Dvid>11</SPAN>, 712=96714 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nm0705-712">Article</A></=
LI></UL>
  <LI id=3DB29>
  <P class=3Ddetails>Calin, G. A. &amp; Croce, C. M. <SPAN=20
  class=3Datl>MicroRNA-cancer connection: the beginning of a new =
tale</SPAN>.=20
  <SPAN class=3Djtl>Cancer Res.</SPAN> <SPAN class=3Dvid>66</SPAN>, =
7390=967394 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-06-0800">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16885332&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000239483500003&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xn=
sFyrtL4%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D8f3015595a435=
616b5da98859ac66620">ChemPort</A></LI></UL>
  <LI id=3DB30>
  <P class=3Ddetails>Chen, C. Z. <SPAN class=3Datl>MicroRNAs as =
oncogenes and tumor=20
  suppressors</SPAN>. <SPAN class=3Djtl>N. Engl. J. Med.</SPAN> <SPAN=20
  class=3Dvid>353</SPAN>, 1768=961771 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1056/NEJMp058190">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16251533&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000232813000004&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tFKrtLjK&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D592f5cbe2f77ad0=
799150e84982f68cb">ChemPort</A></LI></UL>
  <LI id=3DB31>
  <P class=3Ddetails>Calin, G. A., Garzon, R., Cimmino, A., Fabbri, M. =
&amp;=20
  Croce, C. M. <SPAN class=3Datl>MicroRNAs and leukemias: how strong is =
the=20
  connection?</SPAN> <SPAN class=3Djtl>Leuk. Res.</SPAN> <SPAN=20
  class=3Dvid>30</SPAN>, 653=96655 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.leukres.2005.10.017">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16330098&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xi=
vValu7s%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D28f7c7eabd090=
5541313e2af6b8f651f">ChemPort</A></LI></UL>
  <LI id=3DB32>
  <P class=3Ddetails>Hwang, H. W. &amp; Mendell, J. T. <SPAN =
class=3Datl>MicroRNAs=20
  in cell proliferation, cell death, and tumorigenesis</SPAN>. <SPAN=20
  class=3Djtl>Br. J. Cancer.</SPAN> <SPAN class=3Dvid>94</SPAN>, =
776=96780 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/sj.bjc.6603023">Article</=
A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16495913&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xi=
s1GktLc%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D5f40bea4a8468=
9f100df73ec9ccacbe3">ChemPort</A></LI></UL>
  <LI id=3DB33>
  <P class=3Ddetails>Hammond, S. M. <SPAN class=3Datl>MicroRNAs as =
oncogenes</SPAN>.=20
  <SPAN class=3Djtl>Curr. Opin. Genet. Dev.</SPAN> <SPAN =
class=3Dvid>16</SPAN>, 4=969=20
  (<SPAN class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.gde.2005.12.005">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16361094&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000235435500002&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xl=
vVOhsA%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D73b2d98b6c2=
ac027dee60f2b8c02cc5d">ChemPort</A></LI></UL>
  <LI id=3DB34>
  <P class=3Ddetails>Esquela-Kerscher, A. &amp; Slack, F. J. <SPAN=20
  class=3Datl>Oncomirs- microRNAs with a role in cancer</SPAN>. <SPAN=20
  class=3Djtl>Nature Rev. Cancer</SPAN> <SPAN class=3Dvid>6</SPAN>, =
259=96269 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).<BR><B>An excellent review on the =
role of=20
  miRNAs in human cancers.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nrc1840">Article</A></LI>=
</UL>
  <LI id=3DB35>
  <P class=3Ddetails>Calin, G. A. <I>et al</I>. <SPAN class=3Datl>A =
unique microRNA=20
  signature associated with prognostic factors and disease progression =
in B cell=20
  chronic lymphocytic leukemia</SPAN>. <SPAN class=3Djtl>N. Engl. J. =
Med.</SPAN>=20
  <SPAN class=3Dvid>352</SPAN>, 1667=961676 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).<BR><B>The first evidence of =
germline and=20
  somatic mutations in miRNA genes.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1056/NEJMoa042280">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15843669&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXj=
sFCltrk%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D230be8107d108=
abf5c51a19854f5e90d">ChemPort</A></LI></UL>
  <LI id=3DB36>
  <P class=3Ddetails>Diederichs, S. &amp; Haber, D. A. <SPAN =
class=3Datl>Sequence=20
  variations of microRNAs in human cancer: alterations in predicted =
secondary=20
  structure do not affect processing</SPAN>. <SPAN class=3Djtl>Cancer =
Res.</SPAN>=20
  <SPAN class=3Dvid>66</SPAN>, 6097=966104 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-06-0537">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16778182&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xl=
vVSks7k%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dff0c19fad31de=
bbc8315024b5211dfb7">ChemPort</A></LI></UL>
  <LI id=3DB37>
  <P class=3Ddetails>He, H. <I>et al</I>. <SPAN class=3Datl>The role of =
microRNA=20
  genes in papillary thyroid carcinoma</SPAN>. <SPAN class=3Djtl>Proc. =
Natl Acad.=20
  Sci. USA</SPAN> <SPAN class=3Dvid>102</SPAN>, 19075=9619080 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).<BR><B>The first report about =
germline=20
  alterations in miRNA-recognition sequences located in a messenger =
RNA.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0509603102">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16365291&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xi=
vV2htA%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D7b3670ad3e7=
ea491f865496ce1b87256">ChemPort</A></LI></UL>
  <LI id=3DB38>
  <P class=3Ddetails>Abelson, J. F. <I>et al</I>. <SPAN =
class=3Datl>Sequence=20
  variants in SLITRK1 are associated with Tourette's syndrome</SPAN>. =
<SPAN=20
  class=3Djtl>Science</SPAN> <SPAN class=3Dvid>310</SPAN>, 317=96320 =
(<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1126/science.1116502">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16224024&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000232670100053&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tV2hurvP&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D33893f975a688ca=
c5a948c3c070eb502">ChemPort</A></LI></UL>
  <LI id=3DB39>
  <P class=3Ddetails>Liu, C.-G. <I>et al</I>. <SPAN class=3Datl>An =
oligonucleotide=20
  microchip for genome-wide miRNA profiling in human and mouse =
tissues</SPAN>.=20
  <SPAN class=3Djtl>Proc. Natl Acad. Sci. USA</SPAN> <SPAN =
class=3Dvid>101</SPAN>,=20
  9740=969744 (<SPAN class=3Dcite-month-year>2004</SPAN>).<BR><B>The =
first study to=20
  report on miRNA profiling using an oligonucleotide microchip.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0403293101">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15210942&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXl=
vVaht74%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D5c298e3ae35dc=
b651d7b37af18cab4c5">ChemPort</A></LI></UL>
  <LI id=3DB40>
  <P class=3Ddetails>Hammond, S. M. <SPAN class=3Datl>MicroRNA detection =
comes of=20
  age</SPAN>. <SPAN class=3Djtl>Nature Methods</SPAN> <SPAN =
class=3Dvid>3</SPAN>,=20
  12=9613 (<SPAN class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nmeth0106-12">Article</A>=
</LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16369545&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tlagurzL&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dae8677090165ac1=
ab2350a94b228bff2">ChemPort</A></LI></UL>
  <LI id=3DB41>
  <P class=3Ddetails>Lu, J. <I>et al</I>. <SPAN class=3Datl>MicroRNA =
expression=20
  profiles classify human cancers</SPAN>. <SPAN =
class=3Djtl>Nature</SPAN> <SPAN=20
  class=3Dvid>435</SPAN>, 834=96838 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).<BR><B>A comprehensive study of =
miRNA=20
  expression in various human cancers by a new method: bead-based miRNA=20
  profiling.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature03702">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15944708&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000229638700054&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXk=
vVGgsLc%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D665beb07e7d86=
6cf7081d3712dc2d07c">ChemPort</A></LI></UL>
  <LI id=3DB42>
  <P class=3Ddetails>Schmittgen, T. D., Jiang, J., Liu, Q. &amp; yang, =
L. <SPAN=20
  class=3Datl>A high-throughput method to monitor the expression of =
microRNA=20
  precursor</SPAN>. <SPAN class=3Djtl>Nucleic Acids Res.</SPAN> <SPAN=20
  class=3Dvid>32</SPAN>, 43=9653 (<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).<BR><B>The first quantitative =
real-time PCR=20
  developed for miRNA profiling, designed for the amplification of =
precursor=20
  molecules.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1093/nar/gnh040">Article</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXh=
vFSqtL0%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D3b383baa59a0e=
2e619640dc25e536e0f">ChemPort</A></LI></UL>
  <LI id=3DB43>
  <P class=3Ddetails>Chen, C. <I>et al</I>. <SPAN class=3Datl>Real-time=20
  quantification of microRNAs by stem-loop RT-PCR</SPAN>. <SPAN=20
  class=3Djtl>Nucleic Acids Res.</SPAN> <SPAN class=3Dvid>33</SPAN>, =
e179 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1093/nar/gni178">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16314309&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tlSju77P&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dfc5c28b9baae90c=
17e7ea44821338142">ChemPort</A></LI></UL>
  <LI id=3DB44>
  <P class=3Ddetails>Raymond, C. K., Roberts, B. S., Garrett-Engele, P., =
Lim, L.=20
  P. &amp; Johnson, J. M. <SPAN class=3Datl>Simple, quantitative =
primer-extension=20
  PCR assay for the direct monitoring of microRNAs and short-interfering =

  RNAs</SPAN>. <SPAN class=3Djtl>RNA</SPAN> <SPAN class=3Dvid>11</SPAN>, =
1737=961744=20
  (<SPAN class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1261/rna.2148705">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16244135&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tF2ktrbI&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Ddbbb6ae5807d150=
5b51b8351924929ec">ChemPort</A></LI></UL>
  <LI id=3DB45>
  <P class=3Ddetails>Cummins, J. M. <I>et al</I>. <SPAN class=3Datl>The =
colorectal=20
  microRNAome</SPAN>. <SPAN class=3Djtl>Proc. Natl Acad. Sci. USA</SPAN> =
<SPAN=20
  class=3Dvid>103</SPAN>, 3687=963692 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0511155103">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16505370&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xi=
vFWisrw%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D4d7c3bc89dcc6=
9fd2eb63e59f255553b">ChemPort</A></LI></UL>
  <LI id=3DB46>
  <P class=3Ddetails>Nelson P. T. <I>et al</I>. <SPAN =
class=3Datl>Microarray-based,=20
  high-throughput gene expression profiling of microRNAs</SPAN>. <SPAN=20
  class=3Djtl>Nature Methods</SPAN> <SPAN class=3Dvid>1</SPAN>, =
155=96161 (<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nmeth717">Article</A></LI=
>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15782179&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000226753800020&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXi=
sVGhu7k%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D63261118a63d9=
728c45e0f82468b4891">ChemPort</A></LI></UL>
  <LI id=3DB47>
  <P class=3Ddetails>Volinia, S. <I>et al</I>. <SPAN class=3Datl>A =
microRNA=20
  expression signature of human solid tumors define cancer gene =
targets</SPAN>.=20
  <SPAN class=3Djtl>Proc. Natl Acad. Sci. USA</SPAN> <SPAN =
class=3Dvid>103</SPAN>,=20
  2257=962261 (<SPAN class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0510565103">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16461460&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xh=
slGjsbg%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D171ff7580ef8f=
602c3e9a180b27cf267">ChemPort</A></LI></UL>
  <LI id=3DB48>
  <P class=3Ddetails>Garzon, R. <I>et al</I>. <SPAN class=3Datl>MicroRNA =

  fingerprints during human megakaryocytopoiesis</SPAN>. <SPAN =
class=3Djtl>Proc.=20
  Natl Acad. Sci. USA</SPAN> <SPAN class=3Dvid>103</SPAN>, 5078=965083 =
(<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0600587103">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16549775&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xj=
sVGlsbY%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D269d4a13bfe69=
d4a899a32077ba38535">ChemPort</A></LI></UL>
  <LI id=3DB49>
  <P class=3Ddetails>Calin, G. A. <I>et al</I>. <SPAN =
class=3Datl>MicroRNA profiling=20
  reveals distinct signatures in B cell chronic lymphocytic =
leukemias</SPAN>.=20
  <SPAN class=3Djtl>Proc. Natl Acad. Sci. USA</SPAN> <SPAN =
class=3Dvid>101</SPAN>,=20
  11755=9611760 (<SPAN class=3Dcite-month-year>2004</SPAN>).<BR><B>The =
first paper=20
  to explore, by using genome-wide miRNA profiling by microarray, the =
potential=20
  importance of miRNAs in the diagnosis and prognosis of a human=20
  malignancy.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0404432101">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15284443&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXn=
tVersro%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dd6f1fa267dc3a=
a21724cb93a4258e48d">ChemPort</A></LI></UL>
  <LI id=3DB50>
  <P class=3Ddetails>Iorio, M. V. <I>et al</I>. <SPAN =
class=3Datl>microRNA gene=20
  expression deregulation in human breast cancer</SPAN>. <SPAN =
class=3Djtl>Cancer=20
  Res.</SPAN> <SPAN class=3Dvid>65</SPAN>, 7065=967070 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-05-1783">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16103053&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000231188600007&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXn=
s1WrtL8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dfa2fb2b038532=
caa9a89769cc8661dca">ChemPort</A></LI></UL>
  <LI id=3DB51>
  <P class=3Ddetails>Ciafre, S. A. <I>et al</I>. <SPAN =
class=3Datl>Extensive=20
  modulation of a set of microRNAs in primary glioblastoma</SPAN>. <SPAN =

  class=3Djtl>Biochem. Biophys. Res. Commun.</SPAN> <SPAN =
class=3Dvid>334</SPAN>,=20
  1351=961358 (<SPAN class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.bbrc.2005.07.030">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16039986&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000231190900053&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXn=
tVOitb8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D6df5540d5da47=
15a3c76a25aa59fa3dd">ChemPort</A></LI></UL>
  <LI id=3DB52>
  <P class=3Ddetails>Murakami, Y. <I>et al</I>. <SPAN =
class=3Datl>Comprehensive=20
  analysis of microRNA expression patterns in hepatocellular carcinoma =
and=20
  non-tumorous tissues</SPAN>. <SPAN class=3Djtl>Oncogene</SPAN> <SPAN=20
  class=3Dvid>25</SPAN>, 2537=962545 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1038/sj.onc.1209283">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16331254&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xj=
s1agu7c%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dde45ae5d5de99=
458a60347ea31c60248">ChemPort</A></LI></UL>
  <LI id=3DB53>
  <P class=3Ddetails>Yanaihara, N. <I>et al</I>. <SPAN =
class=3Datl>microRNA=20
  signature in lung cancer diagnosis and prognosis</SPAN>. <SPAN=20
  class=3Djtl>Cancer Cell</SPAN> <SPAN class=3Dvid>9</SPAN>, 189=96198 =
(<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.ccr.2006.01.025">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16530703&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xi=
vFWjtLw%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D3ba70c99e0483=
4f220824eb3e461498e">ChemPort</A></LI></UL>
  <LI id=3DB54>
  <P class=3Ddetails>Roldo, C. <I>et al</I>. <SPAN class=3Datl>MicroRNA =
expression=20
  abnormalities in pancreatic endocrine and acinar tumors are associated =
with=20
  distinctive pathological features and clinical behavior</SPAN>. <SPAN=20
  class=3Djtl>J. Clin. Oncol.</SPAN> <SPAN class=3Dcite-month-year>11 =
Sept.=20
  2006</SPAN> [epub ahead of print].</P>
  <LI id=3DB55>
  <P class=3Ddetails>Chan, J. A., Krichevsky, A. M. &amp; Kosik, K. S. =
<SPAN=20
  class=3Datl>MicroRNA-21 is an antiapoptotic factor in human =
glioblastoma=20
  cells</SPAN>. <SPAN class=3Djtl>Cancer Res.</SPAN> <SPAN =
class=3Dvid>65</SPAN>,=20
  6029=966033 (<SPAN class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-05-0137">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16024602&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000230633400010&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXm=
t1eht7c%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D9246395f146c5=
4f38dda543a90c7a5fc">ChemPort</A></LI></UL>
  <LI id=3DB56>
  <P class=3Ddetails>Meng, F. <I>et al</I>. <SPAN =
class=3Datl>Involvement of human=20
  microRNAs in growth and response to chemotherapy in human =
cholangiocarcinoma=20
  cell lines</SPAN>. <SPAN class=3Djtl>Gastroenterology</SPAN> <SPAN=20
  class=3Dvid>130</SPAN>, 2113=962129 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).<BR><B>The first report to show =
that the=20
  chemotherapeutic treatment of human cancer cells can influence miRNA=20
  expression.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1053/j.gastro.2006.02.057">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16762633&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000238207500018&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xn=
tVWit7g%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D231c166af4c5c=
1a82324727461d17901">ChemPort</A></LI></UL>
  <LI id=3DB57>
  <P class=3Ddetails>Ali, I. U., Schriml, L. M. &amp; Dean, M. <SPAN=20
  class=3Datl>Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor =
with lipid=20
  phosphatase activity</SPAN>. <SPAN class=3Djtl>J. Natl Cancer =
Inst.</SPAN> <SPAN=20
  class=3Dvid>91</SPAN>, 1922=961932 (<SPAN =
class=3Dcite-month-year>1999</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1093/jnci/91.22.1922">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D10564676&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK1MXotV=
aitr4%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D14802237d13cecc=
1cb1f844ac968ac45">ChemPort</A></LI></UL>
  <LI id=3DB58>
  <P class=3Ddetails>Johnson, S. M. <I>et al</I>. <SPAN class=3Datl>RAS =
is regulated=20
  by the let-7 microRNA family</SPAN>. <SPAN class=3Djtl>Cell</SPAN> =
<SPAN=20
  class=3Dvid>120</SPAN>, 635=96647 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).<BR><B>An elegant study that =
shows a=20
  pathogenetic link between miRNAs and target oncogenes.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.cell.2005.01.014">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15766527&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000227771400010&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXi=
s1yhsbs%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D10071b51a66cd=
9ac5a5a662d6cd34108">ChemPort</A></LI></UL>
  <LI id=3DB59>
  <P class=3Ddetails>Voorhoeve, P. M. <I>et al</I>. <SPAN class=3Datl>A =
genetic=20
  screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular =
germ cell=20
  tumors</SPAN>. <SPAN class=3Djtl>Cell</SPAN> <SPAN =
class=3Dvid>124</SPAN>,=20
  1169=961181 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).<BR><B>Describes a very=20
  powerful method of genetic screening to identify new functions of =
miRNAs that=20
  are important for tumorigenesis.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.cell.2006.02.037">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16564011&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000237241400018&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xj=
t1Khsrg%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Db5841d7d10777=
786f60736c04f235e35">ChemPort</A></LI></UL>
  <LI id=3DB60>
  <P class=3Ddetails>He, L. <I>et al</I>. <SPAN class=3Datl>A microRNA =
polycistron=20
  as a potential human oncogene</SPAN>. <SPAN class=3Djtl>Nature</SPAN> =
<SPAN=20
  class=3Dvid>435</SPAN>, 828=96833 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature03552">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15944707&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000229638700053&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXk=
vVGgs70%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D021061e4a8733=
8ca58337524d9518537">ChemPort</A></LI></UL>
  <LI id=3DB61>
  <P class=3Ddetails>Costinean, S. <I>et al</I>. <SPAN class=3Datl>Pre B =
cell=20
  proliferation and lymphoblastic leukemia/high grade lymphoma in Emiu =
miR 155=20
  transgenic mice</SPAN>. <SPAN class=3Djtl>Proc. Natl Acad. Sci. =
USA</SPAN> <SPAN=20
  class=3Dvid>103</SPAN>, 7024=967029 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).<BR><B>The first paper to show =
that the=20
  deregulation of a single miRNA gene can lead to cancer.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0602266103">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16641092&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xk=
slCktrg%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D0b61afc8f1050=
4c0cdb001c22354a198">ChemPort</A></LI></UL>
  <LI id=3DB62>
  <P class=3Ddetails>Metzler, M., Wilda, M., Busch, K., Viehmann, S. =
&amp;=20
  Borkhardt, A. <SPAN class=3Datl>High expression of precursor =
microRNA-155/BIC=20
  RNA in children with Burkitt lymphoma</SPAN>. <SPAN class=3Djtl>Genes=20
  Chromosomes Cancer</SPAN> <SPAN class=3Dvid>39</SPAN>, 167=96169 =
(<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1002/gcc.10316">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D14695998&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000187851500010&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXj=
tVWqtrY%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dbc19b1e070dfb=
f41801e593c33e759d5">ChemPort</A></LI></UL>
  <LI id=3DB63>
  <P class=3Ddetails>Eis, P. S. <I>et al</I>. <SPAN =
class=3Datl>Accumulation of=20
  miR-155 and BIC RNA in human B cell lymphomas</SPAN>. <SPAN =
class=3Djtl>Proc.=20
  Natl Acad. Sci. USA</SPAN> <SPAN class=3Dvid>102</SPAN>, 3627=963632 =
(<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0500613102">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15738415&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXi=
sVOgsL8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dee43a46136f63=
9bee51a59b7b8c1cf3b">ChemPort</A></LI></UL>
  <LI id=3DB64>
  <P class=3Ddetails>Kluiver, J. <I>et al</I>. <SPAN class=3Datl>BIC and =
miR-155 are=20
  highly expressed in Hodgkin, primary mediastinal and diffuse large B =
cell=20
  lymphomas</SPAN>. <SPAN class=3Djtl>J. Pathol.</SPAN> <SPAN=20
  class=3Dvid>207</SPAN>, 243=96249 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1002/path.1825">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16041695&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000232213500013&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tFKnsr%2FI&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dcd35e283d2582=
1c5ab7be9081e8656b7">ChemPort</A></LI></UL>
  <LI id=3DB65>
  <P class=3Ddetails>Croce, C. M. &amp; Nowell, P. C. <SPAN =
class=3Datl>Molecular=20
  basis of human B cell neoplasia</SPAN>. <SPAN class=3Djtl>Blood</SPAN> =
<SPAN=20
  class=3Dvid>65</SPAN>, 1=967 (<SPAN =
class=3Dcite-month-year>1985</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-medline first"><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D3880642&amp;dopt=3DAbstract=
">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaL2MXptl=
Oktw%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D965c94eddd95a=
0ad55663a109ef0c146">ChemPort</A></LI></UL>
  <LI id=3DB66>
  <P class=3Ddetails>Tam, W., Hughes, S. H., Hayward, W. S. &amp; =
Besmer, P. <SPAN=20
  class=3Datl>Avian bic, a gene isolated from a common retroviral site =
in avian=20
  leukosis virus-induced lymphomas that encodes a noncoding RNA, =
cooperates with=20
  c-myc in lymphomagenesis and erythroleukemogenesis</SPAN>. <SPAN =
class=3Djtl>J.=20
  Virol.</SPAN> <SPAN class=3Dvid>76</SPAN>, 4275=964286 (<SPAN=20
  class=3Dcite-month-year>2002</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1128/JVI.76.9.4275-4286.2002">Article</A></L=
I>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D11932393&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000174966700014&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD38Xi=
vFGisrY%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D9069b099cdb65=
8ec9553fef675a401e3">ChemPort</A></LI></UL>
  <LI id=3DB67>
  <P class=3Ddetails>O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., =
Dang, C. V.=20
  &amp; Mendell, J. T. <SPAN class=3Datl>c-Myc-regulated microRNAs =
modulate E2F1=20
  expression</SPAN>. <SPAN class=3Djtl>Nature</SPAN> <SPAN =
class=3Dvid>435</SPAN>,=20
  839=96843 (<SPAN class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature03677">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15944709&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000229638700055&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXk=
vVGgsLg%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D8eb045d94d9a3=
d0d34142cc26ee8a7fa">ChemPort</A></LI></UL>
  <LI id=3DB68>
  <P class=3Ddetails>Cimmino, A. <I>et al</I>. <SPAN class=3Datl>miR-15 =
and miR-16=20
  induce apoptosis by targeting BCL2</SPAN>. <SPAN class=3Djtl>Proc. =
Natl Acad.=20
  Sci. USA</SPAN> <SPAN class=3Dvid>102</SPAN>, 13944=9613949 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0506654102">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16166262&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tVOqsbjK&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D3ec5788a62dc606=
72f7dae231ac6fdbd">ChemPort</A></LI></UL>
  <LI id=3DB69>
  <P class=3Ddetails>Jiang, J., Lee, E. J., Gusev, Y. &amp; Schmittgen, =
T. D.=20
  <SPAN class=3Datl>Real-time expression profiling of microRNA =
precursors in human=20
  cancer cell lines</SPAN>. <SPAN class=3Djtl>Nucleic Acids Res.</SPAN> =
<SPAN=20
  class=3Dvid>33</SPAN>, 1=9610 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-medline first"><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15640442&amp;dopt=3DAbstrac=
t">PubMed</A></LI></UL>
  <LI id=3DB70>
  <P class=3Ddetails>Carpenter, B. <I>et al</I>. <SPAN class=3Datl>The =
roles of=20
  heterogeneous nuclear ribonucleoproteins in tumour development and=20
  progression</SPAN>. <SPAN class=3Djtl>Biochim. Biophys. Acta</SPAN> =
<SPAN=20
  class=3Dvid>42</SPAN>, 295=96309 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <LI id=3DB71>
  <P class=3Ddetails>Calin, G. A. <I>et al</I>. <SPAN class=3Datl>Human =
microRNA=20
  genes are frequently located at fragile sites and genomic regions =
involved in=20
  cancers</SPAN>. <SPAN class=3Djtl>Proc. Natl Acad. Sci. USA</SPAN> =
<SPAN=20
  class=3Dvid>101</SPAN>, 2999=963004 (<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).<BR><B>A genome-wide study =
proving that=20
  half of the annotated human miRNAs are located in genomic regions =
involved in=20
  cancer.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0307323101">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D14973191&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXi=
tlWhtr8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D6f2197b0ae939=
5cd9041d415b859f2c6">ChemPort</A></LI></UL>
  <LI id=3DB72>
  <P class=3Ddetails>Zhang, L. &amp; Al, E. <SPAN class=3Datl>MicroRNAs =
exhibit high=20
  frequency genomic alterations in human cancer</SPAN>. <SPAN =
class=3Djtl>Proc.=20
  Natl Acad. Sci. USA</SPAN> <SPAN class=3Dvid>103</SPAN>, 9136=969141 =
(<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0508889103">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16754881&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
sVWjsb8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dd8fb6b1df8f00=
8b9838bd09fa95e1cd8">ChemPort</A></LI></UL>
  <LI id=3DB73>
  <P class=3Ddetails>Bottoni, A. <I>et al</I>. <SPAN class=3Datl>miR-15a =
and=20
  miR-16=961 down-regulation in pituitary adenomas</SPAN>. <SPAN =
class=3Djtl>J. Cell=20
  Physiol.</SPAN> <SPAN class=3Dvid>204</SPAN>, 280=96285 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1002/jcp.20282">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15648093&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXk=
vF2qsb4%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D61280456b938f=
b2cd9bde84d4dcd0f13">ChemPort</A></LI></UL>
  <LI id=3DB74>
  <P class=3Ddetails>Tagawa, H. &amp; Seto, M. <SPAN class=3Datl>A =
microRNA cluster=20
  as a target of genomic amplification in malignant lymphoma</SPAN>. =
<SPAN=20
  class=3Djtl>Leukemia</SPAN> <SPAN class=3Dvid>19</SPAN>, 2013=962016 =
(<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/sj.leu.2403942">Article</=
A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16167061&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000232833100027&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tFCjtbzK&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dff36c1929e5c95f=
e56ad38df46aa4bee">ChemPort</A></LI></UL>
  <LI id=3DB75>
  <P class=3Ddetails>Hayashita, Y. <I>et al</I>. <SPAN class=3Datl>A =
polycistronic=20
  microRNA cluster, miR-17=9692, is overexpressed in human lung cancers =
and=20
  enhances cell proliferation</SPAN>. <SPAN class=3Djtl>Cancer =
Res.</SPAN> <SPAN=20
  class=3Dvid>65</SPAN>, 9628=969632 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-05-2352">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16266980&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000232967000006&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tFKkt7jE&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Db9ab22b30e46e81=
187ab2c5accdf1c08">ChemPort</A></LI></UL>
  <LI id=3DB76>
  <P class=3Ddetails>Fraga, M. F. &amp; Esteller, M. <SPAN =
class=3Datl>Towards the=20
  human cancer epigenome: a first draft of histone modifications</SPAN>. =
<SPAN=20
  class=3Djtl>Cell Cycle</SPAN> <SPAN class=3Dvid>10</SPAN>, 1377=961381 =
(<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <LI id=3DB77>
  <P class=3Ddetails>Scott, G. K., Mattie, M. D., Berger, C. E., Benz, =
S. C. &amp;=20
  Benz, C. C. <SPAN class=3Datl>Rapid alteration of microRNA levels by =
histone=20
  deacetylase inhibition</SPAN>. <SPAN class=3Djtl>Cancer Res.</SPAN> =
<SPAN=20
  class=3Dvid>66</SPAN>, 1277=961281 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-05-3632">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16452179&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xp=
sVejtQ%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D2b2e8abd5e5=
d9db463c2591a5b8e701a">ChemPort</A></LI></UL>
  <LI id=3DB78>
  <P class=3Ddetails>Saito, Y. <I>et al</I>. <SPAN class=3Datl>Specific =
activation=20
  of microRNAs-127 with downregulation of the proto-oncogene BCL6 by=20
  chromatin-modifying drugs in human cancer cells</SPAN>. <SPAN =
class=3Djtl>Cancer=20
  Cell</SPAN> <SPAN class=3Dvid>9</SPAN>, 435=96443 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).<BR><B>Shows the link between =
epigenetic=20
  changes that affect miRNAs and target protein-coding genes involved in =
cell=20
  survival.</B></P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.ccr.2006.04.020">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16766263&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000238514400005&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
t1eksLY%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Db3e32eab3306c=
ca206974063f65f8db7">ChemPort</A></LI></UL>
  <LI id=3DB79>
  <P class=3Ddetails>Thomson, J. M. <I>et al</I>. <SPAN =
class=3Datl>Extensive=20
  post-transcriptional regulation of microRNAs and its implications for=20
  cancer</SPAN>. <SPAN class=3Djtl>Genes Dev.</SPAN> <SPAN =
class=3Dvid>20</SPAN>,=20
  2202=962207 (<SPAN class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1101/gad.1444406">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16882971&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000239790600004&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xo=
slWqu70%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D9db880fa36ee1=
7d1e78ae626fd5f247d">ChemPort</A></LI></UL>
  <LI id=3DB80>
  <P class=3Ddetails>Karube, Y. <I>et al</I>. <SPAN class=3Datl>Reduced =
expression=20
  of Dicer associated with poor prognosis in lung cancer =
patients</SPAN>. <SPAN=20
  class=3Djtl>Cancer Sci.</SPAN> <SPAN class=3Dvid>96</SPAN>, 111=96115 =
(<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1111/j.1349-7006.2005.00015.x">Article</A></=
LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15723655&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000227826400007&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXi=
slOhs7g%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D301c9a9f0ef4e=
7bbf8600c1153176aee">ChemPort</A></LI></UL>
  <LI id=3DB81>
  <P class=3Ddetails>Harris, K. S., Zhang, Z., McManus, M. T., Harfe, B. =
D. &amp;=20
  Sun, X. <SPAN class=3Datl>Dicer function is essential for lung =
epithelium=20
  morphogenesis</SPAN>. <SPAN class=3Djtl>Proc. Natl Acad. Sci. =
USA</SPAN> <SPAN=20
  class=3Dvid>103</SPAN>, 2208=962213 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0510839103">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16452165&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xh=
slGjsLk%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D68bbae91e7844=
c3d1aa99076f863d9cf">ChemPort</A></LI></UL>
  <LI id=3DB82>
  <P class=3Ddetails>Takamizawa, J. <I>et al</I>. <SPAN =
class=3Datl>Reduced=20
  expression of the let-7 microRNAs in human lung cancers in association =
with=20
  shortened postoperative survival</SPAN>. <SPAN class=3Djtl>Cancer =
Res.</SPAN>=20
  <SPAN class=3Dvid>64</SPAN>, 3753=963756 (<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1158/0008-5472.CAN-04-0637">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15172979&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000221727300006&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXk=
sVKgurs%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dcd1f69aeeea4e=
96a025e657e6ddc8f33">ChemPort</A></LI></UL>
  <LI id=3DB83>
  <P class=3Ddetails>Harfe, B. D., McManus, M. T., Mansfield, J. H., =
Hornstein, E.=20
  &amp; Tabin, C. J. <SPAN class=3Datl>The RNaseIII enzyme Dicer is =
required for=20
  morphogenesis but not patterning of the vertebrate limb</SPAN>. <SPAN=20
  class=3Djtl>Proc Natl Acad Sci USA.</SPAN> <SPAN =
class=3Dvid>102</SPAN>,=20
  10898=9610903 (<SPAN class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1073/pnas.0504834102">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16040801&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXn=
vVWjt7k%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Ddb19e75385a36=
3ddd0a5d700330dce83">ChemPort</A></LI></UL>
  <LI id=3DB84>
  <P class=3Ddetails>Kanellopoulou, C. <I>et al</I>. <SPAN=20
  class=3Datl>Dicer-deficient mouse embryonic stem cells are defective =
in=20
  differentiation and centromeric silencing</SPAN>. <SPAN =
class=3Djtl>Genes=20
  Dev.</SPAN> <SPAN class=3Dvid>19</SPAN>, 489=96501 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1101/gad.1248505">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15713842&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000227124400011&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
s1OhsL4%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D09d6166b58b53=
7ce7087bdeebd3de31e">ChemPort</A></LI></UL>
  <LI id=3DB85>
  <P class=3Ddetails>Lau, N. C. <I>et al</I>. <SPAN =
class=3Datl>Characterization of=20
  the piRNA complex from rat testes</SPAN>. <SPAN =
class=3Djtl>Science</SPAN> <SPAN=20
  class=3Dvid>313</SPAN>, 363=96367 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1126/science.1130164">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16778019&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000239154300048&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
vFyqsbk%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D9ff8635f09edc=
8e275aa63e83a017ff5">ChemPort</A></LI></UL>
  <LI id=3DB86>
  <P class=3Ddetails>Girard, A., Sachidanandam, R., Hannon, G. J. &amp; =
Carmell,=20
  M. A. <SPAN class=3Datl>A germline-specific class of small RNAs binds =
mammalian=20
  Piwi proteins</SPAN>. <SPAN class=3Djtl>Nature</SPAN> <SPAN=20
  class=3Dvid>442</SPAN>, 199=96202 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-medline first"><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16751776&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000238979700047&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
vFahu74%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3De4399cc832ad9=
15ff174872f7fcbba96">ChemPort</A></LI></UL>
  <LI id=3DB87>
  <P class=3Ddetails>Aravin, A. <I>et al</I>. <SPAN class=3Datl>A novel =
class of=20
  small RNAs bind to MILI protein in mouse testes</SPAN>. <SPAN=20
  class=3Djtl>Nature</SPAN> <SPAN class=3Dvid>442</SPAN>, 203=96207 =
(<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-medline first"><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16751777&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000238979700048&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
vFahurk%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Da28a88f93f353=
b1830d9d7a3fac142e0">ChemPort</A></LI></UL>
  <LI id=3DB88>
  <P class=3Ddetails>Watanabe, T. <I>et al</I>. <SPAN =
class=3Datl>Identification and=20
  characterization of two novel classes of small RNAs in the mouse =
germline:=20
  retrotransposon-derived siRNAs in oocytes and germline small RNAs in=20
  testes</SPAN>. <SPAN class=3Djtl>Genes Dev.</SPAN> <SPAN =
class=3Dvid>20</SPAN>,=20
  1732=961743 (<SPAN class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1101/gad.1425706">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16766679&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000238768300008&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
vV2ksLs%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Ddb34cad9bd4c7=
fb028dc5fbcef30ba42">ChemPort</A></LI></UL>
  <LI id=3DB89>
  <P class=3Ddetails>Grivna, S. T., Beyret, E., Wang, Z. &amp; Lin, H. =
<SPAN=20
  class=3Datl>A novel class of small RNAs in mouse spermatogenic =
cells</SPAN>.=20
  <SPAN class=3Djtl>Genes Dev.</SPAN> <SPAN class=3Dvid>20</SPAN>, =
1709=961714 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1101/gad.1434406">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16766680&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000238768300004&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
vV2ksL8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D622ac9dcc1576=
f9a0424f9a7b526b825">ChemPort</A></LI></UL>
  <LI id=3DB90>
  <P class=3Ddetails>Qiao, D., Zeeman, A. M., Deng, W., Looijenga, L. H. =
&amp;=20
  Lin, H. <SPAN class=3Datl>Molecular characterization of hiwi, a human =
member of=20
  the piwi gene family whose overexpression is correlated to =
seminomas</SPAN>.=20
  <SPAN class=3Djtl>Oncogene</SPAN> <SPAN class=3Dvid>21</SPAN>, =
3988=963999 (<SPAN=20
  class=3Dcite-month-year>2002</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/sj.onc.1205505">Article</=
A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D12037681&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000175869900005&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD38Xk=
slWqtL8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Ddcd8fd805c23a=
8c7c848afb6919a351a">ChemPort</A></LI></UL>
  <LI id=3DB91>
  <P class=3Ddetails>Liu, X. <I>et al</I>. <SPAN class=3Datl>Expression =
of hiwi gene=20
  in human gastric cancer was associated with proliferation of cancer=20
  cells</SPAN>. <SPAN class=3Djtl>Int. J. Cancer</SPAN> <SPAN=20
  class=3Dvid>118</SPAN>, 1922=961929 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1002/ijc.21575">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16287078&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xj=
t1Gqtbs%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3De4938056bfa58=
f8925e0f927033e0b89">ChemPort</A></LI></UL>
  <LI id=3DB92>
  <P class=3Ddetails>Pavlidisa, N. &amp; Fizazib, K. <SPAN =
class=3Datl>Cancer of=20
  unknown primary (CUP)</SPAN>. <SPAN class=3Djtl>Crit. Rev. Oncol.=20
  Hematol.</SPAN> <SPAN class=3Dvid>54</SPAN>, 243=96250 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-medline first"><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15890271&amp;dopt=3DAbstrac=
t">PubMed</A></LI></UL>
  <LI id=3DB93>
  <P class=3Ddetails>Chiorazzi, N., Rai, K. R. &amp; Ferrarini, M. <SPAN =

  class=3Datl>Chronic lymphocytic leukemia</SPAN>. <SPAN class=3Djtl>N. =
Engl. J.=20
  Med.</SPAN> <SPAN class=3Dvid>352</SPAN>, 804=96815 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1056/NEJMra041720">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15728813&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000227147500010&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
sFCiu74%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D137e8f5543902=
2d6d3c6fe5f7bdcdd21">ChemPort</A></LI></UL>
  <LI id=3DB94>
  <P class=3Ddetails>Kipps, T. J. in <SPAN class=3Dbooktitle>Williams=20
  hematology</SPAN> (eds Beutler, E., Lichtman, M. A., Coller, B. S., =
Kipps, T.=20
  J. &amp; Seligson, U.) 1163=961194 (McGraw-Hill, New York, <SPAN=20
  class=3Dcite-month-year>2001</SPAN>).</P>
  <LI id=3DB95>
  <P class=3Ddetails>Tsimberidou, A. M. &amp; Keating, M. J. <SPAN=20
  class=3Datl>Richter syndrome: biology, incidence, and therapeutic=20
  strategies</SPAN>. <SPAN class=3Djtl>Cancer</SPAN> <SPAN =
class=3Dvid>103</SPAN>,=20
  216=96228 (<SPAN class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1002/cncr.20773">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15578683&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000226379000002&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tFGltrY%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D8a537728ab924=
9a150b787a134fc6470">ChemPort</A></LI></UL>
  <LI id=3DB96>
  <P class=3Ddetails>Cheson, B. D. <I>et al</I>. <SPAN =
class=3Datl>National Cancer=20
  Institute-sponsored Working Group guidelines for chronic lymphocytic =
leukemia:=20
  revised guidelines for diagnosis and treatment</SPAN>. <SPAN=20
  class=3Djtl>Blood</SPAN> <SPAN class=3Dvid>87</SPAN>, 4990=964997 =
(<SPAN=20
  class=3Dcite-month-year>1996</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-medline first"><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D8652811&amp;dopt=3DAbstract=
">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3DA1996UQ70900008&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK28XjsF=
Gisb8%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D810bbcaf797b85c=
b2286818467bbf5e7">ChemPort</A></LI></UL>
  <LI id=3DB97>
  <P class=3Ddetails>Dohner, H. <I>et al</I>. <SPAN class=3Datl>Genomic =
aberrations=20
  and survival in chronic lymphocytic leukemia</SPAN>. <SPAN =
class=3Djtl>N. Engl.=20
  J. Med.</SPAN> <SPAN class=3Dvid>343</SPAN>, 1910=961916 (<SPAN=20
  class=3Dcite-month-year>2000</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1056/NEJM200012283432602">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D11136261&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000166082700002&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3MXk=
tlSlsQ%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3De2dee3e485e=
f3b962cccaa7063a462c4">ChemPort</A></LI></UL>
  <LI id=3DB98>
  <P class=3Ddetails>Herling, M. <I>et al</I>. <SPAN class=3Datl>TCL1 =
shows a=20
  regulated expression pattern in chronic lymphocytic leukemia that =
correlates=20
  with molecular subtypes and proliferative state</SPAN>. <SPAN=20
  class=3Djtl>Leukemia</SPAN> <SPAN class=3Dvid>20</SPAN>, 280=96285 =
(<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1038/sj.leu.2404017">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16341048&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xm=
sl2rug%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D80719700f31=
b2ae49d1f4fbf879c346c">ChemPort</A></LI></UL>
  <LI id=3DB99>
  <P class=3Ddetails>Nagy, B. <I>et al</I>. <SPAN class=3Datl>Abnormal =
expression of=20
  apoptosis-related genes in haematological malignancies: overexpression =
of MYC=20
  is poor prognostic sign in mantle cell lymphoma</SPAN>. <SPAN =
class=3Djtl>Br. J.=20
  Haematol.</SPAN> <SPAN class=3Dvid>120</SPAN>, 434=96441 (<SPAN=20
  class=3Dcite-month-year>2003</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1046/j.1365-2141.2003.04121.x">Article</A></=
LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D12580957&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000180846900007&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD3sXi=
t1ymtrg%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D82970bf26d4d7=
c5bb138527af3703d4f">ChemPort</A></LI></UL>
  <LI id=3DB100>
  <P class=3Ddetails>Adachi, M., Tefferi, A., Greipp, P. R., Kipps, T. =
J. &amp;=20
  Tsujimoto, Y. <SPAN class=3Datl>Preferential linkage of bcl-2 to =
immunoglobulin=20
  light chain gene in chronic lymphocytic leukemia</SPAN>. <SPAN =
class=3Djtl>J.=20
  Exp. Med.</SPAN> <SPAN class=3Dvid>171</SPAN>, 559=96564 (<SPAN=20
  class=3Dcite-month-year>1990</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1084/jem.171.2.559">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D2106002&amp;dopt=3DAbstract=
">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3DA1990CM11100017&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK3cXhtl=
emt7o%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dfac9a450244662e=
bfcf75218595c9b9a">ChemPort</A></LI></UL>
  <LI id=3DB101>
  <P class=3Ddetails>Beasley, M. B., Brambilla, E. &amp; Travis, W. D. =
<SPAN=20
  class=3Datl>The 2004 World Health Organization classification of lung=20
  tumors</SPAN>. <SPAN class=3Djtl>Semin. Roentgenol.</SPAN> <SPAN=20
  class=3Dvid>40</SPAN>, 90=9697 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1053/j.ro.2005.01.001">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15898407&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000228473300005&amp;DestApp=3DWOS_CPL">ISI</A></LI></UL>
  <LI id=3DB102>
  <P class=3Ddetails>Mascaux, C. <I>et al</I>. <SPAN class=3Datl>The =
role of RAS=20
  oncogene in survival of patients with lung cancer: a systematic review =
of the=20
  literature with meta-analysis</SPAN>. <SPAN class=3Djtl>Br. J. =
Cancer</SPAN>=20
  <SPAN class=3Dvid>92</SPAN>, 131=96139 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/sj.bjc.6602258">Article</=
A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15597105&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000226501500023&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
tFSjsrs%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D2dee65532f7d9=
cfdf33d18abc2e4f175">ChemPort</A></LI></UL>
  <LI id=3DB103>
  <P class=3Ddetails>Orom, U. A., Kauppinen, S. &amp; Lund, A. H. <SPAN=20
  class=3Datl>LNA-modified oligonucleotides mediate specific inhibition =
of=20
  microRNA function</SPAN>. <SPAN class=3Djtl>Gene</SPAN> <SPAN=20
  class=3Dvid>372</SPAN>, 137=96141 (<SPAN =
class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.gene.2005.12.031">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16503100&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000237579600016&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xj=
slOqtrs%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3De68bb78360ea3=
efd4334f68fcd363403">ChemPort</A></LI></UL>
  <LI id=3DB104>
  <P class=3Ddetails>Weiler, J., Hunziker, J. &amp; Hall, J. <SPAN=20
  class=3Datl>Anti-miRNA oligonucleotides (AMOs): ammunition to target =
miRNAs=20
  implicated in human disease?</SPAN> <SPAN class=3Djtl>Gene =
Ther.</SPAN> <SPAN=20
  class=3Dvid>13</SPAN>, 496=96502 (<SPAN =
class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1038/sj.gt.3302654">Article</A></LI></UL>
  <LI id=3DB105>
  <P class=3Ddetails>Krutzfeldt, J. <I>et al</I>. <SPAN =
class=3Datl>Silencing of=20
  microRNAs <I>in vivo</I> with 'antagomirs'</SPAN>. <SPAN=20
  class=3Djtl>Nature</SPAN>. <SPAN class=3Dvid>438</SPAN>, 685=96689 =
(<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature04303">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16258535&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000233593100054&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXh=
t1Gqs7zP&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D45414765a2bd7a3=
ff18ca1b3337258a9">ChemPort</A></LI></UL>
  <LI id=3DB106>
  <P class=3Ddetails>Cheung, V. G. <I>et al</I>. <SPAN =
class=3Datl>Natural variation=20
  in human gene expression assessed in lymphoblastoid cells</SPAN>. =
<SPAN=20
  class=3Djtl>Nature Genet.</SPAN> <SPAN class=3Dvid>33</SPAN>, =
422=96425 (<SPAN=20
  class=3Dcite-month-year>2003</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/ng1094">Article</A></LI><=
/UL>
  <LI id=3DB107>
  <P class=3Ddetails>Morley, M. <I>et al</I>. <SPAN class=3Datl>Genetic =
analysis of=20
  genome-wide variation in human gene expression</SPAN>. <SPAN=20
  class=3Djtl>Nature</SPAN> <SPAN class=3Dvid>430</SPAN>, 743=96747 =
(<SPAN=20
  class=3Dcite-month-year>2004</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/nature02797">Article</A><=
/LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15269782&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000223233600032&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2cXm=
sVGls7k%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Db6d0df3a5e38f=
7e7bc4b830d6e4f6dfe">ChemPort</A></LI></UL>
  <LI id=3DB108>
  <P class=3Ddetails>Stankovic, T. <I>et al</I>. <SPAN =
class=3Datl>Inactivation of=20
  ataxia telangiectasia mutated gene in B-cell chronic lymphocytic=20
  leukaemia</SPAN>. <SPAN class=3Djtl>Lancet</SPAN> <SPAN =
class=3Dvid>353</SPAN>,=20
  26=9629 (<SPAN class=3Dcite-month-year>1999</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/S0140-6736(98)10117-4">Article</A></LI>=

    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D10023947&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000077934800013&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK1MXmtV=
artQ%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Db069e795ea1ef=
6f7a0a731cb43c4e68b">ChemPort</A></LI></UL>
  <LI id=3DB109>
  <P class=3Ddetails>Bullrich, F. <I>et al</I>. <SPAN class=3Datl>ATM =
mutations in=20
  B-cell chronic lymphocytic leukemia</SPAN>. <SPAN class=3Djtl>Cancer =
Res.</SPAN>=20
  <SPAN class=3Dvid>59</SPAN>, 24=9627 (<SPAN=20
class=3Dcite-month-year>1999</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-medline first"><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D9892178&amp;dopt=3DAbstract=
">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000077979300006&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DyaK1MXmsF=
Kquw%3D%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dcbc49405c5bb0=
9877a4c65223f9c25a9">ChemPort</A></LI></UL>
  <LI id=3DB110>
  <P class=3Ddetails>Calin, G. A. <I>et al</I>. <SPAN =
class=3Datl>Familial cancer=20
  associated with a polymorphism in ARLTS1</SPAN>. <SPAN class=3Djtl>N. =
Engl. J.=20
  Med.</SPAN> <SPAN class=3Dvid>352</SPAN>, 1667=961676 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1056/NEJMoa042280">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15843669&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD2MXj=
sFCltrk%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3D230be8107d108=
abf5c51a19854f5e90d">ChemPort</A></LI></UL>
  <LI id=3DB111>
  <P class=3Ddetails>French, D. B. &amp; Jones, L. A. <SPAN =
class=3Datl>Minority=20
  issues in prostate disease</SPAN>. <SPAN class=3Djtl>Med. Clin. North =
Am.</SPAN>=20
  <SPAN class=3Dvid>89</SPAN>, 805=96816 (<SPAN=20
  class=3Dcite-month-year>2005</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    =
href=3D"http://dx.doi.org/10.1016/j.mcna.2005.02.003">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D15925651&amp;dopt=3DAbstrac=
t">PubMed</A></LI></UL>
  <LI id=3DB112>
  <P class=3Ddetails>Gottwein, E., Cai, X. &amp; Cullen, B. R. <SPAN =
class=3Datl>A=20
  novel assay for viral microRNAs function identifies a single =
nucleotide=20
  polymorphism that affects Drosha processing</SPAN>. <SPAN =
class=3Djtl>J.=20
  Virol.</SPAN> <SPAN class=3Dvid>80</SPAN>, 5321=965326 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1128/JVI.02734-05">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16699012&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xl=
sVGntLg%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3Dd745939af1ad8=
b0d5c799fb0adcaf1ff">ChemPort</A></LI></UL>
  <LI id=3DB113>
  <P class=3Ddetails>Dews, M. <I>et al</I>. <SPAN =
class=3Datl>Augmentation of tumor=20
  angiogenesis by a Myc-activated microRNAs cluster</SPAN>. <SPAN=20
  class=3Djtl>Nature Genet.</SPAN> <SPAN class=3Dvid>38</SPAN>, =
1060=961065 (<SPAN=20
  class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-nature first"><A title=3D"Article on Article - "=20
    =
href=3D"http://www.nature.com/doifinder/10.1038/ng1855">Article</A></LI><=
/UL>
  <LI id=3DB114>
  <P class=3Ddetails>Pallante, P. <I>et al</I>. <SPAN =
class=3Datl>MicroRNA=20
  deregulation in human thyroid papillary carcinomas</SPAN>. <SPAN=20
  class=3Djtl>Endocr. Relat. Cancer</SPAN> <SPAN class=3Dvid>13</SPAN>, =
497=96508=20
  (<SPAN class=3Dcite-month-year>2006</SPAN>).</P>
  <UL class=3Darticle-views>
    <LI class=3D"ref-doi first"><A title=3D""=20
    href=3D"http://dx.doi.org/10.1677/erc.1.01209">Article</A></LI>
    <LI class=3Dref-medline><A title=3D"Article on PubMed - "=20
    =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=3Dnpg&amp;c=
md=3DRetrieve&amp;db=3DPubMed&amp;list_uids=3D16728577&amp;dopt=3DAbstrac=
t">PubMed</A></LI>
    <LI class=3Dref-isi><A title=3D"Article on ISI - "=20
    =
href=3D"http://links.isiglobalnet2.com/gateway/Gateway.cgi?&amp;GWVersion=
=3D2&amp;SrcAuth=3DNature&amp;SrcApp=3DNature&amp;DestLinkType=3DFullReco=
rd&amp;KeyUT=3D000238315700015&amp;DestApp=3DWOS_CPL">ISI</A></LI>
    <LI class=3Dref-coi><A title=3D"Article on ChemPort - "=20
    =
href=3D"http://chemport.cas.org/cgi-bin/sdcgi?APP=3Dftslink&amp;action=3D=
reflink&amp;origin=3Dnpg&amp;version=3D1.0&amp;coi=3D1:CAS:528:DC%2BD28Xn=
tF2mtLc%3D&amp;pissn=3D1474-175X&amp;pyear=3D2006&amp;md5=3De525bebe4cdaa=
b0d3fe5a87735a99eb5">ChemPort</A></LI></UL></LI></OL></DIV>
<DIV class=3Dno-header-art><A class=3Dbacktotop=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#top">T=
op<SPAN=20
class=3Dhidden> of page</SPAN></A></DIV>
<DIV id=3Daffiliations-notes>
<H3>Author affiliations</H3>
<OL>
  <LI id=3Da1>Department of Molecular Virology, Immunology and Medical =
Genetics=20
  and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio =
43210,=20
  USA.</LI></OL>
<P class=3Dcaff>Correspondence to: Carlo M. Croce<SUP><A =
title=3D"affiliated with "=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#a1">1<=
/A></SUP>=20
Email:&nbsp;<A=20
href=3D"mailto:Carlo.Croce@osumc.edu">Carlo.Croce@osumc.edu</A></P></DIV>=

<DIV class=3Dno-header><A class=3Dbacktotop=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#top">T=
op<SPAN=20
class=3Dhidden> of page</SPAN></A></DIV><!-- generated by Nature-branded =
standard table template -->
<DIV id=3Dmore-like-this>
<H3>MORE ARTICLES LIKE THIS</H3>
<P class=3Dexplain>These links to content published by NPG are =
automatically=20
generated.</P>
<DIV class=3Dwrapper>
<H4 class=3Darea>RESEARCH</H4><A class=3Darticle=20
href=3D"http://www.nature.com/doifinder/10.1038/ng.2007.30">Widespread =
microRNA=20
repression by Myc contributes to tumorigenesis</A>
<P class=3Djournal>Nature Genetics <SPAN>Article (01 Jan =
2008)</SPAN></P><A=20
class=3Dallmatches=20
href=3D"http://sherlock.nature.com/arls/Query?src_jrnl=3DNature Reviews =
Cancer&amp;query=3Dhttp://xml.nature.com/nrc/journal/v6/n11/xml/nrc1997.x=
ml&amp;src_vol=3D6&amp;type=3DRV&amp;src_pp=3D857-866&amp;prod=3DNRC&amp;=
src_date=3D2006&amp;src_title=3DMicroRNA signatures in human =
cancers&amp;showall=3Dresearch"=20
target=3D_new>See all 47 matches for Research</A></DIV></DIV>
<DIV id=3Dprev-next>
<UL class=3Dprev-next>
  <LI class=3Dprev><A title=3D"previous article in this issue"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1991.html">Previ=
ous=20
  article</A></LI>
  <LI class=3Dnext><A title=3D"next article in this issue"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc2008.html">Next =

  article</A></LI></UL></DIV></DIV></DIV><!-- value from issueHighlight =
directive to variable -->
<DIV id=3Djournalnav>
<H1 class=3Dhidden>Main navigation</H1><!-- whitespace removed to deal =
with IE5.0 PC bug. --><MAP=20
class=3Djournal-nav id=3Dmain-journal-nav title=3D"journal content =
navigation">
  <UL>
    <LI class=3Dmenu-heading>
    <H2>Journal content</H2>
    <LI><A href=3D"http://www.nature.com/nrc/index.html">Journal =
home</A>
    <LI><A=20
    =
href=3D"http://www.nature.com/nrc/journal/vaop/ncurrent/index.html">Advan=
ce=20
    online publication</A>
    <LI><A href=3D"http://www.nature.com/nrc/current_issue">Current =
issue</A>
    <LI class=3Dselected><A=20
    href=3D"http://www.nature.com/nrc/archive/index.html">Archive</A>
    <LI><A href=3D"http://www.nature.com/nrc/focus/index.html">Web =
Focuses</A>=20
    <LI><A href=3D"http://www.nature.com/nrc/series/index.html">Article =
Series</A>=20

    <LI><A =
href=3D"http://www.nature.com/nrc/podcast/index.html">Podcasts</A>=20
    <LI><A=20
  =
href=3D"http://www.nature.com/nrc/posters/index.html">Posters</A></LI></U=
L></MAP><!-- whitespace removed to deal with IE5.0 PC bug. --><MAP=20
class=3D"journal-nav supplementary" id=3Dsupplementary-journal-nav=20
title=3D"journal information navigation">
  <UL>
    <LI class=3Dmenu-heading>
    <H2>Journal information</H2>
    <LI><A =
href=3D"http://www.nature.com/nrc/info/guide_reviews.html">Guide to=20
    Nature Reviews Cancer</A>
    <LI><A class=3Donsub href=3D"http://mts-nrc.nature.com/">Online =
submission</A>
    <LI><A =
href=3D"http://www.nature.com/nrc/info/guide_referees.html">Guidelines=20
    for referees</A>
    <LI><A =
href=3D"http://www.nature.com/nrc/info/about_journal.html">About the=20
    journal</A>
    <LI><A =
href=3D"http://www.nature.com/tracker/nrc/H10905B01">Subscribe</A>=20
    <LI><A class=3De-alerts href=3D"mailto:nrc@nature.com">Feedback for =
editors</A>=20
    </LI></UL></MAP>
<DIV class=3Dbox id=3Dnpg-services>
<H2><ABBR title=3D"Nature Publishing Group">NPG</ABBR> services</H2>
<UL>
  <LI><A=20
  =
href=3D"http://nature.custhelp.com/cgi-bin/nature.cfg/php/enduser/std_alp=
.php">Help</A>=20

  <LI><A href=3D"http://www.nature.com/authors/">Authors and =
Referees</A>=20
  <LI><A=20
  =
href=3D"http://npg.nature.com/npg/servlet/Content?data=3Dxml/07_home.xml&=
amp;style=3Dxml/07_home.xsl">Librarian=20
  gateway</A>=20
  <LI><A =
href=3D"http://npg.nature.com/media/nature/index.html">Advertising=20
  information</A>=20
  <LI><A=20
  =
href=3D"http://npg.nature.com/npg/servlet/Content?data=3Dxml/03_welcome.x=
ml&amp;style=3Dxml/03_jobs.xsl">work@<ABBR=20
  title=3D"Nature Publishing Group">npg</ABBR></A>=20
  <LI><A href=3D"http://www.nature.com/reprints/">Reprints and =
permissions</A>=20
  </LI></UL></DIV>
<DIV class=3Dbox id=3Dnpg-resources>
<H2 class=3Dnpg-resources><ABBR title=3D"Nature Publishing =
Group">NPG</ABBR>=20
resources</H2>
<UL class=3Dnpg-resources>
  <LI><A href=3D"http://www.nature.com/reviews/index.html">Nature =
Reviews</A>=20
  <LI><A href=3D"http://www.nature.com/nature/">Nature</A>=20
  <LI><A href=3D"http://www.nature.com/nm/">Nature Medicine</A>=20
  <LI><A href=3D"http://www.nature.com/ncb/">Nature Cell Biology</A>=20
  <LI><A href=3D"http://www.nature.com/nrm/">Nature Reviews Molecular =
Cell=20
  Biology</A>=20
  <LI><A href=3D"http://www.nature.com/nrd/">Nature Reviews Drug =
Discovery</A>=20
  <LI><A href=3D"http://www.nature.com/ng/">Nature Genetics</A>=20
  <LI><A href=3D"http://www.nature.com/onc/">Oncogene</A>=20
  <LI><A =
href=3D"http://www.nature.com/natureconferences/index.html">Nature=20
  Conferences</A>=20
  <LI><A href=3D"http://www.nature.com/stemcells/index.html">Nature =
Reports Stem=20
  Cells</A> </LI></UL></DIV>
<DIV id=3Dglobal-subject-areas>
<H2><SPAN><ABBR title=3D"Nature Publishing Group">NPG</ABBR> =
Journals</SPAN></H2>
<H3 class=3Dview>by Subject Area</H3>
<UL class=3Dcategory-list>
  <LI>
  <H4>Chemistry</H4>
  <UL>
    <LI><A =
href=3D"http://www.nature.com/chemistry/index.html">Chemistry</A>=20
    <LI><A href=3D"http://www.nature.com/drugdisc/index.html">Drug =
discovery</A>=20
    <LI><A =
href=3D"http://www.nature.com/biotech/index.html">Biotechnology</A>=20
    <LI><A =
href=3D"http://www.nature.com/materials/index.html">Materials</A>=20
    <LI><A href=3D"http://www.nature.com/protometh/index.html">Methods =
&amp;=20
    Protocols</A> </LI></UL>
  <LI>
  <H4>Clinical Practice &amp; Research</H4>
  <UL>
    <LI><A href=3D"http://www.nature.com/cancer/index.html">Cancer</A>=20
    <LI><A =
href=3D"http://www.nature.com/cardio/index.html">Cardiovascular=20
    medicine</A>=20
    <LI><A =
href=3D"http://www.nature.com/dentistry/index.html">Dentistry</A>=20
    <LI><A title=3D""=20
    =
href=3D"http://www.nature.com/endocrinology/index.html">Endocrinology</A>=
=20
    <LI><A =
href=3D"http://www.nature.com/gastrohep/index.html">Gastroenterology=20
    &amp; Hepatology</A>=20
    <LI><A href=3D"http://www.nature.com/protometh/index.html">Methods =
&amp;=20
    Protocols</A>=20
    <LI><A href=3D"http://www.nature.com/pathology/index.html">Pathology =
&amp;=20
    Pathobiology</A>=20
    <LI><A href=3D"http://www.nature.com/urology/index.html">Urology</A> =
</LI></UL>
  <LI>
  <H4>Earth &amp; Environment</H4>
  <UL>
    <LI><A href=3D"http://www.nature.com/earthsciences/index.html">Earth =

    sciences</A>=20
    <LI><A href=3D"http://www.nature.com/evoeco/index.html">Evolution =
&amp;=20
    Ecology</A> </LI></UL>
  <LI>
  <H4>Life sciences</H4>
  <UL>
    <LI><A =
href=3D"http://www.nature.com/biotech/index.html">Biotechnology</A>=20
    <LI><A href=3D"http://www.nature.com/cancer/index.html">Cancer</A>=20
    <LI><A =
href=3D"http://www.nature.com/development/index.html">Development</A>=20
    <LI><A href=3D"http://www.nature.com/drugdisc/index.html">Drug =
discovery</A>=20
    <LI><A href=3D"http://www.nature.com/evoeco/index.html">Evolution =
&amp;=20
    Ecology</A>=20
    <LI><A =
href=3D"http://www.nature.com/genetics/index.html">Genetics</A>=20
    <LI><A =
href=3D"http://www.nature.com/immuno/index.html">Immunology</A>=20
    <LI><A =
href=3D"http://www.nature.com/medicalresearch/index.html">Medical=20
    research</A>=20
    <LI><A href=3D"http://www.nature.com/protometh/index.html">Methods =
&amp;=20
    Protocols</A>=20
    <LI><A =
href=3D"http://www.nature.com/micro/index.html">Microbiology</A>=20
    <LI><A =
href=3D"http://www.nature.com/molcellbio/index.html">Molecular cell=20
    biology</A>=20
    <LI><A =
href=3D"http://www.nature.com/neurosci/index.html">Neuroscience</A>=20
    <LI><A =
href=3D"http://www.nature.com/pharma/index.html">Pharmacology</A>=20
    <LI><A href=3D"http://www.nature.com/sysbio/index.html">Systems =
biology</A>=20
    </LI></UL>
  <LI>
  <H4>Physical sciences</H4>
  <UL>
    <LI><A href=3D"http://www.nature.com/physics/index.html">Physics</A> =

    <LI><A =
href=3D"http://www.nature.com/materials/index.html">Materials</A>=20
  </LI></UL></LI></UL>
<H3 class=3Dview><A title=3D"View A to Z list of Nature Publishing Group =
journals"=20
href=3D"http://www.nature.com/siteindex/index.html">by A - Z=20
Index</A></H3></DIV></DIV></DIV>
<DIV class=3Darchive id=3Dextranav>
<H1 class=3Dhidden>Extra navigation</H1>
<DIV class=3D"ad-rh marketing">
<DIV>
<H2>Subscribe</H2>
<P>Subscribe to <SPAN class=3Djournal-name>Nature Reviews =
Cancer</SPAN></P>
<FORM action=3Dhttps://secure.nature.com/subscribe/nrc method=3Dpost>
<DIV><INPUT title=3D"Subscribe to Nature Reviews Cancer" type=3Dsubmit =
value=3DSubscribe></DIV></FORM></DIV></DIV>
<DIV id=3Darticlenav>
<H2>This issue</H2>
<UL>
  <LI class=3Dtoc><A class=3Dtoc=20
  href=3D"http://www.nature.com/nrc/journal/v6/n11">Table of =
contents</A>
  <LI class=3Dprev><A title=3D"previous article in this issue"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1991.html">Previ=
ous=20
  article</A>
  <LI class=3Dnext><A title=3D"next article in this issue"=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc2008.html">Next =

  article</A></LI></UL>
<H2>Article tools</H2>
<UL>
  <LI class=3Ddownload-pdf><A class=3Ddownload-pdf=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/pdf/nrc1997.pdf">Downloa=
d=20
  PDF</A>=20
  <LI class=3Dsendtofriend><A class=3Dsendtofriend=20
  =
href=3D"http://www.nature.com/foxtrot/svc/mailform?file=3D/nrc/journal/v6=
/n11/full/nrc1997.html">Send=20
  to a friend</A>
  <LI class=3Dexport><A class=3Dexport=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/ris/nrc1997.ris">Export =

  citation</A>
  <LI class=3Dcited><A class=3Dcited=20
  =
href=3D"http://www.nature.com/cited/cited.html?doi=3D10.1038/nrc1997">Art=
icles in=20
  CrossRef citing this article</A>
  <LI class=3Dexport><A class=3Dexport=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/ris/nrc1997refs.ris">Exp=
ort=20
  references</A>=20
  <LI class=3Dpermissions><A class=3Dpermissions=20
  =
href=3D"https://s100.copyright.com/AppDispatchServlet?publisherName=3DNPG=
&amp;publication=3DNature Reviews Cancer&amp;title=3DMicroRNA signatures =
in human cancers&amp;author=3DGeorge A. Calin and Carlo M. Croce =
&amp;contentID=3D10.1038/nrc1997&amp;publicationDate=3D11/01/2006&amp;vol=
umeNum=3D6&amp;issueNum=3D11&amp;pageNumbers=3D857-866">Rights=20
  and permissions</A>=20
  <LI class=3Dcommercial_reprints><A class=3Dcommercial_reprints=20
  =
href=3D"https://s100.copyright.com/AppDispatchServlet?publisherName=3DNPG=
R&amp;publication=3DNature+Reviews+Cancer&amp;title=3DMicroRNA =
signatures in human cancers&amp;author=3DGeorge A. Calin and Carlo M. =
Croce =
&amp;contentID=3D10.1038/nrc1997&amp;publicationDate=3D11/01/2006&amp;vol=
umeNum=3D6&amp;issueNum=3D11&amp;numPages=3D10&amp;pageNumbers=3Dpp857-86=
6&amp;orderBeanReset=3Dtrue">Order=20
  commercial reprints</A>
  <LI class=3Dsave><A class=3Dsave=20
  =
href=3D"http://www.connotea.org/add?uri=3Dhttp://www.nature.com/nrc/journ=
al/v6/n11/full/nrc1997.html">Bookmark=20
  in Connotea</A> </LI></UL>
<H2>Article navigation</H2>
<UL>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#abs">A=
bstract</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#MiRNA-=
profiling-of-tumour-versus-normal-tissues">MiRNA=20
  profiling of tumour versus normal tissues</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#Causes=
-of-abnormal-miRNA-expression">Causes=20
  of abnormal miRNA expression</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#MiRNA-=
profiling-as-a-new-clinical-tool">MiRNA=20
  profiling as a new clinical tool</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#A-miRN=
A-perspective-in-cancer-therapy">A=20
  miRNA perspective in cancer therapy</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#A-new-=
form-of-cancer-predisposition">A=20
  new form of cancer predisposition?</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#In-con=
clusion">In=20
  conclusion</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#links"=
>Links</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#Refere=
nces">References</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#acknow=
ledgements">Acknowledgements</A>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#affili=
ations-notes">Author=20
  affiliations</A></LI></UL>
<H2 class=3Dhidden>Article view</H2>
<UL class=3Dview-tools>
  <LI><A class=3Dpage=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/execsumm/nrc1997.html">A=
t a=20
  glance</A>
  <LI><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/glossary/nrc1997.html">G=
lossary</A>
  <LI><A=20
  =
href=3D"http://www.nature.com/nrc/journal/v6/n11/fig_tab/nrc1997_ft.html"=
>Figures=20
  and tables</A><A class=3D""=20
  =
onclick=3D"window.open('http://sherlock.nature.com/arls/Query?prod=3DNRC&=
amp;query=3Dhttp%3A%2F%2Fxml.nature.com%2Fnrc%2Fjournal%2Fv6%2Fn11%2Fxml%=
2Fnrc1997.xml&amp;type=3DRV&amp;src_title=3DMicroRNA+signatures+in+human+=
cancers&amp;src_jrnl=3DNature+Reviews+Cancer&amp;src_vol=3D6&amp;src_pp=3D=
857-866&amp;src_date=3D2006&amp;target=3Dpopup', 'autonomypopup', =
'resizeable=3Dyes,scrollbars=3Dyes,scrolling=3Dyes,statusbar=3Dno,navbar=3D=
no,width=3D550,height=3D550');return false;"=20
  href=3D"javascript:void(0)">More articles like =
this</A></LI></UL></DIV>
<DIV class=3D"extra grey" id=3Dsearch-pubmed>
<H2>Search Pub<SPAN class=3Dhidden> </SPAN>Med for<SPAN class=3Dhidden> =
the=20
following terms:</SPAN></H2>
<UL>
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=3Dsearch&amp;te=
rm=3DCalin+G+A">George=20
  A. Calin</A>
  <LI><A=20
  =
href=3D"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=3Dsearch&amp;te=
rm=3DCroce+C+M">Carlo=20
  M. Croce</A></LI></UL></DIV>
<DIV class=3Dbox id=3Dnatjob>
<H2 class=3Dnatjob><A href=3D"http://www.nature.com/naturejobs/"><SPAN=20
class=3Dfirst>nature</SPAN><SPAN class=3Dhidden> </SPAN><SPAN=20
class=3Dsecond>jobs</SPAN></A></H2>
<UL class=3Dnatjob>
  <LI>
  <H3 class=3Dfirst><A=20
  href=3D"http://nature.com/naturejobs/science/jobs/51597">Research =
Studentships=20
  Diabetes UK</A></H3>
  <UL>
    <LI>Diabetes UK=20
    <LI>London United Kingdom </LI></UL>
  <LI>
  <H3><A =
href=3D"http://nature.com/naturejobs/science/jobs/50557">Postdoctoral=20
  Position</A></H3>
  <UL>
    <LI>University of Heidelberg=20
    <LI>Heidelberg Germany </LI></UL></LI></UL>
<DIV class=3Dnatjobmore><A=20
href=3D"http://www.nature.com/naturejobs/science/jobs">More science =
jobs</A></DIV><!--=0A=
<div class=3D"natjobmore"><a href=3D"/naturejobs/science/jobs/new">Post =
a job for free</a></div>=0A=
--></DIV>
<DIV class=3Dbox id=3Dnatprod>
<FORM action=3Dhttp://www.biocompare.com/nature/search.asp =
method=3Dpost>
<H2 class=3Dnatprod><A href=3D"http://www.biocompare.com/nature/"><SPAN=20
class=3Dfirst>nature</SPAN><SPAN class=3Dhidden> </SPAN><SPAN=20
class=3Dsecond>products</SPAN></A></H2>
<DIV class=3Dnatprodmore><LABEL class=3Dhidden for=3Dbuyerguide>enter =
buyers guide=20
search text here</LABEL><INPUT id=3Dbuyerguide name=3Dsearch><BR><INPUT =
class=3Dbutton type=3Dsubmit value=3D"search buyers =
guide"></DIV></FORM></DIV><!-- skyscraper ad -->
<DIV class=3D"ad-rh skyscraper wide">
<P>Advertisement</P>
<SCRIPT type=3Dtext/javascript><!--//--><![CDATA[//><!--=0A=
		document.write('<script type=3D"text/javascript" =
src=3D"http://ad.doubleclick.net/adj/naturereviews.cancer/article;abr=3D!=
webtv;type=3Drv;artid=3Dnrc1997;date=3D200611;issue=3D11;subco=3D;chaco=3D=
;keywd=3D;njdis=3D;njreg=3D;crstg=3D;pos=3Dright;fidid=3D7;posid=3D10;pla=
id=3D157;prisp=3D75;sz=3D160x600;ptile=3D2;ord=3D' + ord + '?" =
><\/script>');=0A=
=0A=
	if ((!document.images && navigator.userAgent.indexOf('Mozilla/2.') >=3D =
0) || (navigator.userAgent.indexOf("WebTV") >=3D 0)) {=0A=
		document.write('<a =
href=3D"http://ad.doubleclick.net/jump/naturereviews.cancer/article;keywd=
=3D;sz=3D160x600;ord=3D' + ord + '?">');=0A=
		document.write('<img =
src=3D"http://ad.doubleclick.net/ad/naturereviews.cancer/article;keywd=3D=
;sz=3D160x600;ord=3D' + ord + '?" width=3D"160" height=3D"600" =
border=3D"0"></a>');=0A=
	}=0A=
//--><!]]></SCRIPT>
<NOSCRIPT>
<DIV><A=20
href=3D"http://ad.doubleclick.net/jump/naturereviews.cancer/article;abr=3D=
!NN2;type=3Drv;artid=3Dnrc1997;date=3D200611;issue=3D11;subco=3D;chaco=3D=
;keywd=3D;njdis=3D;njreg=3D;crstg=3D;pos=3Dright;fidid=3D7;posid=3D10;pla=
id=3D157;prisp=3D75;sz=3D160x600;ptile=3D2;ord=3D123456789?"><IMG=20
style=3D"BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; =
BORDER-BOTTOM-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px"=20
alt=3DAdvertisement=20
src=3D"http://ad.doubleclick.net/ad/naturereviews.cancer/article;abr=3D!N=
N2;tile=3D1;type=3Drv;artid=3Dnrc1997;date=3D200611;issue=3D11;subco=3D;c=
haco=3D;keywd=3D;njdis=3D;njreg=3D;crstg=3D;pos=3Dright;fidid=3D7;posid=3D=
10;plaid=3D157;prisp=3D75;sz=3D160x600;ptile=3D2;ord=3D123456789?"></A></=
DIV></NOSCRIPT></DIV><!-- end skyscraper ad --></DIV>
<DIV class=3Dcleardiv><!-- --></DIV>
<P class=3D"back-to-top hidden"><A title=3D"Return to the top of this =
page"=20
href=3D"http://www.nature.com/nrc/journal/v6/n11/full/nrc1997.html#top">T=
op</A></P>
<DIV class=3Dfooter id=3Dftr>
<DIV id=3Dfooter-journal>
<P class=3Djournal-name>Nature Reviews Cancer</P>
<P class=3Dissn style=3D"BORDER-RIGHT: #000 1px solid"><ABBR=20
title=3D"International Standard Serial Number">ISSN</ABBR><SPAN=20
class=3Dhidden>:</SPAN> 1474-175X</P>
<P class=3Deissn><ABBR=20
title=3D"Electronic International Standard Serial =
Number">EISSN</ABBR><SPAN=20
class=3Dhidden>:</SPAN> 1474-1768</P><SPAN class=3Dcleardiv><!-- =
--></SPAN></DIV>
<DIV id=3Dfooter-links>
<UL>
  <LI><A class=3Dabout-npg href=3D"http://www.nature.com/npg/">About =
<ABBR=20
  title=3D"Nature Publishing Group">NPG</ABBR></A>
  <LI><A href=3D"http://www.nature.com/npg_/contact/">Contact <ABBR=20
  title=3D"Nature Publishing Group">NPG</ABBR></A>
  <LI><A href=3D"http://www.nature.com/naturejobs/">Nature<SPAN =
class=3Dhidden>=20
  </SPAN>jobs.com</A>
  <LI><A href=3D"http://www.nature.com/info/privacy.html">Privacy =
policy</A>
  <LI><A href=3D"http://www.nature.com/info/legal_notice.html">Legal =
notice</A>
  <LI><A=20
  =
href=3D"http://www.nature.com/info/accessibility_statement.html">Accessib=
ility=20
  statement</A>
  <LI><A class=3Drss href=3D"http://www.nature.com/webfeeds/"><ABBR=20
  title=3D"RDF Site Summary">RSS</ABBR> web feeds</A>
  <LI><A href=3D"http://www.nature.com/help/">Help</A> </LI></UL><SPAN=20
class=3Dcleardiv><!-- --></SPAN></DIV>
<DIV id=3Dfooter-copyright>
<P class=3Dlogo><A class=3Dfooter-copyright title=3D""=20
href=3D"http://www.nature.com/info/copyright_statement.html">=A9 2008 =
Nature=20
Publishing Group</A> =96 partner of <A=20
href=3D"http://www.nature.com/info/partners.html">AGORA, HINARI, =
CrossRef and=20
COUNTER</A></P></DIV></DIV></DIV></DIV><!-- close constrain divs -->
<SCRIPT src=3D"http://www.nature.com/common/scripts/jquery.js"=20
type=3Dtext/javascript></SCRIPT>

<SCRIPT src=3D"http://www.nature.com/common/scripts/global.js"=20
type=3Dtext/javascript></SCRIPT>
<!--[if IE 6]>
<![endif]--></BODY></HTML>

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: http://ad.doubleclick.net/ad/naturereviews.cancer/article;abr=!NN2;tile=1;type=rv;artid=nrc1997;date=200611;issue=11;subco=;chaco=;keywd=;njdis=;njreg=;crstg=;pos=top;sz=728x90;ptile=1;ord=123456789?
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==

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://www.nature.com/nrc/images/journal_header_v3.gif
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==

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: image/jpeg; image/spj
Content-Transfer-Encoding: base64
Content-Location: http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f1.jpg
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------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: image/jpeg; image/spj
Content-Transfer-Encoding: base64
Content-Location: http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f2.jpg
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------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://www.nature.com/common/images/table_thumb.gif
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------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: image/jpeg; image/spj
Content-Transfer-Encoding: base64
Content-Location: http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f3.jpg
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------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: image/jpeg; image/spj
Content-Transfer-Encoding: base64
Content-Location: http://www.nature.com/nrc/journal/v6/n11/thumbs/nrc1997-f4.jpg
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------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: application/octet-stream
Content-Transfer-Encoding: base64
Content-Location: http://ad.doubleclick.net/ad/naturereviews.cancer/article;abr=!NN2;tile=1;type=rv;artid=nrc1997;date=200611;issue=11;subco=;chaco=;keywd=;njdis=;njreg=;crstg=;pos=right;fidid=7;posid=10;plaid=157;prisp=75;sz=160x600;ptile=2;ord=123456789?

R0lGODlhoABYAvf/AAAAAP///wCf0gCd0QCa0NcaIe6Ag/Oanfa5vPrb3fjN0frn6uStvdGKp+bD
1u7Y5/fr9MukyPz0/ODQ4c281HNZhH9nkaqZyOXh7Leu1Kimy8/O5AQEDPT0/JaZy7m73Ojp9Kar
1Nja7MXJ43uEs9bc9EZcq1ZrtIeVyGh8u3iJw5mo1czU7Obs/FRspwwbO0hqtDpTikpoqkVfm1h3
upSlzKm85Ki52myQ1GiJxLnI4nmXx0t8xHic1LfM7ICLm8TU7Eh4u0x1rYep1Zi23Mnc9Kq3x9nl
9FeKxGic1GiXywwUHHukzMzc7Nzk7EmJxHmp16nI5cPU41iWy7jU7DyJxVac1Ie33Lzc9Geq2Iu/
5JjF5MTc7CmMyUac1EmYy3q13Iqcpzec1Fip2GOlyXi84hiMxTaYzEio2Gm13azc9KzX7KSwtgSU
1Cic1CiXzC6k3Dik1AyUzBic1BmYzCKk3Aw3SCyk1Das3ITM673k9ASk3ASc1ASUzASMwQSCsARv
lQyc1AZQaw+k3CSs3CSk1FS85EqkxFa53FWlw3KxyZjC0papsASczASUxAyk1AyczBak1DGs1jS0
3AwmLkS23G3I5YnU7Nz0/LS9wASk1CSs1FTE45za7Kzk9Mzr9ASkzFG6znGosYi2vz60xlilq0qi
p13CyOz7/PT8/PL09LfPzle9tpu/vKjJwwQODMji3WTDoMfV0BWLRBJuOB6gSyebSGO/fSWCPRtW
Ky2vSxIhFBYwGRs/HilaKgQMBAwXDPT89FK3R16SVzhsL2i7W8/lyyVGHlObP3y+aG/IT2e8Rmio
TmSjP3q7U3PAQo3IZIDGRBQcDH6hWJG1ZWWGNn+iRo6lXniPQK/RM6OnZn6AYZ+hVW5vTAwMBPz8
9ObfHXNwMY+MSZiVXYaBOu+uGI9tNK6QXqN7QX1YKamAWPz07JRuSqJkOZZVLrxuV5A3IaJAKLRb
RLNIMdFLO3pGQLElIddbV8wyMQwEBJlGRvz09Pz8/AwMDAQEBP///yH5BAEAAP8ALAAAAACgAFgC
AAj/AEGIGDECQoAAEjZsEAFBlaoRGUKMECHiQYKLE1goJOjggMd7Bu45KCECw4KTGFKCSJnyCIiT
EDBQ3LhhxIYPHnJSnKHjSBMuQIA0adJixwsASIkJWyrMFwB/SJ/28wc1KtJXu3jt2vXrKVV/v169
+vULatV+vNKmBcaWLa1as+ACs2rVn7etWUF8yJBBRAdVIB4IVjniw4cRE2YqrIlYMAKPBxKcLJxh
AwQIHSR06LASQ2cHCEJDAEGaYskHEy54CEGap0+gQomqOIoUF9NlTumWrWoVmNpdwHj729WrV9pX
T5HyBvDrWK7ntOLOmoVrLt2owKJHx5BBgwbLMSeI/6fggMKElCIUluxMcYIDBw8grBtNWqYIJ/Ut
xs+sgEFoBQokgJkEEvDDDwYjUABRCBmk5NpQQHAxFAhGRaUUU04t99V1aKkVXFT+pGUcL8gtF9Uv
udCiYnS1wDWLddcBkN10swRgoAQQLADBBBnsxcCPCn4gwo2kgbAZPxekkAIK6GlwwQUboNfejwws
kBkEF1lJH2n78CPBPjpy16N4rhXRRIRDtTBbVLZhmByIVHGolVYwPkVccbz086ZuKT6XC43T1UnX
K9rNsgEIDYmg4AbvOYCBExhE0EADDIxmnwgOAPkBBRRswEJJKTG2UEn8fPONfRYpoONlj2Jw2T45
Lv/wQGEfCPYgUEMRVWFSTAlDzJ5PlSVnVsAJlxWeU8XInJ/QTVdLdcoC8AqgDmDWwUCdCjYrRwgo
QMGm327KgEcKfOMlCEdAQGAAlw2II5XfjvDAOgskEJoDPTa4zz72bRCCBiEoNMMIPv0UW1G0AeCL
MLroIkwuMcapGzC7SANMV16FWNwxvcxlIlIoMosLoIJaRegsKnYgEwYbRMDpYiuzdFkHDpjgggkN
GGAAZAyYpkpmKT1gpEPrFE0rBgdBoG1iFV0EwT4SgMBXBq31BGGuIKz5VC8qosxLtBFLTFcv0OXi
ccR3FlcoLSVHReiKEEQgNwMAIrDzAYlhwKl5m3H/d0EG/iEw6aQAPuCAennX9y0FVDqQwAOrWvpS
lvs+0ICklz3IAhcSloBwVLysSMvXYF8ntnL+cN1ncB8/xYtxak+nYtsgi76p3PA9YLfO2j4dq46I
qstPKiBMwCjPPz7gpYHfLMA4eQyUt/en7ingAIDYAwiZ9QP7VAQXLKS5KwChq5gL6aXDqSzXtDz3
yukgvg772rRLm6KKxo/AAgM6Q3YA9vs4iAAX4B8GBDAA9kIAAwaHPfGc50vrwN5iClMYDaxmAqgR
Xr0SoADIfOtBQ+GCmSh0FKiUT0XoS59XIqa69tVPY8XhGspQhhxlZad9tPDWYai0wB+tw0AK9E+A
/xTIswMEDgEKooC6JPCtDFCggYya2kQoUqSLSGZVJ0kAZCDQAhDGxnNaS110vAa/aIEFfhwgm5/e
1zryjSh0NGJbtF5xP1ok4CYUiIBHGGCfFoxmAtiz4j6CoYoD9K9bDiDICFRzgcOMoCNGfEBKCnQg
ihgOe90KTbcuo0WPJGAC3WuCmbA2PmI8YxnLUMavynidX1CMLRhTDi9y4ZxjTIU3/WBLLvtBll9I
Y4zUkUa0vCG6w31qXEY8zAdcFoH46OhnAimJJrtlvb3t5QMLwUBH/gOgLvEDMIjKohWxt8BJQcYB
oLTaT1hQhBJgYnzViIY8o7FKFboSLx+SJceK8/8+ELUll2bxRz7eQqN8XoeOKxJQOE/igJxcQDAL
8AwIbnKYIoGGblnKkaUwcATPMOAeIA2p8vhxSQdOoEASMNx7XDaunR0ulD8hZcLi+Yxn0HNDpesH
sYBTl9ftM5ZSaQvGzELQ6exijnV8AGMogIBGoRNyC9jAt0aVHoVcoAEXmICN9kFNyQiNNLoLzeUa
MIHHWeRxLDnJAjL1owZ4pH/76AAIw9cEMCaMGNGwKT2BNUdpaKVYVpEfx/RUlXu+UjlIYZFR24hQ
FTXgcDx6UiM5NbjcXdIBHcWAexywgIMoICR3Q0ACNCMBAXYAM/TSkUsw4NWpnVUBmjTkAXT0IDP/
SagJJIxKPOdZz/T9Ai88Tc5wYsiL3QSLYhWzjln+NJ3qtNEbfcoFBUBVVcYxIAI60lGXOuiRwf0o
AhP4ywN+tDsDOICKvmtPqiZgmOuFJgIZaGZpwbSAz+5MQDAFX13fSZsQ+eK/vuBFPlhJF6qMhSzL
cWU/+uGNqkBlF7iIMC6IMWFiWFgtWgEqMGJonFdK4zvpkQ+Y3hNIK3Vgg/aCLUSNpxGFUOABAGLM
BOoV0Y7mzAB8RI0m1dqAd7wjArDS4s4CBEJR1jW3Bc6HCpesLKj0wmEME0YqlaEMYRy1wCYEJi2s
QpkMlDVL9dLkFUsrwFR4CWqocQ+VsHcBEpBA/wM5mgAJUkAC0HAze/sw1XvoVi/uHiA0XsyVmhLG
5EKXrhe9WsoypLyMKxeYfIDKBW8YEK4ZL4BeOYJvMw3EIyc6UK2/u54DKAVfw5CnPH/TAHmeCNvH
eMQgAWh1gDgo28eEcpRNcMn4DM3rGCHaYVBG5aJTCCc4okzSUSkPQTCwrwmgAAUeWIx4HkCBSUXA
M9p8L19Y7SiKeLO+APoSBK4bPQBZUZJByx6t32oAEILPTJ/rtbzHFmWHCRuVjlYfL1C2IqtMlDwW
zImbURBAfpSzSvERIKYnQBCmdmsBX0ImAjaoSQUI5oonKRpmINDqBOxrARV3AExjWgIkz1veJv+0
hYRtgQwo6+IYGN4NVXbxHDVi2KltJoEHjCceS2ZJgAYKwGY6AGMYV/wirmaAeDqys05RAAOm6mSV
TIXik8DWI7RV521lQ+iT99qV3siHK1c0HUYvJYW/6EcNe5FKVLrMMCEIgQcyoK1GXXEd+4rrZjwA
7QvILQIcvCLHrSc0DFw8AW6lVMUBtIB9tXqa2xO51YrwxXh7vdcaumHXGI3Kr/FGWABg+ymfIaSS
ZMChEaF7Ruv7Iwd0SQKnjzZplqiKjSBqX5nZx+Mh0z+PTJxe1rveEGXrkRgQDEJ0tfzlUT5z0dFC
F8IWhufVF3phPyPa9klJCViSIJsYj9l4J1D/B0bAoCciYD/XEoGlF8DeTbkae281pM4kk8BuXcTP
HtEcEOiata4vv9D+oEu7oB0qchvSh2VIwXao9AxQMhiIYhKC8WwoUBkjgAFmNjypIAHpIQI/8mcG
wg+m8TT70GkRoDMGoABFw13TBGZWF1t3cwCagyu4tWv/Z2hpN3b8Rgucd4CFBQy8lDr3hgGNQxKd
5mUhhiMxUTw54QHY1BiSJAHfAAF+dwHC9wCbAQE75nix9WfqVn+u9mcIoH8sED6DVoNedzJdY2/D
9iYblhY01zANg4QQgBOrQUGbUVr8gBCXMQEq8GwTMHs4IgFZ9FYKIIgoNk7dMi78A1oJEADf/8BW
mKRJ89E9Y7h/4uN/Zlho/aBlUsZoKbRhI5ILcKgLTCMTTrB9lzFR3tceGzE1ClE93ZKHXPVnnRVr
/uN7rcZuIAFx/LBBC5CHCyBbWecTLBAUl5iJKDcjaRh90ycjeDJLo0hWY7g03qEBiXEeqUgRI7CE
G0ASZ6VW4KYqlxFWqsJQjTJNoaEtj2F/9SVbRKZ1QDBCWoOMSyZzM8JvnbiG2PGMogiHDNde70EB
fHEYUgUCRAIBIhB3DNIjIpAKqeAAJphJgSRuI6ADFCBZQiRrixeJsvU4t4ImuoKJ9Pho/jAV3pBL
hTILasiDSOEbauELo6g3hvGHsqJIBRIAxf+TElAjAks4NSzgGRMgW5CjNNpCkQTRhVYkZP5DTX4G
IKEUFMlHgyN5InjxOjiUIvUmZXmVV71QF7mUdqJ3ShlgExsASNYzkHhYVeJRE0+yGhHBAi1AM+8A
EiCQNGpFf5oEVUmZSRuZAMAHGQoUA1YTFEJRBMo3lVEhDRxGC7bQIrUAffc2T/LUlcrCC5K5EpYU
IA3lARrQAQcRTaexAX2IAvqzECsRlHv0HlBFYwqQM4+lWRYBcv2zAM3zeJnkjglwK5wzIfOImFGR
Nr3gC43pmPe2DHolT8cQLbxgUzYVAHvhZRexmXA2H+03ATnyAFJEEM9JAWpFJZ1lIPsAfBz/BHGU
xA+ddADrEADBIH9gyG4KVCYREo9NwF++SRfEsU+50JhxUQvFKZnRQJkxYpl6JTUe0EiaRVEfIIID
8YoTQAEesAIXADAaMALoAgJf8iWXRmb1xUGSGJ6PF1rac4vydzfG9xogeZi+CYrFIZyOCZkL6J/J
WZmSeS0bYRixdwG+k4dCdwQtMAJzlgJjKSQyYaG9GBr/Y27ilJR9dnVGZEXIJKKR8QC6KZ9lWJ8n
0ha+wSzPB2xq2HnRsgu9gpDfVyAboCQkAFWwkoo7Am3Ylx4EsQFQuA5LGYuOaEV3GUgX0SXfwJ4m
uD0KAJ+7OYMiaaW+VJXAtJ+PWQv5NiiA/6I3mZI3DpoTi+M4FmdxFOBmJIA0AeAvTrRBdfN+9MJB
5oZ0ffk4lxZBt/lnkjGlooSiVqocyOVXgDILttCYumAL9QMMgCICBMIP0TQCz+YBJYEp/xGQGfA3
UEWHF7BHq/KkG0mbuvcYhQgrmoQBLQAYVvR+f2o1QHFbrvqq95QVvDAyNOKYtWALi2oygEICdRkA
mtWgbuYBf5c9J/EAhlErFoduqHkAmKEKUPgNDxAB1+UAEUBis3aIrdZWDvCX5CJ5R/A9J9qbr0qV
hspvcaELiZqubgMoD4V3SsVwkgU59/c471ETm2Jn5dgfCgQCP3MQ3wQqkiSyklFa9WeCdP9TN0x6
pB8ZGyY3sdghP8VBIyMDhwyTb2DRSwM4Q7KCQdoSH+2iLh/gHQJrROiUKenYLu5xHiwRKnsTeI9j
qvVSQOg0AY2TReuoM4LpE4RJhhLrs7swq7MqDDV1SgDqjLRENqITGLAJEwchAd91ASqgAoDHodGz
KpSkGWYWiLEXAXUjlOO4Z4pYH41zWg/gP+2mAyVAmJZYpT4LOnDrIrMgt8apDF1ZFTTnJ863kH1R
JNjWKOTmAIgyXnuUPARSu+XJGHZ2ACB1gqclK0vqcQSyWQlgLkq5qpgLG5bYs527b6Abt6O3DJT5
YMxSR7TQMnIzXelhGBRqJJBUiKlgL03/Co6NZyC1J1UKwQJs1VIG4LQwZi+zmaYpoVHFK6U6cCZr
i1ttO7HMCyhwARdyW1PQi1i74AuoKzoeUEARoAE9chkLQBGGJxhstYKCEUj0kRkPMTXb9qkKdF7u
YYKzhnddchDByDMz8AFnIgVAIAVj2H+di1j76yzSUQuiS7cCPL2yU71qxTILsQB6SxJGQnRixoLn
thgdwGk2IQKkAZE6Q01fNQHXCwFeclEJYCAjDIYzcANn4gMEsX/K+39tVJK6xD7l2iINw3kBjB0c
8zoLs2jLoDcuc15lWa9TwxCTIxlQIwGI2FSLAQLXqlE8DAEOIFKoAMV5yB2GESuPF4ma/3TFQEAQ
PoDCLHAE+et1ODUxW7FhonOxtlDG91a30nAM+2RK8vQMGyBZFVgSamUanhkA6xB4g7jEVHcvG3eg
ntEC56kAK+E7ENBRqVKOobpub8XIOqADBKHCLJyJCPYxHPBKmGyxtYqxXXqA2HG3vWBKc+sCJBAG
A4cCmEoCKBC43ZzNJPAD41wB5mwBmGrOFeDNP6okZmoBFYDO4fyjbqbN2hzO8GwB+hwDN1CRwzwC
XDzJJ1fJVvFbl9wLFquSo2h9Z4wUu7BP1Ty3z6ACJBC43KwCO8DNO0ACG70DgevRgWvRErgDG43R
JE3RGc3R7IzRKNDR4GzR3uzRLf1sJf9d0RQ9ZyRgA8P8z/t3BFKJmAEIHM08RqPooqlUt6CYFsSg
DPNUBJ+Qay2ACqQR1VENAlIt1aqACU7wCTyKCtcq1UfA1S0Q1aiACqqACn9R1mZt1i1wBG6NCamA
1mWd1ptx1pvR1nVlv0Cw0zutP8c8sTfIAcSRC2o0q5t82EardmrHCyxXqz7gA1TQBJ9QApN9BCxA
BULh1iXg1k1ABVQgIW7t1p9AmLkW2pxdBKYd2pzDBal9BJlbV6ltv3xtGDZgAx8wzCosyYNan+Ga
Fc6Xg7RQQzGCIisSBVHgA7kyFCwQBbgtAk1wij6B2Zl9BPfR2Zhd2qFtv9gd2sZ4BND/7QROoMLh
49ZO4N0soEj+zNc8zQJ/3cJYYajUKzre0GT+IDpbsAVRUIyx4QNRkCAUIAuP4t0lIAVSoAMi4N3g
nbkRYhreXTBDEdoBPhQlh+DUHT5jCCneLRMbgd4VWZG37dcCXZ86NScn5HwqAlR1AV0rQgREEAWa
2wQ+8AGZsArmAd7eLdvgfR8lcCY/cR/QrbZSMBE27gTpIQW5Vt4u0QRjOIYZ7t0Dgd59vdeH8Sm6
3cJRoVOGauIrguIg8guicwUtTpic4wM0zilIDt5nogNScOCmLSESAt6nKAJQKQXkHeD7x+aP4gRN
AMlUjgEl4AT67eGKxNf6c+DzCBZi/wF6QP0KbZG0cXTDgkIVZaF5tHAFV7AFQPDZESIFmUABmSAL
5U3kRN7IUoDk5E2Ym03eajveCF7eWOPWIkASS47EB85RVTXot83Xn4LEYXSfHCNMPvsKRQ260HLl
4poWgHIFWrAF0s05DcopExDqkJK5Ru7WIIAfBfMp5U0aDp5rneHqFOES4o4u4Y4fFSoCS84YjezP
AM3kvQ7Kz3E2r9oPmwyHxC7vLikicWTpWuADIlQE6ocBxqASRQICmNAEVDTWU83Z5s7HbW3jDt8C
pEESSMzHU23xEi/x3E4RSn7efU0QS37Mw+EnvaCxiAkMyMAwDdMi0iHvHaLvNKIFyv++BY8tBbCw
AbIgHghvGoAuBeqR40SuEAgP5zmeK6J+H+iu5EhPEUBP5KZBEZWY3gTxz/oTye9ecyY/lb9AtLe6
n7OQb7/wOjA/HTM/BDEwA2if9mq/9mt/9myf9m7/9nIf93LP9jHwASXwzyEfRkndMfX5FVQBDPXe
MLggOnUSgNKwFQgd8/g9BDOgCiygAw5x7apQEg6hCuD9ASxQAzdBmiJwrwJRA3InAymgAieQAjWg
A8oUMCNQAzfQzx+wAkzIAnGnA7C/AhtwAzoQMCHwAVcc+Tqw5JG8a4DfSsCQ+D6oS8liaM2n5Sqy
C3ZhXDY0nLZw31EwBC5wEKSSh9z/zw99c+2kofk3MCS0Hwwg4PErsAM0oAI0sAJxVwMqIALuT/sK
ofr/3PsEcQOfYuATARAsRtxgMYOgjhEjgGxgAULFCwARJU6M6M/fLoy8MG4E9oviR5D+APCaVbIk
LZS0cr0CCRKYLV26ahHZsmaIiwAB+I0AoSonP1UdQGAQwa+nEykYPuhgIaKpqoEeUqjIcSLFjRoh
PtzQceNDDR0fEt4gK+LDBicrbqAYoUrgBrM3NhgUqJDFXYcQW0q0uIuXRo0bd3ncW5ikyVkpVbIs
LPFlLV22tmyhsgKnzg4jOuhU9a2DExAinLQNChotaCcMQ6BIkQJJihMhsq74EGKt/wcdtkdsCOHh
xgixOpSKRbFUyoeGMz6ISLgQSMMdegv3DYxR2q7rjBtTFMkr5cmUuQhvfxm51pYoVIi48OwTxAid
IECkCq0KBEIMTkAPBRF8RAgVYKCBBhimsm0Dr3L7QCyyWLhhBQ9CGMGsBaUALqH3nDJIhOc2eI6F
Ix7aDoCLqtsFGBRPHJG7kRIzSbFcgFmxPJnQUw8nfvjJyQkW+JEgx29UUUWEDZpgQSyzQGhKyd9Q
yAEGJGBQQYUQdFihyoRE0GqFLK904gYRQKiBK7K4LCos5QS6iwUgmgAhuhH9yWXOOXv56y8ZV6To
MJPu/KuXXHoR9BeRXLKlFsiiiP8CCyMu+ykAtHIasgN+nAgzlQntU4onEBCkKggaTrCKygev/G0F
FFDQoQbVPsBt1Q9Q3cqDEXT4TDmn7nrOTRG380cxWo4RVNA89ZSIJERL4gWYjIDtp9CPXsEF0VoU
ZfQyHXMMgCegnAhKKRGg4ikASy0F4QYVaEDiiykKTAGFcyPUQVXgaKuhhqUQciIDhLxqytIQRLgB
VxaaEEGK596Ubi9/fslFMWGHLdZYAHaxpaRacDlxo4dRysUbaCnyZpZko1iDhUZ1VGUfoDpQZQP7
IBBSPhCc+OyDDgS2lAUUVNghCHZDpWGFKVU4SwUPuEw61gW3GgGFGo7QCiHRJBT/QbkSDG5i17zi
BDZQYY+Z2Fg+EzMxl8RQ0u4jYKZFVNENMnEhWwxA0PY9IQMYSgQRPkOorREkcOIDFNTlgYcggoAh
hxtO8ABfEZZ++sHfvPqPLeCcCOE9HXTwTbkj1pQCr14b+xVGQImlmMSKSU5WmhR3eThtQlsCxvVq
dZClUZ1yDOanIXlyL0Oi3BJIPgBp4AGNLw5BIoh3ZfOArQVvsA3qBaGWTSuyRmjqeIGUs9QpruHc
7hVaEMNl/fV7WV2kXoQRRpf5A6Uz/ZJwGXuitqmNYhUH8I4fm8lWtxBCqbqFxiiiSY3mPKCCFAAt
FGh4Ag1yMCUUrIBLnZtSCDRI/xZ00eY3F6pLT5SENb6xYHS8WthevAETagnjGct4hjJ8sbqI+CIa
O4zGMxCDO0TxYi+PSRQFdoetnCSxdx9wQgDcYjzmVOlIyQvCE0KBCCTIgDXv6hnUIvTBG2BAQo8j
HG0awoINLEg0GwCBQcaHsIIpbESPkQn9lnHHZdwQhzp8xjN6+EMg7mKIuNMBBSbAuwCkQhU58onK
zNKQIXXKUivgG0KcRIMvhOIUX0ACDcaUKhY8EFWqqg33UOCbHXjAQV2p0gekILCr6SB0bBpdQ0pX
mFfAUCbCWAYvbYhDABxjh3704Q8PFcQhHiomRjwktr4hgZ4E4BsmPBIIOgAzqP84QThDQteTvpCI
U4TiCzDomQpSpYIr9Qw5NXggVizHlQwQhCHVfBnoyPehrpEHMnXkJR6JAUwd9vCPP6RWLYTYklzK
pBaZMKIAGykkIAFlSA0J15D49hVzpssKlWBFKLwApamYM4M1KI5sEHIv2pBRgxNSkvDkswEZfOAI
5KulHE3Xj1zgghY67ecyfolDYfaxjwQ9pi0EaTtcuI4ChmyUZ3oCFAm4zEdBggpypKCkcOWGaDmg
wRPQEIpEVOEJMLDKDmqAtLWM4F1UGmUNRrmaBW0gN3EJRhs/EBoVfihELQwJiSxCImTgcRn/BKoy
aHhHokKmFkcFCU5TkolX3gD/W5uJjxOtyY9UpOJ4ozkSmFZwAhgEoRKhiMUpTjEFGRToBBA05wgg
uANznhWdI1garLrCNyXpAKYyLYFAgNAmm1IssHf8qbFEcgzBCiOxyLRdx2bBTEQqkZFFwS0/ggEm
IgHHg6k6AQ/iwArwoiEIJqABa1IlSpLSRqRQW0EKpPA4rXhPFeNjogt0EJrfrjCfwhUsYY0bTMEu
g6AFZWy0OkYLhjbzUUGxT5i8JSRVYOBpcj0LC4jmpCccAryH+ChsQqoCIpiztr1BAVkyiDS2HAED
NwDBEUaAgQ1gYAb33Rocm3AE8/GXuHr87zEMe0dh1AIxtVCmLQ7aWMUstQmS/00iUORjn56gRQS5
6VwIBsecK8FmCppkxSkOQSBRQTBVRFPBWckiFdaYczUnHkENiBQwEDRhxnFmE9duqafh3tG/ejpu
gIVsEiIjyqguTB9KGPolR+noG0axz2fkkyvC1aYGru3ZumLRZfGSdUBTSdVZe6bBjE5pKlc6ywhW
sAG2GKw/ylESwnbVghwbCxm8FEZx+QyAXvy4l4B03SwKTBFpmYQCkXWUNO0WDLdsoAMYQEhYQtCE
5WBwNUpAwyFK+wVQFYhAboVgCmiAQaOZt9sqGGGtvBemnsy5zghjIQ5n3cs8vg/AguW1SfbnGEJK
oQRMllS2cjZfJjrlcb9RZf8op5SDL3wBvKwIKw12cMHywgad0ytne2kwlZC6Vi1wEZJqZjCC0P22
fHz1FS6AHG+KHVfXyq33LO4dkf6VxAYjWPLcdLKPRQrpGxKujQ6Ykxt2Ei4EKcjBE7xg2o5O4QlK
uLhZW5MCDbLGBGXutrerwtbiIEdNookpj4Bg4/3KWn535PGtkUtvXgv55QBom+t0AASBXSYo1vxG
RX+ePbl8ZS07QMEOeGDF0k6igjI4AQ22C0FR9l0qVklBgdKVgu2BaUh3Dc2MQ/7bON55RbgwbK3L
viKVo73eL/dHP0hGsrcjOidCERwGcuRzqNjGgwDSSqoujoSvnmIScZjCCXL/YF4aPG4HsLV9EE6Q
WhjAoILeLm8amejoysuyzrs6AglIbjpkzLCGewY9ruUnP12kDSWIoQXpvXFgH8Cd30ECQXt4xDey
lFEHIt2BVZSHhlOw4hCImIIJvH2C9pISUUsX0KIBJZgCJHgCMVgcFQDAWAkYs4AZJwCdrcG8JnAC
63O3YYoG7ouTkYiJmLAFYMGfxCA9fwAUX8gFhai5HMmRo8CABJo/VEmB2kCnG2i8wvu7/GMFRBgQ
UWmNLWqv1rg4GEi4LzA6Hki+AiELpjALfZlAHfC6rysYDLy+xkCGHvKjDvSVDwRBXQCWk0iMX5uI
XzgGOnm7uAsAoegJVQgB/0gyCwxCAQ8SMQiSgcT5gtEKhSqAASXYAXfJqBpgPq56gilAAy9Ag0r4
gj10vCthDspbkBnLGpFrExHIwNXBQj/iQHnjBS8UQTA8CWAImYmQkzPUN0SSqJnBrQ66DSqBPB0Q
lSAwxEOoBDF4ggoiQNgKlRQYghQgLx7Aw0MAJ/BSRK4CwFqRixFADdChpd8qAViwROHKQk1MOVzr
xE8stLUjxTlhgRJQvd5xvX87F6hrL6gxGpIKFRN4gjj4glNgni9gOqngNBqYuhwAlSCYgirQsFjY
x3CKA1BRJwwhEn74gBiQJSNpkyNoAlmARlkTqGn8L04EwVr4xPzJxo7JBf/56AAdsLkGm5n30ArW
upKzeiATAK0ERARSqAIruLjVgoHpqQoZ6IHb8yqOugWbtMl25IF34Yq2kCvmGAEZsJUW2w+FZEg8
k8YtHJGIDEGP+Y6K3AuHUQlacIIjUIUPkDvQMArkWIF5Ya1uC0QISscp8AJEaJ4nABWr6LteLLwT
eAIrSLhwYoVkKAZnSIZbCAUkMIEc+Aq42I9UIIoZU4UWoJkWYIEJiLWj7KOHpJiljAypnJ0/0x+o
PDDmSEM1lI/82I3HG5XVAMCpgAETAJonEKsnSK0cUIJRaQ2IgwEeOERWiAWbvKNiYAVSOAPQVBU1
EQjQUAXlWMOhTAoUsML/wsBELQSmxrSFh0nOkrgYl4NKxWixFkAkmpkvcfy2d3mXVHq8JEQcTuKB
PTQBwoMNCypJdbGCBASnW3iGYjAsZbgFVsA2dPI5htgJZfsG+0KFFmiBEsivBTDKFSHOxSQba3zM
05sFyWyJqESJjLzKHNnNFHqgnpEBxgmB1WrAARlENJgCxSHCkjwB8hoQAlE+NEgE2Dws9by0UEEa
VdKP92CBfbganJGPCpQFDEDMkLCIhvGHVwDQpNyO41QJ5TSJAwUJbyg0WnATq5ybVHCZWgmBaYMg
q/iABvQw2HgCJFiXKpjHi5OBsLSKE0icHECCQiStYigGPCqGRPgCHpCB/+ALC8objXQTyhaowFXA
gDAQTr7gBUHhhVxYBofs0cb40fshwSFlm2OqBUjayNV7mSEhKa6qClUyp8arCsThASQ4HB4AT6Ir
vAbMAdiAEho4hElghVtIhjuaoWQIhUq4OKOpm4eypg5QDvyMs+fIhBrF04rgBTOck2b4U+O0xuSc
nadsiX6AiZigmavkDIDzCj80QE8FkCnx0NA8widIQiHIARMQEFGBLSV4ktCUoFgoU+IqhljQw6FZ
gbtwPR5ZtJqZsTWssUxYSFwlEUChEz/lIUA1DGClE/VZu/KAjJnCgKYaEvuYl4cDlaFZjRRgUxiw
wyDIgSpIHFBJF6p4kv8T2IEpoAEZMLoqIIPXLNMZuoVL6zCo6w8WWDQIE5IZG8yQ04F49c+QqNc5
8dNMzNe94MR9Qs5BxZ/ySyYQDIsNiK5lC6XQstQc8IDhW61erCKgkYF1SZwUCMR5lFDXUBcRPQWb
XM9isMtT8AK9VDOaWTQnCwoXuIEjmMRVYAN5jROZpYVexddflUggnZNCK0GfjYzOscyeeBoaSJzk
OwHZyoEVeI3QhIGMnYKq8LYVIAFRmUcB6dsq+KrXDFe6FNlTqKASi0IRCBIRwAB2FRIXkKnpy4R4
1byQOAYgpQVhQErj3KeYoJMDSwl/dZta+A0R4J1UcIIVQ4HuOssKldT/vu1bGDBPpvu2bzs45vM9
JYCBRMg92Nxa90yDKjAB7UHXjGQwu8mRsr08IDCCeA3OOIFd1RWqZ7DZluAFY3XM5JRKj/FXxHCl
uPMRvtmAAJkCxEmBHaBS2ACV0bQCKMgilkwBqdA21vy7yEWE17TJfeQwqpgSscCAFggGqYIw+Qhd
J+CC/GKDl51XUpTK7KOhAPXAxpzI+4ndteuHpCoJNJQsHamZ9voCCvLUKfU9ArHSBFw6aYWN1cJW
GVjeKjqDTMq/S+uodiQnDVqBpOAH0XiyRZIoy6szHdDgtTUdOUldGZohZTBfFhFU9r3ItQu2klCI
NOyWEKCBaquC1vjB/+4akCu90myFnqlI3MYjOsNVOi8IBTzuqFnU0IvNCjZSw/mqG5WxJlXY3jr7
ACmGWe7gADOUyisuTmrkBcVSX/FtX1GUCGn5M4RwEJzQFBWAYVJQnMXh0MRRF1tMQuhhS8ILFeNT
Amw7A3HKpERcxG+7Ad8AgQBgASdYNAxopM4dINARuUxIZFztC7/wi+Hipc/zwPj5Pl0YVPI7YRLs
HCAIgblRkhDgAQ07BLJiSwGpor9jWi5tDVEjPG9OwL87wgk6BMTxVOzpDRuYOxPKG5/ICUP+LSPQ
YApQ5MbAhe8ThlwAJuSiNWF4zPShFltYuyI1iZmL3wDQgRSogo7KtP8gAOALHU1sCy3YkAEdDt4Q
NcApUNMqGMsq6CQmcKsxIYvNabARYCRVSAUdSYVIxGAgYAMNXgV+Lgx//r6ABqrkSt2DFjRpxh+E
aIKUgYAaOAESjYWx0tZs5YEvVdMnOIOV9EFQ/TtSyIF2Sb50BpooydYOgiAuYVHcshsnkIAmHoFl
5IIoJub3wQX6kZ+eXp2B7qWCZt+CKlSRmWamsOYAwAAVeILXJIUKGmkl/GpCVBxQ0csaPoPIPYQq
OAPFwegqOJyxkuGKa8S6aQt+8Fy0/oYA+IAmKNsSwOC23mAcsoV/XmYuPIaeAuj1xZ2EJjQXsQGm
YGGHeAL3rAQg9oL/MzhLpasC4faCLyCQ1+hbhUNg9wwF8GJabPNO4/u9i10t2VCBMwKN3rkb+LDg
30Jkt065na4featruYbd08uYUCRWElwKTg4AEZgCViBXQ+TBQ0gcK6iCL0AE5qnWkkQCL3gCUyhV
rS3VWDDEt4zY8dJFclZaOdwbyvqJb2iLALA8IOCCfL7pnB7Fv/oFuAbBub61ZuZpQWlkxJBmk9hk
3hGBICiGWziEMVi4UDgEPESD1zwFTvCCyhYrRCjRACPXTRIrtPzb62wN6vUgFuiMek6iGNOJ7cXg
C0ftFakdf4DrfToGeQvx+bETLSfBnrWdurVtFrBmfmiBWHiGu+QE/9hkhTNAgzhAg1hIhva8tEMI
RmszVTyaIRoi1zgo6cNBx4sbQk8dE8/NXiUikp+IqSPAYJv+bmPhcC/88O7Dcl2IGEEZP7tVb4bW
gZr7Bie4hWXoqFtgcWcoBXYs81NdBhYX8ADLQtks8LNUnCd53P9TAd2ScJ3TCb3ZAB2xZ7MtgrbW
5wwfRRJpGy90H2qU9GPQUz3l8jHE5LolAhuQAr+WgjLVMBoyc1P42AA7LMHyo2zIhh6ioVtAg98e
LwGRkrNKS6ZQhR+RLqDQgV3n9UT/9UzA6Xkd9n7wBmCgBVvod1sw9v+Kn7ie9GHphe/ociQziRuI
dssIAFgQhlQN1/87ugVSeHPt23ZvzwZw2HhwyAY8Z4UpUAIluFJp40rIAYHfyZsm2xZcbrLQPYIi
uHAMn9d+MHg6OREU6YjWpZZZKHiDV4zZFbKZ4Aoxh4XZPAUz9SlTMAU4B2E8V0yNB4dymPqNj4aJ
z9SLyzpTY4EEohQl+nr3biLpKttPsPBFJ91gZ7sDy4V+AKY9AbRZoHRAUYxmhzlc6Peh9wHL4Aej
D3D2XAaRTfphwqNo0PippwfELwdwEHfFUQKkOQsQ+Gy7AXuw7xRcV6LtrWlGWHR7H0VCEUXHSgmQ
uWTGxJiS8HkTJn22O1S1sJK5gQWbvPhiCPA7KnyPF6xokHp6KID/Aph69TSFMeAqCFniJqZ8yocK
mI53Xm8CKWADRth8DWbI0qudiQh9lZAR1deTXfghSkfd8UN4tsEdIiCCVcEJo8dzM70FUzDTZ6h6
E6Uhqef93m/PREgCUguT+Gg/1zN+6QKIEaoCECwYgJ+LG0V0MGrIhk2mFC8AUKT4C4C/ihhf0erY
ERhGjSJHjszIaxZKlLmOsexFa9ZLWiBJAgA2qxbOFUR01HARANayoMtu3TJ1S9myaOCyPVNG9FbS
cgUK0Mt2K9GVGiNYqFIFQhU/fiD4HTRoliDZJiLOok1YZFVDh5lITKSp0WYtlLhAZrTrF6M/YLwG
D87l8SXKvLvs/wLDhbPWECI2evKDJSyoslhFiwXNli1asSdnxsSKWg6dM1E2BGLg51WCBLQEO3Rg
axYDC9sEZdzgYiRMXIh0/1IEZksXcluL+xJvjjEmzFq6pNfixdgWTl06b/QMYCya0GTFjgZ99uwW
jBMpVAgx5b6UqBsYuoKQTfbsfd2qdORn64IIF2yEMWBDrrhQ11/GTaeLLTM559wviL0kHXLVMXYT
TjfowJML/BjzmVBEJaNMMcWYgkMNIoDwgQg6GLEBBhKAUF9ZAUwwkG45CpQjQkRQwciABLIhEQdF
GnmkkbtgVwt2uyD5JJRRHskRTDAtiRMvUuKVoQ08zQDCh9Ews/+Mie4hgQQNJ3iAgg5OfIDBfPTN
6JVXLXSTCZ1f6ZknnzOOIIJXewqqygw7BRkkIy7EsCijjTr6KKSRSjoppZTe0GUNMczg6KaMzrAp
qKF+Oiqpn2paKqqpqppqDETc8EMYP8gKK6KMPGSEEZnoumuuu2aSa6/A/jqssKsYe6yxmawyLLG/
9rrrKrJEG60s1UoBBBdcAAGEqzbY4OqGOkjhgw9AULHtCNtem64U7UoxQrjhSqEDuyPA6667I+DL
Agv4StHvv/2GG0UUNhBcw6wJ1/oQRL46zOzDEUMrbbXLJitxxNVqbIwsHMNSBMhFcEGEq5fKC8S1
/G7bBL/8stz/MgtAxEsvECqrzPLLLNfMQglN+NxECSz8XIIIPmdLBdI+rEEwIwkrvLCtDEs99UNR
Ry311a5orXUmrnTN8NVUR+0KstNGuy3SVJAs2Q1EEDwz3D7IK/eGNlx6aZczm6sD3dvqgDIVMf+9
7srbmkuuDwQTbIMoTjt9KCOttMJGK3FZfjnmmTOytdaXY605kF1vzUZcRviQttok39A23t7ybbAO
BQ8c+4Ztr62TqwUbDLvrUcTNN+10l2uu4opvEQURjj+OaOWVX34o9NFDH7nkrlQOHHCSSw6k9AOy
oXUrrkAeReJL43776niv7q3dBq/vLRErDKHT/CusAP/dl0ax/77+BPuQt+/kBgS5EbB4BDte8pSn
MFiNYhSMcGBDgMO97lFwQNqT3PSoN0HpUQ+DiCLY0qIwhPmtrYSs65btvuWq+I2whUNgQmRGWAPJ
rM127zPY/nwXvA0F0IBRON4WRqHAWcWKQA+MiwQrqMQOXg9ylXNgBS/YigHRSnFLI8II48fCEpYw
MjW8gfx2wAQm9GCMPYCC/ORHhC14UYtsk0z7YhfADcnNdz5UHMKUV8RDjUJ7EISgEilIPetdD0gN
0d4Goxc5QjaNQAbMYgxbWEI13i6SO9hBGZkAhR6I0YVeTCMWVVeygumQgFSQQtLuyLRAEoiQ4ePc
FFkZvfCtgv9srpSi9RJ5qO9tbYN8W4PSXHgFLL6QZJAkpgsvqYRlQiEJSsDkJcvoySye0G0m4xvd
/mY4KiROaeT7pi4Rhb1Fcq6WxnIF6NIZBrIdC3yv5Bw6QffOeBqSb2lrofxiOMZItnAHyVRCDpSQ
BUUsUwll7EEProDQF86vjar71tvmNS60AaEJ5kJd2nxQtY1ajXSkY2fZzukQW5HUoyUt6feMYSxp
eY1rIHUF1UyqrGN59CF/u+c0R9gDT8LQhZwEqBLIINQk5ACaZnwhGY3ZRhv0bVtC+9kRfsYFkWUr
W0WQAkSEpVVd5Upj1TIGWMG6LF5h7Fm6WgUswsqxaXm1Wg7/Myu13OqrJoCMrjkdYU95yoQdPDOg
UxjqFArKV4SSMa9b9NYN3rYhwz0VZ4Z7LLZ04CuzchVayGrrKoRV2cly1ghtlVbZKLYszTKLWtOq
7L+4wLK76nSfDB2CMnOAhBwkQaiBnS1tEaoE2A5BmktdAacWBargdqpSwj2upjwlqeE2qlPFbS5y
KfVc6D4qVLtDZgvJiNcX7nQHs0WCFYQqVCXMtqDL7C4mXeg2IsQAHvqIhzzYAQ9zhCMd4zAHOtgR
jm1MoxrTEEc4xEEOclyjGtjARjWusY1wYAMZwpgGMpgxDnKIIyjJYAYyxBEPfVxjGc5ghjCSId9x
CIMZxRBG/zGSUeJqhGMazliGOMzBDggzQ8XTmEc83lEAfMjDHexQhzmAXI9zuGMcER5HONRhD3u8
wx7qYAYzrhGOcbQDZTLb7hCuwFsz/hSgSPireMkb0POSUYzazSLJdABcfLQjHeqQbzvaMQ8g4xe/
AOaGfmNsjnGkwxwYFo8wXrwMajCYyO2ohn/JEQ52uKMd3KgGOZqBjGvgowDvQIo1sMENaAjjGeaw
L4LF0ecCT2PB5Mj0OeLRaHe8A8njwAc+1GFfFIt6wuJAMjee4QxqNIMa5PDBvLjFU4MWtrdjzgGY
yTCFKYy5oLpdaCgjE7sbxCAd7YAHO8YBaXSYQxvhIAc2GP8MZHUgWNFTDoeBW3xt+p67G+qAhzsQ
PI0GWyMc4aCGgzFMDf1eQ9L1FkcyIozga5jDHADuRn+tAeFmDNzAjEZHf8eBjnZ4exzYEAeAr3Fg
bVQDz+TAdzKwQS5xEeGMZS7jbv251x3INtlkIOqXx8zJMms3lGlm7zzcAY92AHni8zjHgOWx43vY
4x7ldod97f1nAItDGM2QMjZk7Q6dPxkb1qjGMKQ+cGUIgxoHRgd8ZU2OZYQYw1dXONaRLI5MayMa
1qj3Ngo8Dnrg4xwJbsY0phGOa0CZ19QQRtd7PYxrAUGEMByjGXPAhKL2YMzLFu8UzoQE8/bgmQb1
JxSyrJP/LlEbv25WR5ynfo44o8MdoIeHPEovjmY8fcBkF7E7BkwOPpvjHfGYRztMj3R5zGMe3LC6
PJjMDnNw4+3WiLA6Gm1vdfQeHeRAh9qRTI6pqyMe8cg9Ou5haXSg4xzEN3DEG11ganAGGs+ARjHW
pknuVv6gZMzBsZWQ7GXLn7wGNa9Bpbk2plIbGxieRvC1QzNUwznYAz40nTNoHDUs2MLhGzPUF39V
Q4zNnjmQg6yZAz7YgzzEgz3k3DxoGzYomsSZXsG1QwcSnQFqoPW1mZulQ/c935K9QziYQzvAFzq4
mTvEA69BA5k4gy5QQzqkA9PRYH9NQzEMQeaRUSY9kxgp/0GZWd7jjVdgmRcMsVwm+VYWcV4MMJx/
6R02BOF9mYM1NIMznNiHIUOmYcPfLUO4jUPCBQXUNVk8tKGiAViSNdq1qUMGyoO9MRo7sEOf0ZeS
2QM7SGDAFUPw4Rg8vEPvzYMGEt09YNzfUQP4JVg3YEMyNEPIYSIyXNjADIFBDUHs2M0K7Ja3FMwW
gIFQWcGyRV4P7AT7RAETsA/foJkNAAG1PV+QccPzwcMi3t40oFg0nB+3rV4z3BeFkQM3TEMzMEMz
CAM0NEMx8Nrb9dqLiUOjMaI8iODwjZ47oMO3nYMLFtw7VBrvtYPtyQM97Fh9vVs8iIME0oMG2pvf
4Z04EP/DOMyDPPjdgKkYNEzD3gABKDphvLTNB+hALOrAFbBi5E3BLGZT3QSQ3MDQ5uFiDAgD1yWD
M3SaMyZDNSAD2TlDNKLfiqkhMjRjJ57YMkgaJUaZgX2aOiDFRi4Dpy0DB27jHU5dn70b0rmZObgD
PF5cOrCDPOxcmyVfO3zaH7oZObDD30EDM5RhiFVggWmcplFg34CiP9UN76RP8ZCBFUweFHSJ63SJ
DiEkQu5UZPiODWzhSiaDijnDM9DkZcglNPAiN7yYoCWDUIRYXC7DM3idGgbF1VGDMwqaxr1dNVCD
OGjagY3hNKhYUJRdoC2DMvAgXJIh4HFaoKEYp0HD2/n/ndWdQ/ftWJO9A4Ul3zk4A/DowEDuAEJq
iN20DsGsQhRcQeQhgWTEJluyD+yI0DBtAVN9wEU6QzNAg4qZx/nVpYfxIDS8WDQow2Wax0ZqpK4F
hTbgF69hA+tdQzEeGL41w1yiny5AgzigwzBCQzRagzNSw0rKpUg+QzRogzKmp/H5V1U6gzNoAzpw
Q3+uo/bRg/Zpn6XFgzpwQ7jYQOMhQQ8gJFneQOUNAQ75DhFMIS16CygOgR0xVRRkHsmQZQxYJk3G
5YBpQ1CkJ3g8p4cFRU2+2D9WgzWYx3ry2jOEpqKNoTXwmlzS5IlRwzCCx34mYzhwgzJc52U2Z1KY
R3ae/1qE+R3GnaY+QuLQ4UM54sOA3kMd2QATANQsxtEQ8MATTIHbKE6F7paDdslA6qbi8A0UXMEW
LEIUWCQa+heAYQOLNoM1bGQxjCE1yCSiOeDrvSFNyifHWV2vYZgzMoOvicN4GqdgjmF8ut1grqhI
0qT5gceg4dfxFYNzmkeqnUOJgd457FjwyQOsvQM9AJ0U2M0HDMFs7QDnbQh5gdeYEgwRTN4QJFZs
FhQSiCJTUcFtXsEiHI8UREEMNBp82V47OJ/3mYOeMp35OcPGWV3xacPVnSc6mGgxXMOARUOvcYYz
vB00RIPb5ahdvp1/qgMPmsdxFulMmh80FJg1VGu3nv8fvB7YOfxcarIaPaSq6clDO9wDlaIDLbLc
MtXN6igBD0zBF4ypwRDBMsFibDrTsl1B4mzIKlzBKMBpnPbftcnDhJmbjhVAIU7DDYqDcdbblA1Y
pi0jjA7Y300j6w2c2R2Y+ZkHMrxorlmD20WDZLKoXpZYNDpDJsrlMzwajOLnpHGftbqnMzBilb6D
m9HdgCLo/twAUMEqYtmA/H2Zw35L5Pnq3fTA5Ikp+azBKuhAAy0CnFJBW7rD8TkDIJIDMiCDYGIj
O+BlHdqb9Mnb3B7Y72EDkaEDi80bjH4bkoXD68HjfQkhhYXsn0Gqh21kpUYD4FHD28GjOHCDOZBm
5/b/J0Zi4znAmjokGVXYnjqIw2xqKRLwwA7sz2xCwRNYQcPqzrcAFBzhDRRMAStuAbDqgLE0UCsc
jw4QZzO8JYS9nRrWZaC5aNAOGp7+Wb9Zw+U+7gyKoDMCGIFFmL7VoDq83UYqw+C27Axag4epWDEk
n/N9HLliozhAbZwRmfepAzrAgx7OmTucA++5Gjqkzw0MQQ64LmK5ShJ8GRJcwdUiz5nAav/YwBBk
wfFEgbFIwSo0EBHAqQ9QmzBk2jXcl55dQ91agzKWnjq8mAhv7/GGGDh+sGXSHrd5nwuSgzlIZgg2
LpF6WDPS59o1gzbkXjDSZTLw4nl2bgXeIDuIGmnK/wPHccPmInGcnWY7yMPvaYMzvI93PRP/cO2y
PcEVzGbbnImYts+E+k7ZrK1wUoEOxMC3BRjT/WmEydc8iJo4rJuBFVi6iUN/hRs28FmSwZuiccMw
VAOULQMIR1hK6oKKrdgw4JvKGu7x1RgyFIPabSaiIViUTVobThl+JZ+OWSmTHRjzrWa36MCsKkH6
eEsSfMEUPIGEDrBsTV5i4U3xlPHGuorcxIA5NFjeVYOkCcM4WB99kYOjHl9/JdhJjiFceljDdUPI
5p6sDeVO7tzAIRgvPt83Sp/3VnKfQVgxJG/BgV47yJusfa81aEM6cEMzBl+VluqB2d47yMPqIKRs
8f+AEoixLD7BF/RqwVzKrX6XKfvQItjmsYzCFQyTDUgBta2xOCwYglUDn6UDZBZhpo1hr+Ep9qLh
gRUYM9jePLzw8DWYMFRfPLzwMEza1G3gBw4Yjr3D1zWa9lYfOIZDs3IbOoxfaOoCwYmDqPaetl3D
21XfO3CDZOyPdwWBKddQEoQpK+dPPy/bl0EByWzBFYhCQCMLQWuBZKBxDJADiHUz9z4dul2di4WY
GS6DSxqYEMLj8dktg/GxzqHDANJYgR1YggFi6aYDOUjgBYrggZHDNiMfXg+glIWDzgHsIsKaNjQD
N8QZgHlfto5w90X25NkfEjzBE3xZK66yAUveZC//05lYdpiOQSKIAkjpwCKAARhcwQ34QBOkMTY8
Q4jx4DDS5IEZp37SJNNNXb/B2JTpw3wFBTXSJzo44jsgXaT12mUUZqZhLhlaZr7i5ITdYTscYly+
XXZyH7bZNcYN6LIO6FQQ3ToWwJXOahBYNpha9iqDtgEzW27eFoNqQTMJlSJUtQRLwSJAgYfawEIU
pybqnTUgBSWeWmDqZcoWnInWKDb4tIF9pE9zgzZYHZ/WYIU5A+0JGBUP2koOozPkKzrwacGdp07j
V8A5w9qNqj1wmzokH/1mn3h3t3hThXe/+D2gA2eDtmVXNhKocphOHmcHVkPWam0KdNp2aBJERmK1
/zYuU2/6fttK8lozYGPqTpkZJmWB4WmvJZzNYmSqtYOA6W9Hu4OMwQNeT1mMaRuk9RnQoQOCkd8G
GxyfQZyBibBVgl1/Din3ze880MM7n0O/Qu09CKh4QwOOR155W/YX4LNmTzZnfzbv1qqQG0sUSIEW
OOEwRQEVHEEaMxh+vuxVMikzcMOQtvEeD9jAzZvxeVvUBaKbTVyPFRmi6dw73Fljilq2fRuLhaGA
6XR2p8OqJV+joZ463zk60oM8NJnAUuk8lCOg34MzSN5l37jkqTJmz2qPJ7USJI4dQbpt6oAqKoGW
GUxF+UAM3F4HyivrjcOSweN/GdwGsqDFWYM6r/9bwY1etlpdY3KuC+IeCFtDHpIw6VGYYw9Y8Wka
fmncNWjfNpLD6OEXOopj4NLnL7eDXUexwz8xk5lDZdu4oW/xZvP4ojOsFbjp20hwFLBtFgTWTpGM
pSO5ThLlzsXDItpDPOQZgI1DN2i6MdO14ZIDzFcfxTGcDFcfvAUhUsLknSla+L6bACaYvQkdPZQu
HqOhI/o69hWYNoA5kSVf6uVvaE6aJPYaPmQ8D+Qzw36BFaj3mQRUjX+BKi/bGCgC3Mc9WDrkGUE1
+QABpreXUubxpzUr08mjPOgxd7ojrCMq4AXcRt+eCOIYO3QnL1v4wPVho1Ej2XmdBM6gM0Rywgn/
GKgb3OzJnZxZK39ywxRv7oMvdhQzWTs8wTJpkutnnmf3eOs2JH6jdkEXNNyPgRWwIhLgd5YdD9Ls
NzKMZ8DF6PkFBdhx+Z4B2HDr6/N1H5A1ZoJbXciaY6Whg3RK2YCt7JSR3XDLwwVagzhQIoxanYol
g7yGZnmQoT8esY5pHz6AsDb0K3cHrHizA+t70ia5ELUDBJInUwQmuXJlyMGDixQmQYIkSRImV4hE
ieIDSBMdMZBhqzaNXTpy5MJRayZMXDhx7+Chm/axmbVr4aphCzdOnj157typS5funDmh6di5gydO
GLNx6Yay0wdPXbVq6ObJGxcOGzpz3GySSxcu/xmyYuzgmbN5Taq1j9CaUZsX7xy5c/TonQt3bt68
ezpHvsN3T14VJUOYDIEyBPHhwkwEPnzycEoWxAoVIkasRAkUJlCubImyBeOnjeZSipvWER06bcKU
kdX3bt47cdisCRNGrSYzXcnEjYzX0x07dfHaLROWbBptqergxfN4LSXXZujaobuGzNqzZdCUdW/G
jCs3Z82ceeTW29myZMluu2sHG7Y8dPHe2Ysde+Q5d+cCJyEMBQrMeijMMiUec2wgKxJCCAwAE7Js
iCQAPMwzizLayB2SxjmNGeOo+Uqcaq5BpyebxEEGmWuwoa2ZZIpJqpm2kjqtpmrGiccedmq6jv+Z
cG4KUUVsvDLHJGaaEZG6EKuBZhlnkompN25GimY7bmzEBx/4qkKLGnKwGU4dc8Kp7x16nhhMsSfU
RAIxFIbooTE1BzJosiS++GKKIYjYk4geJoSiQh98EC0GbKI5bhqsmklRKK3QKQaZZNgJZz64yEFH
LejCscZDrNDKyhx18LHvN5/MaScedazBRj935rGPpXY0nC0lcqh5BpqXsGmnJ3MyrEnKc9qRJ6hz
8JnnqnPi0auAe1IL85x3qpAQigblRKIHy3q4c4opHhsIIc6SIOiJbPUkYgoJK4qCCioyOmKEGJSx
hhxu3olHnrfUISm8e9/pzpmaTHqmN23C5Ob/GVy704Y0a9oiSRxz0CkyJW0ilpIcddBRB7Z5qDvH
SIfBw4Ybddyhbp7h4oFYSm7aaUebas6xB59xbHyZzNSKtWZawwC8trDDoLjziS+KfsI/MBBL4kAm
iNDzTTIqEtTdJj45AogYzEJmmlrJMeeaGNWyxpnjIhYnRm1oM4coSK15mStrcNvVnXt1quret3Rq
Byp34qnNGbUjTmccochy5ypxqLFGnJeZg6edUO9pdiRt0DlPvGa0KSDL2HRWTZyeBxxCICWyBeMg
Mr44xAsv1MQTIcS8ncLc2KGQMIo1dGiXiyOOkCKGcNhmhz3jbvNRSNNE9EitargJh5x44JHH/yOP
qlHHvhCxefUdZqphBhlhcrLHqHdCUplXdPbC5yd22CaxHZ/YiU/6+uLRSh167HlnRYa5scYap6EG
bYLCDZ214xziOINBNCM0JihtFFdQRCkScYhEJOJOX1ACgwgzugcZJglKyIJFtgAaLpTgdzH4GlFM
hg6PYA8f6FDJS6ahq3S44zrNsMk43CYPmJFHP+2gR7M8Mo3vUAM7qHqH39SxqLPpBx2jeoevqIMO
lshjL/Rw3MvSR6aRmGRxZIuUbdAStmZYSRvMOAMZoDCgwyhtCKMYhShMUYo6VtAKd/LPYSBkmad1
K4ScsQG7uFCEFmQNX/SRBzwylLEC5Kgjhf/jRkgmFQ60ICMk4wgTVVJmjvnZQyep8p7D1COMZQBw
gFfCR76IRY7Z2Mgj6ICVTnIyD1+FqTqSa1bB5CYMJ91GHNxI3KpwY8A4ZOFPCZGjHEVhR2ce4hBG
y5Nl+Ai1AJ0JmVfwgbsK2QQQAG86PQkJOTp0jgIUAB3VCGa9QqSkq7gSHXERyUie9yVG5iso6aBK
K8khD0XuTx4BtUddqmMUdfAqPlJaiceWA8p8vUNY53gWPMYhjGJAA1ffURFXFCe3dxxCMpwZAhnI
sExmOpOCGfSPtoLWA4d0i41boAK7qMAFq6VwGSTiWFXiQZ95xFCdTILGqsTxk3GMREMqsob/MraD
DGYkihxveQdJ2NHTd/50ioQDYEqyAg9b9oSVoJyGRT8lpnGsyB32yckUidQMJiljPNTgiTZu0o55
3AoazDCFIkzqTJOOwpmmwKA0EzMEJUBmdlYAEBgsQrV2eROc1rAkk6KhlXMw0lEtY+U86iKxZ7Ro
PFRaxkxYZY5Lxe8pXBxYxfypDuapcylRjY04esMUZ4jFJ5hqBl48pkvAzMMuQWGHlBgWz3Tkry7k
0EY7TCEKk5oCuqJoxTKf6QWi5YmPSiAXIKsFBtDQtLFNwFoMMqQSm82GVb9ZpDxKYxS7xsY+3OOb
O461PlO5Q5/zgJxp8+Y4f94rHkPsnBbr//YWViZuiflKGU9IdLl6CYVh50hHO17Co6WoimTOk0dz
+1oKUUi3FdOlYwUzOBA/9kAJ46IW6jpzkTXMNAo2TSHNdCLgc06uAP5sByVH9Rb62AcfBaAL5+zR
LM4t0a704VVOsgTkZgX5HkF+lV5oduNXCXiIQ8ZSs4qM30++Q2ex4Rw1hMEdZYCpO12yHIdHEWJR
hCEMjHDFdOVYCqMhoVu0gxoRAITM7l4BdURYw0XaBQQZx8saw8vJy3ryE/3d41Xy6LFUgWyPe+hv
HvhlScogp6EewwMek9tylJtlV0raDBtsu0o42gHKydFloKDs2KTEMbko48MnJmsHlywq4f9xAJC4
6GhuiNnAhjD8AM50luMXqrAmJGwmCnu6AaA5w2IWX8HFvMtIC4AnjFVdYzycamozyDIsfJGlKOao
jz2kJ4/Uruolw1iKOSL9qnaEoxvMmcdP1JGSVR+ucGaxpDA68pNtVGMbsTUSNTpkDWQMo2zUALVf
EqpcdqxkfysaTplM0eZis+EHIQ/DMhUBhdlNQYQGscEWBglol1v7IFrIXbu2yQVMAO9kJ9uLfBB4
Q1QJ9B1P4UlPiCPDcZDFLNhYSqPprUiP0YQ57mCGLabxFHYYqajsQCK9biKmkOhDfkUdSTi4opxp
XOVG8VCbsZDVdXUXoHvMUFYCmwvnH1j/4O5hsKMpDmGFk0tkQgxCXbVRB/MraKGEFWlXCTB05ZwQ
p26gxIZT24mjdhAchkZhR0jMIWv3UGMZ2vHloshij6tUo3z181uIplGft8DjHeeUh0pqqQ921++c
JyrGEO/BE19Dz98rAj3D5d4T5pbi2HdHth1ZhyeU+6laf3ojGKgP6OqzWAtaIEKL20Uo6KVjG16x
a5Pt8RR9vEhSWJGKsuy6P6+QA0XjcM8mpXINo9jeHuoQXv34tm5/CtSWjustsEzIdG1USK0diGKt
8ClUzu0mVqSMuqOMxMEUQs4C8O4H+I5bMuNPlGaxDGPwrO/6DqIMtADQiMAzHmsjkCEc/1howrDE
//CFhjyiG/iNJxDKJqxn3rbhK4anBlswHHStfM4HqaAn6qQK1HhFH2rpcDzPHXJCHvRHHmzQL+jh
KlREHKChzKIhGjAKGtBBFEIu5ErhEJ7ACiICCvysA4Wmuwqv8F4O5irkxY5gI3YFchSKJ/LmRJwB
f9iGnJaBOVYmHcRhUtjmuDzpnZjhOEiCJG4CevhGHfzpHMSmGYrhnTRveNwhVNzj4MhBf2KvAMwB
4WytGzZxONphG25iJBLna9DOGUrhB0qhFNSEDNRQ+hpEaRqku9qQ+noRdcrgCjgD8VKQCjQiBnTo
I5Ih9BZlJi7lZMgCHfQB8tRNrVJlnP90aCYWir3IYRzeIgERhymE4qB+TCck5p14RVjcAx5eIzay
yK7OoRpYDV9sZhxwJv/qz0Y8iTnCBGxSJHTKEAnYqM8WiyCHQBffaBd78eVcrloOr4QIjVDygpaW
hVf4MSfoAQqDTH8sDZSgDNNkbVlErSJ5YpF+bNT0S9KEjHNEDSTxhd3qAwC5px7SAUfmIZOiQRkG
SBsASEXCCIy6Q6jMATMAREJ08SCN0kFwkfoM0hebMg04wyErpBg3wiXLpAB+an+wJCTEYZFgYx3h
oR7GB8qu7Jz0L98YSUNa0BBFTfMOcFQ0cn2gjFf0Bx+yjC4P8JwScH7oA4CEyhq4gbj/lKELcYUL
vRAdJgSZkBIKhKDkog8XCbIpR5D6oDIqCc0Yo8o+6HLiHGodb6vq7KMlRwUjIWdZXM8uomd62GZ8
WMJvYK8bwoEdQGnKTOVVSE3AmCwuuewqp2eI/kUZtGE/UoMrqKE7roIb4IpJqEEdpC/6AIQMXKA5
hYYpJ1MEqzMNFSL7HpJdjJHI6IEl96en9Acj7wY04WseILEo0ioebs1UcETSSIXT1FEduOcG5484
SAJ7dCId9EHUOtEJXyVL6KMaukE/zuEvyyavLHEQu4MbgAIdpiCDIhRPTEEI8sxCu8XvMNQKNpRD
N3QM0gBEezE7LYILbiAGusEoopDG/8AzHljP34ahGsjBHeohECFxkZLMJzKGKVqQHf4vHpawOVzN
PUFNR75kwvKiY17FJQNqWUbFn2gMvt7hZYLLPdDIR5JFOKvBcrqAS9/AS9+gC87gDMJUTMu0CsTU
S8v0DdzgDMSgTds0DuJADFrHC9BgDLIgC1DHM4ggeH5u53rKL/CB1krDe7DhJ8aHbQ6KkUDJJ3Co
JlbRJmLTHniQ1aBC1qTCHNYxKEgE9m6QKVJR6WBT1mSTZsgERtnjGogiJdBiGEzCGZxBbtpCGbrA
S+kATN9ATM9UTMlUV8tUTN3gDsTATeVUDOJUWL0gDtDATsegIWVuC2IAHnjvIvESnf9U4nwMLA/h
wR5qcBumjFGJYinULzmqgSyg4is05FXUAUV0ZdUMykfGR/+E4wXhLi/Wi+KEz63IxoiIUxmECihx
5Rpo1UtpdUwL1ldz9Qxw9VfPgE2F1U3FIFgftnXsFE+pD/H49IamJ29G1R70smwkhSg0kSV6anpC
wlGGQx50TSqmYRiQwSuOa1kSlT6JgyjKTaoijTjWaz7k4ZyWyFWEzF9oK2auoUl6EjmXgRoAc3EW
B0xtdWDLNEzD9EzPNE1xdU2B9U0hlli9oFiT1QrutCG3YAhioKdq7CqFYt30MiXUwepQJBClZ/NC
FnGcKrZ2CCWtqibqR4o8VTjcw6D/XpMGEwUbUlFGYa+nWAk+TkUb5KIq4gqAUHVZuKEtxIEOnJZL
C5ZMzTRhrZZh3YBNGbZN7yBixbRr0eBrK7YzxvZldCLBbhYf0seyqGMn9sM9ErWKhERtrGHeRhJy
5s9vYU+KVqSdNpUkjCXWOEvISCQlIW2VYuNe+k0u0oEbLIpEJtEaikUY3KrM2oEOaJVgDfZyyVRg
N9cNrpZN7wBYG1ZO4zQOvOBrazENwEALoEBrWnYY7JcYhmEbuoF/iaEb7Jd/u6Ee6iEVu8H29AGB
9YF/t2Fw2aEeFDgc9vd/71eCBXh/68GA13GAza8e4MEp9MGBNy+BwXKAJXgmnWId//k3NiuAf5+i
Aii4G7Zh81p2G+qhcr03ag32DKogTL8UV8u3fEE3fYO1TbW2fQ9hDO40TxtkBkzAiWFABqL4BKJY
CKr4BIQgil0gi4VAi11Ai2HgBFwAi724i2XAi6M4i8k4jbVYBrBYBqC4jafYi2EABsbYBaa4jem4
irnYjN34jbn4BKCYjGHgjNEYjfHYBbr3Vr03YXN4c33YfNfUfB/2DES3fVvHQ7MgfuVXO18MCz6Z
C7CAC/SgCAqplA2tkEy5kEiZC1rZlU1ZD1S5lGc5lVt5lovglk0Zl3FZl1O5CJrgl28ZmHd5l4e5
CYY5l23qmJe5CAQ2fBt5TM9UYP+/1A3moHwl2XMLwXN/VXTnlE6TWImrLztLqBMsIncGDZ3NOXfO
+ZzReQ3eGZ7fuZ3jmZ7j2QfqmZ6pAJ4v4p7ZJdvwuZ71+Z4Feg0ExaAv4iLowAy6FIcVVmCd1kvn
gA6A+Gq1GVfFYIjFdGLrNIkrVpzHuYRCWqRHmqRL2qRPmqQ/wzNWWqU/Q6UfkqVh2qVn2pxD2qVj
ukJW2la991bBNGrfAKIr13O99JrnQJuvOZuF9Qzi4Avq1E5P16PLQKpLMPvyIPuuOuauWqu3mqu7
GvG0egu+eqvDeqzBOqy3YE++mqzPWqyvmq2vmgi0j0/mmggWmqEXeUyBunJrlQ7/5gCogbiaC+GH
s/lzzwBZD9t9OxpPQTQNygAMGnuqfVEEwcCxKTuypxqzHXuqryCzS9CxORsYY26qtcCzOdu0KQO1
OTv7SJC0tzq0Uxu2D4KnZ3tMadVpK3cOJHqiy7evrRmbC0Gbi1hM49QLDgENvGAMvjaJEQERGNu5
GTsNoSB+n5u6q7sMpvu6pbqxH5u7qQ+7KRu8w9u7I9MpqS+yH1uqyZu8CVJgzeBLubRL5cBWK7ev
hXq+c5ui3aAQrHlhHZa467S4lVVZwXm5EUGJ8RTBNXmxm/tDP7S5n1uTqfvBQTTCq9vCGXux8TQN
L/zCEzy6mROZFtoMsuAKrMC9/7uUvukbEgIhxasZDYBxDCR5DiIhiMu0m+EUufMURBFBwHl8wAmc
wJd1DNDAwIMcyIHcwJP8yIfxQ8M6DYA8Cw48waf8Qz/jCj40ytOAtK8bdQFtyr/8DNwbCvjMp7uA
DuSbvuUAEnRbt9HgqtFgoiPBqAe7cxu2iDtDpMtAWeOgEvBAwE13Q/9cwCvhzwmd0NHg0BFd0Iec
0QmcycvAIph7uY8cyMmAwNPAM8qAwCHdIp58hDxDC8CZDJJgDEbd1MPcva2gzM9cDsygcvuAANpA
vnU7ELQcDMRgTekgECRaksk3iJX68LQAEUpwCxDhDvAADuCAfekUDZI1TptdEv/wwNmlnX2bXVn9
vNARHdv/vDO0ANFBVND/fMgD3UO/dsBLSM8FvAxCOg3QANNLqMSTuEM7NAu8gA7q9AvA1AzcAMDP
fA6cnb7/vQTBYAzcoK/9fAy8wEvFIInvwE7XtE29qwwigRAQLw3uoA4qARGyoNkZPsrRgOPjlLl5
PA7gQBKam8ejPQ7A3d0RQdr9/MGHPFnX3dsf3E6d+7EHXMGT2wpuHkRLqN3Vna3RoNvDmueZFQyy
oEP5zAzAgAjAYKHHgCK2Tw7iIPvi+g7kOxBK8CC2QAwKgZO3L8bFIPvS4OmH+gzktwweAQ/KvhC0
vIS0IAvOIAu2gLO3YAysnt3/j53YnfwO9H7dgR4P8CDw0b3ZvUsLVr6EKuHdQ9rbx2AY7X4MvqDu
Vxro/3zdqdrNtQDxrcALKh/eIRQKEp4OOAMKzMAKDuLJ0UAOUCcNklWiA2EA4kB+wQDOtfzKtVwL
vOAOgh3QIN4NPFv3tQAPKmEL9DwLsu/zydrbMV3Yefztw3rYEa/Zr5rYvf0OHpzYXx/x8eDdlfW6
h/H1O4Pgyd8KvlqqgT5Zwf/4173uqS+skbiE0hAFocAKtgDVTb/pAY0OAKJPHz5ptFzJEkcOpAED
CKS5AkbOHC1astARc0XLGDcZwYhx40bMGzdltOTZQhFNpJJawJQkMiYLRURw/+6kQVlmjBhJFMsU
wqNlS5o4QX3e1FIJzpiSKIXGAYMSz1FEceIgCgomzpgtWyAGPch16FanaNDEKbOlzE20WY6iybKF
yJWMcuGe8fMGykE5YCDKEUhgzhgwBtEQYMiHMJhGkShmkYNRY6GMFt9YBlmyDB48hSKt7NnyyluU
ce6YRsQ0DZygaSIR1aKaYpo7iFBWqlR0DGsxaLVIcisJTdGqWylSnAtXqBg0YeOYFS60Nlc0R60k
l0tEC5QsRLKIMaMXSp8xc8eUJnDHzVONhwcE6puGD5+SWXUTiTOHMp1Clt8UKmnJHJ5FskdtV4yB
xhhjnFEcHm7cgcZmLN3BEv8eV20xxh2sFXKUhSiVtVtvv00HHWwKQgeGglmMYUVQsKHlVFVooJUG
dFd4Ud1YYGTBoxVkxAUGeN31QUdf2YGRn0EG3cEQAXy1NIAAcdDlWCCTVUTHSCM9glYZc3T2yB4r
oXTcGx26wSGZWyASCVBchXUHT0IVIh0eJQYl1B1QaQGHdNQ19WYcyb2ZxReDNjXUc6yhKMZNGHoB
FRFxYfjFjl90ERMaAtGRYI2BdDpGIYcR4OQYaYwhgACQiGFqFmjMMcAcaYDx6mVzaGJIGmx6tocm
e9xh6o4bzZiGJGhWkkayaNRRRySSIKLsHYXYVAYidJah2SYz5pRGTo1i2yf/tmighi22WWkFRrpQ
jOGFF1m4RJ1GceDhXEmISJWiVhCx625fYEBhxRdfmEHwXwIdTCqpfRCwcHtOytHIYQLwQUfFFjfC
xxwWZ+kGHY/4qkkgkTwS5h6PzPGlG2e8YZobkRSCJskvdzZgHYXYPG0hOudcyCamTWuaaVUFLckd
pUlSFdJVLe2FGHGI0a4XS08979RKM8101AJ7IfAXXhBsxsEIK5xwwg0RAIkcpKYayMZ0BDIAxXSg
zPGtvWrySCAf9zqzG2+cARKakQg+yCAvDzhgZzjr/LPNhNwctBhCOx0HHHAUjbTRRlMtNdRRS011
6JtNLXXppnuN+tdhi71w/8MMv+5wH2oTkCoBFWtcMR/u3W7xHAJo4isfH//eK8pzqAw4zJF8affJ
YBqOuM6L67zJzpAHjT32R2seOuhOew061fTSW9XoWMfxOdfqC7w666677jDsUarqtu5yQ9J2x4EI
sEevw4OsCeP9bSSFENCXCNSr5z0CcZ6h2c6aVYdN4OxBkQsaIbIXp81tDn1V+dzU4BC6pMXhaqXr
oHPU1y6B+cF97yNb/MwmgAHIgQ5ymGEgDiO3tt2OeJpIFf9AlrFH+I2AAlrgHD6Gt0IEAniPgF4D
BTSzAW3iZTZrGdAsiEGhaVAMTuMi16pCOatVrnKSuFwIP4e6rX1BbI4ADP/ZXHc22NGuIQppm9oY
Agk64M9i+wNZqvbww5AFIhBDdAPKSHZEX5nsVsBjYiQMB8Xl0axmjKPggx4kPWll8Q5d5OLTPLe0
O4CwNKSsyuVE+cmnmTAO4EuhF9z3utbJz4USe5js6BAxOqqtERrznSJ7mCrgAXKQgegPyiIhgJMJ
M4BIXObHGAjNxMFMZxS8A86kdUUMdvIMXuCm07RnmprURJRFW1oX48BN9KmRayxMmCxH5cIo0XFh
kFgYQxoBMQIEYoZ8+CEgf8c/QPIhEBmzzBEJKshlLhGAjQzZyIwYTWqiCWbpsd7OsJke7HHRaF6k
XDg1t8maqLKLnVMfN7n/KZAVvu+dZYOjLuP5MD446W1RupsPbZoqihl0DksUwP76B7w+NrSHIfvY
Aj3TxEdKc2cgkRazrIfRlqWHi2I4A9TO8LRNatWTkvMiK7nJNYHBMpZyVFjDYsgwlr40psT7ZzB7
5UM+WOZtCJ0YD+Uz1IYutKhGJVnhlie4aepsZhbNpmkkx0mrdrM0WsUi0LpK1S5+4QwnXePY0lpW
WkYJs25sSCMalrZGRKmRfySeD326w34Cs6HBBCjwABrMvDLRiJ1B2TSjR1hqUhR5D6qqVT/yMwrm
7Gc3e2zL0OlFsJ5UbGTFbEsb1qSGwVGONaRdQE/rx/lliQ79PO3vfOVD/9YSNbauHSptBVTAYzJw
sNZDU0guWdWNYvKKF5Ue4zgZEk5S9aRnmOwZLgsYN7rTbA1hKTxdJwfdBfK0No2S3GDlXdOG17Xf
bW1s85qxI0ryedF82URhFjir/railSwszuqQ0YyqbL/dpKxlA9xcd7qUrNAtG2b/6NY/9nB+OmxE
hL+7WgrD9rUXzitPQ2a8h3a4gNNUWYgpm54PC9aiNrPZezNq1TtQ1qr+dSPC4Cfj2MH4wDa2LnjD
C1d5zpAO8/Pumcn7T2DCFsisDcSR7bw8JJLsqAMynkRBwjIog+RmhI3E4qQZOPieIbEtpqyXmfvc
GsOus7S0p4RvuuPNVv9MDm1Gs5wBKechYzevqWKkyAZpXpmJrDPp9duTAYcm5imvgYaOHogTDTjf
bvm/Zm0d/AQcXV/buIXW7R+D0xylRtDQut7NsZstHGpST2x/PiUmaRuZN0QuL2X+cTWsBffEDnvm
eIMGCWWRt+szcNa5YSZVgYXd0kmvDadvTZWaadjp+cE1vKH+cZHP3F278kG2sT31tkGyH8ucO70j
O2CfPTMI2gbu1uZOt68h/UZ7vtvAcjxraUcdQ03fsdMTbra/R01ae/uwzdce77SJGYksaQzQIzkm
Io8oM6TuGbD7SfhI0k1Zs7Jb6O4WuoCd60YemjzkA5DdyFd+af6dPML/Q4W6yi9c4WAOXHiD9A/K
+lPzkS2xiEzcK/CWt5/j0cHV6F6Zur887M6+e+hltbSzf2jvAo98fvrut9SnTmcix9DqWZdzqPvZ
tl72p2M8ReKRg0oyvX5pbnNztcL/trIv/xrGG7/suj3+5nqLuT1WBybJvXv6qludIfMjst9PSzGe
zs2Ycwh43lw78IYO1HgzJ+CWFT7WXheds2AWsKXnrGOmC50hVw894N38Wrcyn+nknbPfKRYI/C3+
bar1aZD/bec5QEKAHQO7ZVgXabOlFf1ET/p1sZv3ubP+6oR//Y9Zu3K+M1/wgKcYJAaaJW8wN9TW
Q90leKzFS/iTfds1/wcD1B8Yt36Sxn7CNzYWhmnxh1nzN31p9nxUl3J5x3StV3L+RjG6k0dz5Tv3
h3LApID404AaY35vAIFw13kAJl2vM1r0J3UNcTbQpX+tNX1/d1qpd22rN3/292N8AAmHkUfbBTdD
aIF0llMLEQi8JIANaH6QdnHDp3np5377dlO1E2zuxndheHqo54HRZ2/WxXqjhYTxp4SkIje5k2/3
l3JFtztvE4OeB2k1uHlhJoKdBkwHpnHypG862IFSmH/xR3L2x3qwo2wVsxB1mIaDOCoDEIltM1fn
t3lHt35DF2BfSH//xIPONX3TZ3qAl3o/dopH+HyPWDZrtoSUSHWnhf+HtjMHyiaAu2h8fRiBYzY2
7rdj8CcAo0d6xXiIZwiFKhhqEsODyriMsJgwa3aMiNhar3U2cbRsAbhdvUhpxPeHn0henQZIpZiB
zBeE1jiEnWAJEdYJARBqPIhWqPhjlhAAmICBLVVdEkN4z7aG8OQkSygHAmgxK3Uw9pgH64eQCVMJ
n3CPiBAAEfkJlVBaA0AIeoAKqHAJtTMqCMMQhGAJGxhyUzcA/NAJzfeOoXaRGXkJ1fhjqDCReVdm
tjM7tOiPaAWQ+IQ2biNjCOOQmCA2P7kwlRAAn5AGlgCReoAIqICPPvQIGWkJedCOcWSKA/CO6ZiO
EUaL73hagwCVUun/khEWAJ1giFT5OrPDj+o4YWZZNpFIB2ZABz0pEIUwlgFQCXM5lvxQCQSgBwGw
hAszln3Ql393CXZZWvb4CY/QBwGAkZhQCPYYkSDJkgTQCZiAke1YmZdJAGMpAGqACgGgBo/AlT50
CXo5j5bQAahgCZqQmaopABE5lo+gBkWpmIyJCshCm5RpmapJALKZkY9gCSy5cjOZMG85Q2pzcQtj
j4EQAHkgEMvZnJv5CQHGD0qJCmoAUAMwmAA1CfxgCZigBouJCfZ4CRdpl90plXb5jpfwCaggAOvZ
ngPAmZZQCZwQAJYwmjHUl/JEAIZwn3kQAJwAn+5JlHpACJdwm+C5/5mokAeSEABpoKADOgCeyQmG
gJ72SJE4GW+kcpz7yFx9YJl8CZQgqgeCiQnSKV2wiQqDsHKD+U/2uAlrgAqL2QmbSZZXaY+EQAgB
cAlc6aMB8J4BIJ9keQmYEJH4CaQ+tJ9odZWv2Qk/mipjSQCWuQmeuZhqQAD2WAgySplC+o4EcJ2p
kqM7upEaOpMz5HS/2AcOCpsBIAkOyg+wKQl9GQgHM5b+uZohV5gZGqSwSaM2apVA+o6w+aSCaqhB
OqQY+pp5kJ8CsKdMKqROCqVOKp9taqNdCptdiqhh2qcReZJmOmC2FIoIU5iIUAkQmQcAaqqoSpSf
YAlIKaWY8Al59/+Uqvmq9mgIt9EHJgmoncAPhoCnlWAIhAClUDqWuGqPSLpygQCVr4qnACqgh+qk
InobexmYaRAAprqXV3mVs2kJwHqf9UkI/zhsCmMwybkwsnowmMCun5Aw7NoHDckPqACRRBoAk4CO
hKAGqYAKNRqcqFAGfyqlkoAJqBAJ31mUk/CjgRqoThoJDumZPQqk/dQQheCZHeCvLNmwozmWA/AI
fdkBlkAAvJqlqBCymvqlHxsAqDAJCPsJk0CuG8pCfNhOaup+KtdpcTdjafmMUDg//JiVqLc22Rhw
Jxc/TZd+MIRWrziT0jWzkcZ+H9pZ+YeVz1U2TZKWyDh1QAuNTcL/nwmjio9ollt4jPLYjzEbqk9r
kBineaI4f3+XtGSYtWaLhq3Ytc94tWHrtR3HbqfIbCM5hGw5aU/ba1H7tAGngcPZkwTmbrZ4hszH
tcqItVjbuCQptmV2WX4buFrZtIXLtjUbgZ8oMeU4R7Yol4z7t3QLgvMYf/42uVQJjWuYjXUHbD/7
t4MntJjruUfXTskZuqkrklTpeV7bZqpLffLYhieXjbDruvkovBg3fWtztmjrQoRrs047VjU1j0H4
vDubs3OLuw3BiK47u2WzjFcnjXx7dLZbvCQnuI82g737iZDmuNwbt0c7nOg4eOgovW/Liupnvs2L
t+0GvbaLhkNI/0vt10beOFYze3zbW7zpF5F6EEemyxB4EJIMMcFm67+Bu7x525eRCnUDXL0FzJH6
577Eib28KxCVEKdtGgCE22YOY7qFu5mMubw+5G5GSsEajMPO2MGOK7cwFMIoHEOV4Jn3WKNrS2A4
WYYpTLvoKpdECcMx3E5tJlP+272A+cM82x4bzBC3MQmNm7z/O8SNW8StC5ltysDq58TjW8NxpzAL
LJeQgAZUPJFUjKQC0QkO2a+DQCpHWpifgAekYggOWZSScMN6QCqVgJFFaQhZCsOVUKmMTABVKpEZ
2pd6cMhFWcgE4Mif+QmGECVpzHRUHK6WEJ6U6cedUE83bAmDXP/IUYLEGakHqTIJfnwJNwTLX2q4
7jPBAhGRHRCRAsEPsuqphxGRRiqRBMCmsGmtjEkq9vjIAVAIANqmlDzBvfmZ2SwAfcnMzSzJ1Tyu
adyGs3mfAyaeDmmSXBzO7joAqByRAkAIoowJ/JCQN0zMAWDD1xvMu+qpd9kHeVDKK6vMETkIzCzJ
frmmorLNWQqzehwlYFzJC20IjxCR2BnClhAJCp2liqzH3zzPIdjNkRBvCSmYK8vFAfAICj2hR8oH
hhCknzAAdGnNNzyWe4l+DvzPy+yRhFAJg+rDtxzCBIDNmFAGjxDI0twetwHTr4nDQ00A6Ewqfeme
Iaw7Rc2QVJz/ByKdpG0Im8JLKoUQ1MW8yNoZkYfxmZigO1FipJYgU0d6wyOaVnT8tAFQncIcAFhw
MHMKw0Pt1foUzqigyNvMB8HZpgRdyay3zVodwl7NEEV92N18pF7NiN0sKu7k13ht1o2d1ovNfFUc
AGWwyKPqwIDR04wJGH35CSAZkYBd1H0ACWXAzDW6zRJ9pEPN2DhM1Wh91a+N1vysxzfc1Y8dgugs
su7E2v/R2Thc1AOw1vP3mXoglVIZzSUaigt816q9mNwNy3wg1Gdd1Doj29u8zZDJBzat2Mu82xQM
mRed0ZAd3AtNADbdjkXchvFMqMLaCd1tCX0wqFzMyM+N3AMw/wmyeY9KDcoC7mUqRbipXaJVvbII
CtyeLdwvDNMbTMVqsNGRDc2LHQmUHZEUid9FveEhXNzAPX+YysZWnQfdLOB8+dnyfJ6fiQp6YKRL
jd2nDXd4jd0+3jCT0JedgM0HPeBpDaHLLLKLPdmY4J/NyRBCHpGkDMYWm8mpUuJpXbJOXtmPnd+N
nMTguaZDjs0x/tzx7Jk3TggGjs5iXtoB5uC968BpSYYRfLoALL0yVef5LbZ7e3qUS5xUG4Lvu8Ke
GEdfnm/VS4GnvbseOcNlXIxQe7Vga7vtgejLm8OoJ7gBfLxt2LToaugERrw4G6qhm1JyPufMhrc5
tcXTVedOzP/nA0y5Wenpw8fpdgvoBPyhqGvpXovANDa/jJ7qcXPCQUgqbdDPZUbssM7nR3vo7muW
0d66zY65ph3qe666cXSDmhfnbVuz+Ut6/QS1YCbqz365s/7snIu5yB65g07ou2tj5p6Nv36DwY7q
T+tgE1N0dtXqkw62+t7rng67eevBpW5jITjoKgzqYCbvlUuu2x5g2i21MpxTeGhXkbZCxAnE5d7n
Zwy0MrnpHE/t1Q7v/t7rDq+hssRC3X69HsnvRdddOgtsV/u1AU+8vN7r+fhr7F6WAk/o1s7w5Y7y
2p5xwu4+dEznl+hgw4bXWCDj/Jy3Wa3is4vuHC+TuvvvxHv/851rs/Eu6kr7j16mpnEegRieBgKx
BrBpyWQYchkXzEVM88WI33v7QrCbvJbwyOO5MFYOmqLisej8sqQimqIcyYsbfHhe60+szi0/8Rje
32Cq9sNH7HG3zZJwG2TDv5ZPyZY+k4BexnqA4emMyM08AKO/sqIyqLCZ2eB4+HYv8ka3uw7+i7DJ
D9P5zExNABQ+ka8DoJjApkcO9aCc5sCvwfiMsGrAy7k84Y/A52pAn9i8Bk+OCBCZrU9uCZsQkS2Z
/fbdB5C58Jn19diu7SoP9AejUhOc1tT80AB64ytbB90fkfywz8DfyDD89D4czjxa3/bMowAxQOAA
AQIG8CFA/yBAAD2WFiZcmMdhgEAEPjEkgCpAnkALLRGY2EfkyJEJTZ4kMNDkQJUERCbs45JkHz8v
Z/ZZWGZhpU4BJuohUGihIQE9OxHQwy8ApDQLgep5SECNRz6GkC4UuDAAHjxOCfT8FHThpoEGBRKo
5BFqAIgM16Z8+zNAWLRlLNkU6agkypMDULL061JmTJKDCc/0uMYnpgCTvE4s6BATToZ9IDnt8zZj
AEx8Aq/NilEhRsYfR1sqqxIqpkCanb4d8LbQWp8xYeItzLdv4ISATdo+TLKm4ZE5dV7EJOCxVuaj
sYj0ujamU96gB3gdDZS5VtQEVfYMgOhqgOluH8beubDTxP+jt2/a1J3y7EqWvwkTv1mzuE9JWjtd
x2giiSQqIyN+9OhDjuii0giT6rACEKjsNmvIEokq8W0i0yZqy5KJHhngIj2mYsuiqEoiSa+X4vOL
N/laWjG4kYZ7L6fNAjAkQgK68skvSPAYT46mMNKMxI8kaQ2rCXWcCpNIEsIQMPZsmwgRRIa60ieh
NlIsAEnmYAyTuu7Cz7b4dPONuDLfg86nrxYC0asBwPsEqo+GDAAVxp6KKi3mKrFOTuok0agDPRgD
DEDmgLpIq08EanQhVDbxk7kCQ2JzxZNicrG3+mSCqUz99NvvUob8wo4PSxhjSLw+8uAMEaj4ZEug
StRABRX/PeqATdBTCZCEREzUSHQ7jAohUQ2yBkB2oU8qgZLET0yDlTzD9BPsTBc/vQ3UTNk0qaBO
CUJo07zg46slTzv9K91Ef9t0N97Y5aswcFGyTd0X58NL1G89FeAv70KVCVt8AfaL0zP7EvhdgkPN
d76UFhbs2/tYbJjffi2eCeG/BCjXvtzQDLhhijPW10x3510YuPewVZlibjeeqSZSO06ooHQNIlgk
g800k6CHW9R25TSzNcxT+uqt12KmWUz5sDWF20vcjwPDbS802SW6aHm5fRhp+VbSDeipUTyZPolp
rvle78YV2lya0BU45N4mTntdsFWWeuy7z5Tx37z3xZrt/xnvBblk+kDuFmez704Y8vjagPpopDV9
keynK2bT4IMrX5vj9zxGiWdzb+Z76d0IoKSfP/7oh5KwW/+DcIlZdx1ipROCXXa+aHcPXMxP6v1r
9xqnenQCAGmdEkBOstpbnOHd3SXmYwekH9f/oMQOhgmwg5I/HD5J+9oJEER77SnhjXvv4zU/8Hvj
JQD2flYPnXOOE0o/dkoEURvWbkOqy62uD/2jxP+054eW6S1lC3SJIFoXu/dVDyXmmxoBY2YSP2gP
fwkTHepi0sF+PI8AjvhD+PphB+YtQYLO80MKlyA+P9hhhQykhAt9RwASmtAR5iteDgXhQtyNT4bi
O+LzMP9IAMpp73lCFF/s6meHGSpxe1T8n0xS2DoWws4O4QNEH1rYP+PZR3pOy94STlJDQaRvggmM
XR9atwQWps+OfVAf+xKSxokNYIH2I8D6zGc+ATSvi22UIgZt40Q/9sMbUbzfHxApO/NxsY0jSeEk
7dc8PyxhhRP8WuFEN7eY8CGN7VOh+rY3yH4wsA9LWMIfYBnIEp6EjyYxHwlpaT8S/oGEjkhJCtWH
x9wtsoSNfB4ghenBBTZPEH/AZCpd149YOpGa9fOg6iAmv0zBRHsA5GEOw+hJIA5yCSNUZSshCBMS
CsIvP2wlIFnJS9gtYSC08yQtaURMK9ZOl/i8HxCHKEX/kbQOEJ2cpjpLOMvs3U+bwcuUzVZEkPTN
8H8G7V8utSdHCgLChm10JyFPUtEE9s+XzFQoLwsJjO5dj4yKTAgjIQjI1r3UdYKwgxtHUlOTstIR
nkzl6vDFTeURIGAerSLzLgrH18UxiUcEIPCQhlTn0S6IrqMd7QZQw6R2L4EchaZMDFpEbMqOeeGT
He2GSEdoikSpL+xd78RYUil+LyFtuMnZEBYjsuHmZ357aLdABa8NEqAR6zKqGRtnwfig6HCCA1pM
TPdQqYkuXJ7JWMXw8zQY5e1xSrvdw+6Tr8Fly7IxK6zmRPYtAhqVD4pTW898xtew0auB9MMfbjX7
N4oB/+dsrS2tiypL1IhxDbPIsxf9BFKu1AY3c0PVHadsi1uXiY5ygvVs1opqVHqZTrt0CxrePBuv
mDQiMPoarO7Ee9vRvgxtn0sbcacHMq7xyz0w0+1Zmttbw/bGvJ262HtDy9+zjYx6GBuq0wCmG7No
Nq98VdiAb6tc1Sp2t+sFnIMj+t4DoynBBU7Ia9F0XP0B98C8KWxWXYdazflFqpQz28XYFVeC/oZ2
lr2u2DxM2P2lhL59sB/2ShYjxykWxfExX/jCWjSBLJGj/RCEGNdHWpTYz32m7YOS3Uu3Dp9slPI5
7iZh6dvDaLDLR+bLEsvWXzY3koEx1Z73bLhR3poEkP89g2jyOKxjL1v2U/YbgCcB4Qgb2qEmOVQy
FgEoTDvUDorOm2IVG8k9rKpv0C8E4ADO6snz0XKWOfRgDVcITBn2lBIiGeJFXZe9L7qQJoUeDnyz
67SDKI6EPbQjlIkJS0tGdYWJ9J8UJenGQFbTdV90JCDSl1Mo//TXuYOzDVm90VwD0IZwTCj6qMns
VT5bmHYU2/AaKDqBwDbIsQt0LMfsxDY48w98FHQ5+wHkOQc0obXTqUF7l0YBeJKBTSxh7AJ+P1jK
Uo2Cbqj9OPo8PpTznOYr+JhlPeu2jYRcvCFhTv8AT/X1EsgDdd4sBc1pmrounws0XxrHR871AQIY
B4f/NjHtt4Rbp9MP+kb5vMcqc4WzsuMFLO0oy0087QHTLx+9ZPxwSmwuolveuLOplT3ZUirmVBCD
BuoCjUnoG3oQ6e689pwVXtGcknyjSYZyG8O9QbyumdywxWY/HBEYqILVEWttNL1X6OhVmtWraa00
pT0JQAlWcXlejXnr/JC9gwpb0ZF2o1zvXlKrxlHfivbthfu8ZZFMdiXHjSwp92LgsOkWuyrzy2FD
vM3gCYYgAeta0xwrQrxqLXWmJy/HBjww2ZJ+x/vFvZlUzy5NjTbohPVXXnHfW9HBfV+9x+9n0exl
WZsXcETWPH+H2zm05VjcbW8s90ViXP3qb/T5LT1K/3IM9A0KN73eGpzxiSrCi6W/ZZbNrGzNbOHy
jxe+5y0b3Hi/xjqw79IzHRO3DMO/3VCc6kquDps+AnuYw1I9vqg9MkvA+8MyzuOwBFw/2ROcAIqc
++Iy1BMg/+uyCXOs+BOZ39qzAeSz1coPrTEJPiAxbhItspmuDOuZw9rBkYAx+KO+wXJAPSO9+tO+
HjsvndE/GoTAFCRA+Bo+4uMbJGSayEIu8aOt0gO+BfQx0JPBvhEb+0LBGMSwCzweJ3Q7+DBA0StB
4APBEEwJEeOx6Tmz0orChKjAAGxBOMTC9tLCN7RAAtwwTSk3MnSJ1kqtzjoT79ug9uPDIFRDPTQt
M/+SL+GxMPsLQzY5i4vrvQeknq6BQ0I0CetjFzRUk+PTsEDEnEkkRN3rjQaTm/ODwB3MQ5TYw9uB
sT80wwtDG4tBHcGyQivcxMeKGNCrLhPbsV6cOGacRfOLL+S7RDeULWdMsBCMnjAswKDpvzIkGOvD
sNPjsrBBLfmbQfqrwmYsxtF5PTSbLVcMLDysLVNcMyaSnvg4rMcxxy+rxpP4wADkPPlosCLcwola
GxY8mFwEwdbzQ8UCxHN8wF2kn8IaJU6RxQ2ER8mxRi78i+FrGnNhRn3knALrmHQcxXUkCe9wvnek
SKGSR86qMHsMsBfcnMViLTdEwke8Py0sN7vJM03/PEhvFAwK7C8Ae79xzEM25CZ0hK7PWkOLeZs6
nERDRER5FD4A/Mg03Eg8u8RgXJEgrMc4zJSC8LwykRlbvMV5pBfbQ8orjK6uLLIBJMZZnME+YMLL
ET0z/JSTREBKBEddzMG+YZc9VC/5or+1C7rmC63tOjG0lMcBMEUqlEF8RD6uLDCvzERNNL+xdEc7
bMyqlEDqqcC1hLDs075PpBrMzEzq0z0AOxzNRK+XLEX/qjN4uS4BG6+HPK1+9Mf9usk+6MbNWhii
4Us+U5kplL23rE02k7U2ZMlxLM7NfA8qzI1FlDCrZJgWWcvci0lS1E0jhM7inEbgTDAVWZ5scpeG
/0obCYqzTgMET3IhHzRF9rwhkai3RiMY3qDPvOOfOQKgmHhPaooykVimRlPEFIwJ8APIb3HNwlDP
UBSIAE2bqpu6PfKGFRo8wzovCtU1OWq1FUpADrWn5QEGDNU1QLhQKurQqeOiF8zAnYSsyTxPh2KY
13pQihEEYEo48IGy8xzRu8lRKTsnklDPwhIEP9A0DPooIc2yE6UmKWulhmrLF33KbrpG2wjQJHUo
9bSfa+OfHkWyWhK0EzIfH3QRKR2pGgvHlHAiAhjTXhI0mtComwJRNlzNLuwxbZxRTcun5fEkLW0o
BopT3TglWgKEw2Ikdlk2k8Cp2FmyNS3UNuUnJ/8SCUodqNi5mZrMzTa8UpNoKC1NiU+VUoSrK76Q
JSjzizY1VO20M0nlUWp6Hiojngw1VDhrqDDiJ0qbswHVPHHDUwX7yVDVHgF4UPsxJQ9aNnAz1akr
mTGFpyADp1P9z1DRqQprhFPdoTeFuBKS00o7UtjxhrbqS934xzpck2tMCAayITUKUEAYgDkjVg/a
JGib1dgBppT4KB9thC9iofrJ0OJD0zrD1nvl0SjjoyVNI37q1jCKwegkydArjIoCU5YjJz91qDdi
F3LqHhaCUhV1J6J00/X5onfb2Dg7Tz0yCY39IndqKI+dUY9tUjqaOtuDwiQkKj1NoyPdo+YBpAf/
7R9BcL50AtMAjU91EVpACFABZaAhAtrySSd3slhXcyv4HFA/uNS8E0Psqlm6LKrpKUcf472VCNj4
Ak5WXU4xXBEbejO70q9HlB8RMsPCKtdtutlghRo6JB6XfUmBMNPttET0MaHj+85u+tqX7DHl0xzS
GjAUbTY8pEDI1E7iA8lNIUwVzLOKo0XNhNFzTUVt6UTHRDB3MdOsXK3uVEDUJFw+tEoF88ytuU7Z
1EPIfC7oykHAQkjDBMWtVUBORdzaLItlPJk9bIS+BZsuq7/XpcSjfNiNWT6y/ZfW3ZZDdBfY1dD/
ik0WM0E8HL3fzECHTRrh8T2jsS3Q3Zq+rcn2/1pOHqSeL2tJw63ImNHSHhWIjArcNY0PRyDYovwv
vJHcTEQvSSKnfk2IXSXI5/1A7x2Mh/2Lhrqmg5igJQjc2GsXk5A2XBwI6yVdoLPdU/2kWuIh9Tkn
6TRGYqTS3VXgvghQg9oqgTsm26EYRqJEvv0UoyQvHTyJdT0fpN0jKKPU5W0uOCRN5xQ3LQW3XKul
AWDP/zmqFUrhd1Ml77FaZ0pSZnOnJLY2grqjPipFJ7pX8mzSLr3cA2zf4bzCaeSLeA049pE2WNU2
mYWyeIXP9pyzLLq2wrs6ahLQimrUO16xMa2zQOWLDjq1OXMlftTJ4QxiEDtj9bSmJRAAJ+ohLf9d
vG9C4mxiY5X6IUhyp0KqJUF+pRLKnlNTLS0lTCnznlv14YY9ywUFVrKR0HXtUSdqKIN4ZFD2JIOQ
UGSKX1Wa5SZLJzVKVl2z3Q+mV5OYI2Sr00Ls3rQ5LwHCPsacmE+91DCaU0AgVn/7VDRm02NqJ6QF
BCfuh7OoKW9OJkEKK/RqHoJFIaGNH/YNS8/lrdHpXYD5VBJqJWRqY4/VZm0eAENCn5f7ov/51B1e
oZV1iTcCUHSrMvgMaGVbJ/sZUH7U1OlVXSv9noHmIludX2cyqk/VUr+4nvsRAPp0nj8oUbwJaUhr
40xj2hm7VOcpNBubIXtJEZpt3gkOnZL0zPn/OAjyeRuzSJT5QIjgJEvvGN2Faah7VVu/1UDHwsR3
dt2/6Rvtouh1ucjMic1twUXbuV47c9mYuLrKVd9nfF6ojuqc3r4hFpir5uoJTl/5MC/rvc5KhrK1
NVvYpemRUJEpPcu7TmCnrup9Kcug1mrT1VDCnlwCYC4TdBGx5kinfmp1NBnhWkHfu51DlBjEnpfo
5Yv/kmvHhF/yreHvtei9tRw7tezo5ZbIBZvL7hTPRmwEzc/LxsfUymt5NmvxpewE5u2HOkTPI+zM
3g3ChFwZ/tyxjq2VcOza/UXclk2HCY6/Hh7XjkoRXG3OFt2gbsbQtkWxhli9GmPPRa9npsHQ/2IJ
4NZu3x7MCyYfAkMv2Q3N5n4w2CWf94pu9a5uBzoa2rbg4m7vQ14alhFcpUTc8HbdqJFuzHFtWlbt
9AYsvu1I4z5u3dWbMvzuVr5p665GQFRvWp6s4N5slxxuBx+c1dbev+Zc+j5t+Usv6s5GrlYX/u5v
/96bz+FGiVlu3brt+QZw8Ubwh+zwFwdxbRow2I7tsS5e2yrlFpwa6nVhkCSyiGFA6dXv/R7uCKfx
2Jy44nVs297xeabwJ9efM7KgchOXzT5y1y5fEt9IdQFH7YXY8MXD/9ZHg5QXIQ9uIh/MlDByLd/y
GMcw7+7D1FXxvUlr6ULzog6ld4lxeinuz/+mYUSWcYorRtPUXDGvXVBZ8DO3bkbP7PXOcj/nLLDJ
cer68oxk5qPZR5nQFzNH7yFXcyyHdFvkbuFe3TjP3DlvbyK0j0Y38wb3aTSf8VmPdNAp7NlkPhFu
y9DV8D7UHxfPRhD/XGHH8lDX9ZaAcLcOP7pt3Wsv3hhj9ehV9E6f4U/vbPZm85OxHPfFyJJkZt02
yswbv80myw+X9tkdZu0kdm/PbMIs9eSan1RHmcXMPFZnwHGH8frwdQu2Xkj3v/0W7b8ldLvqa0N/
S/K0ak6v8jxHrIbZd9Or9U5kzviDMGgm44G/HeO7DXof9/7QCgexFa2AePgOiu4gdtAthI//8A1j
wYRLeATnxbJKoYwAgBatgJZ2qS86586Mj55L2I5JiHkI+XSiKYSL4IeGT/f1qvrzqA9jCYADIVsN
E3qjHw2iH5d8J/FnRpqy0HhWIZFLSIlKuW7ekPubT5tKsR3uaISJ8BK0LD6RqASlIA+yr4TCB5HA
3niHTGxXN50tQQU/gflKsYQOCIBOeIRI6ARWwQQP2Q6+JxRLmATamJY5CIpO0Ii54HuPwGC9jwTu
AAk90IhPEA9JEH1LmIM+QATG+ASdWIihL/r02Ank0HlLgP25yJEIWczTW5xxZw9FgfpKYY48WIs6
2fzU34iX34i00IPir/xAOH2tqBbw7/qI/0AVj7AEfuCHTyCRQtB+7u+EQvh+5vD9sq+U0+cHVBiA
858LEiELgAgQQM+AAQQOEuiTEOFChQQKDhAgUYBBAp8EXqp0McClAZUEBnjUSSAqkJUOFmr0UWBB
kBwrbaozqZIhgfwsgbREIBCBlQEgQiSQ8yHIPJgEnhSYp1AhSZUQ5QQpCarAPiaFIgWJiGoAAkcD
JOU4II8lSwURKnSY9qDDghMponTpElNPkANwClQzF5FHu41yFqxUUi7ergh9AoWYs9GmnPzkDhQM
uXAfn1aRYgVrEjHkgYkrog2dUCHEtxULQ54JMtLIAHQt5dmIqq5AQ42RFvxa6BHImgJ17v/2aRto
5k6V9Aos9FUN7LK6A0UVOBXkZbCZfVZCvLy5zuYPGaplK770xIobOxUklNOnS0t63usR+GkA7+hg
Cw6+FF+gRZtI6/+WWGccEYAXKu99IlkAeewXQCCDyVVdWJoh5VOBJCFYyQAB8EMQaOKJlxZ55REA
oFkFbZSgQHpcEgAqlzRyyVeYXPKIQZaUhElhlVBkyFGoFFZiJ199IkmBOZ6omFyfnEgAIvt1ONWP
aYBEgCQXoUIlf1eZtJldBBgCpR6TbOjZhwuhydaIcB0U1GdvImTQmd8N0IhbiX3HUJ56xvmmn3Py
GWgfaQ0aaJtn4tnnZ+AxKqJbJB7656L/keZZkJ0RXUpRon0a+pCklxLX6WhrDVpqqWkydFaqQa06
aYh89vGoRKpK6mekqhJwaSMCgKopq6saWqutojbUqKnBfrjpraGKVmysEZVXkbCbEgdanW71yiyn
gbpa57KA6lloQ6aKy22y2nrqapoOxfkWm+lCW6ui1oIK6p2/bssnnG4SC2t4zhbKLrDzIgono6GR
5q60QPn657xt6iqRvQ3r2+m+19K5p6jsEkquxedqO6xoAveh8MLTsgpUI3TqyrC6bX4cKr/S9nvq
q8cKnC+8Bb9MMkIKEzyrpLdmXCdFoDisJ676JnqtnBkTK65a5OasaKv4ilzsuibDK5eN/xDe9zDL
lpZG35Dy6aQzAXoMxmQkBYlUEiqdPNImIikigpAlG2HSCU9oBjwaqlYTDLK6VSsEdNcuwSSXhssq
uiuvEaEoECb5qQ3ZfI9sBNIndaP2GwEtukhkzgGXy7ThSycdbpqmLUyR5wFYUtNXYcMbZ66W2qnp
JCA94lsHameECHIBTIIXQftZ8shg2ZH0oECIQCcdwKMOTmnhJ/d8OgGw3wrSSHrgdHwlkzTIJOcB
grRJ7wP8ztJKsx1qKIAaBYjXJ1wZ1NvzmRlpZMcy1+qslTWf/QxSAvqNi+Kzo4+8ZzCdwIsaJCGf
eFFkI5ZozSW0xyffoKJMCxqLffr3G//SMUc+/iJUzK6WsqxlLyHROhRFBNAlF1EILEyZiW8CcBsd
/SZTBZnE7QaiNr09hnYiNEth8vClogSiQa4pxFoAVkWlsa5bBjuYwGZYNhuyxCX3U5BLBnARfpBu
EjWMiPMEgge8dKJ+enoEcoBUOX7koRH6419mnvQbC/IDE97zGAG3tz18ue4gXiSPXfgmwkp8ZRMA
ustc7AQqnxAiSPH5hJ4kMRgdZScSyhsA89oIlvmZqBBXCQ/qkJXFprUOcKEh0Zrs0hr0mCQ/DRrA
bTBiNE09ooh5wUraDuOSJFYiEp0jydtCRzsCICeJroEEwkZ1RbF9i3svM5TQ0vUWu+D/xRJ8MImP
XFSYghwPEUi7kwAIcbYAuM2CAYiEnthjErPJjW4IMQTeDPKIvVmuE4VwHQtdWUBtKguB32sYBqPF
B/Lg6iwqIx0qKPI+yskJNOWLmcNotTRBVZFUgiOgAVGGLm5q6iHlidZnUuon1JhFcrJCF7h2JlFE
/mpOVQOczbD4ykUNrVmvS4y7GOqyjH4GR+aU3K4girWPZhOoO9OdoG7mLJIeEqlb7FTJblpUo8pM
Wexsag2FFlGoRrVp6UpVVX02QNWd1aSIPNj3GLZSjNpKqirj1RqhRTEP+lReSGVrv6yaMy3KdWk7
tWlZGWpUmz6kZXx1GktBhiyw8mut/zADaaOsCde4JparQbvroy4W1t41Vabxeiqg8ko2T2kWtrCa
beA+W9LQCvVqK92taTNLNr5qqrKWZVpfLxZbjdHViiQFrVwLa1e/BtesLp2U01ArK7PeloCYddOl
BpZI8ASuaojFbW5vVdSyHdVTvqKTpSQ2K5PF1ZXb3SpUr0mq1BUuq/Iqb6S+Gt2jondhqCXrTFmr
3T+B6riireapxEutxKIVRN4872pLa1Ot/pLAlW2VueabNXDttGPL1e+fUkqs68IOu9PFk8oo9z7Y
vfLAb7IXsyIMUpEG9qDTSu6q/FvaH6u3WqBCmmphnF3VeRgi3ZUjbUMkYtuSOKiiQv8xbwF8rxlj
673YPXKOsUzfqtK2ti50YXNPDF3TbDnJd2rEi/36YLQG+DP2WvJmZ4uQRtzXwTWGsImn7OMKC9dP
bJ7Ii4VLuMBids45BVSIW9nl25Z4q8H6s3Snq6k51/BSSIMvl3uMVzm32LvfvVkfVtZlMpu0X2dG
83Mx3GJMCWCda8QuNj0NVho/FcwMvmY200pUSQeK0ir2cnVj3Vcjd1pRanaa0grLloKe2tdWniuf
/Atfx5aYqZTjdK37VNxa2enQPB4XryEr7ThTW0/WZmmavQyKyWmZ1uIOmrASDFgJh0vMZI4yoNcr
Kh+zu2Fbtuuu3t3UCns0pzT89I7/jzi4PC8X0n4S+EnV/VV2/vjKidlVwaNl5G73l+Fko29NCTrS
aF+4pVpON0MA7nGKbxzW7r34ouEscpRp70OD1Bqq54XZY7M8gedF87KxxVQKR7TPuiXvCwvbU0Oe
G71mJZbLoftrOc+c6PJWaWvRreSk2VtViJOlbW878G3PFLkWh3FwEb7djksu3n+9F6cwXubYlpzc
O6XutI86Q6oPXeBFPxpwka5Nqn7x17iueZ11zeuWavPsx/4rSrUe775TluNypzy1vInwke8r5yXH
sQtntayzr5al/1bYbof98463fu6whNe3hQUzWo37viQ1/c5Qj1GGrl7rTtX412Ef/3dWJzyipw/t
wphsKFbmmPdE/fnwS37tWQ8euO9urOz7jGGwTi5pMOxs9qaP0BL/N+jrbmzfI6Z5mqesm9+qPV8X
/zSRmZqzn2UT5N8ktK0H28tVmd19hsFtH/zRivxdmFEd3KvRjMGMXank3/zxX6v9Gvupn+WVFeZZ
0lvE3ZlVC17N381BxCNwQiVwQh6o4Arqhx78yHuQRSUM1J2Rn+48FwX6Hwja2EK5nIf1Ctwh4MJ5
VO+pWL1ciyUZRLg9xFTkgRqgwmMcSB6cBMSRmfSZ3wUWmPWtX6UhmLEdH7cF2FrZVdElX6gUgvGU
xGMwx0ApxAQyVgVWn8vUXvCtmv/b3Zp7fSEYVpgYlpavZMcKegJ8vEcnqOAJFsJWrQwidAKE7A81
sdXVnR74oZ0IdsoWUtwdbl8jHKAeUozKBQ+DHAU/iKI0yQUpDsQlGMIhgksg3A1IzM0Mjhb3IJvd
UV4Art+0lNWgWVsIdiJQVMIlnNGAyIcgwocwycclBJChVIIU6cFJ5GDkDdzk+VvlrVscKtnM5eGG
aZynVMIiDggmeIIUSsLQ0AcKMshcLIWdLaNL6IEqphcRTty2TV0l3qI1Pgrs7aJHrdcjGEVn0Agi
2IjXOSBQSEJscEgAdEIyMgoiFFGNjAg0Tt//IRw9VqM1ctwBZiOtoVchtIZc6Mj/JhjVfKXcWRSC
JSwHLK5MoUAC6ZCEIaQdPPrKBs5axSlSPZIgeejin3mVAGxCR7pEJ6iRkdnfC23VOnIENbUhu5CR
WIjgFT5XdNXi2uVjxn2R9hkb/KlXHoCNi+SBjRjeTd4UsK0jJpzE4ATCMn0O6r2XHMpjVLZcRZYW
jUnOu21iEHqEMKFCV67JsA3lSIILJOGRG7aJT6KCGrlaoM0kAEolAqIeEEpEXZrGQbCk+NjIhPlK
CmoIMKngJrDYAEgCbOSBIUgCfKggQDLESgaAGjiiohDmOL7hM2KgjdlkY06EwdVjISyTazxOREoE
VOBRpnmCKGoIUPDjVxxIITCI/wuKokAIFEMgQip8wmrCS2sSYUjey4ZRI/zVnlvQpbFBpml4klzo
k/9NhCnlEa9wwj1pCiIgCWeGyhxwgnEiQv5dSXQSzPG4yDiO4aclpmK+ZT6Wx+JZ5fqlp0ugAieE
5ZqQUlFQxCZAyHA2wi0FpKtEQh2x4UGcpRqszGesD0hgwoS6meChnX8KnXYGmtF0Z21+VeigAh5I
ylvghCcoRQbNDW4IwC3FUolIEEM0wlnmwbfIE0iowVMKYFuGzH/S3IkOwKZdJSh8Jx9wAimigiR4
mERYkCd8xG86UQrihm/Mh8NMIOkIUq4ghCc5I1E5UXs4lXSxE3Y2XkVu4KvFWv8mWpskpIKBUul8
SQTnoMIjrIQUBoAnkBBYmNJwjl+aGoae3M2fFFGf/liacd80agycupfKIY2TWpspkUSe1opEtAiP
rISMfGgjpGkl6M9+5R+i5kobIoQacAJj2RN6hOh+ch/WICmFnaj2RcR3CoAU3YfvQQtUXIJEsMdw
5sFj4M8ISRlCbIQaJJIyTVxucub13RUAfghcChdfdWeKwihhuFmJOegnTIRP5IGllOo9LeuFYAar
MkRoyqEAFKj4IJ9M6qDylSjrbaCiPeZVFpWmmomSugXbBKUArIQewFuaIqp7tg5HasVBpCSZHoRI
jKFE3KkrPsL/rWXsPZjQ6SD/oYUkv4KsRPhkAKgiwJKQcWSHqTJnynajUtiFnziFqZ7jipSlqHQE
lY0sJ/CB3DWU1S3avQpgonknk76FerhEuWbhZ0yCKUKGKSIqzHZGOvLJyuTfACBCZhZVvAqEJ2we
631evkzlWkbk9kHmZDqqz3Lo5bBsJSAqymbHSOCRVLzJJmSHSXpO3dhZpJyIwvQSSQjbdW1sTeKq
m2XLvvIq2HRQ0ibGSPBIed5OHrzXuQoEgkrKWQqpnuSfqUGES64aAWzlwAYe2p4L0G5eA7YX2S6p
u9gTISjoZ9TEsL6FjCKsr5SqjKZmX1oJhMSRmR0ixlKErxrCFiou2AovQ9km/7e+BaLC08R+Rri6
S3oC6ghpyrGCRbzq57CE5+RSLZkKDG/Oiq9C7i3GZkkJLq7Gmv+R7b6+hRTdrOhChMC+hZ3OR5bm
UUGAQqkKwEZ4iMho7XwaVEPNivL+JtJt3p6R7lf+UopCJthwrvuSkFm8xSegAmf+aXngb5C2r7Ko
awCkQjKyq/mZhvIuSJIWMOPxYDU6lneGrETIhcIimwUN6b62SPASrFJ0IPXyyADEawbbakeiwkC5
4X6uFn6OcKTi69bhiiXSmLaq8CYCCEu0LtxcTkASK0LOSgVPL1JoCidUbDPSnQ0ezyf8TdUS6ffK
Rfii8Mdpz/qpVnup6Hfak/8Q0wc/IeS0NoLzfOgVc0j98pLt6qVBbEL6SGFlrkqHugYiwGJ1mkZu
onGK6ST5rlqkLvGcqm9RycVe2tOKSISMBmVEVLCDHpNrTGgl2C5IdBClDABuTsYbKgxkcEIPGh7h
FO8XzeUKs3AZoVgKruAKgiTBcipF+ClM8FJ26LIhCPNn0IQK4i2TseIuW8KG0qoeO44lclvunDCl
XUv6Iu9bgM2EAmwlt51EZtqyWc2HbG+rXJwIBwA1x7IiF5W2/Z7h2rIUDecsTiyhQcumjShY/myn
kPFeZtCS7CJcnoxK+df2qZwKFxUhSARMAe4/weAm7PIJKjNPFuIu54Euq6D/OZ4I24KmfiKCFK7g
QWw0ShRiJPpV384oLLez955X4WqiPL9F48bPipwZ53yCMX8CWdxENz5CcHpIJ1zCTHQCP2THTxs1
227CUZQr5xhCek6p1X7OJfADXzgJP3DSQYzEQEWkX02mQPQyO2OnSw+di70xOKPxMl1s8gaAfj6C
n4LFRGilWKjgux3r9PJDebBNALikFx/F5ywjqYaNUknCyhxrpVDZI1Ss54i1HgaFtYFCm8nzNguA
JUyE1jZyr/6EL8KTHnDC/RqkLvOKE2GKE72Hhng2KkypF5NPai4jAThRWWKCBcWRYEciW8vFKw/0
VEJj7J2vRflV+hYV7AoA/x/cTp/qdUhwNo/sijKjQjCEo0Q4UQ2R9vdCzyckCCkNwPgQRGz3RF5e
DjU50W3v6VZigvjyNnkbXmNta8g+9UT0UBFTRHomSV/wiCSpYA0vCNIcK+XctWeSkobgBWrTx0Xo
AWwb9XZLIU7M52ED+F5+dQDodmMbGllXK6xp81c9gsGaMUkwtKaMBCF69keEIyY8iR5cLE5A7oYr
0f1yxCVMKY0UhIyiYCpoSCEcyIKionVYEFlexCVo5cRm8nlTuD3fs7tcVOG1d1F5wocLgKaKq68U
pLsGc3bQbSUEJJbfcXbk6ZVbeXbAjYY4BWcSQFNUuVMMVCFw+dqOYTBBRv/jpjFvJ/Q7izMl86pE
GALXzkqQWvHEAVz69lvDPeCUmV8pm3KRG/mRG9skzuWu2rJEkKXQaC3lzjmrzWvqAnNAvnW3oERF
zGAjpITPNbTmRAI7fydQKXqdM7ECfxUnRHlBQKlLUHo8e61tXstlEgQieIInXMIlBCInwMYndITu
sIhn00gzCnuC5IGMeLPWbiqiJzpAs17vNOmjSwQfsAh5GAKEZLAR+27GYorBEuKTfClBbMLnWMsm
GEKMHMF8usd8ZkSAA4Uz8TWVUXin+hhZrbq1T8TvcO6sTELneII3h6w8at6IGiw/Fma5mxGZpHJG
f0cnTFB3JMjomGoGR6n/K9s7ZD8yedL5nZBthq+bVo7jWzwCS5Llxttv4aHduxmsGSGCAPh6OKog
q9gJTmc0JhjF3cQGbgKFs08uH1A7tIvt9xXVu+GVklf7urFNnpYHJFGmsJWHPrNUWEsCSCosQjUC
JJRlIJSlO6qzEkn7vb/oQbdle9+5yUsw6EKEUnHlxdalX+m70RBYxsneSWkufRDx5H470XcmQCN0
cH1h2sMOjhcmu/2TceZBWCO510LqsLxM1UqCMaICDXft+vHqTfqXhg2tTE+lJx3ozjpVnoOEJ3BC
qctc/WlK4CvuitEkbHfGJ5BJ0Po9CWKzbaooNZcGIVwE3WjcnnKCJ3TA/9ZaApUe4IiqWPqZ2Db1
RG5u7VoHHNF/c+PjVYZTNgE/eXyk/MsdINt6wgtmNJb/Xxtj7J6hC8NCRuWbqPT7nrscP3srtCWi
GOnQzeV77B+qIHwAefgjAkBwejRggACCBwsSJIBQIQGHj/KgCjCRYgBPjwRk1KiR4EaPHwWAArmR
4cGRCTM2yihSZMiRHjt6rIQpAKo8Awu+1AgK1ICePwWoNNixZEKHRQkUiliRIqZKOk3qlPqxaM6N
jXJabclyKkerHB9dmmgT40uhKDmSzGqS6ICFDCV1YkoRlaWYL+92lVr1a8uMBYWudDkY6te0AyTp
GdtpklmSf2F+XWvwKP/BTZY+zR17M+9JvZ+rfsQK2SXXrXsN/41ZSfFETJYa79SoUqXJwFFLUh5Q
CLNm15xy4039GSRfvH5Ngx5uMG0lTxUxXUJUFiZp5nkRCtjEqRNN3wE6VSLQ6G32k8uJkw4t+/Hp
rX6FU+2ccVMe70095akkqaXV2lEFeKQSTvLQQ6LvAlCDk0gcqowhqNLDS7XgZlONvdME0AQ1+dAT
YJJL7guAH7r0KDGPE1H0pMTMEKRLwUfGa9BB84qLUMLc7oIvp8Aw7Gq5mHIkbLvuvuPHSCNbbEoN
SyQ5iDwZZwRQPhsLozAl5oIqjTD4ziuuQ5AaETCPTgxMEjo9LtHvEaz/SoKyQSsj+zK99QjDUss6
uYyMQ6vkHEnASgAlUD9AAR1qwqoWcvPB+Kg8D07rNkpOw8K8hFSqPGtMS63yEEoUykfVatTRRTFV
KTnlOLQUU54qrFEyyaJ0y81YIRTVSysDyzI5rlBLbT69Sp3wMSwP4rTYAZ6kVcL0MFUruGZlgw9a
O519adVWqaIWO4UQVXTRLm2Nsy1rtTRt0o9ik1JYQz0S8KM8aTvUK42adKso8mR9E6FNCFlWu37D
DW1awQauJIBK1F23r4wM3iTSK28clkxZq0pW34NK9DfjgIsaydSQeG32EZqe+vVXj2ITjNzriM3I
kAD04BbRfNk8iN+X/zrhJCNCHOY4t2vd0+hcjcgMYKjhiKJ2pB6xRQktAQjR45OY7UUKWRk7BumR
g8MV17xc3x0MU0PSNHqAPC4RgBNPNjHEkyZd9sSQRzqxhG5O3O45LE8aa2RtS3S25CJJPLGE5b/0
mARmguLqZCBL9LBkIUTUyAOS8TjRI4+zN89okk4u4YQQS+TKQ4ATNYJcZ7pNdztl4X72yNRThd4o
6tONzsOSACyB3JNOTiyok/A+8SRz4PUg0/RN6gL+keQbmbp33j0xOKGsehcAvAEeQSWSS3q/ZABM
GrnkE9YH6ESNSvg50Wi1UZnk5cbU8ESA0N//pBMBPnFud04sUaC9HP+NRh5BDsFAoof8KEYA1QtA
2mDGv80ZAhWP8MQnpscJUORhEwHQ2dRcAqJI8A9y2vtEJAzBj+sURBI2yUMANieJgxEkDyccgMEK
0YgCISIAmyAI+FDhId4NgBOYyAgqgFO3VJyuggJIXh5eZj8yTYVOYVNZ7TRyIkApZgCXCQAhXlYJ
QvDjKZj4nR4wcoklZmR3KAyAIUTSQZ11cBKbMJjOLmgo7umBUDBcyCcqeMPtqeETBCETJjqBEP05
ERMF+Z0AGpYRRAogOhr6xCXC0kMB1IWKRclT0GjnIT1oxEAGUdH9PiEAS6BiADyMnEYWmZFFXgIV
LclDKlRin0fUZ4n/W7MLSi5hCI20zzIdSOQAdtfCPIwHE4oxxEFkODcPaueNhADRAAhhsEpsTZiE
4B3/9veynlXpW60Kmdb0ADAnjnIA38SE6fRHugA8jl9vDIk33VYin6jIft3LmSEWKc6YZQQR9tMI
DB9RCAJkThID+cQLEdGIO/ZwAIYgECY2QZN+yWUTnbgk4EBEiOc4bJWPwKcAPNrRTpZTVw8TzKRE
ehHPYQIVkngZIWTYmAc68BGWSNsqXWKw3lkCE2EBIBq70wm22dM+UBQJBYEToN2p4RIx86ke5oYJ
SVTuEQ8txMFY0whPqEiGkuDEJ6JjsKoOQIFoRIUhJvFWtc3TiWMd/+eoCviwUGoIgHjLCBQNoR/D
EcJ0AggsRgLICT6ozXBZ1FkkAogIUEAkD5NABAfrE8c8ICIjEKkEBz2kHwAG0BJ8kIQWuafF8QTW
bojJgyQMqzvCCjOwDptEZUP7WobpDJK47RVDuATKO9VKT0szLsiWdT1txcpJbnlSzU4mrD4pB1QG
/MjQspWpl2CXPdbtz+GoYqxjYeUoxtpQ15zF0nKFklHVidDAIOO0WyElUc6t7rzQm152QWxLGZkU
d937GQ01i1fW1SPsuuXci0VXU/k9VMKQEzSQELayJ7NKJAQFG94a+Lj49RKKTsQJhB1rwQy2FEgy
l5m7knO/KgOFJv+Yht3u2dSg2qXgAwFqEQBf0cAJU4t9jGSfABS1vOTNznSnsjsj6sU8CyvXVIZn
IbykcJoBsskn8eSqKmUmZh30o72i5GCxpI3JcJLWkz8i164QQiJ6WGxGqqeTAl/RxJaZiF22BkMw
X029jaKJMEHC3SOnhiVMy5BGJrE7QxBiEr9rTObals6MyIVrGtnEI8KCinfqgROSoGl9NO2wDdIE
jZBUzCckMQmaTsJAzyTiRJr0QlT40G+ZUcMjJAFISTtnyI0xBE2qOkqx5AwVqaxEZjAxCW/yjqZP
+a115tzf/3rIE07hRE0pSAgyJe9tRxzydTPzCU7cGa0B0B/JUMr/uxcCziJb8yhNaKrnRqhhIgWC
Wb3kYgkezoSPMBz3RRI07lQUEWZrGzImUsE7mClOQTWZGgx3rN/h8IS9G0keJZcHs+c10XMT2V+k
ZB2JSEwEb1zWXgAmMW5MgMIQekBEwutjkcxpnDMDaLNYkk0QHjZSMV8Fawu/+MJbfvM5pHsZ7yqx
yoNFTZ4VLB18jxyt7rqEux4UJyS/qD0yM6zeG3mEqh9oWJhNdiKVeJkRFZM2keDcEzYRwMjt+ReD
vZGtCSIIl9GKiLqjgrBDbrvuaiJJlKvy24RfsrcNJxFn+3e+J0ZutDfSMPtkhJZCfN2yC5sh0JU9
3YZTeboxORE4/2ZEMZwuy8uCyJEXzrPuVPO43t3SPfCUXiDp3p/ilpyZxsqlxoqrIOox/WwsnepU
2J28ADF+v8OT0twaGfe456m4g+kv7DQRnEQ4y2rF5KERk0ilXD7+Fy4TpPRdLDsRDWSJl5UIhh4q
XvufM7y5A2zYAXooeO4HnjizWGkrKfC5zuWRfg0izoeStg7RJCI/KG1kzA0TaAIVKgH7QGEsPsTc
aCnlagJEGkMiAE07xGLINuc5LFAu9AfVEiQP+MGiMjDZxq3YMgMVjKf5uA4VQKQ3hEkEO2FoBA03
pE5spu6IGou1ymKbtCaAdCflQKE+OCiwnqJQYmsSCkJQaE0KGf9m8QKEUAYkTBJLC3WHQT5LP6Lw
RHomsSKhC7NJnXpLPyDJ2W6rsVZKVXywWSaBHwAGyUZixwoM8shpZrilPBzsurDoVrwLgV7s0DRk
UjBDVKZFD7MLwdqCvvqsa1pCB/dkac6pdvgIq8LlEEGCwOaEL9okEv/QEBuvIIhvMDgxQz7LCm0k
4iTMpRwvvUCxIfJqFH3Ex3alThhPEjvsvBzxEWfRDoljwBgPwAooF3cxFUcRDzuROIKxUzjFFgER
wboLGQEwv5SxB30maawmGqUxEI1RSnJRJKYNG7sCy4ZlDwkoFH3MHAOxErPsEncRvcixGXtRTjrm
WPSxHekxGRttT+okhRS/0aWCy0a+hQ+FkUoiziuCZFeI8dAcLBs5bCJvEUCCcSAhUiBTZRBLIxUX
0kYmERZ10SDZ4npAESO7a8eiYlcKMdC6xiPDxhOd0SIh0cTCpR4zslIMLGjKkRc/smso5CK/ccfC
USMCAgA7

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/includes/header/03/style/header.css

BODY {
	PADDING-RIGHT: 0px! important; PADDING-LEFT: 0px! important; =
BACKGROUND: url(/common/includes/header/03/images/bg_body.gif) #fff =
repeat-y 50% 0px; PADDING-BOTTOM: 0px! important; MARGIN: 0px; =
PADDING-TOP: 0px! important
}
#constrain {
	MARGIN-TOP: 0px! important; BACKGROUND: =
url(/common/includes/header/03/images/bg_constrain.gif) #fff repeat-y =
50% 0px; PADDING-BOTTOM: 1px! important
}
#hdr {
	BORDER-BOTTOM: #fff 15px solid
}
#hdr .publications-search {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 4px; PADDING-TOP: 0px
}
#hdr .publications-search {
	FLOAT: left; WIDTH: 100%
}
#hdr .publications {
	FLOAT: left; WIDTH: 100%
}
#hdr .publications UL {
	PADDING-RIGHT: 0px; MIN-WIDTH: 24em; PADDING-LEFT: 0px; FLOAT: left; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: =
none
}
#hdr .publications A {
	FONT-WEIGHT: bold; FONT-SIZE: 70%
}
#hdr .publications A:link {
	COLOR: #313131
}
#hdr .publications A:visited {
	COLOR: #313131
}
#hdr .publications A:hover {
	COLOR: #ce0808
}
#hdr .publications LI {
	PADDING-LEFT: 10px; BACKGROUND: =
url(/common/includes/header/03/images/bg_publications_links.gif) =
no-repeat 0px 1.5ex; FLOAT: left; PADDING-BOTTOM: 2px; MARGIN-RIGHT: =
1.5em; PADDING-TOP: 3px
}
#hdr .publications LI.li1 {
	PADDING-LEFT: 10px; BACKGROUND: =
url(/common/includes/header/03/images/bg_publications_links.gif) =
no-repeat 0px 1.5ex; FLOAT: right; MARGIN-LEFT: 1.5em; MARGIN-RIGHT: =
0px; PADDING-TOP: 5px
}
#hdr .publications LI.li2 {
	PADDING-LEFT: 10px; BACKGROUND: =
url(/common/includes/header/03/images/bg_publications_links.gif) =
no-repeat 0px 1.5ex; FLOAT: right; MARGIN-LEFT: 1.5em; MARGIN-RIGHT: =
0px; PADDING-TOP: 5px
}
#hdr .jumplink {
	DISPLAY: none
}
#hdr LI.nature-link {
	PADDING-LEFT: 25px; BACKGROUND: =
url(/common/includes/header/03/images/bg_nature_home.gif) no-repeat 0px =
5px
}
#hdr .nature-link A {
	PADDING-LEFT: 0px; FONT-SIZE: 100%; BACKGROUND: =
url(/common/includes/header/03/images/nature.com.underline.gif) =
no-repeat 0px 90%; FONT-FAMILY: Garamond,serif; TEXT-DECORATION: none
}
#hdr .nature-link A:link {
	COLOR: #ce0808
}
#hdr .nature-link A:visited {
	COLOR: #ce0808
}
#hdr .search {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 70%; Z-INDEX: 1; =
RIGHT: 0px; BACKGROUND: =
url(/common/includes/header/03/images/bg_search.png) no-repeat left top; =
PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #fff; BOTTOM: 0px; PADDING-TOP: =
6px; POSITION: absolute; TEXT-ALIGN: right
}
#hdr .search A {
	COLOR: #fff
}
#hdr .search LABEL {
	FONT-WEIGHT: bold
}
#hdr .search SELECT {
	FONT-SIZE: 85.4%
}
#hdr .search INPUT {
	FONT-SIZE: 85.4%
}
#hdr .button {
	BACKGROUND: #f9f9f9; COLOR: #000
}
#hdr .leaderboard-links {
	CLEAR: both; PADDING-RIGHT: 208px
}
#hdr .leaderboard {
	MIN-HEIGHT: 93px; BACKGROUND: =
url(/common/includes/header/images/backgrounds/01/leaderboard.gif) =
no-repeat left top; FLOAT: left; OVERFLOW: hidden; WIDTH: 100%
}
#hdr .leaderboard .padder {
	MARGIN-LEFT: 15px; OVERFLOW: hidden; WIDTH: 728px; MARGIN-RIGHT: 15px
}
#hdr .user-services {
	FLOAT: right; WIDTH: 208px; MARGIN-RIGHT: -208px
}
#hdr .user-services .list {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 0px 3px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#hdr .user-services LI {
	BORDER-RIGHT: #a8a8a8 1px solid; BORDER-TOP: #e5e5e5 1px solid; =
BACKGROUND: url(/common/includes/header/03/images/bg_user_services.gif) =
#efecef repeat-x left top; MARGIN-BOTTOM: 2px; BORDER-LEFT: #cecece 1px =
solid; BORDER-BOTTOM: #a1a1a1 1px solid
}
#hdr .user-services .us-link A:link {
	PADDING-RIGHT: 2px; DISPLAY: block; PADDING-LEFT: 37px; FONT-WEIGHT: =
bold; FONT-SIZE: 70%; PADDING-BOTTOM: 4px; PADDING-TOP: 3px; =
BACKGROUND-REPEAT: no-repeat
}
#hdr .user-services .us-link A:visited {
	PADDING-RIGHT: 2px; DISPLAY: block; PADDING-LEFT: 37px; FONT-WEIGHT: =
bold; FONT-SIZE: 70%; PADDING-BOTTOM: 4px; PADDING-TOP: 3px; =
BACKGROUND-REPEAT: no-repeat
}
#hdr .user-services .li1 A {
	BACKGROUND-POSITION: 10px 0.3ex; BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_account_red_med.gif)
}
#hdr .user-services .li2 A {
	BACKGROUND-POSITION: 10px 0.9ex; BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_ealert_red_med.gif)
}
#hdr .user-services .li3 A {
	BACKGROUND-POSITION: 10px 0.3ex; BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_register_red_med.gif)
}
#hdr .user-services .li4 A {
	BACKGROUND-POSITION: 10px 0.5ex; BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_subscribe_red_med.gif)
}
#hdr .user-services IMG.usi {
	BORDER-TOP-WIDTH: 0px; PADDING-LEFT: 5px; BORDER-LEFT-WIDTH: 0px; =
BORDER-BOTTOM-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px
}
#hdr .user-services .ad203x90 {
	BORDER-TOP-WIDTH: 0px; PADDING-LEFT: 5px; BORDER-LEFT-WIDTH: 0px; =
BORDER-BOTTOM-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px
}
#hdr #header-nav {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; LEFT: 10px; PADDING-BOTTOM: 0px; =
MARGIN: 0px; BOTTOM: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none; =
POSITION: absolute
}
#hdr #header-nav LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; BACKGROUND: =
url(/common/includes/header/03/images/tab_l.gif) no-repeat left top; =
FLOAT: left; PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
#hdr #header-nav LI.hilite {
	BACKGROUND-IMAGE: =
url(/common/includes/header/03/images/tab_l_hilite.gif)
}
#hdr #header-nav A {
	PADDING-RIGHT: 10px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: =
90%; BACKGROUND: url(/common/includes/header/03/images/tab_r.gif) =
no-repeat right top; FLOAT: left; PADDING-BOTTOM: 6px; PADDING-TOP: 6px; =
TEXT-DECORATION: none
}
#hdr #header-nav .hilite A {
	BACKGROUND-IMAGE: =
url(/common/includes/header/03/images/tab_r_hilite.gif)
}
#hdr #header-nav A:link {
	COLOR: #ce0808
}
#hdr #header-nav A:visited {
	COLOR: #ce0808
}
#hdr #header-nav .hilite A:link {
	COLOR: #fff
}
#hdr #header-nav .hilite A:visited {
	COLOR: #fff
}
#hdr .journal-header IMG {
	BORDER-TOP-WIDTH: 0px; DISPLAY: none! important; BORDER-LEFT-WIDTH: =
0px; BORDER-BOTTOM-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px
}
#hdr .journal-header-image {
	BORDER-TOP-WIDTH: 0px; DISPLAY: none! important; BORDER-LEFT-WIDTH: =
0px; BORDER-BOTTOM-WIDTH: 0px; BORDER-RIGHT-WIDTH: 0px
}
#hdr .journal-header {
	LEFT: 0px; WIDTH: 60%; POSITION: absolute; TOP: 15px; HEIGHT: 74px! =
important
}
#hdr .login-nav {
	CLEAR: both; PADDING-RIGHT: 10px; BACKGROUND-POSITION: left top; =
PADDING-LEFT: 10px; MIN-HEIGHT: 124px; PADDING-BOTTOM: 0px; PADDING-TOP: =
0px; BORDER-BOTTOM: #7e7e7e 1px solid; BACKGROUND-REPEAT: no-repeat; =
POSITION: relative; BACKGROUND-COLOR: #666
}
#hdr .logon {
	RIGHT: 10px; POSITION: absolute; TOP: 0px; TEXT-ALIGN: right
}
#hdr .links-above.logon {
	TOP: 2.5ex
}
#hdr .logon A {
	PADDING-RIGHT: 0px; BACKGROUND-POSITION: left 0.3ex; PADDING-LEFT: =
18px; FONT-WEIGHT: bold; PADDING-BOTTOM: 1px; COLOR: #fff; LINE-HEIGHT: =
1.3; PADDING-TOP: 1px; BACKGROUND-REPEAT: no-repeat
}
#hdr .logon A.login {
	BACKGROUND-IMAGE: url(/common/includes/header/03/images/bg_logout.gif)
}
#hdr .logon A.login:hover {
	BACKGROUND-IMAGE: url(/common/includes/header/03/images/bg_login.gif)
}
#hdr .logon A.login:active {
	BACKGROUND-IMAGE: url(/common/includes/header/03/images/bg_login.gif)
}
#hdr .logon A.logoff {
	BACKGROUND-IMAGE: url(/common/includes/header/03/images/bg_login.gif)
}
#hdr .logon A.logoff:hover {
	BACKGROUND-IMAGE: url(/common/includes/header/03/images/bg_logout.gif)
}
#hdr .logon A.logoff:active {
	BACKGROUND-IMAGE: url(/common/includes/header/03/images/bg_logout.gif)
}
#hdr .logon P {
	FONT-SIZE: 80%; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 8px
}
#hdr .logon .user {
	FONT-WEIGHT: bold
}
#hdr .logon .inst {
	FONT-WEIGHT: bold
}
#hdr .login-nav .list {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 70%; RIGHT: 0px; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: =
none; POSITION: absolute
}
#hdr .login-nav .list LI {
	FLOAT: right
}
#hdr .login-nav .list A {
	PADDING-RIGHT: 10px; DISPLAY: block; PADDING-LEFT: 10px; FONT-WEIGHT: =
bold; BACKGROUND: =
url(/common/includes/header/03/images/bg_register_list.png) no-repeat =
left bottom; PADDING-BOTTOM: 6px; COLOR: #fff; PADDING-TOP: 4px
}
#hdr .login-nav .list A:hover {
	BACKGROUND-IMAGE: =
url(/common/includes/header/03/images/bg_register_list_hover.png)
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/includes/footer/03/style/footer.css

#ftr {
	BORDER-TOP-WIDTH: 0px; CLEAR: both; PADDING-RIGHT: 0px; PADDING-LEFT: =
0px; FONT-SIZE: 70%; PADDING-BOTTOM: 0px; MARGIN: 20px 0px; PADDING-TOP: =
0px
}
#ftr #footer-journal {
	PADDING-RIGHT: 1%; BORDER-TOP: #000 1px solid; PADDING-LEFT: 1%; =
BACKGROUND: #eee; PADDING-BOTTOM: 2px; PADDING-TOP: 2px
}
#ftr #footer-journal:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
#ftr #footer-journal P {
	PADDING-RIGHT: 1em; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: =
0px; MARGIN: 0px 1em 0px 0px; PADDING-TOP: 0px
}
#ftr #footer-journal P.journal-name {
	FONT-WEIGHT: bold; FONT-SIZE: 100%; FONT-STYLE: italic
}
#ftr #footer-journal P.issn {
	FONT-SIZE: 100%
}
#ftr #footer-journal P.eissn {
	FONT-SIZE: 100%
}
#ftr #footer-journal P.extra {
	FONT-SIZE: 100%
}
#ftr #footer-links {
	PADDING-RIGHT: 1%; PADDING-LEFT: 1%; BACKGROUND: #000; PADDING-BOTTOM: =
5px; PADDING-TOP: 5px
}
#ftr #footer-links UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#ftr #footer-links UL LI {
	DISPLAY: inline
}
#ftr #footer-links UL LI A:link {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 1em; BACKGROUND: =
#000; FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 1em; =
BORDER-LEFT: #fff 1px solid; COLOR: #fff; PADDING-TOP: 0px; =
TEXT-DECORATION: none
}
#ftr #footer-links UL LI A:visited {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 1em; BACKGROUND: =
#000; FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 1em; =
BORDER-LEFT: #fff 1px solid; COLOR: #fff; PADDING-TOP: 0px; =
TEXT-DECORATION: none
}
#ftr #footer-links UL LI A:hover {
	TEXT-DECORATION: underline
}
#ftr #footer-links UL LI A.about-npg:link {
	PADDING-LEFT: 0px; FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 0px; =
MARGIN-LEFT: 0px
}
#ftr #footer-links UL LI A.about-npg:visited {
	PADDING-LEFT: 0px; FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 0px; =
MARGIN-LEFT: 0px
}
#ftr #footer-copyright {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 1%; PADDING-LEFT: 1%; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-ALIGN: left! important
}
#ftr #footer-copyright A {
	COLOR: #db1a21
}
#ftr #footer-copyright P {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 5px
}
#ftr #footer-copyright P.logo {
	PADDING-RIGHT: 36px; PADDING-LEFT: 36px; BACKGROUND: =
url(/common/images/npg_logo.gif) no-repeat 0px 50%; PADDING-BOTTOM: 7px; =
MARGIN: 5px 0px 0px; PADDING-TOP: 7px
}
#ftr #footer-copyright P A:link {
	FONT-WEIGHT: bold; TEXT-DECORATION: none
}
#ftr #footer-copyright P A:visited {
	FONT-WEIGHT: bold; TEXT-DECORATION: none
}
#ftr #footer-copyright P A.footer-copyright:link {
	FONT-WEIGHT: normal; COLOR: #000
}
#ftr #footer-copyright P A.footer-copyright:visited {
	FONT-WEIGHT: normal; COLOR: #000
}
#ftr #footer-copyright P A:hover {
	TEXT-DECORATION: underline
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/style/layout.css

#header {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px
}
#breadcrumb {
	MARGIN-LEFT: 1%; MARGIN-RIGHT: 1%
}
#constrain {
	FLOAT: left
}
#constrain DIV.constrain {
	FLOAT: left
}
#constrain {
	FLOAT: none
}
#constrain DIV.constrain {
	FLOAT: none
}
#content-journalnav {
	BORDER-TOP: #fff 1px solid; DISPLAY: inline; FLOAT: left; MARGIN-LEFT: =
1%; WIDTH: 79%
}
#content-journalnav:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #content-journalnav {
	HEIGHT: 1%
}
#journalnav {
	FLOAT: left; WIDTH: 21%
}
#journalnav:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #journalnav {
	HEIGHT: 1%
}
#content {
	FLOAT: right; PADDING-BOTTOM: 1em; WIDTH: 76%
}
#content:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #content {
	HEIGHT: 1%
}
#extranav {
	BORDER-TOP: #fff 1px solid; DISPLAY: inline; FLOAT: right; WIDTH: 17%; =
MARGIN-RIGHT: 1%
}
#extranav:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #extranav {
	HEIGHT: 1%
}
#footer {
	CLEAR: both; PADDING-RIGHT: 1%; BORDER-TOP: black 4px solid; =
PADDING-LEFT: 1%; PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
#footer-copyright {
	CLEAR: both; PADDING-RIGHT: 1%; BORDER-TOP: black 1px solid; =
PADDING-LEFT: 1%; PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
#footer-sponsor {
	CLEAR: both; PADDING-RIGHT: 1%; BORDER-TOP: black 1px solid; =
PADDING-LEFT: 1%; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-ALIGN: =
center
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Location: http://www.nature.com/reviews/style/layout.css

#content-journalnav {
	WIDTH: 76%
}
* HTML #content-journalnav {
	WIDTH: 75%
}
#journalnav {
	WIDTH: 23%
}
#content {
	MARGIN-BOTTOM: 20px; WIDTH: 73%
}
* HTML #breadcrumb {
	MARGIN-LEFT: 1%; MARGIN-RIGHT: 1%
}
#extranav {
	WIDTH: 21%
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/style/main.css

* HTML BODY {
	FONT-SIZE: 90%
}
* HTML BODY {
	FONT-SIZE: 89%
}
BODY {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 90%; BACKGROUND: =
#fff; PADDING-BOTTOM: 20px; MARGIN: 0px; COLOR: #000; PADDING-TOP: 0px; =
FONT-FAMILY: Verdana, arial, Helvetica, sans-serif
}
A:link {
	COLOR: #36c
}
A:visited {
	COLOR: #639
}
A:hover {
	COLOR: #c03
}
.print-header {
	DISPLAY: none
}
.hidden {
	LEFT: 0px; OVERFLOW: hidden; WIDTH: 1px; POSITION: absolute; TOP: =
-500px; HEIGHT: 1px
}
.clearfix:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML .clearfix {
	HEIGHT: 1%
}
DIV.cleardiv {
	CLEAR: both; PADDING-RIGHT: 0px! important; PADDING-LEFT: 0px! =
important; PADDING-BOTTOM: 0px! important; PADDING-TOP: 0px! important
}
SPAN.cleardiv {
	CLEAR: both! important; PADDING-RIGHT: 0px! important; DISPLAY: block! =
important; PADDING-LEFT: 0px! important; PADDING-BOTTOM: 0px! important; =
MARGIN: 0px; PADDING-TOP: 0px! important
}
.no-css {
	DISPLAY: none; HEIGHT: 0px
}
#npglogo {
	MARGIN-LEFT: -34px; POSITION: relative; TOP: -10px
}
#npglogo {
	DISPLAY: block
}
HTML > BODY #npglogo {
	DISPLAY: none
}
HEAD:first-child + BODY #npglogo {
	DISPLAY: block
}
#npglogo IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; Z-INDEX: 1; =
BORDER-BOTTOM-WIDTH: 0px; WIDTH: 26px; POSITION: absolute; TOP: 1em; =
HEIGHT: 26px; BORDER-RIGHT-WIDTH: 0px
}
#accessibility-bar #npglogo A {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; =
BACKGROUND-IMAGE: none; PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
.button {
	FONT-WEIGHT: bold; FONT-SIZE: 80%; COLOR: #fff; BACKGROUND-COLOR: #000
}
.clear {
	CLEAR: both
}
.clearleft {
	CLEAR: left
}
OL.decimal {
	LIST-STYLE-TYPE: decimal
}
OL.decimal-leading-zero {
=09
}
OL.lower-alpha {
	LIST-STYLE-TYPE: lower-alpha
}
OL.upper-alpha {
	LIST-STYLE-TYPE: upper-alpha
}
OL.lower-roman {
	LIST-STYLE-TYPE: lower-roman
}
OL.upper-roman {
	LIST-STYLE-TYPE: upper-roman
}
OL.lower-greek {
=09
}
.align-left {
	TEXT-ALIGN: left
}
.align-center {
	TEXT-ALIGN: center
}
.align-right {
	TEXT-ALIGN: right
}
.align-baseline {
	VERTICAL-ALIGN: baseline
}
.align-sub {
	VERTICAL-ALIGN: sub
}
.align-super {
	VERTICAL-ALIGN: super
}
.align-text-top {
	VERTICAL-ALIGN: text-top
}
.align-middle {
	VERTICAL-ALIGN: middle
}
.align-bottom {
	VERTICAL-ALIGN: bottom
}
.align-text-bottom {
	VERTICAL-ALIGN: text-bottom
}
A.seealso {
	MARGIN-TOP: 1em; DISPLAY: block; FONT-SIZE: 70%; TEXT-DECORATION: none
}
A.seealso SPAN.see {
	FONT-WEIGHT: bold; COLOR: #c03
}
A.seealso SPAN.link {
	TEXT-DECORATION: underline
}
A.rss {
	PADDING-LEFT: 24px; BACKGROUND: url(/common/images/icons/rss.gif) =
no-repeat left center
}
A.rss:hover {
	BACKGROUND: url(/common/images/icons/rss.gif) no-repeat left center
}
#extranav A.rss {
	PADDING-LEFT: 22px; BACKGROUND: url(/common/images/icons/newsfeeds.gif) =
no-repeat left center; PADDING-BOTTOM: 2px; PADDING-TOP: 1px
}
#extranav A.receive {
	PADDING-LEFT: 22px; BACKGROUND: url(/common/images/icons/newsfeeds.gif) =
no-repeat left center; PADDING-BOTTOM: 2px; PADDING-TOP: 1px
}
#content SPAN.free {
	COLOR: #c03; TEXT-DECORATION: none
}
.dev-error {
	FONT-WEIGHT: bold; FONT-SIZE: 80%; BACKGROUND: #f00; COLOR: #fff
}
.b {
	FONT-WEIGHT: bold
}
.i {
	FONT-STYLE: italic
}
.latin {
	FONT-STYLE: italic
}
H1.page-header {
	FONT-WEIGHT: bold; FONT-SIZE: 140%; PADDING-BOTTOM: 4px; MARGIN: 15px =
0px 10px; BORDER-BOTTOM: #eaeaea 1px solid
}
SPAN.page-header-spacer {
	DISPLAY: block; FONT-WEIGHT: bold; FONT-SIZE: 140%; VISIBILITY: hidden; =
PADDING-BOTTOM: 4px; MARGIN: 15px 0px 0px
}
SPAN.booktitle {
	FONT-STYLE: italic
}
SPAN.journalname {
	FONT-STYLE: italic
}
SPAN.journalnumber {
	FONT-WEIGHT: bold
}
SPAN.tm {
	VERTICAL-ALIGN: super
}
LEGEND {
	COLOR: #000
}
* HTML #breadcrumb DIV {
	MARGIN-TOP: 0px; PADDING-LEFT: 5px; PADDING-TOP: 1px
}
#breadcrumb DIV {
	CLEAR: left; MARGIN-TOP: 0px; PADDING-LEFT: 5px; BACKGROUND: #fff; =
PADDING-BOTTOM: 10px; PADDING-TOP: 1px
}
#breadcrumb DIV A:link {
	FONT-SIZE: 70%; COLOR: #000; TEXT-DECORATION: none
}
#breadcrumb DIV A:visited {
	FONT-SIZE: 70%; COLOR: #000; TEXT-DECORATION: none
}
#breadcrumb DIV A:hover {
	COLOR: #000; TEXT-DECORATION: underline
}
#breadcrumb SPAN.divider {
	FONT-SIZE: 70%; COLOR: #000
}
#breadcrumb SPAN.thisitem {
	FONT-SIZE: 70%; COLOR: #000
}
#login-inpage {
	MARGIN: 0px; COLOR: #000; BACKGROUND-COLOR: #eaeaea
}
#login-inpage A {
	FONT-SIZE: 70%
}
#login-inpage DIV.userpassbox {
	FLOAT: left; WIDTH: 8em
}
#login-inpage .passdetails {
	CLEAR: left
}
#login-inpage INPUT.text {
	FONT-SIZE: 80%; MARGIN: 0px; WIDTH: 9em; COLOR: #000
}
#login-inpage LABEL {
	FONT-SIZE: 70%
}
#login-inpage INPUT.button {
	MARGIN-TOP: 5px
}
#login-inpage #savepass-inpage {
	MARGIN-BOTTOM: -2px
}
#login-inpage DIV.error {
	PADDING-LEFT: 20px; FONT-SIZE: 80%; BACKGROUND: =
url(/common/images/login_error.gif) no-repeat 0px 4px; MARGIN-BOTTOM: =
5px; COLOR: #c30
}
#login-inpage DIV.error SPAN {
	FONT-WEIGHT: bold
}
#head-er HR {
	DISPLAY: none
}
#head-er .header-nonad-wrapper {
	PADDING-BOTTOM: 15px; BORDER-BOTTOM: #fff 1px solid
}
#head-er .accessibility-login-wrap {
	FLOAT: left; WIDTH: 100%; BORDER-BOTTOM: #000 1px solid; =
BACKGROUND-COLOR: #eaeaea
}
#head-er .accessibility-login {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 4px; TEXT-ALIGN: right
}
#head-er .accessibility-login A.nature-link {
	FLOAT: left; FONT: bold 160%/80% Garamond, serif; WIDTH: 4.9em; COLOR: =
#b1062e; MARGIN-RIGHT: 20px; TEXT-ALIGN: left; TEXT-DECORATION: none
}
* HTML #head-er .accessibility-login A.nature-link:hover {
	BACKGROUND: none transparent scroll repeat 0% 0%
}
#head-er .accessibility-login A.nature-link:hover {
	BACKGROUND: =
url(/common/includes/header/images/nature.com.underline.gif) no-repeat =
left bottom
}
#head-er .accessibility-login IMG.nature-logo {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; FLOAT: left; =
BORDER-BOTTOM-WIDTH: 0px; MARGIN: 1px 20px 0px 0px; WIDTH: 82px! =
important; HEIGHT: 11px; BORDER-RIGHT-WIDTH: 0px
}
#head-er .accessibility-login .jumplinks {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: =
0px; MARGIN: 0px; WIDTH: 45%; PADDING-TOP: 0px; LIST-STYLE-TYPE: none; =
TEXT-ALIGN: left
}
#head-er .accessibility-login .jumplinks LI {
	DISPLAY: inline; PADDING-LEFT: 15px
}
#head-er .accessibility-login .jumplinks LI.first {
	PADDING-LEFT: 0px
}
#head-er .accessibility-login .jumplinks A {
	PADDING-LEFT: 10px; BACKGROUND: =
url(/common/images/icons/b1062e/arrow_down.gif) no-repeat left center; =
COLOR: #000; TEXT-DECORATION: none
}
#head-er .accessibility-login .jumplinks A:hover {
	TEXT-DECORATION: underline
}
#head-er DIV.logon {
=09
}
#head-er .logon .onlyformacie {
	FONT-SIZE: 3px
}
#head-er .logon .onlyformacie {
	DISPLAY: none
}
#head-er .logon A.login {
	PADDING-RIGHT: 15px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; BACKGROUND: =
url(/common/includes/header/images/logon.gif) no-repeat right center; =
PADDING-BOTTOM: 0px; TEXT-TRANSFORM: uppercase; COLOR: #b1062e; =
PADDING-TOP: 0px; LETTER-SPACING: -0.1em; TEXT-DECORATION: none
}
#head-er .logon A.login:hover {
	BACKGROUND: url(/common/includes/header/images/logon_over.gif) =
no-repeat right center; TEXT-DECORATION: underline
}
#head-er .logon A.login:active {
	BACKGROUND: url(/common/includes/header/images/logon.gif) no-repeat =
right center
}
#head-er .logon A.logoff {
	PADDING-RIGHT: 15px; PADDING-LEFT: 15px; FONT-WEIGHT: bold; BACKGROUND: =
url(/common/includes/header/images/logoff.gif) no-repeat right center; =
PADDING-BOTTOM: 0px; TEXT-TRANSFORM: uppercase; COLOR: #b1062e; =
PADDING-TOP: 0px; LETTER-SPACING: -0.1em; TEXT-DECORATION: none
}
#head-er .logon P {
	MARGIN: 0px
}
#head-er .logon .user {
	FONT-WEIGHT: bold
}
#head-er .logon .inst {
	FONT-WEIGHT: bold
}
#head-er .image-user-services-wrap {
	FLOAT: left; WIDTH: 100%; BACKGROUND-COLOR: #d6335c
}
#head-er .image-user-services {
	BORDER-BOTTOM: transparent 1px solid
}
* HTML #head-er .image-user-services {
	BORDER-BOTTOM-WIDTH: 0px
}
#head-er .image-user-services IMG.journal-header {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; FLOAT: left; =
BORDER-BOTTOM-WIDTH: 0px; MARGIN: 0px; WIDTH: 344px; HEIGHT: 74px; =
BORDER-RIGHT-WIDTH: 0px
}
#head-er .user-services {
	FLOAT: right
}
#head-er .div1.user-services {
	WIDTH: 12.35em! important
}
#head-er .div2.user-services {
	WIDTH: 8.7em! important
}
#head-er .user-services UL {
	BORDER-RIGHT: #fff 0px solid; PADDING-RIGHT: 0px; BORDER-TOP: #fff 1px =
solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 22px 0px 21px; =
BORDER-LEFT: #fff 1px solid; PADDING-TOP: 0px; BORDER-BOTTOM: #fff 0px =
solid; LIST-STYLE-TYPE: none; TEXT-ALIGN: right
}
#head-er .user-services UL.list1 {
	BORDER-RIGHT: #fff 1px solid
}
#head-er .user-services LI {
	BORDER-BOTTOM: #fff 1px solid
}
#head-er .user-services A {
	PADDING-RIGHT: 13px; DISPLAY: block; PADDING-LEFT: 0px; BACKGROUND: =
url(/common/images/icons/fff/arrow_s.gif) #767474 no-repeat right =
center; PADDING-BOTTOM: 1px; TEXT-TRANSFORM: uppercase; COLOR: #fff; =
PADDING-TOP: 1px; TEXT-DECORATION: none
}
#head-er .user-services A:hover {
	BACKGROUND: url(/common/images/icons/fff/arrow_s.gif) #000 no-repeat =
right center
}
#head-er .publications-search-wrap {
	BACKGROUND: #000
}
* HTML #head-er .publications-search {
	PADDING-BOTTOM: 3px; PADDING-TOP: 3px
}
#head-er .publications-search {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 4px; =
PADDING-TOP: 4px
}
* HTML #head-er .publications {
	MARGIN: 6px 0px 0px
}
#head-er .publications {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: =
0px; MARGIN: 4px 0px 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#head-er .publications LI {
	DISPLAY: inline; MARGIN-LEFT: 10px
}
#head-er .publications LI.first {
	MARGIN-LEFT: 0px
}
#head-er .publications A {
	PADDING-RIGHT: 15px; BACKGROUND: =
url(/common/images/icons/fff/arrow_s.gif) no-repeat right center; =
TEXT-TRANSFORM: uppercase; COLOR: #fff; TEXT-DECORATION: none
}
#head-er .publications A:hover {
	TEXT-DECORATION: underline
}
#head-er .search {
	TEXT-ALIGN: right
}
#head-er .search FORM {
	DISPLAY: inline; MARGIN: 0px
}
#head-er .search FORM A {
	PADDING-RIGHT: 14px; BACKGROUND: =
url(/common/images/icons/fff/arrow_s.gif) no-repeat right center; =
TEXT-TRANSFORM: uppercase; COLOR: #fff; TEXT-DECORATION: none
}
#head-er .search FORM A:hover {
	TEXT-DECORATION: underline
}
#head-er #searchtext {
	WIDTH: 10em
}
#head-er .publications-search LABEL {
	TEXT-TRANSFORM: uppercase; COLOR: #fff
}
#head-er INPUT {
	FONT-SIZE: 100%
}
#head-er SELECT {
	FONT-SIZE: 100%
}
#head-er .publications-search INPUT.button {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-WEIGHT: bold; BACKGROUND: =
#eaeaea; PADDING-BOTTOM: 0px; COLOR: #000; PADDING-TOP: 0px
}
#head-er .accessibility-login {
	PADDING-RIGHT: 1%; PADDING-LEFT: 1%
}
#head-er .image-user-services {
	PADDING-RIGHT: 1%; PADDING-LEFT: 1%
}
#head-er .publications-search {
	PADDING-RIGHT: 1%; PADDING-LEFT: 1%
}
.header-leaderboard-wrap {
	PADDING-RIGHT: 1%; PADDING-LEFT: 1%; BACKGROUND: =
url(/common/includes/header/images/bg_leaderboard.gif) no-repeat 50% =
0px; OVERFLOW: hidden
}
.header-leaderboard {
	MAX-HEIGHT: 105px; TEXT-ALIGN: center
}
* HTML .header-leaderboard IMG {
	BORDER-BOTTOM-WIDTH: 1px
}
* HTML .header-leaderboard ilayer {
	BORDER-BOTTOM-WIDTH: 1px
}
* HTML .header-leaderboard IFRAME {
	BORDER-BOTTOM-WIDTH: 1px
}
* HTML .header-leaderboard EMBED {
	BORDER-BOTTOM-WIDTH: 1px
}
.header-leaderboard IMG {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; MIN-HEIGHT: 90px; MAX-WIDTH: 728px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: #fff 1px solid; =
HEIGHT: 90px; BORDER-RIGHT-WIDTH: 0px
}
.header-leaderboard ilayer {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; MIN-HEIGHT: 90px; MAX-WIDTH: 728px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: #fff 1px solid; =
HEIGHT: 90px; BORDER-RIGHT-WIDTH: 0px
}
.header-leaderboard IFRAME {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; MIN-HEIGHT: 90px; MAX-WIDTH: 728px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: #fff 1px solid; =
HEIGHT: 90px; BORDER-RIGHT-WIDTH: 0px
}
.header-leaderboard EMBED {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; MIN-HEIGHT: 90px; MAX-WIDTH: 728px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: #fff 1px solid; =
HEIGHT: 90px; BORDER-RIGHT-WIDTH: 0px
}
.header-leaderboard TABLE {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; MAX-WIDTH: 728px; PADDING-BOTTOM: 0px; =
MARGIN-LEFT: auto; WIDTH: 100%; MARGIN-RIGHT: auto; PADDING-TOP: 0px; =
BORDER-BOTTOM: #fff 1px solid; BORDER-RIGHT-WIDTH: 0px
}
* HTML .header-leaderboard TABLE IMG {
	HEIGHT: auto
}
#constrain {
	MARGIN-TOP: 14px
}
#global-subject-areas {
	BORDER-RIGHT: #ebebeb 1px solid; BORDER-TOP: #ebebeb 1px solid; =
BACKGROUND: #ebebeb; MARGIN: 0px 0px 20px; BORDER-LEFT: #ebebeb 1px =
solid; BORDER-BOTTOM: #ebebeb 1px solid
}
#global-subject-areas ABBR {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px; TEXT-DECORATION: none
}
#global-subject-areas A:link {
	FONT-WEIGHT: bold; COLOR: #9d0006; TEXT-DECORATION: none
}
#global-subject-areas A:visited {
	FONT-WEIGHT: bold; COLOR: #9d0006; TEXT-DECORATION: none
}
#global-subject-areas A:hover {
	TEXT-DECORATION: underline
}
#global-subject-areas H2 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; BACKGROUND: =
#b1062e; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: =
5px; BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas H3 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; BACKGROUND: =
#b1062e; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: =
5px; BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas H4 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; BACKGROUND: =
#b1062e; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: =
5px; BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas H5 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; BACKGROUND: =
#b1062e; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: =
5px; BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas H3.view {
	PADDING-RIGHT: 17px; PADDING-LEFT: 17px; FONT-SIZE: 100%; BACKGROUND: =
url(/common/images/bg.7x1.b1062e.gif) #fff repeat-y left top; =
PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #9d0006; PADDING-TOP: 5px; =
BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas H4.view {
	PADDING-RIGHT: 17px; PADDING-LEFT: 17px; FONT-SIZE: 100%; BACKGROUND: =
url(/common/images/bg.7x1.b1062e.gif) #fff repeat-y left top; =
PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #9d0006; PADDING-TOP: 5px; =
BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas H5.view {
	PADDING-RIGHT: 17px; PADDING-LEFT: 17px; FONT-SIZE: 100%; BACKGROUND: =
url(/common/images/bg.7x1.b1062e.gif) #fff repeat-y left top; =
PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: #9d0006; PADDING-TOP: 5px; =
BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: =
0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#global-subject-areas UL UL {
	FONT-SIZE: 100%
}
#global-subject-areas UL LI {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; =
LINE-HEIGHT: 150%; PADDING-TOP: 5px; BORDER-BOTTOM: #fff 1px solid
}
#global-subject-areas UL LI LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 5px; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
#global-subject-areas UL LI H4 {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
FONT-WEIGHT: normal; BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 100%; =
BACKGROUND: none transparent scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: =
0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #666; PADDING-TOP: 0px; =
FONT-STYLE: italic; BORDER-RIGHT-WIDTH: 0px
}
#global-subject-areas UL LI H5 {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
FONT-WEIGHT: normal; BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 100%; =
BACKGROUND: none transparent scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: =
0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #666; PADDING-TOP: 0px; =
FONT-STYLE: italic; BORDER-RIGHT-WIDTH: 0px
}
#global-subject-areas UL LI H6 {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
FONT-WEIGHT: normal; BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 100%; =
BACKGROUND: none transparent scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: =
0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #666; PADDING-TOP: 0px; =
FONT-STYLE: italic; BORDER-RIGHT-WIDTH: 0px
}
MAP.journal-nav {
	DISPLAY: block; MARGIN-BOTTOM: 20px
}
MAP.journal-nav UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none; TEXT-ALIGN: left
}
MAP.journal-nav UL LI {
	MARGIN: 0px; BORDER-BOTTOM: #fff 1px solid; BACKGROUND-COLOR: #eaeaea
}
MAP.journal-nav UL LI.grouped {
	BORDER-BOTTOM: #eaeaea 1px solid
}
* HTML MAP.journal-nav UL LI A {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 2px
}
* HTML MAP.journal-nav UL LI A:visited {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 2px
}
MAP.journal-nav UL LI A {
	PADDING-RIGHT: 5px; DISPLAY: block; PADDING-LEFT: 5px; FONT-WEIGHT: =
bold; FONT-SIZE: 80%; PADDING-BOTTOM: 4px; MARGIN: 0px; COLOR: #000; =
PADDING-TOP: 4px; TEXT-DECORATION: none
}
MAP.journal-nav UL LI A:visited {
	PADDING-RIGHT: 5px; DISPLAY: block; PADDING-LEFT: 5px; FONT-WEIGHT: =
bold; FONT-SIZE: 80%; PADDING-BOTTOM: 4px; MARGIN: 0px; COLOR: #000; =
PADDING-TOP: 4px; TEXT-DECORATION: none
}
MAP.journal-nav UL LI A:hover {
	COLOR: #fff; BACKGROUND-COLOR: #c00; TEXT-DECORATION: none
}
MAP.journal-nav UL LI A.on {
	COLOR: #fff; BACKGROUND-COLOR: #c00
}
MAP.journal-nav UL LI A.on:visited {
	COLOR: #fff; BACKGROUND-COLOR: #c00
}
MAP.journal-nav UL LI A.submission {
	PADDING-LEFT: 20px! important; BACKGROUND: =
url(/common/images/online_submissions.gif) no-repeat left center
}
MAP.journal-nav UL LI UL.subnav {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: =
none; TEXT-ALIGN: left
}
MAP.journal-nav UL LI UL.subnav LI {
	BACKGROUND: url(/common/images/nav_dots2.gif) #fafafa no-repeat 11px =
5px; BORDER-BOTTOM-WIDTH: 0px; MARGIN: 0px
}
MAP.journal-nav UL LI UL.subnav LI.on {
	BACKGROUND: url(/common/images/nav_dots1.gif) #c00 no-repeat 11px 5px; =
BORDER-BOTTOM: #fafafa 1px solid
}
* HTML MAP.journal-nav UL LI UL.subnav A {
	PADDING-RIGHT: 10px! important; PADDING-LEFT: 20px! important; =
PADDING-BOTTOM: 2px! important; PADDING-TOP: 2px! important
}
MAP.journal-nav UL LI UL.subnav A:link {
	PADDING-RIGHT: 10px; DISPLAY: block; PADDING-LEFT: 20px; FONT-WEIGHT: =
normal; FONT-SIZE: 70%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #000; =
PADDING-TOP: 2px; TEXT-DECORATION: none
}
MAP.journal-nav UL LI UL.subnav A:visited {
	PADDING-RIGHT: 10px; DISPLAY: block; PADDING-LEFT: 20px; FONT-WEIGHT: =
normal; FONT-SIZE: 70%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #000; =
PADDING-TOP: 2px; TEXT-DECORATION: none
}
MAP.journal-nav UL LI UL.subnav A:hover {
	BACKGROUND: url(/common/images/nav_dots1.gif) #fab934 no-repeat 11px =
5px; COLOR: #fff; TEXT-DECORATION: none
}
MAP.journal-nav UL LI UL.subnav A.on {
	COLOR: #fff
}
MAP.journal-nav UL LI UL.subnav A.on:visited {
	COLOR: #fff
}
#journalnav MAP.supplementary UL A {
	FONT-WEIGHT: normal; FONT-SIZE: 70%
}
#journalnav MAP.supplementary UL A:visited {
	FONT-WEIGHT: normal; FONT-SIZE: 70%
}
H2.society-resources {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: bold; FONT-SIZE: =
80%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 2px; =
BACKGROUND-COLOR: #fab934
}
UL.society-resources {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 20px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none; TEXT-ALIGN: left
}
UL.society-resources LI {
	MARGIN: 0px; BACKGROUND-COLOR: #eaeaea
}
UL.society-resources A {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; FONT-SIZE: 70%; PADDING-BOTTOM: 3px! important; MARGIN: 0px; =
COLOR: #000; PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
UL.society-resources A:visited {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; FONT-SIZE: 70%; PADDING-BOTTOM: 3px! important; MARGIN: 0px; =
COLOR: #000; PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
UL.society-resources A:hover {
	COLOR: #fff; BACKGROUND-COLOR: #fab934; TEXT-DECORATION: none
}
DIV.society-logo {
	MARGIN-BOTTOM: 20px; TEXT-ALIGN: center
}
DIV.society-logo IMG {
	WIDTH: 100%
}
H2.npg-resources {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: bold; FONT-SIZE: =
80%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 2px; =
BACKGROUND-COLOR: #b1062e
}
UL.npg-resources {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 20px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none; TEXT-ALIGN: left
}
UL.npg-resources LI {
	MARGIN: 0px; BORDER-BOTTOM: #fff 1px solid; BACKGROUND-COLOR: #eaeaea
}
UL.npg-resources A {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; FONT-SIZE: 70%; PADDING-BOTTOM: 3px! important; MARGIN: 0px; =
COLOR: #000; PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
UL.npg-resources A:visited {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; FONT-SIZE: 70%; PADDING-BOTTOM: 3px! important; MARGIN: 0px; =
COLOR: #000; PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
UL.npg-resources A:hover {
	COLOR: #fff; BACKGROUND-COLOR: #b1062e; TEXT-DECORATION: none
}
H2.npg-subjects {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: bold; FONT-SIZE: =
80%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 2px; =
BACKGROUND-COLOR: #c03
}
UL.npg-subjects {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 20px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none; TEXT-ALIGN: left
}
UL.npg-subjects LI {
	MARGIN: 0px; BORDER-BOTTOM: #fff 1px solid; BACKGROUND-COLOR: #eaeaea
}
UL.npg-subjects A {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; FONT-SIZE: 70%; PADDING-BOTTOM: 3px! important; MARGIN: 0px; =
COLOR: #000; PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
UL.npg-subjects A:visited {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; FONT-SIZE: 70%; PADDING-BOTTOM: 3px! important; MARGIN: 0px; =
COLOR: #000; PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
UL.npg-subjects A:hover {
	COLOR: #fff; BACKGROUND-COLOR: #c03; TEXT-DECORATION: none
}
UL.npg-subjects A.npgsubject-browseall:link {
	COLOR: #c03
}
UL.npg-subjects A.npgsubject-browseall:visited {
	COLOR: #c03
}
UL.npg-subjects A.npgsubject-browseall:hover {
	COLOR: #fff
}
A.backtotop:link {
	MARGIN-TOP: 5px; PADDING-LEFT: 10px; FONT-SIZE: 70%; BACKGROUND: =
url(/common/images/arrow_white_up.gif) no-repeat 0px 0.6em; FLOAT: =
right; MARGIN-LEFT: 7px; COLOR: #fff; MARGIN-RIGHT: 10px
}
A.backtotop:visited {
	MARGIN-TOP: 5px; PADDING-LEFT: 10px; FONT-SIZE: 70%; BACKGROUND: =
url(/common/images/arrow_white_up.gif) no-repeat 0px 0.6em; FLOAT: =
right; MARGIN-LEFT: 7px; COLOR: #fff; MARGIN-RIGHT: 10px
}
A.backtotop:hover {
	COLOR: #fff
}
H1.page {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; FONT-WEIGHT: bold; FONT-SIZE: =
100%; BACKGROUND: #fab934; PADDING-BOTTOM: 3px; MARGIN: 0px 0px 10px; =
COLOR: #fff; PADDING-TOP: 3px
}
IMG.arrow {
	MARGIN-RIGHT: 5px
}
A.arrow-blue {
	PADDING-LEFT: 10px; BACKGROUND: url(/common/images/arrow_blue.gif) =
no-repeat 0px 0.5em
}
A.arrow-grey {
	PADDING-LEFT: 10px; BACKGROUND: url(/common/images/arrow_grey.gif) =
no-repeat 0px 0.5em
}
A.arrow-red {
	PADDING-LEFT: 10px; BACKGROUND: url(/common/images/arrow_red.gif) =
no-repeat 0px 0.5em
}
DIV.research-reviews {
	BORDER-RIGHT: #eaeaea 1px solid; BORDER-TOP: #eaeaea 1px solid; =
MARGIN-BOTTOM: 2em; BORDER-LEFT: #eaeaea 1px solid; BORDER-BOTTOM: =
#eaeaea 1px solid
}
DIV.research-reviews H1 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 90%; BACKGROUND: =
#eaeaea; PADDING-BOTTOM: 4px; MARGIN: 0px; COLOR: #900; PADDING-TOP: 3px
}
DIV.research-reviews P {
	FONT-SIZE: 70%; MARGIN: 1em 10px; COLOR: #900
}
DIV.research-reviews UL {
	PADDING-RIGHT: 0px; BORDER-TOP: #eaeaea 1px solid; PADDING-LEFT: 0px; =
PADDING-BOTTOM: 0px; MARGIN: 0px 10px 1em; PADDING-TOP: 1em; =
LIST-STYLE-TYPE: none
}
DIV.research-reviews LI {
	MARGIN: 0px 0px 0.5em
}
DIV.research-reviews LI A {
	FONT-WEIGHT: bold; FONT-SIZE: 90%
}
DIV.research-reviews LI SPAN {
	FONT-SIZE: 70%
}
DIV.ad-horiz {
	CLEAR: both; BORDER-TOP: #eaeaea 1px solid; FONT-SIZE: 70%; =
MARGIN-BOTTOM: 20px; COLOR: #ccc; PADDING-TOP: 10px; TEXT-ALIGN: center
}
DIV.ad-horiz IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MAX-WIDTH: 468px! important; MARGIN: 4px 0px 0px; WIDTH: 100%; =
HEIGHT: 60px; BORDER-RIGHT-WIDTH: 0px
}
DIV.ad-horiz EMBED {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MAX-WIDTH: 468px! important; MARGIN: 4px 0px 0px; WIDTH: 100%; =
HEIGHT: 60px; BORDER-RIGHT-WIDTH: 0px
}
* HTML DIV.ad-horiz {
	MAX-WIDTH: 468px! important; MARGIN-LEFT: auto; OVERFLOW: hidden; =
WIDTH: 100%; MARGIN-RIGHT: auto
}
#extranav A.topten:link {
	PADDING-RIGHT: 0px; BORDER-TOP: #eaeaea 1px solid; MARGIN-TOP: 0.6em; =
DISPLAY: block; PADDING-LEFT: 10px; FONT-SIZE: 70%; BACKGROUND: =
url(/common/images/arrow_blue.gif) no-repeat 0px 1.2em; PADDING-BOTTOM: =
0px; PADDING-TOP: 0.8em
}
#extranav A.topten:visited {
	PADDING-RIGHT: 0px; BORDER-TOP: #eaeaea 1px solid; MARGIN-TOP: 0.6em; =
DISPLAY: block; PADDING-LEFT: 10px; FONT-SIZE: 70%; BACKGROUND: =
url(/common/images/arrow_blue.gif) no-repeat 0px 1.2em; PADDING-BOTTOM: =
0px; PADDING-TOP: 0.8em
}
#extranav A.topten:hover {
	BACKGROUND: url(/common/images/arrow_red.gif) no-repeat 0px 1.2em; =
TEXT-DECORATION: underline
}
DIV.ad-vert {
	FONT-SIZE: 70%; MARGIN-BOTTOM: 20px; COLOR: #ccc; TEXT-ALIGN: center
}
DIV.ad-vert IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MAX-WIDTH: 120px! important; MARGIN: 4px 0px 0px; WIDTH: 100%; =
HEIGHT: 600px; BORDER-RIGHT-WIDTH: 0px
}
DIV.ad-vert EMBED {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MAX-WIDTH: 120px! important; MARGIN: 4px 0px 0px; WIDTH: 100%; =
HEIGHT: 600px; BORDER-RIGHT-WIDTH: 0px
}
* HTML DIV.ad-vert {
	MAX-WIDTH: 160px! important; MARGIN-LEFT: auto; OVERFLOW: hidden; =
WIDTH: 100%; MARGIN-RIGHT: auto
}
.ad120x90 {
	CLEAR: both; FONT-SIZE: 80%; BACKGROUND: #fff; COLOR: #ccc; TEXT-ALIGN: =
center
}
.ad120x90 IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; MIN-HEIGHT: 90px; =
BORDER-BOTTOM-WIDTH: 0px; MAX-WIDTH: 120px! important; MARGIN: 7px 0px; =
WIDTH: 100%; HEIGHT: 90px; BORDER-RIGHT-WIDTH: 0px
}
.ad120x90 EMBED {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; MIN-HEIGHT: 90px; =
BORDER-BOTTOM-WIDTH: 0px; MAX-WIDTH: 120px! important; MARGIN: 7px 0px; =
WIDTH: 100%; HEIGHT: 90px; BORDER-RIGHT-WIDTH: 0px
}
.box#natjob {
	BORDER-RIGHT: #e7e7e7 1px solid; PADDING-RIGHT: 6px; BORDER-TOP: =
#e7e7e7 1px solid; PADDING-LEFT: 6px; BACKGROUND: #fff; PADDING-BOTTOM: =
6px; MARGIN: 10px 0px; OVERFLOW: hidden; BORDER-LEFT: #e7e7e7 1px solid; =
COLOR: #000; PADDING-TOP: 6px; BORDER-BOTTOM: #e7e7e7 1px solid
}
H2.natjob {
	PADDING-RIGHT: 7px; PADDING-LEFT: 7px; FONT-SIZE: 120%; BACKGROUND: =
#d8d8d8; PADDING-BOTTOM: 5px; MARGIN: 0px 0px 0.75em; TEXT-TRANSFORM: =
lowercase; PADDING-TOP: 5px; LETTER-SPACING: -0.04em
}
H2.natjob A {
	TEXT-DECORATION: none
}
H2.natjob SPAN.first {
	COLOR: #f00
}
H2.natjob SPAN.second {
	COLOR: #000
}
UL.natjob {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
PADDING-BOTTOM: 10px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: =
none
}
UL.natjob H3 {
	FONT-WEIGHT: bold; FONT-SIZE: 110%; MARGIN: 10px 0px 0px
}
UL.natjob H3.first {
	MARGIN: 0px
}
UL.natjob H3 A:link {
	COLOR: #000; TEXT-DECORATION: underline! important
}
UL.natjob H3 A:visited {
	COLOR: #000; TEXT-DECORATION: underline! important
}
UL.natjob LI H3 A:hover {
	COLOR: #c03
}
UL.natjob LI H3 A:focus {
	COLOR: #c03
}
* HTML UL.natjob UL {
	LINE-HEIGHT: 120%
}
DIV.natjobmore {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
FONT-SIZE: 110%; PADDING-BOTTOM: 5px; MARGIN: 0px; PADDING-TOP: 5px
}
DIV.natjobmore A:link {
	DISPLAY: inline; PADDING-LEFT: 15px; FONT-SIZE: 100%; BACKGROUND: =
url(/common/images/icons/next.gif) no-repeat 0px 0.3em; MARGIN: 0px; =
COLOR: #c03; TEXT-DECORATION: none
}
DIV.natjobmore A:visited {
	DISPLAY: inline; PADDING-LEFT: 15px; FONT-SIZE: 100%; BACKGROUND: =
url(/common/images/icons/next.gif) no-repeat 0px 0.3em; MARGIN: 0px; =
COLOR: #c03; TEXT-DECORATION: none
}
.box#natjob DIV.natjobmore A:hover {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif); =
TEXT-DECORATION: underline
}
.box#natjob DIV.natjobmore A:focus {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif); =
TEXT-DECORATION: underline
}
UL.natjob UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; PADDING-BOTTOM: =
0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
P.natjobmore {
	PADDING-BOTTOM: 5px; MARGIN: 0px
}
P.nateventmore {
	PADDING-BOTTOM: 5px; MARGIN: 0px; PADDING-TOP: 5px
}
.box#natprod {
	BORDER-RIGHT: #e7e7e7 1px solid; PADDING-RIGHT: 6px; BORDER-TOP: =
#e7e7e7 1px solid; PADDING-LEFT: 6px; BACKGROUND: #fff; PADDING-BOTTOM: =
6px; MARGIN: 10px 0px; BORDER-LEFT: #e7e7e7 1px solid; COLOR: #000; =
PADDING-TOP: 6px; BORDER-BOTTOM: #e7e7e7 1px solid
}
H2.natprod {
	PADDING-RIGHT: 7px; PADDING-LEFT: 7px; FONT-SIZE: 120%; BACKGROUND: =
#d8d8d8; PADDING-BOTTOM: 5px; MARGIN: 0px 0px 0.75em; TEXT-TRANSFORM: =
lowercase; PADDING-TOP: 5px; LETTER-SPACING: -0.04em
}
H2.natprod A {
	TEXT-DECORATION: none
}
H2.natprod SPAN.first {
	COLOR: #f00
}
H2.natprod SPAN.second {
	COLOR: #000
}
.box#natprod FORM {
	MARGIN: 0px
}
DIV.natprod {
	BORDER-RIGHT: black 1px solid; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; =
BACKGROUND: #f3f2f2; PADDING-BOTTOM: 4px; BORDER-LEFT: black 1px solid; =
PADDING-TOP: 4px; BORDER-BOTTOM: black 1px solid
}
DIV.natprodmore {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0.75em; =
PADDING-TOP: 0px
}
DIV.natprodmore A:link {
	DISPLAY: block; PADDING-LEFT: 7px; FONT-SIZE: 70%; BACKGROUND: =
url(/common/images/arrow_red.gif) no-repeat 0px 0.5em; COLOR: #c03; =
TEXT-DECORATION: none
}
DIV.natprodmore A:visited {
	DISPLAY: block; PADDING-LEFT: 7px; FONT-SIZE: 70%; BACKGROUND: =
url(/common/images/arrow_red.gif) no-repeat 0px 0.5em; COLOR: #c03; =
TEXT-DECORATION: none
}
DIV.natprodmore A:focus {
	TEXT-DECORATION: underline
}
DIV.natprodmore A:hover {
	TEXT-DECORATION: underline
}
DIV.natprod SPAN {
	DISPLAY: block; FONT-SIZE: 70%; MARGIN-BOTTOM: 10px; LINE-HEIGHT: 110%
}
#natprod FORM {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px
}
DIV.natprodmore FORM {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px
}
DIV.natprodmore INPUT {
	MARGIN-TOP: 5px; FONT-SIZE: 110%; WIDTH: 98%! important
}
* HTML DIV.natprodmore INPUT {
	WIDTH: 96%! important
}
DIV.natprodmore INPUT {
	WIDTH: 80%
}
DIV.natprodmore INPUT {
	WIDTH: 100%
}
DIV.natprodmore INPUT.button {
	FONT-WEIGHT: bold; COLOR: #fff; BACKGROUND-COLOR: #000
}
#article-related #journal-header {
	DISPLAY: none
}
#article-related H2.atl {
	FONT-WEIGHT: bold; FONT-SIZE: 90%; MARGIN: 0px
}
#article-related H2.figure-title {
	CLEAR: both; FONT-WEIGHT: bold; FONT-SIZE: 90%; MARGIN: 0px 0px 1em
}
#article-related P.from {
	FONT-WEIGHT: bold; FONT-SIZE: 70%; MARGIN: 0px; COLOR: #c03
}
#article-related P.aug {
	FONT-SIZE: 70%; MARGIN: 0px
}
#article-related A.back-to-article:link {
	CLEAR: both; PADDING-RIGHT: 1em; PADDING-LEFT: 1em; FONT-WEIGHT: bold; =
FONT-SIZE: 70%; BACKGROUND: #000; FLOAT: right; PADDING-BOTTOM: 3px; =
MARGIN: 10px 0px; COLOR: #fff; PADDING-TOP: 3px; TEXT-DECORATION: none
}
#article-related A.back-to-article:visited {
	CLEAR: both; PADDING-RIGHT: 1em; PADDING-LEFT: 1em; FONT-WEIGHT: bold; =
FONT-SIZE: 70%; BACKGROUND: #000; FLOAT: right; PADDING-BOTTOM: 3px; =
MARGIN: 10px 0px; COLOR: #fff; PADDING-TOP: 3px; TEXT-DECORATION: none
}
#article-related A.back-to-article:hover {
	BACKGROUND: #fab934; COLOR: #fff; TEXT-DECORATION: none
}
#article-related DIV.container-image {
	BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BACKGROUND: #eaeaea; PADDING-BOTTOM: 10px; BORDER-LEFT: #000 1px solid; =
PADDING-TOP: 10px; TEXT-ALIGN: center
}
#article-related DIV.container-image-text {
	BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BACKGROUND: #eaeaea; PADDING-BOTTOM: 10px; BORDER-LEFT: #000 1px solid; =
PADDING-TOP: 10px
}
#article-related DIV.container-image-text P {
	FONT-SIZE: 90%
}
#article-related FORM {
	MARGIN: 0px
}
#article-related DIV.container-image-text UL {
	FONT-SIZE: 90%
}
#article-related DIV.container-image-text OL {
	FONT-SIZE: 90%
}
#article-related DIV.prevnext {
	CLEAR: both; BORDER-RIGHT: black 1px solid; BORDER-TOP: black 1px =
solid; BACKGROUND: #fff; BORDER-LEFT: black 1px solid; BORDER-BOTTOM: =
black 1px solid; TEXT-ALIGN: center
}
#article-related DIV.prevnext .hide {
	DISPLAY: none
}
#article-related DIV.prevnext A {
	FONT: 70% verdana, arial, helvetica, sans-serif; TEXT-DECORATION: none
}
#article-related A.previous:link {
	BORDER-RIGHT: black 1px solid; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BACKGROUND: url(/common/images/arrow_blue_left.gif) no-repeat left =
center; FLOAT: left; PADDING-BOTTOM: 2px; MARGIN-LEFT: 10px; =
PADDING-TOP: 2px
}
#article-related A.previous:visited {
	BORDER-RIGHT: black 1px solid; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BACKGROUND: url(/common/images/arrow_blue_left.gif) no-repeat left =
center; FLOAT: left; PADDING-BOTTOM: 2px; MARGIN-LEFT: 10px; =
PADDING-TOP: 2px
}
#article-related A.previous:hover {
	BACKGROUND: url(/common/images/arrow_red_left.gif) no-repeat left =
center
}
#article-related A.index:link {
	PADDING-RIGHT: 5px; PADDING-LEFT: 10px; BACKGROUND: =
url(/common/images/arrow_blue_up.gif) no-repeat left center; =
PADDING-BOTTOM: 2px; VERTICAL-ALIGN: middle; PADDING-TOP: 2px
}
#article-related A.index:visited {
	PADDING-RIGHT: 5px; PADDING-LEFT: 10px; BACKGROUND: =
url(/common/images/arrow_blue_up.gif) no-repeat left center; =
PADDING-BOTTOM: 2px; VERTICAL-ALIGN: middle; PADDING-TOP: 2px
}
#article-related A.index:hover {
	BACKGROUND: url(/common/images/arrow_red_up.gif) no-repeat left center
}
#article-related A.next:link {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; BACKGROUND: =
url(/common/images/arrow_blue.gif) no-repeat right center; FLOAT: right; =
PADDING-BOTTOM: 2px; BORDER-LEFT: black 1px solid; MARGIN-RIGHT: 10px; =
PADDING-TOP: 2px
}
#article-related A.next:visited {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; BACKGROUND: =
url(/common/images/arrow_blue.gif) no-repeat right center; FLOAT: right; =
PADDING-BOTTOM: 2px; BORDER-LEFT: black 1px solid; MARGIN-RIGHT: 10px; =
PADDING-TOP: 2px
}
#article-related A.next:hover {
	BACKGROUND: url(/common/images/arrow_red.gif) no-repeat right center
}
#article-related DIV.container-figtab {
	CLEAR: both; BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 10px; =
BORDER-TOP: #000 1px solid; PADDING-LEFT: 10px; BACKGROUND: #eaeaea; =
PADDING-BOTTOM: 10px; BORDER-LEFT: #000 1px solid; PADDING-TOP: 10px; =
BORDER-BOTTOM: #000 0px solid
}
#article-related DIV.last {
	BORDER-BOTTOM: #000 1px solid
}
#article-related DIV.container-figtab DIV.container-image IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MAX-WIDTH: 150px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.container-figtab DIV.container-image {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; FLOAT: left; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; WIDTH: =
150px; PADDING-TOP: 0px; TEXT-ALIGN: right; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.container-figtab DIV.container-image-text {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN-LEFT: 160px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.container-figtab DIV.container-image-text H3 {
	FONT-SIZE: 90%; MARGIN: 0px
}
#article-related DIV.container-figtab DIV.container-image-text P {
	FONT-SIZE: 90%; MARGIN: 0px
}
#article-related DIV.container-figtab A.full {
	MARGIN-TOP: 0.5em; DISPLAY: block; PADDING-LEFT: 25px; FONT-SIZE: 70%; =
BACKGROUND: url(/common/images/full_figure.gif) no-repeat 0px 0px
}
#article-related DIV.container-figtab A.pdb {
	MARGIN-TOP: 0.5em; DISPLAY: block; PADDING-LEFT: 25px; FONT-SIZE: 70%; =
BACKGROUND: url(/common/images/icons/pdb_small.gif) no-repeat 0px 0px; =
PADDING-BOTTOM: 3px
}
#article-related DIV.container-figtab A.threed-view {
	MARGIN-TOP: 0.5em; DISPLAY: block; PADDING-LEFT: 25px; FONT-SIZE: 70%; =
BACKGROUND: url(/common/images/icons/threed_small.gif) no-repeat 0px =
0px; PADDING-BOTTOM: 3px
}
#article-related DIV.container-figtab A.pp {
	PADDING-RIGHT: 0px; MARGIN-TOP: 0.5em; DISPLAY: block; PADDING-LEFT: =
25px; FONT-SIZE: 70%; BACKGROUND: =
url(/common/images/icons/fff/powerpoint.gif) no-repeat 0px 0px; =
PADDING-BOTTOM: 4px; PADDING-TOP: 0px
}
#article-related DIV.container-supplementary {
	CLEAR: both; BORDER-RIGHT: black 1px solid; PADDING-RIGHT: 0px; =
PADDING-LEFT: 0px; BACKGROUND: #eaeaea; PADDING-BOTTOM: 0px; =
BORDER-LEFT: black 1px solid; PADDING-TOP: 0px
}
#article-related A.download-plugins:link {
	CLEAR: both; BORDER-RIGHT: black 1px solid; PADDING-RIGHT: 0px; =
BORDER-TOP: black 1px solid; DISPLAY: block; PADDING-LEFT: 17px; =
FONT-SIZE: 70%; BACKGROUND: url(/common/images/arrow_blue.gif) no-repeat =
10px 0.45em; PADDING-BOTTOM: 3px; BORDER-LEFT: black 1px solid; =
PADDING-TOP: 0px; BORDER-BOTTOM: black 1px solid
}
#article-related A.download-plugins:visited {
	CLEAR: both; BORDER-RIGHT: black 1px solid; PADDING-RIGHT: 0px; =
BORDER-TOP: black 1px solid; DISPLAY: block; PADDING-LEFT: 17px; =
FONT-SIZE: 70%; BACKGROUND: url(/common/images/arrow_blue.gif) no-repeat =
10px 0.45em; PADDING-BOTTOM: 3px; BORDER-LEFT: black 1px solid; =
PADDING-TOP: 0px; BORDER-BOTTOM: black 1px solid
}
#article-related A.download-plugins:hover {
	BACKGROUND: url(/common/images/arrow_red.gif) no-repeat 10px 0.45em
}
#article-related DIV.container-supplementary H2 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-WEIGHT: bold; FONT-SIZE: =
90%; PADDING-BOTTOM: 10px; MARGIN: 0px; PADDING-TOP: 10px
}
#article-related DIV.container-supplementary P {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 90%; =
PADDING-BOTTOM: 10px; MARGIN: 0px; PADDING-TOP: 0px; BORDER-BOTTOM: =
black 1px solid
}
#article-related DIV.container-supplementary P.last {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 10px; PADDING-TOP: 0px
}
#article-related DIV.container-sendfriend {
	CLEAR: both; BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 10px; =
BORDER-TOP: #000 1px solid; PADDING-LEFT: 10px; BACKGROUND: #eaeaea; =
PADDING-BOTTOM: 10px; BORDER-LEFT: #000 1px solid; PADDING-TOP: 10px; =
BORDER-BOTTOM: #000 1px solid
}
#article-related DIV.container-more {
	CLEAR: both; BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 10px; =
BORDER-TOP: #000 1px solid; PADDING-LEFT: 10px; BACKGROUND: #eaeaea; =
PADDING-BOTTOM: 10px; BORDER-LEFT: #000 1px solid; PADDING-TOP: 10px; =
BORDER-BOTTOM: #000 1px solid
}
#article-related DIV.container-plugins {
	CLEAR: both; BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 10px; =
BORDER-TOP: #000 1px solid; PADDING-LEFT: 10px; BACKGROUND: #eaeaea; =
PADDING-BOTTOM: 10px; BORDER-LEFT: #000 1px solid; PADDING-TOP: 10px; =
BORDER-BOTTOM: #000 1px solid
}
#article-related DIV.container-more2 {
	CLEAR: both; BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 10px; =
BORDER-TOP: #000 1px solid; PADDING-LEFT: 10px; BACKGROUND: #eaeaea; =
PADDING-BOTTOM: 10px; BORDER-LEFT: #000 1px solid; PADDING-TOP: 10px; =
BORDER-BOTTOM: #000 1px solid
}
#article-related DIV.container-more2 {
	BORDER-BOTTOM-WIDTH: 0px
}
#article-related DIV.wrapper {
	MARGIN-BOTTOM: 10px
}
#article-related P.explain {
	FONT-SIZE: 70%; MARGIN: 0px 0px 1em
}
#article-related DIV.container-plugins P {
	FONT-SIZE: 90%; MARGIN: 0px 0px 1em
}
#article-related DIV.container-plugins P.last {
	MARGIN: 0px
}
#article-related P.results {
	FONT-SIZE: 90%; MARGIN: 0px 0px 1em
}
#article-related A.article {
	DISPLAY: block; FONT-WEIGHT: bold; FONT-SIZE: 90%; MARGIN: 0px
}
#article-related P.journal {
	FONT-SIZE: 70%; MARGIN: 0px
}
#article-related DIV.container-more2 P.journal {
	MARGIN-BOTTOM: 1em
}
#article-related H3.area {
	FONT-WEIGHT: normal; FONT-SIZE: 70%; MARGIN: 0px; TEXT-TRANSFORM: =
uppercase
}
#article-related A.allmatches:link {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 10px; FONT-SIZE: 70%; =
BACKGROUND: url(/common/images/arrow_blue.gif) no-repeat left center; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px
}
#article-related A.allmatches:visited {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 10px; FONT-SIZE: 70%; =
BACKGROUND: url(/common/images/arrow_blue.gif) no-repeat left center; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px
}
#article-related A.allmatches:hover {
	BACKGROUND: url(/common/images/arrow_red.gif) no-repeat left center
}
#article-related DIV.text {
	FLOAT: left; WIDTH: 210px; TEXT-ALIGN: right
}
#article-related DIV.text LABEL {
	FONT-WEIGHT: bold; FONT-SIZE: 90%
}
#article-related DIV.text P {
	FONT-SIZE: 70%; MARGIN: 0px
}
#article-related DIV.form {
	MARGIN-LEFT: 220px
}
#article-related DIV.form INPUT {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; WIDTH: auto; PADDING-TOP: 0px
}
#article-related DIV.form TEXTAREA {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; WIDTH: auto; PADDING-TOP: 0px
}
#article-related DIV.form INPUT {
	WIDTH: 100%
}
#article-related DIV.form TEXTAREA {
	WIDTH: 100%
}
#article-related INPUT.friend {
	CLEAR: both; FLOAT: right
}
* HTML #article-related TABLE.data {
	FONT-SIZE: 100%
}
#article-related TABLE.data {
	BORDER-RIGHT: #999 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: #999 1px =
solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; BORDER-LEFT: =
#999 1px solid; PADDING-TOP: 0px; BORDER-BOTTOM: #999 1px solid; =
BORDER-COLLAPSE: collapse; TEXT-ALIGN: left
}
#article-related TABLE.data THEAD {
	FONT-WEIGHT: bold
}
#article-related TABLE.data THEAD TH {
	BORDER-RIGHT: #999 1px solid; PADDING-RIGHT: 0.5em; PADDING-LEFT: =
0.5em; FONT-SIZE: 90%; BACKGROUND: #f6f6f6; PADDING-BOTTOM: 0.5em; =
BORDER-LEFT: #999 1px solid; PADDING-TOP: 0px
}
#article-related TABLE.data THEAD TH.colspan {
	BORDER-RIGHT: #999 1px solid; BORDER-TOP: #999 0px solid; BORDER-LEFT: =
#999 1px solid; BORDER-BOTTOM: #999 1px solid; TEXT-ALIGN: center
}
#article-related TABLE.data THEAD TH.last {
	BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TBODY TD.last {
	BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TBODY TD.rowsep {
	BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data THEAD TH.rowsep {
	BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TBODY {
	BORDER-TOP: #999 1px solid; BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TBODY TR {
	BACKGROUND-COLOR: #f6f6f6
}
#article-related TABLE.data TBODY TR.odd {
	BACKGROUND-COLOR: #fff
}
#article-related TABLE.data TBODY TD {
	BORDER-RIGHT: #999 1px solid; PADDING-RIGHT: 0.5em; PADDING-LEFT: =
0.5em; FONT-SIZE: 90%; PADDING-BOTTOM: 0.15em; PADDING-TOP: 0.15em
}
#article-related TABLE.data TFOOT TD {
	PADDING-RIGHT: 0.5em; PADDING-LEFT: 0.5em; FONT-SIZE: 90%; =
PADDING-BOTTOM: 0.5em; PADDING-TOP: 0.5em; BACKGROUND-COLOR: #fff
}
#foot-er {
	BORDER-TOP-WIDTH: 0px; CLEAR: both; PADDING-RIGHT: 0px; PADDING-LEFT: =
0px; PADDING-BOTTOM: 0px; MARGIN: 20px 0px; PADDING-TOP: 0px
}
#foot-er #footer-journal {
	PADDING-RIGHT: 1%; BORDER-TOP: #000 1px solid; PADDING-LEFT: 1%; =
BACKGROUND: #eee; PADDING-BOTTOM: 2px; PADDING-TOP: 2px
}
#foot-er #footer-journal:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #foot-er #footer-journal {
	HEIGHT: 1%
}
#foot-er #footer-journal P {
	PADDING-RIGHT: 1em; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: =
0px; MARGIN: 0px 1em 0px 0px; PADDING-TOP: 0px
}
#foot-er #footer-journal P.journal-name {
	FONT-WEIGHT: bold; FONT-SIZE: 100%; FONT-STYLE: italic
}
#foot-er #footer-journal P.issn {
	FONT-SIZE: 100%
}
#foot-er #footer-journal P.eissn {
	FONT-SIZE: 100%
}
#foot-er #footer-journal P.extra {
	FONT-SIZE: 100%
}
#foot-er #footer-links {
	PADDING-RIGHT: 1%; PADDING-LEFT: 1%; BACKGROUND: #000; PADDING-BOTTOM: =
5px; PADDING-TOP: 5px
}
#foot-er #footer-links UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#foot-er #footer-links UL LI {
	DISPLAY: inline
}
#foot-er #footer-links UL LI A:link {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 1em; BACKGROUND: =
#000; FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 1em; =
BORDER-LEFT: #fff 1px solid; COLOR: #fff; PADDING-TOP: 0px; =
TEXT-DECORATION: none
}
#foot-er #footer-links UL LI A:visited {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 1em; BACKGROUND: =
#000; FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 1em; =
BORDER-LEFT: #fff 1px solid; COLOR: #fff; PADDING-TOP: 0px; =
TEXT-DECORATION: none
}
* HTML #foot-er #footer-links UL LI A:link {
	DISPLAY: inline
}
* HTML #foot-er #footer-links UL LI A:visited {
	DISPLAY: inline
}
#foot-er #footer-links UL LI A:hover {
	TEXT-DECORATION: underline
}
#foot-er #footer-links UL LI A.about-npg:link {
	PADDING-LEFT: 0px; FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 0px; =
MARGIN-LEFT: 0px
}
#foot-er #footer-links UL LI A.about-npg:visited {
	PADDING-LEFT: 0px; FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 0px; =
MARGIN-LEFT: 0px
}
#foot-er #footer-copyright {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 1%; PADDING-LEFT: 1%; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-ALIGN: left! important
}
* HTML #foot-er #footer-copyright .footer-constrain {
	TEXT-ALIGN: left
}
#foot-er #footer-copyright A {
	COLOR: #b1062e
}
#foot-er #footer-copyright P {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 5px
}
#foot-er #footer-copyright P.logo {
	PADDING-RIGHT: 36px; PADDING-LEFT: 36px; BACKGROUND: =
url(/common/images/npg_logo.gif) no-repeat 0px 50%; PADDING-BOTTOM: 7px; =
MARGIN: 5px 0px 0px; PADDING-TOP: 7px
}
#foot-er #footer-copyright P A:link {
	FONT-WEIGHT: bold; TEXT-DECORATION: none
}
#foot-er #footer-copyright P A:visited {
	FONT-WEIGHT: bold; TEXT-DECORATION: none
}
#foot-er #footer-copyright P A.footer-copyright:link {
	FONT-WEIGHT: normal; COLOR: #000
}
#foot-er #footer-copyright P A.footer-copyright:visited {
	FONT-WEIGHT: normal; COLOR: #000
}
#foot-er #footer-copyright P A:hover {
	TEXT-DECORATION: underline
}
#content .scp {
	FONT-VARIANT: small-caps
}
DIV.ab-ad {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; BACKGROUND: #eaeaea; =
MARGIN-BOTTOM: 15px; PADDING-BOTTOM: 3px; PADDING-TOP: 0px; TEXT-ALIGN: =
center
}
DIV.ab-ad H2.head-main {
	FONT-WEIGHT: normal; FONT-SIZE: 100%; MARGIN: 0px; TEXT-TRANSFORM: =
uppercase; COLOR: #ccc
}
DIV.ab-ad H3.head-main {
	FONT-WEIGHT: normal; FONT-SIZE: 100%; MARGIN: 0px; TEXT-TRANSFORM: =
uppercase; COLOR: #ccc
}
DIV.ab-ad H4.head-main {
	FONT-WEIGHT: normal; FONT-SIZE: 100%; MARGIN: 0px; TEXT-TRANSFORM: =
uppercase; COLOR: #ccc
}
DIV.ab-ad H3.head-supported {
	FONT-WEIGHT: normal; FONT-SIZE: 100%; MARGIN: 5px 0px 0px; COLOR: #000
}
DIV.ab-ad H4.head-supported {
	FONT-WEIGHT: normal; FONT-SIZE: 100%; MARGIN: 5px 0px 0px; COLOR: #000
}
DIV.ab-ad H5.head-supported {
	FONT-WEIGHT: normal; FONT-SIZE: 100%; MARGIN: 5px 0px 0px; COLOR: #000
}
DIV.ab-ad H4.head-products {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: bold; FONT-SIZE: =
100%; BACKGROUND: #e0ebf9; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: =
#333; PADDING-TOP: 5px
}
DIV.ab-ad H5.head-products {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: bold; FONT-SIZE: =
100%; BACKGROUND: #e0ebf9; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: =
#333; PADDING-TOP: 5px
}
DIV.ab-ad H6.head-products {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: bold; FONT-SIZE: =
100%; BACKGROUND: #e0ebf9; PADDING-BOTTOM: 5px; MARGIN: 0px; COLOR: =
#333; PADDING-TOP: 5px
}
DIV.ab-ad H5.head-section {
	FONT-WEIGHT: bold; FONT-SIZE: 100%; MARGIN: 0px; COLOR: #0068b3
}
DIV.ab-ad H6.head-section {
	FONT-WEIGHT: bold; FONT-SIZE: 100%; MARGIN: 0px; COLOR: #0068b3
}
DIV.ab-ad DIV.container {
	BORDER-RIGHT: #e0ebf9 1px solid; BORDER-TOP: #e0ebf9 1px solid; =
MARGIN-TOP: 3px; BORDER-LEFT: #e0ebf9 1px solid; BORDER-BOTTOM: #e0ebf9 =
1px solid; BACKGROUND-COLOR: #fff
}
DIV.ab-ad UL {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; BACKGROUND: #fff; =
PADDING-BOTTOM: 5px; MARGIN: 0px; TEXT-TRANSFORM: none; PADDING-TOP: =
5px; LIST-STYLE-TYPE: none; TEXT-ALIGN: left
}
DIV.ab-ad UL UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; MARGIN-BOTTOM: 5px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
DIV.ab-ad LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 2px; MARGIN: =
0px; PADDING-TOP: 2px
}
DIV.ab-ad A {
	COLOR: #0068b3
}
DIV.ab-ad A.sponsor IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MAX-WIDTH: 118px; WIDTH: 100%; BORDER-RIGHT-WIDTH: 0px
}
DIV.ab-ad P.blurb {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
5px 5px; PADDING-TOP: 0px; TEXT-ALIGN: left
}
.eotm-jotw {
	BORDER-RIGHT: #e7e7e7 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: =
#e7e7e7 1px solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 10px; MARGIN: 0px =
0px 20px; OVERFLOW: hidden; BORDER-LEFT: #e7e7e7 1px solid; PADDING-TOP: =
0px; BORDER-BOTTOM: #e7e7e7 1px solid; LIST-STYLE-TYPE: none; =
BACKGROUND-COLOR: #fff
}
.eotm-jotw .main-heading {
	PADDING-RIGHT: 10px; PADDING-LEFT: 48px; FONT-SIZE: 110%; BACKGROUND: =
url(/common/images/eotm_jotw_bg.jpg) no-repeat 0px 0px; PADDING-BOTTOM: =
10px; MARGIN: 0px; PADDING-TOP: 10px
}
.eotm-jotw .main-heading .type {
	DISPLAY: block; COLOR: #f00
}
.eotm-jotw .main-heading .timeframe {
	FONT-WEIGHT: normal; FONT-SIZE: 100%
}
.eotm-jotw .main-heading .job-or-event {
	TEXT-TRANSFORM: uppercase
}
.eotm-jotw .events-jobs {
	PADDING-RIGHT: 8px; PADDING-LEFT: 8px; PADDING-BOTTOM: 0px; MARGIN: =
-70px 0px 0px; PADDING-TOP: 70px; LIST-STYLE-TYPE: none
}
.jotw .events-jobs {
	BACKGROUND: url(/common/images/jotw.gif) no-repeat 10px 30px
}
.eotm .events-jobs {
	BACKGROUND: url(/common/images/eotm.gif) no-repeat 10px 30px
}
.eotm-jotw .title {
	FONT-SIZE: 100%; MARGIN: 10px 0px 0px
}
.eotm-jotw .events-jobs P {
	FONT-SIZE: 100%; MARGIN: 0px 0px 10px
}
.eotm-jotw .events-jobs P SPAN {
	FONT-WEIGHT: bold
}
.eotm-jotw .more {
	CLEAR: both; PADDING-RIGHT: 8px; DISPLAY: block; PADDING-LEFT: 15px; =
BACKGROUND: url(/common/images/icons/next.gif) no-repeat 0px 0.6ex; =
MARGIN: 10px 0px 0px 8px; LINE-HEIGHT: 110%; TEXT-DECORATION: none
}
.eotm-jotw .more .link {
	FONT-SIZE: 100%; TEXT-DECORATION: underline
}
.eotm-jotw .site {
	MARGIN-TOP: 0.5ex; DISPLAY: block; FONT-WEIGHT: bold; FONT-SIZE: 110%; =
COLOR: #444; FONT-FAMILY: Georgia, serif; LETTER-SPACING: -0.04em
}
.eotm-jotw .site .nature {
	COLOR: #f33
}
INPUT.sermo-submit {
	PADDING-RIGHT: 0px; BACKGROUND-POSITION: 6px center; DISPLAY: block; =
PADDING-LEFT: 10%; FONT-SIZE: 100%; PADDING-BOTTOM: 5px; MARGIN: 0px; =
WIDTH: 100%; CURSOR: pointer; COLOR: #000; BORDER-TOP-STYLE: none; =
PADDING-TOP: 5px; BACKGROUND-REPEAT: no-repeat; FONT-FAMILY: =
Verdana,arial,Helvetica,sans-serif; BORDER-RIGHT-STYLE: none; =
BORDER-LEFT-STYLE: none; BACKGROUND-COLOR: #f3f3f3; TEXT-ALIGN: left; =
BORDER-BOTTOM-STYLE: none
}
INPUT.sermo-submit:hover {
	BACKGROUND-COLOR: #eaeaea! important
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/reviews/style/group.css

#hdr {
	FONT-SIZE: 140%; BORDER-LEFT-COLOR: #f5f5f5; BORDER-BOTTOM-COLOR: =
#f5f5f5; BORDER-TOP-COLOR: #f5f5f5; BORDER-RIGHT-COLOR: #f5f5f5
}
#ftr {
	FONT-SIZE: 100%
}
#hdr .search SELECT {
	FONT-SIZE: 100%
}
#hdr .search INPUT {
	FONT-SIZE: 100%
}
BODY {
	BACKGROUND-IMAGE: url(/reviews/images/bg_body.gif)
}
#constrain {
	BACKGROUND-IMAGE: url(/reviews/images/bg_constrain.gif)
}
* HTML BODY {
	FONT-SIZE: 62.5%
}
* HTML BODY {
	FONT-SIZE: 63%
}
BODY {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 62.5%; BACKGROUND: =
#f5f5f5; PADDING-BOTTOM: 20px; MARGIN: 0px; COLOR: #000; PADDING-TOP: =
0px; FONT-FAMILY: Verdana, arial, Helvetica, sans-serif
}
.global-message H1 {
	FONT-SIZE: 140%
}
.global-message .content P {
	FONT-SIZE: 110%
}
#content A.backtotop:link {
	PADDING-RIGHT: 13px; DISPLAY: block; FONT-SIZE: 100%; BACKGROUND: =
url(/common/images/icons/backtotop.gif) no-repeat right center; FLOAT: =
none; MARGIN: 0.5em 10px; TEXT-TRANSFORM: lowercase; COLOR: #000; =
TEXT-ALIGN: right; TEXT-DECORATION: none
}
#content A.backtotop:visited {
	PADDING-RIGHT: 13px; DISPLAY: block; FONT-SIZE: 100%; BACKGROUND: =
url(/common/images/icons/backtotop.gif) no-repeat right center; FLOAT: =
none; MARGIN: 0.5em 10px; TEXT-TRANSFORM: lowercase; COLOR: #000; =
TEXT-ALIGN: right; TEXT-DECORATION: none
}
#content .box A.backtotop:link {
	MARGIN-LEFT: 0px; MARGIN-RIGHT: 0px
}
#content .box A.backtotop:visited {
	MARGIN-LEFT: 0px; MARGIN-RIGHT: 0px
}
#content A.backtotop:hover {
	BACKGROUND: url(/common/images/icons/backtotop_hover.gif) no-repeat =
right center; COLOR: #c03
}
#content A.backtotop:focus {
	BACKGROUND: url(/common/images/icons/backtotop_hover.gif) no-repeat =
right center; COLOR: #c03
}
A IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
ABBR {
	BORDER-BOTTOM-WIDTH: 0px; TEXT-DECORATION: none
}
ACRONYM {
	BORDER-BOTTOM-WIDTH: 0px; TEXT-DECORATION: none
}
ABBR:hover {
	CURSOR: help
}
ACRONYM:hover {
	CURSOR: help
}
KBD {
	FONT-SIZE: 120%
}
.author {
	FONT-WEIGHT: bold
}
.char-img {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
.icon {
	BACKGROUND-POSITION: left center; PADDING-LEFT: 19px; PADDING-BOTTOM: =
3px; BACKGROUND-REPEAT: no-repeat
}
.i-audio.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/audio.gif)
}
.i-audio-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/audio_grey.gif)
}
.i-bitmap.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/bitmap.gif)
}
.i-bitmap-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/bitmap_grey.gif)
}
.i-compressed.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/compressed.gif)
}
.i-compressed-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/compressed_grey.gif)
}
.i-markup.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/markup.gif)
}
.i-markup-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/markup_grey.gif)
}
.i-movie.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/movie.gif)
}
.i-movie-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/movie_grey.gif)
}
.i-pdf.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/pdf.gif)
}
.i-pdf-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/pdf_grey.gif)
}
.i-postscript.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/printer.gif)
}
.i-postscript-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/printer_grey.gif)
}
.i-powerpoint.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/ppt.gif)
}
.i-powerpoint-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/ppt_grey.gif)
}
.i-svg.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/svg.gif)
}
.i-sif.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/sif.gif)
}
.i-sif-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/sif_grey.gif)
}
.i-svg-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/svg_grey.gif)
}
.i-text.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/text.gif)
}
.i-text-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/text_grey.gif)
}
.i-word.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/word.gif)
}
.i-word-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/word_grey.gif)
}
.i-xls.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/xls.gif)
}
.i-xls-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/xls_grey.gif)
}
.i-microarray.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/microarray.gif)
}
.i-chemical-structures.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/chemical_structures.gif)
}
.plugin-audio.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/audio.gif)
}
.plugin-audio-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/audio_grey.gif)
}
.plugin-bitmap.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/bitmap.gif)
}
.plugin-bitmap-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/bitmap_grey.gif)
}
.plugin-compressed.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/compressed.gif)
}
.plugin-compressed-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/compressed_grey.gif)
}
.plugin-markup.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/markup.gif)
}
.plugin-markup-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/markup_grey.gif)
}
.plugin-movie.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/movie.gif)
}
.plugin-movie-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/movie_grey.gif)
}
.plugin-pdf.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/pdf.gif)
}
.plugin-pdf-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/pdf_grey.gif)
}
.plugin-postscript.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/printer.gif)
}
.plugin-postscript-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/printer_grey.gif)
}
.plugin-powerpoint.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/ppt.gif)
}
.plugin-powerpoint-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/ppt_grey.gif)
}
.plugin-sif.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/sif.gif)
}
.plugin-svg.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/svg.gif)
}
.plugin-svg-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/svg_grey.gif)
}
.plugin-word.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/word.gif)
}
.plugin-word-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/word_grey.gif)
}
.plugin-xls.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/xls.gif)
}
.plugin-xls-grey.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/xls_grey.gif)
}
.plugin-microarray.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/microarray.gif)
}
.plugin-chemical-structures.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/chemical_structures.gif)
}
.plugin-text.icon {
	BACKGROUND-IMAGE: url(/reviews/images/icons/text.gif)
}
.important {
	FONT-WEIGHT: bold
}
.journal-name {
	FONT-STYLE: italic
}
.journalname {
	FONT-STYLE: italic
}
.jtl {
	FONT-STYLE: italic
}
.journal-volume {
	FONT-WEIGHT: bold
}
.noborder {
	BORDER-TOP-WIDTH: 0px! important; BORDER-LEFT-WIDTH: 0px! important; =
BORDER-BOTTOM-WIDTH: 0px! important; BORDER-RIGHT-WIDTH: 0px! important
}
.term {
	TEXT-TRANSFORM: uppercase
}
.valign-bottom {
	VERTICAL-ALIGN: bottom
}
.valign-middle {
	VERTICAL-ALIGN: middle
}
.valign-top {
	VERTICAL-ALIGN: top
}
.vid {
	FONT-WEIGHT: bold
}
#content-journalnav {
	BORDER-TOP-COLOR: #f5f5f5
}
#extranav {
	BORDER-TOP: #f5f5f5 1px solid
}
* HTML #article-related #breadcrumb {
	MARGIN-LEFT: 1%; MARGIN-RIGHT: 1%
}
#head-er .header-nonad-wrapper {
	BORDER-BOTTOM-COLOR: #f5f5f5
}
.header-leaderboard IMG {
	BORDER-BOTTOM-COLOR: #f5f5f5
}
.header-leaderboard ilayer {
	BORDER-BOTTOM-COLOR: #f5f5f5
}
.header-leaderboard IFRAME {
	BORDER-BOTTOM-COLOR: #f5f5f5
}
.header-leaderboard EMBED {
	BORDER-BOTTOM-COLOR: #f5f5f5
}
.header-leaderboard-wrap {
	BACKGROUND-IMAGE: url(/reviews/images/bg_leaderboard.gif)
}
#breadcrumb {
	PADDING-RIGHT: 7px; PADDING-LEFT: 7px; FONT-SIZE: 100%; PADDING-BOTTOM: =
0px; MARGIN: 0px 0px 10px; PADDING-TOP: 0px
}
DIV#breadcrumb DIV {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; BACKGROUND: =
none transparent scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px; =
PADDING-TOP: 0px
}
#breadcrumb DIV A:link {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; BACKGROUND: =
none transparent scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px; =
PADDING-TOP: 0px
}
#breadcrumb DIV A:visited {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; BACKGROUND: =
none transparent scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px; =
PADDING-TOP: 0px
}
#breadcrumb DIV SPAN.thisitem {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; BACKGROUND: =
none transparent scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px; =
PADDING-TOP: 0px
}
DIV#breadcrumb DIV {
=09
}
#article-related DIV#breadcrumb DIV {
	MARGIN-LEFT: 0px
}
#breadcrumb DIV A:link {
	TEXT-DECORATION: underline
}
#breadcrumb DIV A:visited {
	TEXT-DECORATION: underline
}
#content {
	BACKGROUND: #fff; COLOR: #000
}
MAP.journal-nav {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px
}
MAP.journal-nav UL {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 6px; MARGIN: 0px =
0px 10px; PADDING-TOP: 6px
}
MAP.journal-nav UL LI {
	MARGIN: 0px
}
MAP.journal-nav UL LI.menu-heading H2 {
	FONT-SIZE: 110%; MARGIN: 0px 0px 10px
}
MAP#main-journal-nav UL LI.menu-heading H2 {
	TEXT-TRANSFORM: uppercase
}
* HTML MAP.journal-nav UL LI A {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 2px
}
* HTML MAP.journal-nav UL LI A:visited {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 2px
}
MAP.journal-nav UL LI A:link {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: normal; FONT-SIZE: =
110%; PADDING-BOTTOM: 4px; PADDING-TOP: 4px; TEXT-DECORATION: none
}
MAP.journal-nav UL LI A:visited {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: normal; FONT-SIZE: =
110%; PADDING-BOTTOM: 4px; PADDING-TOP: 4px; TEXT-DECORATION: none
}
MAP.supplementary.journal-nav UL LI A:link {
	FONT-WEIGHT: normal
}
MAP.supplementary.journal-nav UL LI A:visited {
	FONT-WEIGHT: normal
}
MAP.journal-nav UL LI A:hover {
	TEXT-DECORATION: none
}
MAP.journal-nav UL LI A:focus {
	TEXT-DECORATION: none
}
MAP.journal-nav UL LI.selected A:link {
	TEXT-DECORATION: none
}
MAP.journal-nav UL LI.selected A:visited {
	TEXT-DECORATION: none
}
#journalnav MAP.supplementary UL A:link {
	FONT-WEIGHT: normal; FONT-SIZE: 110%
}
#journalnav MAP.supplementary UL A:visited {
	FONT-WEIGHT: normal; FONT-SIZE: 110%
}
MAP.supplementary.journal-nav UL LI A.onsub:link {
	PADDING-LEFT: 23px
}
MAP.supplementary.journal-nav UL LI A.onsub:visited {
	PADDING-LEFT: 23px
}
MAP.journal-nav UL LI UL.subnav {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; =
MARGIN: 0px; PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
* HTML MAP.journal-nav UL LI UL.subnav A {
	PADDING-RIGHT: 10px! important; PADDING-LEFT: 20px! important; =
PADDING-BOTTOM: 2px! important; PADDING-TOP: 2px! important
}
MAP.journal-nav UL LI UL.subnav A:link {
	FONT-SIZE: 110%
}
MAP.journal-nav UL LI UL.subnav A:visited {
	FONT-SIZE: 110%
}
DIV#npg-resources {
	BORDER-RIGHT: #fff 1px solid; BORDER-TOP: #fff 1px solid; =
MARGIN-BOTTOM: 10px; PADDING-BOTTOM: 0px; BORDER-LEFT: #fff 1px solid; =
BORDER-BOTTOM: #fff 0px solid
}
H2.npg-resources {
	FONT-SIZE: 120%; BACKGROUND-COLOR: #b1062e
}
* HTML DIV#npg-resources H2 {
	BORDER-RIGHT: #fff 1px solid; BORDER-TOP: #fff 1px solid; BORDER-LEFT: =
#fff 1px solid; BORDER-BOTTOM: #fff 0px solid
}
DIV#npg-resources UL.npg-resources {
	MARGIN-BOTTOM: 0px; BACKGROUND-COLOR: red
}
* HTML DIV#npg-resources UL.npg-resources LI {
	BORDER-RIGHT: #fff 1px solid; BORDER-LEFT: #fff 1px solid
}
UL.npg-resources A:link {
	FONT-SIZE: 110%; BACKGROUND-COLOR: #ebebeb
}
UL.npg-resources A:visited {
	FONT-SIZE: 110%; BACKGROUND-COLOR: #ebebeb
}
UL.npg-resources A:hover {
	BACKGROUND-COLOR: #b1062e
}
DIV#npg-services H2 {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-WEIGHT: bold; FONT-SIZE: =
120%; PADDING-BOTTOM: 2px; MARGIN: 0px; COLOR: #fff; PADDING-TOP: 2px; =
BACKGROUND-COLOR: #b1062e
}
DIV#npg-services UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 20px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
DIV#npg-services UL LI {
	MARGIN: 0px; BORDER-BOTTOM: #fff 1px solid; BACKGROUND-COLOR: #eaeaea
}
DIV#npg-services UL A:link {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; PADDING-BOTTOM: 3px! important; MARGIN: 0px; COLOR: #000; =
PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
DIV#npg-services UL A:visited {
	PADDING-RIGHT: 5px! important; DISPLAY: block; PADDING-LEFT: 5px! =
important; PADDING-BOTTOM: 3px! important; MARGIN: 0px; COLOR: #000; =
PADDING-TOP: 3px! important; TEXT-DECORATION: none
}
DIV#npg-services UL A:hover {
	COLOR: #fff; BACKGROUND-COLOR: #b1062e; TEXT-DECORATION: none
}
DIV#npg-services {
	BORDER-RIGHT: #e7e7e7 1px solid; PADDING-RIGHT: 5px; BORDER-TOP: =
#e7e7e7 1px solid; PADDING-LEFT: 5px; BACKGROUND: #fff; MARGIN-BOTTOM: =
10px; PADDING-BOTTOM: 5px; BORDER-LEFT: #e7e7e7 1px solid; PADDING-TOP: =
5px; BORDER-BOTTOM: #e7e7e7 1px solid
}
DIV#npg-services H2 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 10px; COLOR: =
#000; PADDING-TOP: 0px
}
DIV#npg-services UL {
	MARGIN-BOTTOM: 0px
}
DIV#npg-services UL LI A:link {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-SIZE: 110%; PADDING-BOTTOM: =
4px; PADDING-TOP: 4px; BACKGROUND-COLOR: #f4dddd
}
DIV#npg-services UL LI A:visited {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-SIZE: 110%; PADDING-BOTTOM: =
4px; PADDING-TOP: 4px; BACKGROUND-COLOR: #f4dddd
}
DIV#npg-services UL LI A:hover {
	COLOR: #000; BACKGROUND-COLOR: #efc9c9
}
DIV#global-subject-areas {
	BORDER-LEFT-COLOR: #fff; BORDER-BOTTOM-COLOR: #fff; BORDER-TOP-COLOR: =
#fff; BORDER-RIGHT-COLOR: #fff
}
DIV.marketing.ad-rh {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; MARGIN: 0px =
0px 10px; PADDING-TOP: 5px; TEXT-ALIGN: left
}
* HTML DIV.marketing {
	BACKGROUND: #fff; MARGIN-BOTTOM: 10px
}
DIV.marketing.ad-rh DIV {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 5px
}
DIV.marketing.ad-rh H2 {
	LEFT: 0px; OVERFLOW: hidden; WIDTH: 1px; POSITION: absolute; TOP: =
-500px; HEIGHT: 1px
}
DIV.marketing.ad-rh P {
	FONT-WEIGHT: bold; MARGIN: 0px; COLOR: #000; TEXT-ALIGN: center
}
* HTML DIV.marketing.ad-rh P {
	FONT-WEIGHT: bold; MARGIN: 0px; COLOR: #000; TEXT-ALIGN: center
}
DIV.marketing.ad-rh FORM {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 1em =
0px 0px; PADDING-TOP: 0px; TEXT-ALIGN: center
}
DIV.marketing.ad-rh FORM INPUT {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 3px; FONT: =
bold 100% Verdana, Arial, Helvetica, sans-serif; PADDING-TOP: 3px
}
* HTML DIV.marketing.ad-rh FORM INPUT {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 3px
}
DIV.reg-rec {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 6px; MARGIN: 0px =
0px 10px; PADDING-TOP: 6px
}
DIV.reg-rec UL {
	PADDING-RIGHT: 4px; PADDING-LEFT: 4px; PADDING-BOTTOM: 2px; MARGIN: =
0px; PADDING-TOP: 2px; LIST-STYLE-TYPE: none
}
DIV.reg-rec UL LI {
	MARGIN: 8px 0px
}
DIV.reg-rec UL LI A:link {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 22px; FONT-SIZE: =
110%; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-DECORATION: none
}
DIV.reg-rec UL LI A:visited {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 22px; FONT-SIZE: =
110%; PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-DECORATION: none
}
DIV.links.reg-rec UL LI A:link {
	PADDING-LEFT: 5px
}
DIV.links.reg-rec UL LI A:visited {
	PADDING-LEFT: 5px
}
DIV.reg-rec UL LI A:hover {
	TEXT-DECORATION: underline
}
DIV.reg-rec UL LI A:focus {
	TEXT-DECORATION: underline
}
DIV.reg-rec UL A.e-alerts {
	BACKGROUND: url(/reviews/images/icons/signup.gif) no-repeat 0px 3px
}
DIV.reg-rec UL A.recommend {
	BACKGROUND: url(/reviews/images/icons/tick.gif) no-repeat 0px 1px
}
DIV.reg-rec UL A.newsfeeds {
	BACKGROUND: url(/reviews/images/icons/newsfeeds.gif) no-repeat 0px 0px
}
DIV.reg-rec UL A.rtopten {
	BACKGROUND: url(/reviews/images/icons/topten.gif) no-repeat 0px 0px; =
HEIGHT: 18px
}
DIV.reg-rec UL A.purchase {
	BACKGROUND: url(/reviews/images/icons/purchase.gif) no-repeat 0px 0px; =
PADDING-BOTTOM: 2px; PADDING-TOP: 2px
}
DIV.reg-rec UL A.bookmark {
	BACKGROUND: url(/reviews/images/icons/bookmark.gif) no-repeat 0px 0px; =
PADDING-BOTTOM: 1px; PADDING-TOP: 1px
}
* HTML DIV.reg-rec UL A.japanese {
	BACKGROUND: url(/reviews/images/icons/japanese.gif) no-repeat 0px 3px
}
DIV.reg-rec UL A.japanese {
	BACKGROUND: url(/reviews/images/icons/japanese.gif) no-repeat 0px 1px; =
PADDING-BOTTOM: 1px; PADDING-TOP: 1px
}
.box#natjob {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 6px; MARGIN: 0px =
0px 10px; COLOR: #000; PADDING-TOP: 6px
}
.box#natjob H2.natjob {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 7px; PADDING-LEFT: 7px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 120%; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px; FONT-FAMILY: =
inherit; BORDER-RIGHT-WIDTH: 0px
}
.box#natjob H2.natjob SPAN.first {
	TEXT-TRANSFORM: lowercase; FONT-FAMILY: Verdana, Arial, Helvetica, =
sans-serif
}
.box#natjob H2.natjob SPAN.second {
	TEXT-TRANSFORM: lowercase; FONT-FAMILY: Verdana, Arial, Helvetica, =
sans-serif
}
.box#natjob H2.natjob SPAN.third {
	TEXT-TRANSFORM: lowercase; FONT-FAMILY: Verdana, Arial, Helvetica, =
sans-serif
}
.box#natjob H2.natjob SPAN.first {
	COLOR: #f00
}
.box#natjob H2.natjob SPAN.second {
	COLOR: #000
}
.box#natjob UL.natjob {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 10px; MARGIN: 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
.box#natjob UL.natjob LI H3 {
	FONT-SIZE: 110%
}
.box#natjob UL.natjob LI UL {
	FONT-SIZE: 110%
}
.box#natjob UL.natjob LI H3 A:link {
	TEXT-DECORATION: none
}
.box#natjob UL.natjob LI H3 A:visited {
	TEXT-DECORATION: none
}
.box#natjob UL.natjob LI H3 A:hover {
	TEXT-DECORATION: underline
}
.box#natjob UL.natjob LI H3 A:focus {
	TEXT-DECORATION: underline
}
.box#natjob DIV.natjobmore {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 110%; BACKGROUND-IMAGE: none; =
BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 5px; MARGIN: 0px; PADDING-TOP: =
5px; LIST-STYLE-TYPE: none; BACKGROUND-COLOR: transparent; =
BORDER-RIGHT-WIDTH: 0px
}
.box#natjob DIV.natjobmore A:link {
	PADDING-RIGHT: 0px; DISPLAY: inline; PADDING-LEFT: 15px; FONT-SIZE: =
100%; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; =
TEXT-DECORATION: none
}
.box#natjob DIV.natjobmore A:visited {
	PADDING-RIGHT: 0px; DISPLAY: inline; PADDING-LEFT: 15px; FONT-SIZE: =
100%; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; =
TEXT-DECORATION: none
}
.box#natjob DIV.natjobmore A:hover {
	TEXT-DECORATION: underline
}
.box#natjob DIV.natjobmore A:focus {
	TEXT-DECORATION: underline
}
.box#natprod {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 6px; MARGIN: 0px =
0px 10px; COLOR: #000; PADDING-TOP: 6px
}
.box#natprod H2.natprod {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 7px; PADDING-LEFT: 7px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 120%; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px; FONT-FAMILY: =
inherit; BORDER-RIGHT-WIDTH: 0px
}
.box#natprod H2.natprod SPAN.first {
	TEXT-TRANSFORM: lowercase; FONT-FAMILY: Verdana, Arial, Helvetica, =
sans-serif
}
.box#natprod H2.natprod SPAN.second {
	TEXT-TRANSFORM: lowercase; FONT-FAMILY: Verdana, Arial, Helvetica, =
sans-serif
}
.box#natprod H2.natprod SPAN.third {
	TEXT-TRANSFORM: lowercase; FONT-FAMILY: Verdana, Arial, Helvetica, =
sans-serif
}
.box#natprod H2.natprod SPAN.first {
	COLOR: #f00
}
.box#natprod H2.natprod SPAN.second {
	COLOR: #000
}
.box#natprod FORM {
	MARGIN: 0px
}
.box#natprod DIV.natprodmore {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 1em; MARGIN: 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
.box#natprod DIV.natprodmore INPUT {
	FONT-SIZE: 110%
}
DIV.ad-rh {
	FONT-SIZE: 110%; MARGIN: 0px 0px 20px; COLOR: #d6d6d6; TEXT-ALIGN: =
center
}
DIV.ad-rh P {
	MARGIN: 0px
}
DIV.wide.skyscraper.ad-rh {
	TEXT-TRANSFORM: uppercase
}
DIV.masthead.ad-rh {
	BACKGROUND: url(/naturedotcom/images/graphics/bg.ad.masthead.gif) =
#f3f3f3 no-repeat 50% 0px
}
DIV.ad-rh IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; VERTICAL-ALIGN: bottom; BORDER-RIGHT-WIDTH: 0px
}
DIV.ad-rh EMBED {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; VERTICAL-ALIGN: bottom; BORDER-RIGHT-WIDTH: 0px
}
DIV.wide.skyscraper.ad-rh IMG {
	MAX-WIDTH: 160px! important; MARGIN: 4px 0px 0px; WIDTH: 100%
}
DIV.wide.skyscraper.ad-rh EMBED {
	MAX-WIDTH: 160px! important; MARGIN: 4px 0px 0px; WIDTH: 100%
}
* HTML DIV.wide.skyscraper.ad-rh {
	MAX-WIDTH: 160px! important; MARGIN-LEFT: auto; OVERFLOW: hidden; =
WIDTH: 100%; MARGIN-RIGHT: auto
}
.page-heading {
	PADDING-RIGHT: 10px; PADDING-LEFT: 7px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 10px
}
.page-heading H1 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 150%! important; =
PADDING-BOTTOM: 5px; MARGIN: 0px 3px 1em; PADDING-TOP: 5px
}
.page-heading H1.series {
	PADDING-LEFT: 39px; MIN-HEIGHT: 13px
}
H1.piccie {
	BACKGROUND: url(/reviews/images/rev.jpg) repeat-x left bottom; =
PADDING-BOTTOM: 75px
}
.page-heading H1.page-header {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#content DIV.box {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; MARGIN: =
1em 0px; PADDING-TOP: 0px
}
#content DIV.box H2 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-SIZE: 110%; PADDING-BOTTOM: =
5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px
}
#content DIV.box H3 {
	FONT-SIZE: 110%; MARGIN: 0px 0px 0.5em
}
#content DIV.box H4 {
	FONT-SIZE: 110%; MARGIN: 1em 0px 0px
}
#content DIV.box H5 {
	FONT-SIZE: 110%; MARGIN: 1em 0px 0px
}
#content DIV.box H6 {
	FONT-SIZE: 110%; MARGIN: 1em 0px 0px
}
#content DIV.box UL LI H2 {
	FONT-SIZE: 100%
}
#content DIV.box UL LI H3 {
	FONT-SIZE: 100%
}
#content DIV.box UL LI H4 {
	FONT-SIZE: 100%
}
#content DIV.box UL LI H5 {
	FONT-SIZE: 100%
}
#content DIV.box UL LI H6 {
	FONT-SIZE: 100%
}
#content DIV.box H3.emphasize {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; PADDING-BOTTOM: 5px; MARGIN: 0px =
0px 1em; PADDING-TOP: 5px
}
#content DIV.box H3 .label {
	DISPLAY: block
}
#content DIV.box P {
	FONT-SIZE: 110%; MARGIN: 0px 0px 1em; LINE-HEIGHT: 190%
}
#content DIV.box UL LI P {
	FONT-SIZE: 100%
}
#content DIV.box A.pdf:link {
	PADDING-RIGHT: 3px; MARGIN-TOP: 3px; DISPLAY: block; PADDING-LEFT: =
30px; MARGIN-BOTTOM: 10px; PADDING-BOTTOM: 3px; PADDING-TOP: 3px; =
TEXT-DECORATION: none
}
#content DIV.box A.pdf:visited {
	PADDING-RIGHT: 3px; MARGIN-TOP: 3px; DISPLAY: block; PADDING-LEFT: =
30px; MARGIN-BOTTOM: 10px; PADDING-BOTTOM: 3px; PADDING-TOP: 3px; =
TEXT-DECORATION: none
}
#content DIV.box A.rss:link {
	PADDING-RIGHT: 3px; MARGIN-TOP: 3px; DISPLAY: block; PADDING-LEFT: =
30px; MARGIN-BOTTOM: 10px; PADDING-BOTTOM: 3px; PADDING-TOP: 3px; =
TEXT-DECORATION: none
}
#content DIV.box A.visited.rss {
	PADDING-RIGHT: 3px; MARGIN-TOP: 3px; DISPLAY: block; PADDING-LEFT: =
30px; MARGIN-BOTTOM: 10px; PADDING-BOTTOM: 3px; PADDING-TOP: 3px; =
TEXT-DECORATION: none
}
#content DIV.box A.pdf:link {
	BACKGROUND: url(/reviews/images/icons/pdf.gif) #f5f5f5 no-repeat 10px =
50%
}
#content DIV.box A.pdf:visited {
	BACKGROUND: url(/reviews/images/icons/pdf.gif) #f5f5f5 no-repeat 10px =
50%
}
#content DIV.box A.rss:link {
	PADDING-LEFT: 45px; BACKGROUND: url(/common/images/icons/rss.gif) =
#f5f5f5 no-repeat 10px 50%
}
#content DIV.box A.visited.rss {
	PADDING-LEFT: 45px; BACKGROUND: url(/common/images/icons/rss.gif) =
#f5f5f5 no-repeat 10px 50%
}
#content DIV.box A.pdf:hover {
	COLOR: #cd0033
}
#content DIV.box A.pdf:focus {
	COLOR: #cd0033
}
#content DIV.box A.rss:hover {
	COLOR: #cd0033
}
#content DIV.box A.rss:focus {
	COLOR: #cd0033
}
#content DIV.box UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 110%; PADDING-BOTTOM: =
0px; MARGIN: 0px 0px 1em; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#content DIV.box UL UL {
	FONT-SIZE: 100%
}
#content DIV.box UL LI {
	PADDING-LEFT: 13px; MARGIN: 0px 0px 0.75em; LINE-HEIGHT: 150%
}
#content DIV.box OL LI {
	MARGIN-BOTTOM: 0.75em; LINE-HEIGHT: 150%
}
#content DIV.box DL DT {
	FONT-WEIGHT: bold; MARGIN: 0px 0px 0.5em; LINE-HEIGHT: 150%
}
#content DIV.box DL DD {
	MARGIN: 0px 0px 1em; LINE-HEIGHT: 150%
}
#content DIV.box UL.action-list LI {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat 0px 0.4em
}
* HTML #content DIV.box UL.anchor-list {
	MAX-WIDTH: 50em; MARGIN-LEFT: auto; MARGIN-RIGHT: auto
}
#content DIV.box UL.anchor-list:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #content DIV.box UL.anchor-list {
	HEIGHT: 1%
}
#content DIV.box UL.anchor-list LI {
	PADDING-RIGHT: 1%; PADDING-LEFT: 4%; FLOAT: left; MARGIN-BOTTOM: 0.5em; =
PADDING-BOTTOM: 5px; WIDTH: 43%; LINE-HEIGHT: 100%; PADDING-TOP: 5px
}
#content DIV.box UL.anchor-list LI.even {
	FLOAT: right
}
#content DIV.box OL.conference-list {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 1em; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#content DIV.box OL.conference-list OL {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; MARGIN: =
0px 0px 1em; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#content DIV.box OL.conference-list H4 {
	FONT-SIZE: 110%; MARGIN: 0px
}
#content DIV.box OL.conference-list H5 {
	FONT-SIZE: 110%; MARGIN: 0px
}
#content DIV.box OL.conference-list P {
	FONT-SIZE: 110%; MARGIN: 0px
}
#content DIV.box OL.conference-list H3 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; =
PADDING-BOTTOM: 5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px
}
#content DIV.box OL.conference-list P.date {
	FONT-WEIGHT: bold
}
#content DIV.box OL.conference-list H4 {
	FONT-WEIGHT: normal
}
#content DIV.box OL.conference-list H5 {
	FONT-WEIGHT: normal; MARGIN: 0px 0px 1em
}
#content DIV.box OL.conference-list .no-label H4 {
	FONT-WEIGHT: normal; MARGIN: 0px 0px 1em
}
#content DIV.box DL.faq-list DT {
	PADDING-LEFT: 20px; MIN-HEIGHT: 13px
}
#content DIV.box DL.faq-list DD {
	PADDING-LEFT: 20px; MIN-HEIGHT: 13px
}
#content DIV.box DL.faq-list UL.options {
	LEFT: 0px; OVERFLOW: hidden; WIDTH: 1px; POSITION: absolute; TOP: =
-500px; HEIGHT: 1px
}
#content DIV.box .illustrated {
	BACKGROUND-POSITION: left top; BACKGROUND-REPEAT: no-repeat
}
#content DIV.box .size64px.illustrated {
	PADDING-LEFT: 74px
}
#content DIV.box .size70px.illustrated {
	PADDING-LEFT: 80px
}
#content DIV.box .size76px.illustrated {
	PADDING-LEFT: 86px
}
#content DIV.box .size80px.illustrated {
	PADDING-LEFT: 90px
}
#content DIV.box .size86px.illustrated {
	PADDING-LEFT: 96px
}
#content DIV.box .size116px.illustrated {
	PADDING-LEFT: 126px
}
#content DIV.box .size150px.illustrated {
	PADDING-LEFT: 160px
}
#content DIV.box H3.address-type-heading {
	FONT-SIZE: 110%; MARGIN: 0px
}
#content DIV.box H4.address-type-heading {
	FONT-SIZE: 110%; MARGIN: 0px
}
#content DIV.box H5.address-type-heading {
	FONT-SIZE: 110%; MARGIN: 0px
}
#content DIV.box H6.address-type-heading {
	FONT-SIZE: 110%; MARGIN: 0px
}
#content DIV.box H3.post.address-type-heading {
	LEFT: 0px; OVERFLOW: hidden; WIDTH: 1px; POSITION: absolute; TOP: =
-500px; HEIGHT: 1px
}
#content DIV.box H4.post.address-type-heading {
	LEFT: 0px; OVERFLOW: hidden; WIDTH: 1px; POSITION: absolute; TOP: =
-500px; HEIGHT: 1px
}
#content DIV.box H5.post.address-type-heading {
	LEFT: 0px; OVERFLOW: hidden; WIDTH: 1px; POSITION: absolute; TOP: =
-500px; HEIGHT: 1px
}
#content DIV.box H6.post.address-type-heading {
	LEFT: 0px; OVERFLOW: hidden; WIDTH: 1px; POSITION: absolute; TOP: =
-500px; HEIGHT: 1px
}
#content DIV.box ADDRESS {
	FONT-SIZE: 110%; MARGIN: 0px 0px 1em; LINE-HEIGHT: 150%; FONT-STYLE: =
normal
}
#content DIV.box ADDRESS .line {
	DISPLAY: block
}
#content DIV.box ADDRESS .addressee {
	FONT-WEIGHT: bold
}
#content DIV.box ADDRESS .postcode {
	TEXT-TRANSFORM: uppercase
}
#content DIV.box ADDRESS .country {
	TEXT-TRANSFORM: uppercase
}
.separator {
	CLEAR: both; PADDING-RIGHT: 10px; DISPLAY: block; PADDING-LEFT: 10px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
.box .separator {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px
}
.separator HR {
	DISPLAY: none
}
TABLE.data {
	MARGIN: 0px 0px 1em; BORDER-COLLAPSE: collapse
}
TABLE.data CAPTION {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; BACKGROUND: =
none transparent scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; FONT-STYLE: normal; TEXT-ALIGN: =
left
}
TABLE.data THEAD TH {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; TEXT-ALIGN: left
}
TABLE.data THEAD TD {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; TEXT-ALIGN: left
}
TABLE.data TBODY TH {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; TEXT-ALIGN: left
}
TABLE.data TBODY TD {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; TEXT-ALIGN: left
}
TABLE.data TFOOT TD {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 110%; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; TEXT-ALIGN: left
}
TABLE.data TFOOT TD UL LI {
	FONT-SIZE: 90%
}
#article H1.page-header {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#article #content DIV.box #atl {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
FONT-WEIGHT: normal; BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 160%; =
BACKGROUND: none transparent scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: =
0px; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; =
BORDER-RIGHT-WIDTH: 0px
}
#article #content DIV.box #abs {
	FONT-WEIGHT: bold; MARGIN-BOTTOM: 2em
}
#article #content DIV.box SUP {
	FONT-SIZE: 100%
}
#article #content DIV.box H3 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; PADDING-BOTTOM: 5px; MARGIN: 0px =
0px 1em; PADDING-TOP: 5px
}
#article #content DIV.box H4 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; PADDING-BOTTOM: 5px; MARGIN: 0px =
0px 1em; PADDING-TOP: 5px
}
#article #content DIV.box IMG.valign-middle.char-img {
	VERTICAL-ALIGN: middle
}
#article #content DIV.box IMG.valign-bottom.char-img {
	VERTICAL-ALIGN: bottom
}
#article #content DIV.box DIV.figure-table {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 10px; MARGIN: =
0px 0px 1em; PADDING-TOP: 10px
}
#article #content DIV.box DIV.figure-table H5 {
	MARGIN: 0px 0px 10px
}
#article #content DIV.box DIV.figure-table IMG.thumb {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; FLOAT: left; =
BORDER-BOTTOM-WIDTH: 0px; MARGIN: 0px 10px 10px 0px; BORDER-RIGHT-WIDTH: =
0px
}
#article #content DIV.box DIV.figure-table P {
	MARGIN-LEFT: 160px
}
#article #content DIV.box DIV.figure-table UL.options {
	MARGIN-LEFT: 160px
}
#article #content DIV.box DIV.box.figure-table P {
	MARGIN-LEFT: 0px
}
#article #content DIV.box DIV.box.figure-table UL.options {
	MARGIN-LEFT: 0px
}
#article #content DIV.box DIV.figure-table UL.options LI.full {
	PADDING-LEFT: 25px
}
#article #content DIV.box DIV.figure-table UL.options LI.fti {
	PADDING-LEFT: 25px
}
#article #content DIV.box DIV.figure-table UL.options LI.high-res {
	PADDING-LEFT: 25px
}
#article #content DIV.box DIV.figure-table UL.options LI.powerpoint {
	PADDING-LEFT: 25px
}
#article #content DIV.box DIV.figure-table UL.options LI.chemdraw {
	PADDING-LEFT: 25px
}
#article #content DIV.image-legend {
	BORDER-RIGHT: #ccc 1px solid; PADDING-RIGHT: 1px; BORDER-TOP: #ccc 1px =
solid; PADDING-LEFT: 1px; BACKGROUND: #fff; FLOAT: right; =
PADDING-BOTTOM: 1px; MARGIN: 10px 0px 10px 10px; BORDER-LEFT: #ccc 1px =
solid; WIDTH: 180px! important; PADDING-TOP: 1px; BORDER-BOTTOM: #ccc =
1px solid; TEXT-ALIGN: center
}
#article #content DIV.image-legend P {
	PADDING-RIGHT: 5px; BORDER-TOP: #ccc 1px solid; PADDING-LEFT: 5px; =
FONT-SIZE: 100%; PADDING-BOTTOM: 5px; MARGIN: 0px; PADDING-TOP: 5px; =
TEXT-ALIGN: left
}
#article #content DIV.image-legend IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MAX-WIDTH: 180px; VERTICAL-ALIGN: bottom; BORDER-RIGHT-WIDTH: 0px
}
#article #content DIV.image-legend SPAN {
	FONT-STYLE: italic
}
#article #content P.beforeimage-full {
	MARGIN-BOTTOM: 1em
}
#article #content DIV.image-full {
	PADDING-RIGHT: 10px; MARGIN-TOP: 0px; PADDING-LEFT: 10px; FONT-SIZE: =
100%; BACKGROUND: #fff; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; =
TEXT-ALIGN: center
}
#article #content DIV.image-full IMG {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; MAX-WIDTH: 425px; =
PADDING-BOTTOM: 1px; PADDING-TOP: 1px
}
#article #content DIV.image-full P {
	TEXT-ALIGN: left
}
#article #content DIV.image-full SPAN {
	FONT-STYLE: italic
}
#article #content UL.switch-article-view {
	MARGIN-BOTTOM: 2em
}
#article #content UL.switch-article-view LI {
	PADDING-LEFT: 0px; BACKGROUND-IMAGE: none; MARGIN-LEFT: 0px; COLOR: =
#f00
}
#article #content UL.switch-article-view LI A:link {
	FONT-WEIGHT: bold
}
#article #content UL.switch-article-view LI A:visited {
	FONT-WEIGHT: bold
}
#article #extranav #articlenav {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; MARGIN: 1em =
0px; PADDING-TOP: 5px
}
#article #extranav #articlenav H2 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-SIZE: 110%; PADDING-BOTTOM: =
5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px
}
#article #extranav #articlenav UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article #extranav #articlenav UL.view-tools {
	MARGIN-TOP: 1em; PADDING-TOP: 1em
}
#article #extranav #articlenav UL LI {
	PADDING-LEFT: 18px; MARGIN: 0px 0px 0.75em; LINE-HEIGHT: 150%
}
#article #extranav #articlenav UL.view-tools LI {
	BACKGROUND: url(/reviews/images/graphics/bullet.arrow-right.9e52a0.gif) =
no-repeat 5px 0.6em
}
#article #extranav #articlenav UL LI A:link {
	COLOR: #000; TEXT-DECORATION: none
}
#article #extranav #articlenav UL LI A:visited {
	COLOR: #000; TEXT-DECORATION: none
}
#article #extranav #articlenav UL LI A:hover {
	COLOR: #000; TEXT-DECORATION: underline
}
#article #extranav #articlenav UL LI A:focus {
	COLOR: #000; TEXT-DECORATION: underline
}
#article #extranav #articlenav UL LI.threed {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.fulltext {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.download-pdf {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.sendtofriend {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.export {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.permissions {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.commercial_reprints {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.save {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.toc {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.prev {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.next {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.cited {
	PADDING-LEFT: 26px
}
#article #extranav #articlenav UL LI.cited {
	BACKGROUND: url(/common/images/icons/cited.gif) no-repeat 6px 0px
}
#article #extranav #search-pubmed {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; MARGIN: 1em =
0px; PADDING-TOP: 5px
}
#article #extranav #search-pubmed H2 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-SIZE: 110%; PADDING-BOTTOM: =
5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px
}
#article #extranav #search-pubmed UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 1em; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article #extranav #search-pubmed LI {
	PADDING-LEFT: 13px; MARGIN: 0px 0px 0.75em; LINE-HEIGHT: 150%
}
#article #extranav #search-pubmed LI.more {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: none; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 10px; BACKGROUND-COLOR: =
transparent
}
#article #extranav #search-pubmed LI.more A:link {
	PADDING-RIGHT: 0px; PADDING-LEFT: 15px; FONT-SIZE: 100%; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; TEXT-DECORATION: =
none
}
#article #extranav #search-pubmed LI.more A:visited {
	PADDING-RIGHT: 0px; PADDING-LEFT: 15px; FONT-SIZE: 100%; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; TEXT-DECORATION: =
none
}
#article #extranav #search-pubmed LI.more A:hover {
	TEXT-DECORATION: underline
}
#article #extranav #search-pubmed LI.more A:focus {
	TEXT-DECORATION: underline
}
#article #content DIV.poster.box IMG.poster-graphic {
	PADDING-RIGHT: 1px; DISPLAY: block; PADDING-LEFT: 1px; FLOAT: left; =
PADDING-BOTTOM: 1px; MARGIN: 0px 10px 10px 0px; PADDING-TOP: 1px
}
#article #content DIV.nature-view.box #articlebody {
	MARGIN-TOP: 2em; MARGIN-BOTTOM: 2em
}
#article #content DIV.in-brief.box #articlebody DIV H3 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 1em 0px; PADDING-TOP: =
0px
}
#article #content DIV.in-brief.box #articlebody DIV H3 SPAN.label {
	PADDING-RIGHT: 0px; DISPLAY: inline; PADDING-LEFT: 0px; FONT-SIZE: =
120%; BACKGROUND: #fff; PADDING-BOTTOM: 3px; COLOR: #8a8c9f; =
PADDING-TOP: 3px; BORDER-BOTTOM: #e3e3e3 1px solid
}
#article #content DIV.in-brief.box #articlebody DIV H4 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: normal; FONT-SIZE: =
125%; BACKGROUND: none transparent scroll repeat 0% 0%; PADDING-BOTTOM: =
0px; MARGIN: 1em 0px 0px; LINE-HEIGHT: 150%; PADDING-TOP: 0px
}
#article #content DIV.in-brief.box #articlebody DIV P.aug {
	MARGIN: 0.5em 0px 0px; COLOR: #666
}
#article #content DIV.in-brief.box #articlebody DIV.in-brief-item {
	MARGIN-BOTTOM: 3em
}
#article #content DIV.news-in-brief.box #articlebody =
DIV.news-in-brief-item {
	BORDER-RIGHT: #e7e7e7 1px solid; PADDING-RIGHT: 10px; BORDER-TOP: =
#e7e7e7 1px solid; PADDING-LEFT: 10px; BACKGROUND: #f5f5f5; =
MARGIN-BOTTOM: 2em; PADDING-BOTTOM: 10px; BORDER-LEFT: #e7e7e7 1px =
solid; PADDING-TOP: 10px; BORDER-BOTTOM: #e7e7e7 1px solid
}
#article #content DIV.news-in-brief.box #articlebody =
DIV.news-in-brief-item H3 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
#article #content #more-like-this {
	BORDER-RIGHT: #ccc 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: #ccc 1px =
solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 10px; MARGIN: 25px 0px; =
BORDER-LEFT: #ccc 1px solid; PADDING-TOP: 0px; BORDER-BOTTOM: #ccc 1px =
solid
}
#article #content #more-like-this H3 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-WEIGHT: bold; =
PADDING-BOTTOM: 3px; MARGIN: 0px; PADDING-TOP: 3px; BACKGROUND-COLOR: =
#f6f6f6
}
#article #content #more-like-this DIV.wrapper {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 10px; =
PADDING-TOP: 0px
}
#article #content #more-like-this P.explain {
	MARGIN: 10px
}
#article #content #more-like-this A.article {
	DISPLAY: block; FONT-WEIGHT: bold; MARGIN: 0px; COLOR: #666
}
#article #content #more-like-this A.article:hover {
	COLOR: #c03
}
#article #content #more-like-this P.journal {
	MARGIN: 0px; FONT-STYLE: italic
}
#article #content #more-like-this P.journal SPAN {
	FONT-STYLE: normal
}
#article #content #more-like-this H4.area {
	PADDING-LEFT: 0px; MARGIN: 0px; TEXT-TRANSFORM: uppercase; COLOR: #000; =
BACKGROUND-COLOR: transparent
}
#article #content #more-like-this A.allmatches:link {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 10px; BACKGROUND: =
url(/common/images/icons/c03/arrow_s.gif) no-repeat left center; =
PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #c03; PADDING-TOP: 0px
}
#article #content #more-like-this A.allmatches:visited {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 10px; BACKGROUND: =
url(/common/images/icons/c03/arrow_s.gif) no-repeat left center; =
PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: #c03; PADDING-TOP: 0px
}
#article #content #more-like-this A.allmatches:hover {
	BACKGROUND: url(/common/images/icons/c03/arrow_s.gif) no-repeat left =
center
}
#article-related P.journal {
	FONT-STYLE: normal
}
#article-related P.journal SPAN.journalname {
	FONT-STYLE: italic
}
#article-related H1.page-header {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 110%; =
BORDER-BOTTOM-WIDTH: 0px; MARGIN: 0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.box H2.from {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.box .container-cite H2.note {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.box .container-cite P {
	FONT-SIZE: 110%; MARGIN: 0px
}
#article-related DIV.box .container-cite P.atl {
	FONT-WEIGHT: bold
}
#article-related DIV.box .container-image {
	BORDER-BOTTOM-WIDTH: 0px
}
#article-related DIV.box .container-image-text {
	BORDER-TOP-WIDTH: 0px! important
}
#article-related DIV.box .container-image-text P {
	FONT-SIZE: 110%
}
#article-related DIV.ar-navigation {
	MARGIN: 1em auto; TEXT-ALIGN: center
}
#article-related DIV.align-left.ar-navigation {
	TEXT-ALIGN: left
}
#article-related DIV.ar-navigation UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article-related DIV.ar-navigation UL LI {
	PADDING-RIGHT: 0px; DISPLAY: inline; PADDING-LEFT: 0px; PADDING-BOTTOM: =
0px; PADDING-TOP: 0px
}
#article-related DIV.ar-navigation UL LI.back {
	PADDING-LEFT: 8px
}
#article-related DIV.ar-navigation UL LI.down {
	PADDING-LEFT: 8px
}
#article-related DIV.ar-navigation UL LI.next {
	PADDING-RIGHT: 8px; PADDING-LEFT: 0px
}
#article-related DIV.container-figtab {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.container-figtab DIV.container-image-text H3 {
	FONT-SIZE: 110%
}
#article-related DIV.container-figtab DIV.container-image-text P {
	FONT-SIZE: 110%
}
#article-related DIV.container-figtab DIV.container-image-text {
	MARGIN-LEFT: 164px
}
#article-related DIV.container-figtab DIV.container-image A IMG {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; PADDING-BOTTOM: 1px; =
PADDING-TOP: 1px
}
#article-related DIV.container-figtab UL.options {
	MARGIN-BOTTOM: 0px
}
#article-related DIV.container-figtab UL.options LI {
	MARGIN-BOTTOM: 0px
}
#article-related DIV.container-figtab UL.options {
	PADDING-BOTTOM: 1em
}
#article-related DIV.container-figtab UL.options LI {
	LINE-HEIGHT: 150%
}
#article-related DIV.container-figtab UL.options LI.full {
	PADDING-LEFT: 25px
}
#article-related DIV.container-image-text UL.options LI.full {
	PADDING-LEFT: 25px
}
#article-related DIV.container-figtab UL.options LI.powerpoint {
	PADDING-LEFT: 25px
}
#article-related DIV.container-image-text UL.options LI.powerpoint {
	PADDING-LEFT: 25px
}
#article-related DIV.container-figtab UL.options LI.chemdraw {
	PADDING-LEFT: 25px
}
#article-related DIV.container-image-text UL.options LI.chemdraw {
	PADDING-LEFT: 25px
}
#article-related DIV.box .container-table {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: center
}
#article-related DIV.box .container-image-box {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: center
}
#article-related H2#figure-title {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: =
130%; BACKGROUND: none transparent scroll repeat 0% 0%; PADDING-BOTTOM: =
0px; MARGIN: 1em 0px; TEXT-TRANSFORM: none; COLOR: black; PADDING-TOP: =
0px; BORDER-BOTTOM-STYLE: none
}
#article-related TABLE.data {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-COLLAPSE: collapse; BORDER-RIGHT-WIDTH: 0px
}
#article-related TABLE.data TR {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related TABLE.data THEAD TH {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 9px; PADDING-LEFT: 9px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 100%; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 7px; PADDING-TOP: 7px; BORDER-RIGHT-WIDTH: 0px
}
#article-related TABLE.data TFOOT TD {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 100%; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 7px; PADDING-TOP: 7px; BORDER-RIGHT-WIDTH: 0px
}
#article-related TABLE.data TBODY TR {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related TABLE.data TBODY TR.odd {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related TABLE.data TBODY TH {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 100%; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; BORDER-RIGHT-WIDTH: 0px
}
#article-related TABLE.data TBODY TD {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 100%; BACKGROUND: none transparent =
scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 3px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.box DIV.send-friend-wrapper {
	MARGIN: 6em 0px; TEXT-ALIGN: center
}
#article-related DIV.box DIV.container-sendfriend {
	CLEAR: both; MAX-WIDTH: 53em; MARGIN: 0px auto
}
#article-related DIV.box DIV.container-sendfriend DIV.wrapper {
	MARGIN-BOTTOM: 10px
}
#article-related DIV.box DIV.container-sendfriend LABEL {
	FONT-WEIGHT: normal; FONT-SIZE: 110%
}
#article-related DIV.box DIV.container-sendfriend P {
	FONT-SIZE: 100%; MARGIN: 0px
}
#article-related DIV.box DIV.container-sendfriend DIV.text {
	FLOAT: left; WIDTH: 210px; TEXT-ALIGN: right
}
#article-related DIV.box DIV.container-sendfriend DIV.form {
	MARGIN-LEFT: 220px
}
#article-related DIV.box DIV.container-sendfriend DIV.form INPUT {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; WIDTH: auto; PADDING-TOP: 0px
}
#article-related DIV.box DIV.container-sendfriend DIV.form TEXTAREA {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; WIDTH: auto; PADDING-TOP: 0px
}
#article-related DIV.box DIV.container-sendfriend DIV.form INPUT {
	WIDTH: 100%
}
#article-related DIV.box DIV.container-sendfriend DIV.form TEXTAREA {
	WIDTH: 100%
}
#article-related DIV.box DIV.container-sendfriend INPUT.friend {
	CLEAR: both; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: =
3px; FONT: bold 110% Verdana, Arial, Helvetica, sans-serif; MARGIN-LEFT: =
55px; PADDING-TOP: 3px
}
#article-related DIV.box H2.author {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 1em 0px 0px; =
PADDING-TOP: 0px
}
#article-related DIV.box H2.glossary-term {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 110%; BACKGROUND: =
none transparent scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 1em =
0px 0px; TEXT-TRANSFORM: none; COLOR: black; PADDING-TOP: 0px; =
BORDER-BOTTOM-STYLE: none
}
#article-related DIV.container-supplementary DIV.wrapper {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; =
MARGIN: 0px 0px 1em; PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.container-supplementary DIV.wrapper H2 {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; MARGIN: 0px 0px 0.5em; =
TEXT-TRANSFORM: none; COLOR: black; BORDER-BOTTOM-STYLE: none
}
#article-related DIV.container-supplementary DIV.wrapper P {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; =
BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; =
MARGIN: 0px 0px 1em; LINE-HEIGHT: 150%; PADDING-TOP: 0px; =
BORDER-RIGHT-WIDTH: 0px
}
#article-related DIV.container-supplementary DIV.wrapper P.links {
	MARGIN: 0px
}
#article-related #browser-plugins {
	CLEAR: both; PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: =
10px; PADDING-TOP: 10px
}
#article-related #browser-plugins H2 {
	FONT-SIZE: 110%; MARGIN: 0px
}
#article-related #browser-plugins H3 {
	FONT-SIZE: 110%; MARGIN: 1em 0px 0px
}
#article-related #browser-plugins DIV {
	FLOAT: left; MARGIN-LEFT: 3%; WIDTH: 30%
}
#article-related #browser-plugins DIV.cleardiv {
	FLOAT: none; MARGIN: 0px; WIDTH: auto
}
#article-related #browser-plugins DIV.first {
	MARGIN-LEFT: 0px
}
#article-related #browser-plugins UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#toc #content DIV.box H4 {
	MARGIN-TOP: 0.5em
}
#toc #content DIV.box H5 {
	MARGIN-TOP: 0.5em
}
#toc #content DIV.box H6 {
	MARGIN-TOP: 0.5em
}
#toc #content DIV.issue DIV.details {
	FLOAT: right; WIDTH: 48%
}
#toc #content DIV.issue DIV.details H2 {
	BACKGROUND: none transparent scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: =
0px; COLOR: #000
}
#toc #content DIV.issue DIV.details SPAN.label {
	DISPLAY: block
}
#toc #content DIV.issue DIV.cover-navigation {
	FLOAT: left; WIDTH: 48%
}
#toc #content DIV.issue DIV.cover-navigation P.previous-issue {
	PADDING-RIGHT: 3px; PADDING-LEFT: 11px; PADDING-BOTTOM: 5px; =
LINE-HEIGHT: 100%; PADDING-TOP: 5px
}
#toc #content DIV.issue DIV.cover-navigation IMG.journal-cover {
	PADDING-RIGHT: 1px; DISPLAY: block; PADDING-LEFT: 1px; PADDING-BOTTOM: =
1px; PADDING-TOP: 1px
}
#toc #content DIV.issue DIV.cover-navigation P.about-cover {
	PADDING-LEFT: 18px
}
#toc #content DIV.section {
	MARGIN: 0px 0px 1em
}
#toc #content DIV.section .article {
	MARGIN: 0px 0px 2em
}
#toc #content DIV.section H3 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-SIZE: 110%; PADDING-BOTTOM: =
5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px
}
#toc #content DIV.section H4.atl {
	FONT-SIZE: 110%; MARGIN: 1ex 0px 0px
}
#toc #content DIV.section P.aug {
	FONT-SIZE: 110%; MARGIN: 0px; LINE-HEIGHT: 150%; FONT-STYLE: italic
}
#toc #content DIV.section P.date {
	FONT-SIZE: 110%; MARGIN: 0px; LINE-HEIGHT: 150%
}
#toc #content DIV.section P.page {
	FONT-SIZE: 110%; MARGIN: 0px 0px 0.5em; LINE-HEIGHT: 150%
}
#toc #content DIV.section P.doi {
	FONT-SIZE: 110%; MARGIN: 0px 0px 0.5em; LINE-HEIGHT: 150%
}
#toc #content DIV.section UL.article-views {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0.5em 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#toc #content DIV.section UL.article-views:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #toc #content DIV.section UL.article-views {
	HEIGHT: 1%
}
#toc #content DIV.section UL.article-views LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0.5em; MIN-HEIGHT: 12px; FLOAT: left; =
BACKGROUND-IMAGE: none; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 0.5em; =
LINE-HEIGHT: 100%; PADDING-TOP: 0px
}
#toc #content DIV.section UL.article-views LI.first {
	PADDING-LEFT: 18px; BORDER-LEFT-WIDTH: 0px; MARGIN-LEFT: 0px
}
#toc #content DIV.section UL.article-views LI.pdf {
	FONT-WEIGHT: bold
}
#toc #content DIV.section P.see-also {
	PADDING-LEFT: 18px
}
#toc #content P.seealso {
	FONT-SIZE: 90%
}
#toc #content SPAN.seealso-title {
	PADDING-LEFT: 18px; FONT-WEIGHT: bold; BACKGROUND: =
url(/nrg/images/graphics/bullet.arrow-right.image.gif) no-repeat left =
center
}
#toc #content DIV.section DIV.type H4 {
	FONT-SIZE: 110%; MARGIN: 0px; TEXT-TRANSFORM: uppercase
}
#toc #content DIV.focus DIV.section DIV.type H5 {
	FONT-SIZE: 110%; MARGIN: 0px; TEXT-TRANSFORM: uppercase
}
#toc #content DIV.section DIV.series DIV.type H5 {
	FONT-SIZE: 110%; MARGIN: 0px; TEXT-TRANSFORM: uppercase
}
#toc #content DIV.section DIV.type .article {
	PADDING-LEFT: 15px
}
#toc #content DIV.section DIV.topic H4 {
	FONT-SIZE: 100%; MARGIN: 1em 0px
}
#toc #content DIV.section DIV.topic H4 SPAN.label {
	PADDING-RIGHT: 8px; PADDING-LEFT: 8px; PADDING-BOTTOM: 3px; =
PADDING-TOP: 3px
}
#toc #content DIV.section DIV.topic H4 SPAN.focus {
	PADDING-RIGHT: 45px; MIN-HEIGHT: 13px
}
#toc #content DIV.section DIV.topic .article {
=09
}
#toc #content DIV.focus H3 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-SIZE: 110%; PADDING-BOTTOM: =
5px; MARGIN: 0px; PADDING-TOP: 5px
}
#toc #content DIV.focus H3 A:link {
	TEXT-DECORATION: none
}
#toc #content DIV.focus H3 A:visited {
	TEXT-DECORATION: none
}
#toc #content DIV.focus H3 SPAN.focus {
	PADDING-LEFT: 18px; MIN-HEIGHT: 13px
}
#toc #content DIV.focus DIV.section {
	MARGIN: 0px
}
#toc #content DIV.focus DIV.section H4 {
	PADDING-RIGHT: 14px; PADDING-LEFT: 14px; FONT-SIZE: 110%; =
PADDING-BOTTOM: 6px; MARGIN: 0px 0px 1em; PADDING-TOP: 6px
}
#toc #content DIV.focus DIV.section DIV.series {
=09
}
#toc #content DIV.focus DIV.section DIV.type {
=09
}
#toc #content DIV.focus DIV.section DIV.series H5 {
	FONT-SIZE: 110%; MARGIN: 0px
}
#toc #content DIV.focus DIV.section DIV.series H5 {
	PADDING-LEFT: 5px
}
#toc #content DIV.focus DIV.section DIV.type H5 {
	PADDING-LEFT: 5px
}
#toc #content DIV.focus DIV.section DIV.series H5 SPAN.series {
	PADDING-LEFT: 29px; MIN-HEIGHT: 13px
}
#toc #content DIV.focus DIV.section DIV.series DIV.article {
	PADDING-LEFT: 14px
}
#toc #content DIV.focus DIV.section DIV.type DIV.article {
	PADDING-LEFT: 14px
}
#toc #content DIV.section DIV.series H4 {
	FONT-SIZE: 110%; MARGIN: 0px 0px 0.5em
}
#toc #content DIV.section DIV.series H4 SPAN.series {
	PADDING-LEFT: 29px; MIN-HEIGHT: 13px
}
#toc #content DIV.orphan.section DIV.article H3 {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 110%; BACKGROUND: none transparent =
scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; =
MARGIN: 0px; TEXT-TRANSFORM: none; PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: =
0px
}
#toc #content DIV.orphan.section DIV.type {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 8px; MARGIN: 0px =
0px 1em; PADDING-TOP: 8px
}
#toc #content DIV.orphan.section DIV.type H4 {
	PADDING-LEFT: 5px
}
#toc #content DIV.orphan.section DIV.type .article {
	MARGIN-LEFT: 0px
}
#toc #content DIV.orphan.section DIV.type .article {
	MARGIN-LEFT: 0px
}
#toc #content DIV.archive-calendar UL {
	PADDING-RIGHT: 15px; PADDING-LEFT: 15px; PADDING-BOTTOM: 10px; MARGIN: =
0px; PADDING-TOP: 10px; LIST-STYLE-TYPE: none
}
#toc #content DIV.archive-calendar UL LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: bold; =
BACKGROUND-IMAGE: none; PADDING-BOTTOM: 0px; LINE-HEIGHT: 100%; =
PADDING-TOP: 0px
}
#toc #content DIV.archive-calendar UL LI:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #toc #content DIV.archive-calendar UL LI {
	HEIGHT: 1%
}
#toc #content DIV.archive-calendar UL UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px
}
#toc #content DIV.archive-calendar UL UL LI {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 0.5em; FONT-WEIGHT: =
normal; FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0.5em 0px 0.5em 0.5em; =
PADDING-TOP: 0px
}
#toc #content DIV.archive-calendar UL UL LI.first {
	PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; MARGIN-LEFT: 0px
}
#toc #content #archiveMonths H2 {
	PADDING-RIGHT: 1em; PADDING-LEFT: 1em; BACKGROUND: none transparent =
scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 1em
}
#toc #content #archiveMonths DIV.spacing {
	MARGIN-BOTTOM: 1em; PADDING-BOTTOM: 1em
}
#toc #content #archiveMonths UL {
	PADDING-RIGHT: 1em; PADDING-LEFT: 1em; PADDING-BOTTOM: 1em; MARGIN: =
0px; PADDING-TOP: 1em; LIST-STYLE-TYPE: none
}
#toc #content #archiveMonths UL:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #toc #content #archiveMonths UL {
	HEIGHT: 1%
}
#toc #content #archiveMonths UL LI {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 0.5em; FONT-WEIGHT: =
normal; BACKGROUND: none transparent scroll repeat 0% 0%; FLOAT: left; =
PADDING-BOTTOM: 0px; MARGIN: 0.5em 0px 0px 0.5em; LINE-HEIGHT: 100%; =
PADDING-TOP: 0px
}
* HTML #toc #content #archiveMonths UL LI {
	LINE-HEIGHT: 110%
}
#toc #content #archiveMonths UL LI.first {
	PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; MARGIN-LEFT: 0px
}
#toc #content #archiveArticles A.backtotop:link {
	FLOAT: right; MARGIN: 5px 3px
}
#toc #content #archiveArticles A.backtotop:visited {
	FLOAT: right; MARGIN: 5px 3px
}
#toc #content #archiveArticles H3 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-SIZE: 110%; PADDING-BOTTOM: =
5px; MARGIN: 0px; PADDING-TOP: 5px
}
#toc #content #archiveArticles H4.type {
	FONT-SIZE: 110%; MARGIN: 0px; TEXT-TRANSFORM: uppercase; COLOR: #999
}
#toc #content #archiveArticles DIV.spacing {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 10px; =
PADDING-TOP: 10px
}
#toc #content #archiveArticles DIV.spacing P.aug {
	MARGIN: 0px; LINE-HEIGHT: 150%; FONT-STYLE: italic
}
#toc #content #archiveArticles DIV.spacing P.doi {
	FONT-SIZE: 110%; MARGIN: 0px 0px 0.5em; LINE-HEIGHT: 150%
}
#toc #content #archiveArticles DIV.spacing UL.article-views:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #toc #content #archiveArticles DIV.spacing UL.article-views {
	HEIGHT: 1%
}
#toc #content #archiveArticles DIV.spacing UL.article-views LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0.5em; MIN-HEIGHT: 12px; FLOAT: left; =
BACKGROUND-IMAGE: none; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 0.5em; =
LINE-HEIGHT: 100%; PADDING-TOP: 0px
}
#toc #content #archiveArticles DIV.spacing UL.article-views LI.first {
	PADDING-LEFT: 18px; BORDER-LEFT-WIDTH: 0px; MARGIN-LEFT: 0px
}
#toc #content #archiveArticles DIV.spacing UL.article-views LI.pdf {
	FONT-WEIGHT: bold
}
#archive #content DIV.archive-views {
	MARGIN-BOTTOM: 1em; PADDING-BOTTOM: 1em
}
#archive #content DIV.archive-views H2 {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 1em; PADDING-LEFT: 1em; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; MARGIN: 1em 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
#archive #content DIV.archive-views UL {
	PADDING-RIGHT: 1em; PADDING-LEFT: 1em; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#archive #content DIV.archive-views UL:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #archive #content DIV.archive-views UL {
	HEIGHT: 1%
}
#archive #content DIV.archive-views UL LI {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 0.5em; FONT-WEIGHT: =
normal; BACKGROUND: none transparent scroll repeat 0% 0%; FLOAT: left; =
PADDING-BOTTOM: 0px; MARGIN: 0.5em 0px 0px 0.5em; LINE-HEIGHT: 100%; =
PADDING-TOP: 0px
}
* HTML #archive #content DIV.archive-views UL LI {
	LINE-HEIGHT: 110%
}
#archive #content DIV.archive-views UL LI.first {
	PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; MARGIN-LEFT: 0px
}
#archive #content UL.vol {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 10px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#archive #content UL.vol:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
#archive #content UL.vol LI {
	PADDING-RIGHT: 3px; PADDING-LEFT: 0px; FLOAT: left; BACKGROUND-IMAGE: =
none; PADDING-BOTTOM: 0px; PADDING-TOP: 10px
}
#archive #content UL.vol DIV {
	FONT-SIZE: 100%; WIDTH: 131px
}
#archive #content UL.vol .month {
	PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-WEIGHT: normal; FONT-SIZE: =
100%; PADDING-BOTTOM: 2px; MARGIN: 0px; PADDING-TOP: 1px
}
#archive #content DIV.box UL.vol .issue-no {
	PADDING-RIGHT: 4px; DISPLAY: block; PADDING-LEFT: 4px; FONT-SIZE: 90%; =
PADDING-BOTTOM: 2px; PADDING-TOP: 1px
}
* HTML #archive #content UL.vol .issue-image {
	MARGIN-BOTTOM: 0px; HEIGHT: 170px
}
#archive #content UL.vol .issue-image {
	DISPLAY: block; FONT-SIZE: 90%; MARGIN: 0px auto; WIDTH: 130px; HEIGHT: =
170px; TEXT-ALIGN: center
}
#archive #content UL.vol .supname {
	PADDING-RIGHT: 4px; PADDING-LEFT: 4px; PADDING-BOTTOM: 2px; MARGIN: =
0px; PADDING-TOP: 1px
}
#archive #content UL.vol .pagerange {
	PADDING-RIGHT: 4px; PADDING-LEFT: 4px; FONT-SIZE: 90%; PADDING-BOTTOM: =
2px; MARGIN: 0px; PADDING-TOP: 1px
}
#archive #content UL.vol .noborder {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#archive #subject-category UL.subject-category {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px
}
#archive #subject-category UL.subject-category LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: none; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px
}
#archive #subject-category UL.subject-category LI H3 {
	DISPLAY: inline
}
#archive #subject-category UL.subject-category LI UL.year {
	DISPLAY: inline
}
#archive #subject-category UL.subject-category LI UL.year LI {
	DISPLAY: inline
}
#archive #subject-category UL.subject-category LI H3 {
	MARGIN-RIGHT: 1em
}
#archive #web-focuses DIV.supp {
	MARGIN: 0px 0px 1em
}
#archive #web-focuses DIV.supp IMG {
	PADDING-RIGHT: 1px; DISPLAY: block; PADDING-LEFT: 1px; FLOAT: left; =
PADDING-BOTTOM: 1px; PADDING-TOP: 1px
}
#archive #web-focuses DIV.supp H3 {
	MARGIN-LEFT: 90px
}
#archive #web-focuses DIV.supp H4 {
	MARGIN-LEFT: 90px
}
#archive #web-focuses DIV.supp P {
	MARGIN-LEFT: 90px
}
#archive #web-focuses DIV.supp H3.type {
	MARGIN-BOTTOM: 0.5em; TEXT-TRANSFORM: uppercase
}
#archive #web-focuses DIV.supp H4.atl {
	MARGIN-TOP: 0px; FONT-WEIGHT: normal; MARGIN-BOTTOM: 0.5em
}
#archive #web-focuses DIV.supp H4.atl SPAN.updated {
	PADDING-LEFT: 1em; TEXT-TRANSFORM: lowercase
}
#archive #web-focuses DIV.supp P.date {
	MARGIN-BOTTOM: 0px; LINE-HEIGHT: 100%
}
#archive #web-focuses DIV.supp P.support {
	MARGIN-BOTTOM: 0px; LINE-HEIGHT: 150%; FONT-STYLE: italic
}
#archive #posters DIV.supp {
	PADDING-RIGHT: 7px; PADDING-LEFT: 7px; PADDING-BOTTOM: 15px; =
PADDING-TOP: 15px
}
#archive #posters DIV.supp H2.atl {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 90px; =
PADDING-TOP: 0px
}
#archive #posters DIV.supp IMG {
	PADDING-RIGHT: 1px; DISPLAY: block; PADDING-LEFT: 1px; FLOAT: left; =
PADDING-BOTTOM: 1px; PADDING-TOP: 1px
}
#archive #posters DIV.supp H2 {
	MARGIN-LEFT: 90px
}
#archive #posters DIV.supp P {
	MARGIN-LEFT: 90px
}
#archive #posters DIV.supp P.aug {
	MARGIN-BOTTOM: 0.5em; LINE-HEIGHT: 150%
}
#archive #posters DIV.supp P.description {
	MARGIN-BOTTOM: 0px; LINE-HEIGHT: 150%
}
#archive #posters DIV.supp P.date {
	MARGIN-BOTTOM: 0px; LINE-HEIGHT: 150%
}
#archive #posters DIV.supp P.support {
	MARGIN-BOTTOM: 0px; FONT-STYLE: italic
}
#toc #content DIV.article P.correspondence {
	MARGIN: 1em 0px; LINE-HEIGHT: 150%
}
DIV.reg-rec UL.toc-pdf {
	MARGIN: 0px
}
DIV.reg-rec UL.toc-pdf LI {
	MARGIN: 10px 0px 0px
}
#toc #content DIV.cover-navigation UL.prev-next {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px
}
#toc #content DIV.cover-navigation UL.prev-next:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #toc #content DIV.cover-navigation UL.prev-next {
	HEIGHT: 1%
}
#toc #content DIV.cover-navigation UL.prev-next LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: =
0px; MARGIN: 0px; WIDTH: 34%; PADDING-TOP: 0px
}
#toc #content DIV.cover-navigation UL.prev-next LI A:link {
	PADDING-RIGHT: 8px; DISPLAY: block; PADDING-LEFT: 8px; PADDING-BOTTOM: =
3px; PADDING-TOP: 3px
}
#toc #content DIV.cover-navigation UL.prev-next LI A:visited {
	PADDING-RIGHT: 8px; DISPLAY: block; PADDING-LEFT: 8px; PADDING-BOTTOM: =
3px; PADDING-TOP: 3px
}
#toc #content DIV.cover-navigation UL.prev-next LI.next A:link {
	TEXT-ALIGN: right
}
#toc #content DIV.cover-navigation UL.prev-next LI.next A:visited {
	TEXT-ALIGN: right
}
#toc #content #archiveMonths H2 {
	BORDER-BOTTOM-WIDTH: 0px! important
}
#subscribe-now #content DIV.container {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; MARGIN-BOTTOM: 2em; =
PADDING-BOTTOM: 10px; PADDING-TOP: 10px
}
#subscribe-now #content DIV.container DIV.column1 {
	PADDING-RIGHT: 1%; FLOAT: left; WIDTH: 48%
}
#subscribe-now #content DIV.container DIV.column2 {
	PADDING-LEFT: 1%; FLOAT: right; WIDTH: 48%
}
#subscribe-now #content .button {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-SIZE: 100%; =
PADDING-BOTTOM: 3px; PADDING-TOP: 3px; FONT-FAMILY: Verdana, Arial, =
Helvetica, sans-serif
}
#subscribe-now #content DIV.box DIV.container .button {
	FONT-SIZE: 110%
}
#subscribe-now #content DIV.container P {
	MARGIN-BOTTOM: 0.5em
}
#subscribe-now #content DIV.container H2 {
	MARGIN-TOP: 0px; TEXT-TRANSFORM: none; COLOR: #000; =
BORDER-BOTTOM-STYLE: none
}
#subscribe-now #content DIV.container H3.first {
	MARGIN-TOP: 0px
}
#subscribe-now #content DIV.container A.register {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; FONT-WEIGHT: bold; =
PADDING-BOTTOM: 3px; PADDING-TOP: 3px; TEXT-DECORATION: none
}
#subscribe-now #content DIV.container SPAN.freeaccount {
	FONT-WEIGHT: bold
}
#about-cover #content DIV.coverimage {
	PADDING-RIGHT: 10px; MARGIN-TOP: 1em; PADDING-LEFT: 10px; =
BORDER-BOTTOM-WIDTH: 0px! important; PADDING-BOTTOM: 10px; PADDING-TOP: =
10px; TEXT-ALIGN: center
}
#about-cover #content DIV.coverimage IMG {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; PADDING-BOTTOM: 1px; WIDTH: =
100%; PADDING-TOP: 1px
}
#about-cover #content DIV.covertext {
	BORDER-TOP-WIDTH: 0px! important; PADDING-RIGHT: 10px; PADDING-LEFT: =
10px; MARGIN-BOTTOM: 2em; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; =
TEXT-ALIGN: left
}
#about-cover #content DIV.covertext P {
	MARGIN: 1em 0px 0px
}
#about-cover #content DIV.covertext P .image-title {
	FONT-STYLE: italic
}
#article #content DIV.box OL.twenty-questions LI {
	FONT-WEIGHT: bold
}
#article #content DIV.box OL.twenty-questions UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article #content DIV.box OL.twenty-questions UL LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-WEIGHT: normal; BACKGROUND: =
none transparent scroll repeat 0% 0%; PADDING-BOTTOM: 0px; PADDING-TOP: =
0px
}
#article #content DIV.box OL.twenty-questions UL LI H6 A:link {
	DISPLAY: block; PADDING-LEFT: 18px; MIN-HEIGHT: 12px
}
#article #content DIV.box OL.twenty-questions UL LI H6 A:visited {
	DISPLAY: block; PADDING-LEFT: 18px; MIN-HEIGHT: 12px
}
#article #content DIV.web-watch UL.web-watch-links {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 10px; =
PADDING-TOP: 10px
}
#article #content DIV.web-watch UL.web-watch-links LI A:link {
	FONT-WEIGHT: bold
}
#article #content DIV.web-watch UL.web-watch-links LI A:visited {
	FONT-WEIGHT: bold
}
#article #content DIV.disease-watch #articlebody DIV.item {
	MARGIN: 0px 0px 1em
}
#article #content DIV.disease-watch #articlebody DIV.item H3 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 20px; PADDING-BOTTOM: 0px; MARGIN: =
1em 0px 0px; PADDING-TOP: 0px
}
#article #content DIV.disease-watch #articlebody DIV.item P {
	MARGIN: 0px 0px 0px 20px
}
#article #content DIV.disease-watch #articlebody DIV.item P.source {
	FONT-WEIGHT: bold
}
#article #content DIV.disease-watch #articlebody DIV.item H4 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; PADDING-BOTTOM: 0px; MARGIN: 1em 0px 0px 20px; =
PADDING-TOP: 0px
}
#article #content DIV.box H2#atl SPAN.label {
	DISPLAY: block; FONT-WEIGHT: bold; FONT-SIZE: 62.5%; MARGIN: 1em 0px =
0.5em; TEXT-TRANSFORM: uppercase
}
#article #content DIV.box P.focus {
	FONT-WEIGHT: bold; FONT-SIZE: 100%; MIN-HEIGHT: 13px; MARGIN: 1em 0px =
0.5em; TEXT-TRANSFORM: uppercase
}
#article #content DIV.box P.series {
	FONT-WEIGHT: bold; FONT-SIZE: 100%; MIN-HEIGHT: 13px; MARGIN: 1em 0px =
0.5em; TEXT-TRANSFORM: uppercase
}
#article #content DIV.box P.focus {
	PADDING-LEFT: 18px
}
#article #content DIV.box P.series {
	PADDING-LEFT: 29px
}
#article #content DIV.box P.focus A:link {
	TEXT-TRANSFORM: none
}
#article #content DIV.box P.focus A:visited {
	TEXT-TRANSFORM: none
}
#article #content DIV.box P.series A:link {
	TEXT-TRANSFORM: none
}
#article #content DIV.box P.series A:visited {
	TEXT-TRANSFORM: none
}
#article #content BLOCKQUOTE.box {
	FLOAT: right; MARGIN: 0px 0px 10px 10px; WIDTH: 180px! important
}
#article #content BLOCKQUOTE.box P.quote {
	MARGIN: 10px
}
#article #content BLOCKQUOTE.box P.quote-source {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; MARGIN-BOTTOM: 0px; =
PADDING-BOTTOM: 5px; PADDING-TOP: 5px; FONT-STYLE: italic
}
#article #content BLOCKQUOTE IMG.quoteleft {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; WIDTH: 12px; MARGIN-RIGHT: 5px; HEIGHT: 10px; BORDER-RIGHT-WIDTH: =
0px
}
#article #content BLOCKQUOTE IMG.quoteright {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MARGIN-LEFT: 5px; WIDTH: 12px; HEIGHT: 10px; BORDER-RIGHT-WIDTH: =
0px
}
#article #content #links {
	MARGIN: 2em 0px
}
#article #content #links H5 {
	FONT-SIZE: 100%; MARGIN: 1em 0px 0.5em; TEXT-TRANSFORM: uppercase
}
#article #content #links H6 {
	MARGIN: 0px 0px 0px 20px
}
#article #content #links P {
	MARGIN-LEFT: 20px
}
#article #content #links .source {
	FONT-STYLE: italic
}
#article #content #links UL {
	MARGIN: 0px 0px 1em 20px
}
#article #content #links UL LI {
	PADDING-RIGHT: 0px; DISPLAY: inline; PADDING-LEFT: 0.75em; =
BORDER-LEFT-WIDTH: 0px! important; BACKGROUND: =
url(/reviews/images/link_line.gif) no-repeat left center; =
PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 0.75em; LINE-HEIGHT: 200%; =
PADDING-TOP: 0px
}
#article #content #links UL LI.first {
	PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; MARGIN-LEFT: 0px
}
#article #content #references-links {
	MARGIN: 2em 0px
}
#article #content #References {
	MARGIN: 2em 0px
}
#article #content #references-links H5 {
	FONT-SIZE: 100%; MARGIN: 0.5em 0px; TEXT-TRANSFORM: uppercase
}
#article #content #references-links OL.references {
	PADDING-RIGHT: 0px; PADDING-LEFT: 30px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px
}
#article #content #References OL.references {
	PADDING-RIGHT: 0px; PADDING-LEFT: 30px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px
}
#article #content #references-links OL.references {
	LIST-STYLE-TYPE: none
}
* HTML #article #content #references-links OL.references {
	PADDING-LEFT: 35px
}
* HTML #article #content #References OL.references {
	PADDING-LEFT: 35px
}
#article #content #references-links OL.references LI {
	LINE-HEIGHT: 125%
}
#article #content #References OL.references LI {
	LINE-HEIGHT: 125%
}
#article #content #references-links OL.references LI P {
	MARGIN: 0px; LINE-HEIGHT: 125%
}
#article #content #References OL.references P {
	MARGIN: 0px; LINE-HEIGHT: 125%
}
#article #content #references-links OL.references LI P.details {
	FONT-WEIGHT: normal
}
#article #content #References OL.references LI P.details {
	FONT-WEIGHT: normal
}
#article #content #references-links OL.references LI P.details .author {
	FONT-WEIGHT: normal
}
#article #content #References OL.references P.details .author {
	FONT-WEIGHT: normal
}
#article #content #references-links OL.references LI UL.article-views {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article #content #References OL.references LI UL.article-views {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article #content #references-links OL.references LI =
UL.article-views:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
#article #content #References OL.references LI UL.article-views:unknown =
{
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #article #content #references-links OL.references LI =
UL.article-views {
	HEIGHT: 1%
}
* HTML #article #content #References OL.references LI UL.article-views {
	HEIGHT: 1%
}
#article #content #references-links OL.references LI UL.article-views LI =
{
	PADDING-RIGHT: 0px; PADDING-LEFT: 1em; FONT-WEIGHT: normal; BACKGROUND: =
none transparent scroll repeat 0% 0%; FLOAT: left; PADDING-BOTTOM: 0px; =
MARGIN: 0px 0px 0px 1em; LINE-HEIGHT: 100%; PADDING-TOP: 0px
}
#article #content #References OL.references LI UL.article-views LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 1em; FONT-WEIGHT: normal; BACKGROUND: =
none transparent scroll repeat 0% 0%; FLOAT: left; PADDING-BOTTOM: 0px; =
MARGIN: 0px 0px 0px 1em; LINE-HEIGHT: 100%; PADDING-TOP: 0px
}
#article #content #references-links OL.references LI UL.article-views =
LI.first {
	BORDER-TOP-WIDTH: 0px; PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; =
BORDER-BOTTOM-WIDTH: 0px; MARGIN-LEFT: 0px; BORDER-RIGHT-WIDTH: 0px
}
#article #content #References OL.references LI UL.article-views LI.first =
{
	BORDER-TOP-WIDTH: 0px; PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; =
BORDER-BOTTOM-WIDTH: 0px; MARGIN-LEFT: 0px; BORDER-RIGHT-WIDTH: 0px
}
#article #content #affiliations-notes {
	MARGIN: 2em 0px
}
#article #content #affiliations-notes OL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 20px; FONT-WEIGHT: bold; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px
}
* HTML #article #content #affiliations-notes OL {
	PADDING-LEFT: 25px
}
#article #content #affiliations-notes OL LI {
	FONT-WEIGHT: normal; FONT-SIZE: 110%
}
#article #content #affiliations-notes OL LI LI {
	FONT-SIZE: 100%
}
#article #content #prev-next {
	MARGIN: 2em 0px 0px
}
#article #content #prev-next UL.prev-next {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article #content #prev-next UL.prev-next:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #article #content #prev-next UL.prev-next {
	HEIGHT: 1%
}
#article #content #prev-next UL.prev-next LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0px; =
WIDTH: 49%; PADDING-TOP: 0px
}
#article #content #prev-next UL.prev-next LI.next {
	FLOAT: right
}
#article #content #prev-next UL.prev-next LI A {
	PADDING-RIGHT: 0px; DISPLAY: block; PADDING-LEFT: 0px; PADDING-BOTTOM: =
0px; PADDING-TOP: 0px
}
#article #content #prev-next UL.prev-next LI.next A:link {
	PADDING-RIGHT: 15px; TEXT-ALIGN: right
}
#article #content #prev-next UL.prev-next LI.next A:visited {
	PADDING-RIGHT: 15px; TEXT-ALIGN: right
}
#article #content #prev-next UL.prev-next LI.prev A:link {
	PADDING-LEFT: 15px
}
#article #content #prev-next UL.prev-next LI.prev A:visited {
	PADDING-LEFT: 15px
}
#article #content P.correspondence {
	MARGIN: 1em 0px; COLOR: #8a8a8a; LINE-HEIGHT: 150%
}
#article #content DIV.correspondence P.correspondence {
	MARGIN: 0px 0px 1.7em
}
#article H1.page-header {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
#article #content DIV.correspondence.box #parent {
	BORDER-RIGHT: #e7e7e7 1px solid; PADDING-RIGHT: 6px; BORDER-TOP: =
#e7e7e7 1px solid; PADDING-LEFT: 6px; FONT-WEIGHT: normal; FONT-SIZE: =
110%; BACKGROUND: #f5f5f5; PADDING-BOTTOM: 8px; TEXT-TRANSFORM: none; =
BORDER-LEFT: #e7e7e7 1px solid; COLOR: #000; PADDING-TOP: 8px; =
BORDER-BOTTOM: #e7e7e7 1px solid
}
#article #content DIV.correspondence.box #parent SPAN.label {
	FONT-WEIGHT: bold
}
#article #content P.see-also {
	MARGIN: 1em 0px 0px; COLOR: #c03; LINE-HEIGHT: 150%
}
#article #content DIV.correspondence.box .corres-title {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 0px; FONT-SIZE: 150%; BACKGROUND: =
none transparent scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 0px; MARGIN: 20px 0px 0px; PADDING-TOP: 0px; =
BORDER-RIGHT-WIDTH: 0px
}
#home #content DIV.details {
	FLOAT: right; MARGIN-BOTTOM: 2em; WIDTH: 48%
}
#home #content DIV.details H2 {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: none transparent =
scroll repeat 0% 0%; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; =
COLOR: #000; PADDING-TOP: 0px
}
#home #content DIV.details DIV.featured-article {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 7px; MARGIN: =
0px 0px 2em; PADDING-TOP: 7px
}
#home #content DIV.details DIV.featured-article H3 {
	TEXT-TRANSFORM: uppercase
}
#home #content DIV.details DIV.featured-article P.aug {
	MARGIN: 1em 0px 0px; LINE-HEIGHT: 125%; FONT-STYLE: italic
}
#home #content DIV.details DIV.goto {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 5px
}
#home #content DIV.details DIV.goto UL {
	MARGIN-BOTTOM: 0px
}
#home #content DIV.details DIV.goto UL LI {
	PADDING-LEFT: 17px; FONT-WEIGHT: bold; MARGIN-BOTTOM: 0.5em
}
#home #content DIV.cover-navigation {
	FLOAT: left; WIDTH: 48%
}
#home #content DIV.cover-navigation IMG.journal-cover {
	PADDING-RIGHT: 1px; DISPLAY: block; PADDING-LEFT: 1px; PADDING-BOTTOM: =
1px; PADDING-TOP: 1px
}
#home #content .wrapper .column1 {
	FLOAT: left; WIDTH: 48%
}
#home #content .wrapper .column2 {
	FLOAT: right; WIDTH: 48%
}
#home #content DIV.box-item {
	MARGIN-BOTTOM: 2em
}
#home #content DIV.box-item H3 {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; MARGIN: =
0px; TEXT-TRANSFORM: uppercase; PADDING-TOP: 5px
}
#home #content DIV.box-item H4 {
	PADDING-RIGHT: 5px; PADDING-LEFT: 20px; PADDING-BOTTOM: 5px; MARGIN: =
0px 0px 1em; PADDING-TOP: 5px
}
#home #content DIV.box-item H4 A:link {
	TEXT-DECORATION: none
}
#home #content DIV.box-item H4 A:visited {
	TEXT-DECORATION: none
}
#home #content DIV.box-item H4 A:hover {
	TEXT-DECORATION: none
}
#home #content DIV.box-item H4 A:focus {
	TEXT-DECORATION: none
}
#home #content DIV.box-item IMG.illustration {
	PADDING-RIGHT: 1px; PADDING-LEFT: 1px; FLOAT: left; PADDING-BOTTOM: =
1px; MARGIN: 0px 5px 5px; PADDING-TOP: 1px
}
#home #content DIV.box-item H5.atl {
	MARGIN: 0px 5px 1em 0px
}
#home #content DIV.box-item H6.atl {
	MARGIN: 0px 5px 1em 0px
}
#home #content DIV.research-highlights H5 {
	MARGIN: 0px 5px 1em
}
#home #content DIV.research-highlights H6 {
	MARGIN: 0px 5px 1em
}
#home #content DIV.box-item P {
	MARGIN: 0px 5px 1em
}
#home #content DIV.box-item P.aug {
	MARGIN-TOP: 0.5em; LINE-HEIGHT: 125%; FONT-STYLE: italic
}
#home #content DIV.box-item UL {
	MARGIN: 0px 5px
}
#home #content DIV.box-item UL LI {
	PADDING-LEFT: 0px; BACKGROUND-IMAGE: none; MARGIN-BOTTOM: 2em
}
#home #content DIV.box-item UL LI H5 {
	MARGIN: 0px
}
#home #content DIV.box-item UL LI H6 {
	MARGIN: 0px
}
#home #content DIV.box-item UL.more-in-field {
	MARGIN-TOP: 1em
}
#home #content DIV.box-item UL.more-in-field LI {
	MARGIN-BOTTOM: 0px; WIDTH: 48%
}
#home #content DIV.box-item UL.more-in-field LI UL LI {
	WIDTH: auto
}
#home #content DIV.box-item UL.more-in-field LI.odd {
	FLOAT: left
}
#home #content DIV.box-item UL.more-in-field LI.even {
	FLOAT: right
}
#home #content DIV.box-item UL.more-in-field LI H4 {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; MARGIN-BOTTOM: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
#home #content DIV.box-item DIV.illustrated H4 {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: none transparent scroll repeat 0% =
0%; BORDER-BOTTOM-WIDTH: 0px; MARGIN-BOTTOM: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 0px
}
#home #content DIV.box-item UL.more-in-field LI H4 A:link {
	TEXT-DECORATION: underline
}
#home #content DIV.box-item UL.more-in-field LI H4 A:visited {
	TEXT-DECORATION: underline
}
#home #content DIV.box-item DIV.illustrated H4 A:link {
	TEXT-DECORATION: underline
}
#home #content DIV.box-item DIV.illustrated H4 A:visited {
	TEXT-DECORATION: underline
}
#home #content DIV.box-item UL.more-in-field LI P {
	MARGIN: 0px 0px 1em
}
#home #content DIV.box-item DIV.illustrated P {
	MARGIN: 0px 0px 1em
}
#home #content DIV.box-item DIV.illustrated {
	MARGIN: 1em 5px
}
#home #content P.fn {
	PADDING-LEFT: 10px; BACKGROUND: url(/reviews/images/asterisk.gif) =
no-repeat 0px 0.5em; COLOR: #b4b4b4
}
#home #content .last-update {
	MARGIN: 0px; COLOR: #b4b4b4; TEXT-ALIGN: center
}
#article-related DIV.box H3.article-name {
	MARGIN: 1em 0px 0px
}
#article-related DIV.box P.author {
	FONT-WEIGHT: normal
}
#article-related DIV.box P.sent-to {
	FONT-WEIGHT: bold; MARGIN: 0px
}
#article-related DIV.box P.with {
	FONT-WEIGHT: bold; MARGIN: 0px
}
#article #content #articlebody UL.article-views {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 1em; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#article #content #articlebody UL.article-views:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #article #content #articlebody UL.article-views {
	HEIGHT: 1%
}
#article #content #articlebody UL.article-views LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 1em; FONT-WEIGHT: normal; BACKGROUND: =
none transparent scroll repeat 0% 0%; FLOAT: left; PADDING-BOTTOM: 0px; =
MARGIN: 0px 0px 0px 1em; LINE-HEIGHT: 100%; PADDING-TOP: 0px
}
#article #content #articlebody UL.article-views LI.first {
	BORDER-TOP-WIDTH: 0px; PADDING-LEFT: 0px; BORDER-LEFT-WIDTH: 0px; =
BORDER-BOTTOM-WIDTH: 0px; MARGIN-LEFT: 0px; BORDER-RIGHT-WIDTH: 0px
}
#home #content DIV.web-focus IMG.web-focus {
	DISPLAY: block; FONT-SIZE: 110%; MARGIN: 0px 0px 1em
}
#home #content DIV.web-focus H4 {
	MARGIN-BOTTOM: 0px
}
#toc #content DIV.section DIV.type H4 SPAN.focus {
	PADDING-RIGHT: 45px; MIN-HEIGHT: 13px; BACKGROUND: =
url(/reviews/images/graphics/icon.focus-article.gif) no-repeat right =
center
}
* HTML #article-related TABLE.data TBODY TD SUP {
	FONT-SIZE: 120%! important
}
* HTML #article-related TABLE.data TBODY TD SUB {
	FONT-SIZE: 120%! important
}
* HTML #article-related TABLE.data TBODY TD super {
	FONT-SIZE: 120%! important
}
#content H1.topten {
	PADDING-LEFT: 10px; BACKGROUND: #fff
}
#content P.topten {
	PADDING-LEFT: 10px; FONT-SIZE: 110%; BACKGROUND: #fff; MARGIN: 0px 0px =
1em; LINE-HEIGHT: 190%
}
#content H2.topten {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 7px; PADDING-LEFT: 7px; =
BORDER-LEFT-WIDTH: 0px; BACKGROUND: #e7e7e7; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 3px; PADDING-TOP: 3px; BORDER-RIGHT-WIDTH: 0px
}
#content .topten.backtotop {
	PADDING-RIGHT: 17px; BACKGROUND-POSITION: 99% center; DISPLAY: block; =
PADDING-LEFT: 17px; FLOAT: none; PADDING-BOTTOM: 3px; MARGIN: 0px; =
PADDING-TOP: 3px; BACKGROUND-COLOR: #e7e7e7; TEXT-ALIGN: right
}
* HTML #content OL.topten {
	TEXT-ALIGN: left
}
#content OL.topten {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: #ffffff; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: =
none
}
#content OL.topten LI.topten_1 {
	BACKGROUND: url(/common/images/topten/01.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_2 {
	BACKGROUND: url(/common/images/topten/02.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_3 {
	BACKGROUND: url(/common/images/topten/03.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_4 {
	BACKGROUND: url(/common/images/topten/04.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_5 {
	BACKGROUND: url(/common/images/topten/05.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_6 {
	BACKGROUND: url(/common/images/topten/06.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_7 {
	BACKGROUND: url(/common/images/topten/07.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_8 {
	BACKGROUND: url(/common/images/topten/08.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_9 {
	BACKGROUND: url(/common/images/topten/09.gif) no-repeat 98.5% 10px
}
#content OL.topten LI.topten_10 {
	BACKGROUND: url(/common/images/topten/10.gif) no-repeat 98.5% 10px
}
#content OL.topten {
	PADDING-RIGHT: 0px; BORDER-TOP: #e7e7e7 1px solid; PADDING-LEFT: 0px; =
BACKGROUND: #ffffff; PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px; =
LIST-STYLE-TYPE: none
}
#content OL.topten .spacing {
	PADDING-RIGHT: 7px; PADDING-LEFT: 7px; PADDING-BOTTOM: 7px; MARGIN: =
0px; PADDING-TOP: 7px; BORDER-BOTTOM: #e7e7e7 1px solid
}
#content OL.topten .subject {
	BORDER-BOTTOM-WIDTH: 0px; MARGIN: 0px 0px 5px
}
#content OL.topten {
	PADDING-RIGHT: 10px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; MARGIN: =
1em 0px; PADDING-TOP: 0px
}
#content OL.topten H2 {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-SIZE: 110%; PADDING-BOTTOM: =
5px; MARGIN: 0px 0px 1em; PADDING-TOP: 5px
}
#content OL.topten H3 {
	FONT-SIZE: 110%; MARGIN: 0px 0px 0.5em
}
#content OL.topten H4 {
	FONT-SIZE: 110%; MARGIN: 1em 0px 0px
}
#content OL.topten H5 {
	FONT-SIZE: 110%; MARGIN: 1em 0px 0px
}
#content OL.topten H6 {
	FONT-SIZE: 110%; MARGIN: 1em 0px 0px
}
#content OL.topten UL LI H2 {
	FONT-SIZE: 100%
}
#content OL.topten UL LI H3 {
	FONT-SIZE: 100%
}
#content OL.topten UL LI H4 {
	FONT-SIZE: 100%
}
#content OL.topten UL LI H5 {
	FONT-SIZE: 100%
}
#content OL.topten UL LI H6 {
	FONT-SIZE: 100%
}
#content OL.topten H3.emphasize {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; PADDING-BOTTOM: 5px; MARGIN: 0px =
0px 1em; PADDING-TOP: 5px
}
#content OL.topten H3 .label {
	DISPLAY: block
}
#content OL.topten P {
	FONT-SIZE: 110%; MARGIN: 0px 0px 1em; LINE-HEIGHT: 190%
}
#content OL.topten UL LI P {
	FONT-SIZE: 100%
}
#article #extranav #articlenav UL LI.commercial_reprints {
	BACKGROUND: url(/reviews/images/icons/ocr.gif) no-repeat 5px 0px
}
DIV.reg-rec UL LI.ja A {
	BACKGROUND: url(/common/images/icons/fff/japanese.gif) no-repeat 0px =
0.1em
}
DIV.reg-rec UL LI.en A {
	BACKGROUND: url(/common/images/icons/all/english.gif) no-repeat 0px 0px
}
#article #extranav #articlenav UL LI.sermo {
	MARGIN-TOP: 0px; PADDING-LEFT: 0px; BACKGROUND-IMAGE: none; =
MARGIN-LEFT: 0px; PADDING-TOP: 0px
}
#articlenav LI.sermo IMG {
	MARGIN-LEFT: 5px; VERTICAL-ALIGN: middle
}
#articlenav LI.sermo FORM {
	PADDING-RIGHT: 0px! important; PADDING-LEFT: 0px! important; =
PADDING-BOTTOM: 0px! important; MARGIN: 0px; PADDING-TOP: 0px! important
}
#article #extranav #articlenav UL LI.sermo A {
	PADDING-RIGHT: 0px; DISPLAY: inline; PADDING-LEFT: 0px; PADDING-BOTTOM: =
0px; MARGIN: 0px 0px 0px 6px; PADDING-TOP: 0px
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/nrc/style/site.css

#hdr .user-services .li1 A {
	BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_account_grey.gif)
}
#hdr .user-services .li2 A {
	BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_ealert_grey.gif)
}
#hdr .user-services .li3 A {
	BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_register_grey.gif)
}
#hdr .user-services .li4 A {
	BACKGROUND-IMAGE: =
url(/common/includes/header/images/icons/01/icon_subscribe_grey.gif)
}
#head-er .image-user-services-wrap {
	BACKGROUND-COLOR: #007c88
}
#head-er .image-user-services IMG.journal-header {
	MARGIN: 0px; WIDTH: 276px; HEIGHT: 74px
}
#head-er .image-user-services {
=09
}
#head-er .user-services A:link {
	BACKGROUND: url(/common/images/icons/fff/arrow_s.gif) #000 no-repeat =
right center
}
#head-er .user-services A:visited {
	BACKGROUND: url(/common/images/icons/fff/arrow_s.gif) #000 no-repeat =
right center
}
#head-er .user-services A:hover {
	BACKGROUND: url(/common/images/icons/fff/arrow_s.gif) #666 no-repeat =
right center
}
#head-er .user-services A:focus {
	BACKGROUND: url(/common/images/icons/fff/arrow_s.gif) #666 no-repeat =
right center
}
A:link {
	COLOR: #007d7b
}
A:visited {
	COLOR: #007d7b
}
A:hover {
	COLOR: #c03
}
A:focus {
	COLOR: #c03
}
#breadcrumb DIV A:link {
	COLOR: #007d7b
}
#breadcrumb DIV A:visited {
	COLOR: #007d7b
}
#content {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 1px solid
}
MAP.journal-nav UL {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
MAP.journal-nav UL LI {
	BORDER-BOTTOM: #fff 1px solid
}
MAP.journal-nav UL LI.menu-heading {
	BACKGROUND: #fff
}
MAP.journal-nav UL LI A:link {
	COLOR: #000; BACKGROUND-COLOR: #c8d9db
}
MAP.journal-nav UL LI A:visited {
	COLOR: #000; BACKGROUND-COLOR: #c8d9db
}
MAP.journal-nav UL LI A:hover {
	COLOR: #fff; BACKGROUND-COLOR: #007d8c
}
MAP.journal-nav UL LI A:focus {
	COLOR: #fff; BACKGROUND-COLOR: #007d8c
}
MAP.journal-nav UL LI.selected A:link {
	COLOR: #fff; BACKGROUND-COLOR: #007d8c
}
MAP.journal-nav UL LI.selected A:visited {
	COLOR: #fff; BACKGROUND-COLOR: #007d8c
}
MAP.supplementary.journal-nav UL LI A.onsub:link {
	BACKGROUND: url(/common/images/online_submissions.gif) #e0e9e9 =
no-repeat left center
}
MAP.supplementary.journal-nav UL LI A.onsub:visited {
	BACKGROUND: url(/common/images/online_submissions.gif) #e0e9e9 =
no-repeat left center
}
MAP.supplementary.journal-nav UL LI A.onsub:hover {
	BACKGROUND-COLOR: #007d8c
}
MAP.supplementary.journal-nav UL LI A.onsub:focus {
	BACKGROUND-COLOR: #007d8c
}
MAP.supplementary.journal-nav UL LI A.e-alerts:link {
	PADDING-LEFT: 23px; BACKGROUND: url(/reviews/images/icons/signup.gif) =
#c8d9db no-repeat 5px 7px
}
MAP.supplementary.journal-nav UL LI A.e-alerts:visited {
	PADDING-LEFT: 23px; BACKGROUND: url(/reviews/images/icons/signup.gif) =
#c8d9db no-repeat 5px 7px
}
MAP.supplementary.journal-nav UL LI A.e-alerts:hover {
	PADDING-LEFT: 23px; BACKGROUND: url(/reviews/images/icons/signup.gif) =
#007d8c no-repeat 5px 7px
}
MAP.journal-nav UL LI UL.subnav LI {
	BORDER-TOP: #fff 1px solid
}
MAP.journal-nav UL LI UL.subnav A:link {
	BACKGROUND: url(/nrc/images/graphics/bg.subnav.gif) #efefef no-repeat =
11px 5px
}
MAP.journal-nav UL LI UL.subnav A:visited {
	BACKGROUND: url(/nrc/images/graphics/bg.subnav.gif) #efefef no-repeat =
11px 5px
}
MAP.journal-nav UL LI UL.subnav A:hover {
	BACKGROUND: url(/nrc/images/graphics/bg.subnav.gif) #d0d0d7 no-repeat =
11px 5px; COLOR: #000
}
MAP.journal-nav UL LI UL.subnav A:focus {
	BACKGROUND: url(/nrc/images/graphics/bg.subnav.gif) #d0d0d7 no-repeat =
11px 5px; COLOR: #000
}
MAP.journal-nav UL LI UL.subnav LI.selected A:link {
	BACKGROUND: url(/nrc/images/graphics/bg.subnav.gif) #d0d0d7 no-repeat =
11px 5px; COLOR: #000
}
MAP.journal-nav UL LI UL.subnav LI.selected A:visited {
	BACKGROUND: url(/nrc/images/graphics/bg.subnav.gif) #d0d0d7 no-repeat =
11px 5px; COLOR: #000
}
DIV.reg-rec {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
DIV.reg-rec UL {
	BACKGROUND: #e0e9e9
}
DIV.reg-rec UL LI A:link {
	COLOR: #000
}
DIV.reg-rec UL LI A:visited {
	COLOR: #000
}
DIV.reg-rec UL LI A:hover {
	COLOR: #000
}
DIV.reg-rec UL LI A:focus {
	COLOR: #000
}
.box#natjob {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
.box#natjob H2.natjob {
	BACKGROUND: #d8d8d8
}
.box#natjob UL.natjob LI H3 A:link {
	COLOR: #007d7b
}
.box#natjob UL.natjob LI H3 A:visited {
	COLOR: #007d7b
}
.box#natjob UL.natjob LI H3 A:hover {
	COLOR: #c03
}
.box#natjob UL.natjob LI H3 A:focus {
	COLOR: #c03
}
.box#natjob DIV.natjobmore {
	BORDER-TOP: #cecfce 1px solid
}
.box#natjob DIV.natjobmore A:link {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat left center; =
COLOR: #007d7b
}
.box#natjob DIV.natjobmore A:visited {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat left center; =
COLOR: #007d7b
}
.box#natjob DIV.natjobmore A:hover {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif); COLOR: #c03
}
.box#natjob DIV.natjobmore A:focus {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif); COLOR: #c03
}
.box#natprod {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
.box#natprod H2.natprod {
	BACKGROUND: #d8d8d8
}
DIV.ad-rh {
	BACKGROUND: #fff
}
DIV.ad-rh P {
	COLOR: #cccccb
}
.page-heading H1 {
	COLOR: #000; PADDING-TOP: 0px
}
.page-heading H1.series {
	BACKGROUND: url(/nrc/images/graphics/bg.icon.series.jpg) no-repeat left =
center
}
#content DIV.box H2 {
	PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: 130%; PADDING-BOTTOM: =
0px; TEXT-TRANSFORM: uppercase; COLOR: #bd153b; PADDING-TOP: 10px; =
BORDER-BOTTOM: #e3e3e3 1px solid
}
#content DIV.box H3 {
	COLOR: #000
}
#content DIV.box H3.emphasize {
	FONT-WEIGHT: bold; FONT-SIZE: 130%; PADDING-BOTTOM: 0px; =
TEXT-TRANSFORM: uppercase; COLOR: #bd153b; PADDING-TOP: 10px; =
BORDER-BOTTOM: #e3e3e3 1px solid
}
#content DIV.box H3 .label {
	COLOR: #8a8c9f
}
#content DIV.box A.pdf:link {
	BORDER-RIGHT: #c1bfc1 1px solid; BORDER-TOP: #c1bfc1 1px solid; =
BORDER-LEFT: #c1bfc1 1px solid; COLOR: #000; BORDER-BOTTOM: #c1bfc1 1px =
solid
}
#content DIV.box A.pdf:visited {
	BORDER-RIGHT: #c1bfc1 1px solid; BORDER-TOP: #c1bfc1 1px solid; =
BORDER-LEFT: #c1bfc1 1px solid; COLOR: #000; BORDER-BOTTOM: #c1bfc1 1px =
solid
}
#content DIV.box A.rss:link {
	BORDER-RIGHT: #c1bfc1 1px solid; BORDER-TOP: #c1bfc1 1px solid; =
BORDER-LEFT: #c1bfc1 1px solid; COLOR: #000; BORDER-BOTTOM: #c1bfc1 1px =
solid
}
#content DIV.box A.visited.rss {
	BORDER-RIGHT: #c1bfc1 1px solid; BORDER-TOP: #c1bfc1 1px solid; =
BORDER-LEFT: #c1bfc1 1px solid; COLOR: #000; BORDER-BOTTOM: #c1bfc1 1px =
solid
}
#content DIV.box UL LI {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.gif) no-repeat =
0px 0.5em
}
#content DIV.box UL.page-link-list LI {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-down.gif) no-repeat =
0px 0.6em
}
#content DIV.box UL.page-nolink-list LI {
	BACKGROUND: url(/nrc/images/graphics/bullet_no_link.gif) no-repeat 0px =
0.4em
}
#content DIV.box UL.anchor-list LI {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-down.gif) #e0e9e9 =
no-repeat 10px 50%
}
#content DIV.box OL.conference-list H3 {
	FONT-WEIGHT: bold; FONT-SIZE: 130%; PADDING-BOTTOM: 0px; =
TEXT-TRANSFORM: uppercase; COLOR: #bd153b; PADDING-TOP: 20px; =
BORDER-BOTTOM: #e3e3e3 1px solid
}
#content DIV.box DL.faq-list DT {
	BACKGROUND: url(/nrc/images/graphics/icon.faq.question.gif) no-repeat =
left top
}
#content DIV.box DL.faq-list DD {
	BACKGROUND: url(/nrc/images/graphics/icon.faq.answer.gif) no-repeat =
left top
}
#content DIV.box H3.address-type-heading {
	COLOR: #8a8c9f
}
#content DIV.box H4.address-type-heading {
	COLOR: #8a8c9f
}
#content DIV.box H5.address-type-heading {
	COLOR: #8a8c9f
}
#content DIV.box H6.address-type-heading {
	COLOR: #8a8c9f
}
TABLE.data {
	BORDER-RIGHT: #d0d0d0 1px solid; BORDER-TOP: #d0d0d0 1px solid; =
BORDER-LEFT: #d0d0d0 1px solid; BORDER-BOTTOM: #d0d0d0 1px solid
}
TABLE.data CAPTION {
	BORDER-RIGHT: #d0d0d0 1px solid; BORDER-TOP: #d0d0d0 1px solid; =
FONT-WEIGHT: bold; BORDER-LEFT: #d0d0d0 1px solid; BORDER-BOTTOM: =
#d0d0d0 1px solid
}
TABLE.data THEAD TR {
	BACKGROUND: #e7e6ec
}
TABLE.data TBODY TR.even {
	BACKGROUND: #f5f5f5
}
TABLE.data TFOOT TR {
	BORDER-TOP: #d0d0d0 1px solid
}
#article #content DIV.box #cite {
	COLOR: #7c7c7c
}
#article #content DIV.box #aug {
	COLOR: #8a8a8a
}
#article #content DIV.box H3 {
	BACKGROUND: #fff
}
#article #content DIV.box H4 {
	BACKGROUND: #fff
}
#article #content DIV.box DIV.figure-table {
	BORDER-RIGHT: #e0e0e0 1px solid; BORDER-TOP: #e0e0e0 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e0e0e0 1px solid; BORDER-BOTTOM: =
#e0e0e0 1px solid
}
#article #content DIV.box DIV.figure-table UL.options LI.full {
	BACKGROUND: url(/reviews/images/icons/full_figure.gif) no-repeat left =
center
}
#article #content DIV.box DIV.figure-table UL.options LI.fti {
	BACKGROUND: url(/reviews/images/icons/full_figure.gif) no-repeat left =
center
}
#article #content DIV.box DIV.figure-table UL.options LI.high-res {
	BACKGROUND: url(/reviews/images/icons/highres.gif) no-repeat left =
center
}
#article #content DIV.box DIV.figure-table UL.options LI.powerpoint {
	BACKGROUND: url(/reviews/images/icons/ppt.gif) no-repeat left top
}
#article #content DIV.box DIV.figure-table UL.options LI.chemdraw {
	BACKGROUND: url(/nrc/images/graphics/icon.16x16.chemdraw.gif) no-repeat =
left top
}
#article #extranav #articlenav {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
#article #extranav #articlenav H2 {
	BACKGROUND: #cedbde; COLOR: #000
}
#article #extranav #articlenav UL.view-tools {
	BORDER-TOP: #d8d8d8 1px solid
}
#article #extranav #articlenav UL LI {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-down.gif) no-repeat =
5px 50%
}
#article #extranav #articlenav UL.view-tools LI {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.gif) no-repeat =
5px 0.6em
}
#article #extranav #articlenav UL LI.download-pdf {
	BACKGROUND: url(/reviews/images/icons/pdf.gif) no-repeat 5px 0px
}
#article #extranav #articlenav UL LI.sendtofriend {
	BACKGROUND: url(/reviews/images/icons/send.gif) no-repeat 5px 0.5em
}
#article #extranav #articlenav UL LI.export {
	BACKGROUND: url(/reviews/images/icons/export.gif) no-repeat 5px 0px
}
#article #extranav #articlenav UL LI.permissions {
	BACKGROUND: url(/reviews/images/icons/reprints.gif) no-repeat 5px 0px
}
#article #extranav #articlenav UL LI.commercial_reprints {
	BACKGROUND: url(/reviews/images/icons/ocr.gif) no-repeat 5px 0px
}
#article #extranav #articlenav UL LI.save {
	BACKGROUND: url(/reviews/images/icons/savelink.gif) no-repeat 5px 0px
}
#article #extranav #articlenav UL LI.toc {
	BACKGROUND: url(/reviews/images/icons/toc.gif) no-repeat 5px 50%
}
#article #extranav #articlenav UL LI.prev {
	BACKGROUND: url(/common/images/icons/back.gif) no-repeat 5px 50%
}
#article #extranav #articlenav UL LI.next {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat 5px 50%
}
#article #extranav #search-pubmed {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
#article #extranav #search-pubmed H2 {
	BACKGROUND: #d8d8d8; COLOR: #000
}
#article #extranav #search-pubmed LI {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.gif) no-repeat =
5px 0.5em
}
#article #extranav #search-pubmed LI.more {
	BORDER-TOP: #cecfce 1px solid
}
#article #extranav #search-pubmed LI.more A:link {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat left center; =
COLOR: #684a94
}
#article #extranav #search-pubmed LI.more A:visited {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat left center; =
COLOR: #684a94
}
#article #extranav #search-pubmed LI.more A:hover {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif); COLOR: #c03
}
#article #extranav #search-pubmed LI.more A:focus {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif); COLOR: #c03
}
#article #content DIV.poster.box IMG.poster-graphic {
	BORDER-RIGHT: #ccc 1px solid; BORDER-TOP: #ccc 1px solid; BORDER-LEFT: =
#ccc 1px solid; BORDER-BOTTOM: #ccc 1px solid
}
#article-related DIV.box .container-cite H2.note {
	COLOR: #8a8a8a
}
#article-related DIV.box .container-cite P.journal {
	COLOR: #7c7c7c
}
#article-related DIV.box .container-cite P.doi {
	COLOR: #7c7c7c
}
#article-related DIV.box .container-image {
	BORDER-RIGHT: #e0e0e0 1px solid; BORDER-TOP: #e0e0e0 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e0e0e0 1px solid; BORDER-BOTTOM: =
#e0e0e0 1px solid
}
#article-related DIV.box .container-image-text {
	BORDER-RIGHT: #e0e0e0 1px solid; BORDER-TOP: #e0e0e0 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e0e0e0 1px solid; BORDER-BOTTOM: =
#e0e0e0 1px solid
}
#article-related DIV.ar-navigation UL LI.back {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-left.gif) no-repeat =
left center
}
#article-related DIV.ar-navigation UL LI.next {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.gif) no-repeat =
right center
}
#article-related DIV.ar-navigation UL LI.down {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-down.gif) no-repeat =
left center
}
#article-related DIV.container-figtab {
	BORDER-RIGHT: #e0e0e0 1px solid; BACKGROUND: #f5f5f5; BORDER-LEFT: =
#e0e0e0 1px solid
}
#article-related DIV.first.container-figtab {
	BORDER-TOP: #e0e0e0 1px solid
}
#article-related DIV.last.container-figtab {
	BORDER-BOTTOM: #e0e0e0 1px solid
}
#article-related DIV.container-figtab DIV.container-image A IMG {
	BORDER-RIGHT: #ccc 1px solid; BORDER-TOP: #ccc 1px solid; BORDER-LEFT: =
#ccc 1px solid; BORDER-BOTTOM: #ccc 1px solid
}
#article-related DIV.container-figtab UL.options LI.full {
	BACKGROUND: url(/reviews/images/icons/full_figure.gif) no-repeat left =
top
}
#article-related DIV.container-image-text UL.options LI.full {
	BACKGROUND: url(/reviews/images/icons/full_figure.gif) no-repeat left =
top
}
#article-related DIV.container-figtab UL.options LI.powerpoint {
	BACKGROUND: url(/reviews/images/icons/ppt.gif) no-repeat left top
}
#article-related DIV.container-image-text UL.options LI.powerpoint {
	BACKGROUND: url(/reviews/images/icons/ppt.gif) no-repeat left top
}
#article-related DIV.container-figtab UL.options LI.chemdraw {
	BACKGROUND: url(/nrc/images/graphics/icon.16x16.chemdraw.gif) no-repeat =
left top
}
#article-related DIV.container-image-text UL.options LI.chemdraw {
	BACKGROUND: url(/nrc/images/graphics/icon.16x16.chemdraw.gif) no-repeat =
left top
}
#article-related DIV.box .container-table {
	BORDER-RIGHT: #e0e0e0 1px solid; BORDER-TOP: #e0e0e0 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e0e0e0 1px solid; BORDER-BOTTOM: =
#e0e0e0 1px solid
}
#article-related DIV.box .container-image-box {
	BORDER-RIGHT: #e0e0e0 1px solid; BORDER-TOP: #e0e0e0 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e0e0e0 1px solid; BORDER-BOTTOM: =
#e0e0e0 1px solid
}
#article-related TABLE.data {
	BORDER-TOP: #e0e0e0 1px solid; BORDER-LEFT: #d0d0d0 1px solid
}
#article-related TABLE.data THEAD TH {
	BORDER-RIGHT: #fff 1px solid; BACKGROUND: #cedbde; BORDER-BOTTOM: =
#d0d0d0 1px solid
}
#article-related TABLE.data THEAD TH.last {
	BORDER-BOTTOM-COLOR: #e7e7e7; BORDER-RIGHT-COLOR: #e7e7e7
}
#article-related TABLE.data TFOOT TD {
	BORDER-RIGHT: #fff 1px solid; BACKGROUND: #fff; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
#article-related TABLE.data TFOOT TD.last {
	BORDER-RIGHT-COLOR: #e7e7e7
}
#article-related TABLE.data TBODY TR {
	BACKGROUND: #f5f5f5
}
#article-related TABLE.data TBODY TR.odd {
	BACKGROUND: #f5f5f5
}
#article-related TABLE.data TBODY TH {
	BORDER-RIGHT: #fff 1px solid; BACKGROUND: #fff; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
#article-related TABLE.data TBODY TH.last {
	BORDER-RIGHT-COLOR: #e7e7e7
}
#article-related TABLE.data TBODY TD {
	BORDER-RIGHT: #fff 1px solid; BORDER-BOTTOM: #e7e7e7 1px solid
}
#article-related TABLE.data TBODY TD.last {
	BORDER-BOTTOM-COLOR: #e7e7e7; BORDER-RIGHT-COLOR: #e7e7e7
}
#article-related DIV.box DIV.container-sendfriend {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px solid
}
#article-related DIV.box DIV.container-sendfriend P.essential {
	COLOR: #999
}
#article-related DIV.box DIV.container-sendfriend INPUT.friend {
	BORDER-RIGHT: #8caeb5 1px solid; BORDER-TOP: #fff 1px solid; =
BACKGROUND: #cedbde; BORDER-LEFT: #fff 1px solid; BORDER-BOTTOM: #8caeb5 =
1px solid
}
#article-related DIV.container-supplementary {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px solid
}
#article-related #browser-plugins {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px solid
}
#article-related #browser-plugins H2 {
	BACKGROUND: none transparent scroll repeat 0% 0%; MARGIN-BOTTOM: 10px; =
PADDING-BOTTOM: 3px; COLOR: black; PADDING-TOP: 3px; =
BORDER-BOTTOM-STYLE: none
}
#toc #content DIV.issue DIV.details H2 {
	BORDER-BOTTOM: #e3e3e3 1px solid
}
#toc #content DIV.issue DIV.cover-navigation P.previous-issue {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-left.gif) #e9ddd6 =
no-repeat 3px 50%
}
#toc #content DIV.issue DIV.cover-navigation IMG.journal-cover {
	BORDER-RIGHT: #cfd0cf 1px solid; BORDER-TOP: #cfd0cf 1px solid; =
BORDER-LEFT: #cfd0cf 1px solid; BORDER-BOTTOM: #cfd0cf 1px solid
}
#toc #content DIV.issue DIV.cover-navigation P.about-cover {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.image.gif) =
no-repeat left center
}
#toc #content DIV.section H3 {
	PADDING-LEFT: 0px; FONT-WEIGHT: bold; FONT-SIZE: 130%; PADDING-BOTTOM: =
0px; TEXT-TRANSFORM: uppercase; COLOR: #000; PADDING-TOP: 10px; =
BORDER-BOTTOM: #e3e3e3 1px solid
}
#toc #content DIV.section P.date {
	COLOR: #8a8c9f
}
#toc #content DIV.section P.page {
	COLOR: #8a8c9f
}
#toc #content DIV.section P.doi {
	COLOR: #8a8c9f
}
#toc #content DIV.section UL.article-views LI {
	BORDER-LEFT: #000 1px solid
}
#toc #content DIV.section UL.article-views LI.first {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.image.gif) =
no-repeat left center
}
#toc #content DIV.section P.see-also {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.image.gif) =
no-repeat left center
}
#toc #content DIV.section DIV.type H4 {
	COLOR: #999
}
#toc #content DIV.focus DIV.section DIV.type H5 {
	COLOR: #999
}
#toc #content DIV.section DIV.series DIV.type H5 {
	COLOR: #999
}
#toc #content DIV.section DIV.topic H4 SPAN.label {
	BACKGROUND-COLOR: #fff
}
#toc #content DIV.section DIV.topic H4 SPAN.focus {
	BACKGROUND: url(/nrc/images/graphics/icon.focus-article.gif) no-repeat =
right center
}
#toc #content DIV.focus H3 {
	BACKGROUND: #007d8c; COLOR: #fff; BORDER-BOTTOM: #fff 1px solid
}
#toc #content DIV.focus H3 A:link {
	COLOR: #fff
}
#toc #content DIV.focus H3 A:visited {
	COLOR: #fff
}
#toc #content DIV.focus H3 A:hover {
	COLOR: #e7e6ec
}
#toc #content DIV.focus H3 A:focus {
	COLOR: #e7e6ec
}
#toc #content DIV.focus H3 SPAN.focus {
	BACKGROUND: url(/nrc/images/graphics/icon.focus.gif) no-repeat left =
center
}
#toc #content DIV.focus DIV.section {
	BORDER-RIGHT: #d8d8d8 1px solid; BORDER-TOP: #d8d8d8 0px solid; =
BORDER-LEFT: #d8d8d8 1px solid; BORDER-BOTTOM: #d8d8d8 1px solid
}
#toc #content DIV.focus DIV.section H4 {
	BORDER-BOTTOM: #d8d8d8 1px solid; BACKGROUND-COLOR: #e0e9e9
}
#toc #content DIV.section DIV.series H4 {
	COLOR: #f00
}
#toc #content DIV.focus DIV.section DIV.series H5 {
	COLOR: #f00
}
#toc #content DIV.section DIV.series H4 SPAN.series {
	BACKGROUND: url(/nrc/images/graphics/icon.series-article.gif) no-repeat =
left center
}
#toc #content DIV.focus DIV.section DIV.series H5 SPAN.series {
	BACKGROUND: url(/nrc/images/graphics/icon.series-article.gif) no-repeat =
left center
}
#toc #content DIV.orphan.section DIV.type {
	BORDER-RIGHT: #d8d8d8 1px solid; BORDER-TOP: #d8d8d8 1px solid; =
BORDER-LEFT: #d8d8d8 1px solid; BORDER-BOTTOM: #d8d8d8 1px solid
}
#toc #content DIV.archive-calendar {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px
}
#toc #content DIV.archive-calendar H2 {
	PADDING-LEFT: 10px; COLOR: #000; BORDER-BOTTOM-STYLE: none
}
#toc #content DIV.archive-calendar UL LI A:link {
	COLOR: #000
}
#toc #content DIV.archive-calendar UL LI A:visited {
	COLOR: #000
}
#toc #content DIV.archive-calendar UL UL LI {
	BORDER-LEFT: #000 1px solid
}
#toc #content DIV.archive-calendar UL UL LI A:link {
	COLOR: #007d8c
}
#toc #content DIV.archive-calendar UL UL LI A:visited {
	COLOR: #007d8c
}
#toc #content DIV.archive-calendar UL UL LI A:hover {
	COLOR: #c03
}
#toc #content DIV.archive-calendar UL UL LI A:focus {
	COLOR: #c03
}
#toc #content #archiveMonths DIV.spacing {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 0px solid; =
BACKGROUND: #f5f5f5; MARGIN-BOTTOM: 2em; PADDING-BOTTOM: 0px; =
BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 1px solid
}
#toc #content #archiveMonths UL LI {
	BORDER-LEFT: #000 1px solid
}
#toc #content #archiveMonths UL LI.current-view {
	COLOR: #999
}
#toc #content #archiveMonths UL LI A:link {
	COLOR: #007d8c
}
#toc #content #archiveMonths UL LI A:visited {
	COLOR: #007d8c
}
#toc #content #archiveMonths UL LI A:hover {
	COLOR: #c03
}
#toc #content #archiveMonths UL LI A:focus {
	COLOR: #c03
}
#toc #content #archiveArticles {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 1px solid
}
#toc #content #archiveArticles H3 {
	BACKGROUND: #007d8c; COLOR: #fff
}
#toc #content #archiveArticles DIV.spacing P.doi {
	COLOR: #8a8c9f
}
#toc #content #archiveArticles DIV.spacing UL.article-views LI {
	BORDER-LEFT: #000 1px solid
}
#toc #content #archiveArticles DIV.spacing UL.article-views LI.first {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.image.gif) =
no-repeat left center
}
#archive #content DIV.archive-views {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px solid
}
#archive #content DIV.subject H2 {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px solid
}
#archive #content DIV.archive-views H2 {
	MARGIN: 5px 0px; COLOR: #000
}
#archive #content DIV.archive-views UL LI {
	BORDER-LEFT: #000 1px solid
}
#archive #content DIV.archive-views UL LI.current-view {
	COLOR: #999
}
#archive #content DIV.archive-views UL LI A:link {
	COLOR: #007d8c
}
#archive #content DIV.archive-views UL LI A:visited {
	COLOR: #007d8c
}
#archive #content DIV.archive-views UL LI A:hover {
	COLOR: #c03
}
#archive #content DIV.archive-views UL LI A:focus {
	COLOR: #c03
}
#archive #content UL.vol DIV {
	BORDER-RIGHT: #d7dde3 1px solid; BORDER-TOP: #d7dde3 1px solid; =
BACKGROUND: #f2f4f7; BORDER-LEFT: #d7dde3 1px solid; BORDER-BOTTOM: =
#d7dde3 1px solid
}
#archive #content UL.vol .month {
	BACKGROUND: #e7ebef; BORDER-BOTTOM: #d7dde3 1px solid
}
#archive #content UL.vol .issue {
	BORDER-BOTTOM: #d7dde3 1px solid
}
#archive #content UL.vol .issue:hover {
	BACKGROUND-COLOR: #fff
}
#archive #content UL.vol .not-published .issue:hover {
	BACKGROUND-COLOR: #fafafa
}
#archive #content DIV.box UL.vol .issue-no {
	BORDER-BOTTOM: #d7dde3 1px solid
}
#archive #content UL.vol .supname {
	BORDER-BOTTOM: #d7dde3 1px solid
}
#archive #content UL.vol .not-published DIV {
	BACKGROUND: #fafafa; COLOR: #888
}
#archive #content UL.vol .not-published .month {
	BACKGROUND: #eee
}
#archive #web-focuses H2.year {
	BACKGROUND-COLOR: #fff
}
#archive #web-focuses DIV.supp IMG {
	BORDER-RIGHT: #ccc 1px solid; BORDER-TOP: #ccc 1px solid; BORDER-LEFT: =
#ccc 1px solid; BORDER-BOTTOM: #ccc 1px solid
}
#archive #web-focuses DIV.supp H4.atl SPAN.updated {
	COLOR: #f00
}
#archive #web-focuses DIV.supp P.date {
	COLOR: #999
}
#archive #web-focuses DIV.supp P.support {
	COLOR: #999
}
#archive #posters DIV.odd.supp {
	BACKGROUND: #f5f5f5
}
#archive #posters DIV.supp H2 {
	TEXT-TRANSFORM: none; BORDER-BOTTOM-STYLE: none
}
#archive #posters DIV.supp IMG {
	BORDER-RIGHT: #ccc 1px solid; BORDER-TOP: #ccc 1px solid; BORDER-LEFT: =
#ccc 1px solid; BORDER-BOTTOM: #ccc 1px solid
}
#archive #posters DIV.supp P.description {
	COLOR: #999
}
#archive #posters DIV.supp P.date {
	COLOR: #999
}
#subscribe-now #content DIV.container {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 1px solid; =
BACKGROUND-COLOR: #f5f5f5
}
#subscribe-now #content .button {
	BORDER-RIGHT: #8caeb5 1px solid; BORDER-TOP: #fff 1px solid; =
BACKGROUND: #cedbde; BORDER-LEFT: #fff 1px solid; COLOR: #000; =
BORDER-BOTTOM: #8caeb5 1px solid
}
#subscribe-now #content DIV.container A.register {
	BORDER-RIGHT: #8caeb5 1px solid; BORDER-TOP: #fff 1px solid; =
BACKGROUND: #cedbde; BORDER-LEFT: #fff 1px solid; COLOR: #000; =
BORDER-BOTTOM: #8caeb5 1px solid
}
#toc #content DIV.article P.correspondence {
	COLOR: #8a8c9f
}
DIV.reg-rec UL.toc-pdf {
	BACKGROUND: #fff
}
DIV.reg-rec UL.toc-pdf A:link {
	BACKGROUND: url(/reviews/images/printer.gif) no-repeat 0px 3px
}
DIV.reg-rec UL.toc-pdf A:visited {
	BACKGROUND: url(/reviews/images/printer.gif) no-repeat 0px 3px
}
#toc #content DIV.cover-navigation UL.prev-next {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px
}
#toc #content DIV.cover-navigation UL.prev-next LI {
	BACKGROUND-IMAGE: none
}
#toc #content DIV.cover-navigation UL.prev-next LI A:link {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-left.gif) no-repeat =
left center
}
#toc #content DIV.cover-navigation UL.prev-next LI A:visited {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-left.gif) no-repeat =
left center
}
#toc #content DIV.cover-navigation UL.prev-next LI.next A:link {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.gif) no-repeat =
right center
}
#toc #content DIV.cover-navigation UL.prev-next LI.next A:visited {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.gif) no-repeat =
right center
}
#toc #content #archiveMonths H2 {
	BORDER-RIGHT: #e7e7e7 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: =
#e7e7e7 1px solid; PADDING-LEFT: 5px; BACKGROUND: #f5f5f5; =
MARGIN-BOTTOM: 0px; PADDING-BOTTOM: 0px; BORDER-LEFT: #e7e7e7 1px solid; =
COLOR: #000; PADDING-TOP: 5px; BORDER-BOTTOM: #e7e7e7 1px solid
}
#about-cover #content DIV.coverimage {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 1px solid; =
BACKGROUND-COLOR: #f5f5f5
}
#about-cover #content DIV.coverimage IMG {
	BORDER-RIGHT: #ccc 1px solid; BORDER-TOP: #ccc 1px solid; BACKGROUND: =
#fff; BORDER-LEFT: #ccc 1px solid; BORDER-BOTTOM: #ccc 1px solid
}
#about-cover #content DIV.covertext {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 1px solid; =
BACKGROUND-COLOR: #f5f5f5
}
#article #content DIV.box OL.twenty-questions UL LI H6 A:link {
	BACKGROUND: url(/nrc/images/graphics/icon.arrow.down.gif) no-repeat =
left center
}
#article #content DIV.box OL.twenty-questions UL LI H6 A:visited {
	BACKGROUND: url(/nrc/images/graphics/icon.arrow.down.gif) no-repeat =
left center
}
#article #content DIV.web-watch UL.web-watch-links {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px solid
}
#article #content DIV.disease-watch #articlebody DIV.item H3 {
	BACKGROUND: url(/nrc/images/graphics/bullet_no_link.gif) no-repeat left =
center
}
#article #content DIV.box H2#atl {
	FONT-WEIGHT: bold; FONT-SIZE: 140%; TEXT-TRANSFORM: none; COLOR: #000
}
#article #content DIV.box H2#atl SPAN.label {
	FONT-WEIGHT: bold; FONT-SIZE: 75%; COLOR: #8a8a8a
}
#article #content DIV.box P.focus {
	COLOR: #f00
}
#article #content DIV.box P.series {
	COLOR: #f00
}
#article #content DIV.box P.focus {
	BACKGROUND: url(/nrc/images/graphics/icon.focus.sxtitle.gif) no-repeat =
left center
}
#article #content DIV.box P.series {
	BACKGROUND: url(/nrc/images/graphics/icon.series-article.gif) no-repeat =
left center
}
#article #content BLOCKQUOTE.box {
	BORDER-RIGHT: #ccc 1px solid; BORDER-TOP: #ccc 1px solid; BORDER-LEFT: =
#ccc 1px solid; BORDER-BOTTOM: #ccc 1px solid
}
#article #content BLOCKQUOTE.box P.quote-source {
	BORDER-TOP: #ccc 1px solid
}
#article #content #links H5 {
	COLOR: #8a8a8a
}
#article #content #links UL LI {
	BORDER-LEFT: #000 1px solid
}
#article #content #references-links H5 {
	COLOR: #8a8a8a
}
#article #content #references-links OL.references LI UL.article-views LI =
{
	BORDER-LEFT: #000 1px solid
}
#article #content #References OL.references LI UL.article-views LI {
	BORDER-LEFT: #000 1px solid
}
#article #content #prev-next UL.prev-next LI.prev A:link {
	BACKGROUND: url(/common/images/icons/back.gif) no-repeat left center
}
#article #content #prev-next UL.prev-next LI.prev A:visited {
	BACKGROUND: url(/common/images/icons/back.gif) no-repeat left center
}
#article #content #prev-next UL.prev-next LI.prev A:hover {
	BACKGROUND-IMAGE: url(/common/images/icons/back_hover.gif)
}
#article #content #prev-next UL.prev-next LI.prev A:focus {
	BACKGROUND-IMAGE: url(/common/images/icons/back_hover.gif)
}
#article #content #prev-next UL.prev-next LI.next A:link {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat right center
}
#article #content #prev-next UL.prev-next LI.next A:visited {
	BACKGROUND: url(/common/images/icons/next.gif) no-repeat right center
}
#article #content #prev-next UL.prev-next LI.next A:hover {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif)
}
#article #content #prev-next UL.prev-next LI.next A:focus {
	BACKGROUND-IMAGE: url(/common/images/icons/next_hover.gif)
}
#home #content DIV.details DIV.featured-article {
	BORDER-RIGHT: #e7ebef 1px solid; BORDER-TOP: #e7ebef 1px solid; =
BORDER-LEFT: #e7ebef 1px solid; BORDER-BOTTOM: #e7ebef 1px solid
}
#home #content DIV.details DIV.goto {
	BACKGROUND: #f5f5f5
}
#home #content DIV.cover-navigation IMG.journal-cover {
	BORDER-RIGHT: #cfd0cf 1px solid; BORDER-TOP: #cfd0cf 1px solid; =
BORDER-LEFT: #cfd0cf 1px solid; BORDER-BOTTOM: #cfd0cf 1px solid
}
#home #content DIV.box-item {
	BORDER-RIGHT: #e7ebef 1px solid; BORDER-TOP: #e7ebef 1px solid; =
BORDER-LEFT: #e7ebef 1px solid; BORDER-BOTTOM: #e7ebef 1px solid
}
#home #content H2 {
	TEXT-TRANSFORM: none
}
#home #content DIV.box-item H3 {
	BACKGROUND: #007d8c; COLOR: #fff
}
#home #content DIV.box-item H4 {
	BACKGROUND: url(/nrc/images/graphics/icon.arrow.right.gif) #e0e9e9 =
no-repeat 5px 50%; BORDER-BOTTOM: #e7ebef 1px solid
}
#home #content DIV.box-item H4 A:link {
	COLOR: #000
}
#home #content DIV.box-item H4 A:visited {
	COLOR: #000
}
#home #content DIV.box-item H4 A:hover {
	COLOR: #000
}
#home #content DIV.box-item H4 A:focus {
	COLOR: #000
}
#home #content DIV.box-item IMG.illustration {
	BORDER-RIGHT: #cfcecf 1px solid; BORDER-TOP: #cfcecf 1px solid; =
BORDER-LEFT: #cfcecf 1px solid; BORDER-BOTTOM: #cfcecf 1px solid
}
#home #content DIV.box-item UL.more-in-field LI H4 A:link {
	COLOR: #007d8c
}
#home #content DIV.box-item UL.more-in-field LI H4 A:visited {
	COLOR: #007d8c
}
#home #content DIV.box-item DIV.illustrated H4 A:link {
	COLOR: #007d8c
}
#home #content DIV.box-item DIV.illustrated H4 A:visited {
	COLOR: #007d8c
}
#home #content DIV.box-item UL.more-in-field LI H4 A:hover {
	COLOR: #c03
}
#home #content DIV.box-item UL.more-in-field LI H4 A:focus {
	COLOR: #c03
}
#home #content DIV.box-item DIV.illustrated H4 A:hover {
	COLOR: #c03
}
#home #content DIV.box-item DIV.illustrated H4 A:focus {
	COLOR: #c03
}
#home #content P.fn {
	COLOR: #b4b4b4
}
#article-related DIV.box .container-more {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #f5f5f5; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: =
#e7e7e7 1px solid
}
#article-related DIV.box H2.from {
	COLOR: #8a8a8a
}
#article-related DIV.box P.sent-to {
	COLOR: #8a8a8a
}
#article-related DIV.box P.with {
	COLOR: #8a8a8a
}
#article #content #articlebody UL.article-views LI {
	BORDER-LEFT: #000 1px solid
}
#article #extranav #articlenav UL LI.fulltext {
	BACKGROUND: url(/reviews/images/icons/toc.gif) no-repeat 5px 0.25em
}
DIV.marketing.ad-rh {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid
}
DIV.marketing.ad-rh FORM INPUT {
	BORDER-RIGHT: #000 2px solid; BORDER-TOP: #ccc 2px solid; BACKGROUND: =
#8c3670; BORDER-LEFT: #ccc 2px solid; COLOR: #fff; BORDER-BOTTOM: #000 =
2px solid
}
* HTML DIV.marketing {
	BACKGROUND: #fff
}
DIV.marketing.ad-rh H2 {
	BACKGROUND: #d8d8d8; COLOR: #000
}
DIV.marketing.ad-rh P {
	COLOR: #000
}
* HTML DIV.marketing.ad-rh P {
	COLOR: #000
}
DIV.ad-rh {
	BACKGROUND: #fff
}
DIV.ad-rh P {
	COLOR: #cccccb
}
DIV.marketing.ad-rh {
	BORDER-RIGHT: #e7e7e7 1px solid; BORDER-TOP: #e7e7e7 1px solid; =
BACKGROUND: #fff; BORDER-LEFT: #e7e7e7 1px solid; BORDER-BOTTOM: #e7e7e7 =
1px solid; TEXT-ALIGN: center
}
DIV.marketing.ad-rh H1 {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-SIZE: 100%; BACKGROUND: =
#c8d9db; PADDING-BOTTOM: 3px; MARGIN: 0px 0px 1em; COLOR: #000; =
PADDING-TOP: 3px; TEXT-ALIGN: left
}
#toc #content OL.topten DIV.article UL.article-views LI.first {
	BACKGROUND-ATTACHMENT: scroll; BACKGROUND-IMAGE: =
url(/nrc/images/graphics/bullet.arrow-right.image.gif); =
BACKGROUND-REPEAT: no-repeat; BACKGROUND-COLOR: transparent; =
background-x-position: left; background-y-position: center
}
#toc #content OL.topten UL.article-views LI.first {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.image.gif) =
no-repeat left center
}
#toc #content OL.topten UL.article-views {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0.5em 0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#toc #content OL.topten UL.article-views:unknown {
	CLEAR: both; DISPLAY: block; VISIBILITY: hidden; HEIGHT: 0px; content: =
url(/common/images/clear.gif)
}
* HTML #toc #content OL.topten UL.article-views {
	HEIGHT: 1%
}
#toc #content OL.topten UL.article-views LI {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0.5em; MIN-HEIGHT: 12px; FLOAT: left; =
BACKGROUND-IMAGE: none; PADDING-BOTTOM: 0px; MARGIN: 0px 0px 0px 0.5em; =
LINE-HEIGHT: 100%; PADDING-TOP: 0px
}
#toc #content OL.topten UL.article-views LI.first {
	PADDING-LEFT: 18px; BORDER-LEFT-WIDTH: 0px; MARGIN-LEFT: 0px
}
#toc #content OL.topten UL.article-views LI.pdf {
	FONT-WEIGHT: bold
}
#toc #content DIV.spacing OL.topten UL.article-views LI {
	BORDER-LEFT: #000 1px solid
}
#toc #content DIV.spacing OL.topten UL.article-views LI.first {
	BACKGROUND: url(/nrc/images/graphics/bullet.arrow-right.image.gif) =
no-repeat left center
}
#toc #content OL.topten H5.atl {
	MARGIN-TOP: 0px; TEXT-TRANSFORM: none; COLOR: #000
}
#toc #content OL.topten H4 {
	COLOR: #999999
}
#toc #content OL.topten H5 {
	COLOR: #999999
}
#toc #content OL.topten H5 {
	COLOR: #999999
}
#toc #content OL.topten H4 {
	FONT-SIZE: 110%; MARGIN: 0pt; TEXT-TRANSFORM: uppercase
}
#toc #content OL.topten H5 {
	FONT-SIZE: 110%; MARGIN: 0pt; TEXT-TRANSFORM: uppercase
}
#toc #content OL.topten H5 {
	FONT-SIZE: 110%; MARGIN: 0pt; TEXT-TRANSFORM: uppercase
}
#toc #content OL.topten H4 {
	MARGIN-TOP: 0.5em
}
#toc #content OL.topten H5 {
	MARGIN-TOP: 0.5em
}
#toc #content OL.topten H6 {
	MARGIN-TOP: 0.5em
}
#toc #content OL.topten P.date {
	COLOR: #8a8c9f
}
#toc #content OL.topten P.page {
	COLOR: #8a8c9f
}
#toc #content DIV.section P.doi {
	COLOR: #8a8c9f
}
#toc #content OL.topten P.page {
	FONT-SIZE: 110%; MARGIN: 0pt 0pt 0.5em; LINE-HEIGHT: 150%
}
#toc #content DIV.section P.doi {
	FONT-SIZE: 110%; MARGIN: 0pt 0pt 0.5em; LINE-HEIGHT: 150%
}
#toc #content OL.topten P.aug {
	FONT-SIZE: 110%; MARGIN: 0pt; LINE-HEIGHT: 150%; FONT-STYLE: italic
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/style/restrict_width/966px.css

#head-er .accessibility-login {
	MAX-WIDTH: 966px; MARGIN: 0px auto
}
#head-er .image-user-services {
	MAX-WIDTH: 966px; MARGIN: 0px auto
}
#head-er .publications-search {
	MAX-WIDTH: 966px; MARGIN: 0px auto
}
DIV.footer-constrain {
	MAX-WIDTH: 966px; MARGIN: 0px auto
}
* HTML #head-er .accessibility-login-wrap {
	TEXT-ALIGN: center
}
* HTML #head-er .image-user-services-wrap {
	TEXT-ALIGN: center
}
* HTML #head-er .publications-search-wrap {
	TEXT-ALIGN: center
}
* HTML DIV.footer-constrain {
	TEXT-ALIGN: center
}
#breadcrumb {
	MARGIN-LEFT: 0px; MARGIN-RIGHT: 0px
}
#constrain {
	CLEAR: both; PADDING-RIGHT: 1%; PADDING-LEFT: 1%; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px; TEXT-ALIGN: center
}
.constrain-outer {
	CLEAR: both; PADDING-RIGHT: 1%; PADDING-LEFT: 1%; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px; TEXT-ALIGN: center
}
#constrain .constrain {
	MAX-WIDTH: 966px; MARGIN-LEFT: auto; MARGIN-RIGHT: auto; TEXT-ALIGN: =
left
}
.constrain-outer .constrain {
	MAX-WIDTH: 966px; MARGIN-LEFT: auto; MARGIN-RIGHT: auto; TEXT-ALIGN: =
left
}
BODY DIV.margin-provider#content {
	MARGIN: 0px
}
#content-journalnav {
	MARGIN-LEFT: 0px
}
#content-extranav {
	MARGIN-RIGHT: 0px
}
#extranav {
	MARGIN-RIGHT: 0px
}
#journalnav {
	MARGIN-LEFT: 0px
}
#article-related #content {
	MARGIN-LEFT: 0px; MARGIN-RIGHT: 0px
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/style/print.css

#header {
	DISPLAY: none
}
#head-er {
	DISPLAY: none
}
#breadcrumb {
	DISPLAY: none
}
.no-css {
	DISPLAY: none
}
#journalnav {
	DISPLAY: none
}
#journal-header {
	DISPLAY: none
}
#extranav {
	DISPLAY: none
}
#footer {
	DISPLAY: none
}
#foot-er {
	DISPLAY: none
}
#footer-sponsor {
	DISPLAY: none
}
#npglogo {
	DISPLAY: none
}
#hdr .publications-search {
	DISPLAY: none
}
#hdr .leaderboard-links {
	DISPLAY: none
}
#hdr .logon {
	DISPLAY: none
}
#hdr .header-nav {
	DISPLAY: none
}
#hdr #header-nav {
	DISPLAY: none
}
#ftr {
	DISPLAY: none
}
#hdr .journal-header IMG {
	DISPLAY: block! important
}
#content-journalnav {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; WIDTH: 100%; PADDING-TOP: 0px
}
#content {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; WIDTH: 100%; PADDING-TOP: 0px
}
#footer-copyright {
	CLEAR: both; BORDER-TOP: black 2px solid; MARGIN-TOP: 15px; FONT-SIZE: =
90%; COLOR: #999; PADDING-TOP: 15px
}
#footer-copyright A {
	FONT-WEIGHT: normal; COLOR: #000; TEXT-DECORATION: none
}
#footer-copyright .non-copyright {
	DISPLAY: none
}
.print-header {
	MARGIN-BOTTOM: 15px; PADDING-BOTTOM: 15px; BORDER-BOTTOM: black 2px =
solid
}
BODY {
	FONT-SIZE: 12pt; BACKGROUND: #fff; COLOR: #000; FONT-FAMILY: georgia, =
serif
}
H1 {
	FONT-SIZE: 16pt
}
H2 {
	FONT-SIZE: 14pt
}
H3 {
	FONT-SIZE: 12pt
}
H4 {
	FONT-SIZE: 12pt
}
H5 {
	FONT-SIZE: 12pt
}
H6 {
	FONT-SIZE: 12pt
}
A:link {
	FONT-WEIGHT: bold; BACKGROUND: none transparent scroll repeat 0% 0%; =
COLOR: #009; TEXT-DECORATION: underline
}
A:visited {
	FONT-WEIGHT: bold; BACKGROUND: none transparent scroll repeat 0% 0%; =
COLOR: #009; TEXT-DECORATION: underline
}
#content A:link:unknown {
	FONT-WEIGHT: normal; content: " (" attr(href) ") "
}
#content A:visited:unknown {
	FONT-WEIGHT: normal; content: " (" attr(href) ") "
}
#article #content DIV BLOCKQUOTE {
	BORDER-RIGHT: #000 1px solid; PADDING-RIGHT: 0.5em; BORDER-TOP: #000 =
1px solid; PADDING-LEFT: 0.5em; PADDING-BOTTOM: 0.5em; MARGIN: 1.26em =
0px; BORDER-LEFT: #000 1px solid; PADDING-TOP: 0.5em; BORDER-BOTTOM: =
#000 1px solid; TEXT-ALIGN: center
}
#article #content DIV BLOCKQUOTE P {
	MARGIN: 0px
}
#article #content DIV BLOCKQUOTE IMG {
	DISPLAY: none
}
.backtotop {
	DISPLAY: none
}
.back-to-article {
	DISPLAY: none
}
.prevnext {
	DISPLAY: none
}
* HTML #article-related TABLE.data {
	FONT-SIZE: 7pt; WIDTH: 100%
}
#article-related TABLE.data {
	FONT-SIZE: 7pt; WIDTH: 100%
}
#article-related TABLE.data {
	BORDER-RIGHT: #999 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: #999 1px =
solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; BORDER-LEFT: =
#999 1px solid; PADDING-TOP: 0px; BORDER-BOTTOM: #999 1px solid; =
BORDER-COLLAPSE: collapse; TEXT-ALIGN: left
}
#article-related TABLE.data THEAD {
	FONT-WEIGHT: bold
}
#article-related TABLE.data THEAD TH {
	BORDER-RIGHT: #999 1px solid; BACKGROUND: #f6f6f6; BORDER-LEFT: #999 =
1px solid
}
#article-related TABLE.data THEAD TH.colspan {
	BORDER-RIGHT: #999 1px solid; BORDER-TOP: #999 0px solid; BORDER-LEFT: =
#999 1px solid; BORDER-BOTTOM: #999 1px solid; TEXT-ALIGN: center
}
#article-related TABLE.data THEAD TH.last {
	BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TBODY TD.last {
	BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TBODY {
	BORDER-TOP: #999 1px solid; BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TBODY TR {
	BACKGROUND-COLOR: #f6f6f6
}
#article-related TABLE.data TBODY TR.odd {
	BACKGROUND-COLOR: #fff
}
#article-related TABLE.data TBODY TD {
	BORDER-RIGHT: #999 1px solid; BORDER-BOTTOM: #999 1px solid
}
#article-related TABLE.data TFOOT {
	POSITION: relative
}
#article-related TABLE.data TFOOT TD {
	FONT-SIZE: 7pt; BACKGROUND-COLOR: #fff
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Location: http://www.nature.com/common/includes/header/03/style/ie-specific/lte-ie-7.css

#hdr .pub1 A {
	MARGIN-TOP: 7px; DISPLAY: block
}
#hdr .list-container {
	FLOAT: left
}
#hdr .list-container UL {
	FLOAT: left
}
#hdr .user-services .us-link A:link {
	PADDING-BOTTOM: 2px; PADDING-TOP: 0px
}
#hdr .user-services .us-link A:visited {
	PADDING-BOTTOM: 2px; PADDING-TOP: 0px
}
#hdr .list-container UL.list1 {
	MARGIN-LEFT: 0px; MARGIN-RIGHT: 4px
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Location: http://www.nature.com/reviews/style/ie-specific/lte-ie-7.css

INPUT.sermo-submit:hover {
	BACKGROUND-COLOR: #fff! important
}
INPUT.sermo-submit {
	PADDING-LEFT: 13.5%; BACKGROUND-COLOR: #fff
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Location: http://www.nature.com/common/includes/header/03/style/ie-specific/ie-7.css

#hdr .list-container UL {
	WIDTH: 114px
}
#hdr .list-container UL.list1 {
	MARGIN-RIGHT: 5px
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Location: http://www.nature.com/common/style/ie-specific/ie-7.css

BODY {
	FONT-SIZE: 89%
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Location: http://www.nature.com/reviews/style/ie-specific/ie-7.css

BODY {
	FONT-SIZE: 62.5%
}
#article #content #references-links OL.references LI {
	MARGIN-BOTTOM: 10px
}
#article #content #References OL.references LI {
	MARGIN-BOTTOM: 10px
}
#article #content #references-links OL.references LI P.details {
	CLEAR: left
}
#article #content #References OL.references LI P.details {
	CLEAR: left
}
#article #content #references-links OL.references LI P.details SUP {
	LINE-HEIGHT: 0
}
#article #content #References OL.references LI P.details SUP {
	LINE-HEIGHT: 0
}
#toc #content DIV.issue DIV.cover-navigation IMG.journal-cover {
	CLEAR: left; MARGIN-TOP: 10px
}
#toc #content DIV.section .article {
	CLEAR: both
}

------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/scripts/jquery.js

/*=0A=
 * jQuery 1.2.1 - New Wave Javascript=0A=
 *=0A=
 * Copyright (c) 2007 John Resig (jquery.com)=0A=
 * Dual licensed under the MIT (MIT-LICENSE.txt)=0A=
 * and GPL (GPL-LICENSE.txt) licenses.=0A=
 *=0A=
 * $Date: 2007-09-16 23:42:06 -0400 (Sun, 16 Sep 2007) $=0A=
 * $Rev: 3353 $=0A=
 */=0A=
(function(){if(typeof jQuery!=3D"undefined")var _jQuery=3DjQuery;var =
jQuery=3Dwindow.jQuery=3Dfunction(selector,context){return this =
instanceof jQuery?this.init(selector,context):new =
jQuery(selector,context);};if(typeof $!=3D"undefined")var =
_$=3D$;window.$=3DjQuery;var =
quickExpr=3D/^[^<]*(<(.|\s)+>)[^>]*$|^#(\w+)$/;jQuery.fn=3DjQuery.prototy=
pe=3D{init:function(selector,context){selector=3Dselector||document;if(ty=
peof selector=3D=3D"string"){var =
m=3DquickExpr.exec(selector);if(m&&(m[1]||!context)){if(m[1])selector=3Dj=
Query.clean([m[1]],context);else{var =
tmp=3Ddocument.getElementById(m[3]);if(tmp)if(tmp.id!=3Dm[3])return =
jQuery().find(selector);else{this[0]=3Dtmp;this.length=3D1;return =
this;}else=0A=
selector=3D[];}}else=0A=
return new jQuery(context).find(selector);}else =
if(jQuery.isFunction(selector))return new =
jQuery(document)[jQuery.fn.ready?"ready":"load"](selector);return =
this.setArray(selector.constructor=3D=3DArray&&selector||(selector.jquery=
||selector.length&&selector!=3Dwindow&&!selector.nodeType&&selector[0]!=3D=
undefined&&selector[0].nodeType)&&jQuery.makeArray(selector)||[selector])=
;},jquery:"1.2.1",size:function(){return =
this.length;},length:0,get:function(num){return =
num=3D=3Dundefined?jQuery.makeArray(this):this[num];},pushStack:function(=
a){var ret=3DjQuery(a);ret.prevObject=3Dthis;return =
ret;},setArray:function(a){this.length=3D0;Array.prototype.push.apply(thi=
s,a);return this;},each:function(fn,args){return =
jQuery.each(this,fn,args);},index:function(obj){var =
pos=3D-1;this.each(function(i){if(this=3D=3Dobj)pos=3Di;});return =
pos;},attr:function(key,value,type){var =
obj=3Dkey;if(key.constructor=3D=3DString)if(value=3D=3Dundefined)return =
this.length&&jQuery[type||"attr"](this[0],key)||undefined;else{obj=3D{};o=
bj[key]=3Dvalue;}return this.each(function(index){for(var prop in =
obj)jQuery.attr(type?this.style:this,prop,jQuery.prop(this,obj[prop],type=
,index,prop));});},css:function(key,value){return =
this.attr(key,value,"curCSS");},text:function(e){if(typeof =
e!=3D"object"&&e!=3Dnull)return =
this.empty().append(document.createTextNode(e));var =
t=3D"";jQuery.each(e||this,function(){jQuery.each(this.childNodes,functio=
n(){if(this.nodeType!=3D8)t+=3Dthis.nodeType!=3D1?this.nodeValue:jQuery.f=
n.text([this]);});});return =
t;},wrapAll:function(html){if(this[0])jQuery(html,this[0].ownerDocument).=
clone().insertBefore(this[0]).map(function(){var =
elem=3Dthis;while(elem.firstChild)elem=3Delem.firstChild;return =
elem;}).append(this);return this;},wrapInner:function(html){return =
this.each(function(){jQuery(this).contents().wrapAll(html);});},wrap:func=
tion(html){return =
this.each(function(){jQuery(this).wrapAll(html);});},append:function(){re=
turn =
this.domManip(arguments,true,1,function(a){this.appendChild(a);});},prepe=
nd:function(){return =
this.domManip(arguments,true,-1,function(a){this.insertBefore(a,this.firs=
tChild);});},before:function(){return =
this.domManip(arguments,false,1,function(a){this.parentNode.insertBefore(=
a,this);});},after:function(){return =
this.domManip(arguments,false,-1,function(a){this.parentNode.insertBefore=
(a,this.nextSibling);});},end:function(){return =
this.prevObject||jQuery([]);},find:function(t){var =
data=3DjQuery.map(this,function(a){return jQuery.find(t,a);});return =
this.pushStack(/[^+>] =
[^+>]/.test(t)||t.indexOf("..")>-1?jQuery.unique(data):data);},clone:func=
tion(events){var ret=3Dthis.map(function(){return =
this.outerHTML?jQuery(this.outerHTML)[0]:this.cloneNode(true);});var =
clone=3Dret.find("*").andSelf().each(function(){if(this[expando]!=3Dundef=
ined)this[expando]=3Dnull;});if(events=3D=3D=3Dtrue)this.find("*").andSel=
f().each(function(i){var events=3DjQuery.data(this,"events");for(var =
type in events)for(var handler in =
events[type])jQuery.event.add(clone[i],type,events[type][handler],events[=
type][handler].data);});return ret;},filter:function(t){return =
this.pushStack(jQuery.isFunction(t)&&jQuery.grep(this,function(el,index){=
return =
t.apply(el,[index]);})||jQuery.multiFilter(t,this));},not:function(t){ret=
urn =
this.pushStack(t.constructor=3D=3DString&&jQuery.multiFilter(t,this,true)=
||jQuery.grep(this,function(a){return(t.constructor=3D=3DArray||t.jquery)=
?jQuery.inArray(a,t)<0:a!=3Dt;}));},add:function(t){return =
this.pushStack(jQuery.merge(this.get(),t.constructor=3D=3DString?jQuery(t=
).get():t.length!=3Dundefined&&(!t.nodeName||jQuery.nodeName(t,"form"))?t=
:[t]));},is:function(expr){return =
expr?jQuery.multiFilter(expr,this).length>0:false;},hasClass:function(exp=
r){return =
this.is("."+expr);},val:function(val){if(val=3D=3Dundefined){if(this.leng=
th){var elem=3Dthis[0];if(jQuery.nodeName(elem,"select")){var =
index=3Delem.selectedIndex,a=3D[],options=3Delem.options,one=3Delem.type=3D=
=3D"select-one";if(index<0)return null;for(var =
i=3Done?index:0,max=3Done?index+1:options.length;i<max;i++){var =
option=3Doptions[i];if(option.selected){var =
val=3DjQuery.browser.msie&&!option.attributes["value"].specified?option.t=
ext:option.value;if(one)return val;a.push(val);}}return a;}else=0A=
return this[0].value.replace(/\r/g,"");}}else=0A=
return =
this.each(function(){if(val.constructor=3D=3DArray&&/radio|checkbox/.test=
(this.type))this.checked=3D(jQuery.inArray(this.value,val)>=3D0||jQuery.i=
nArray(this.name,val)>=3D0);else if(jQuery.nodeName(this,"select")){var =
tmp=3Dval.constructor=3D=3DArray?val:[val];jQuery("option",this).each(fun=
ction(){this.selected=3D(jQuery.inArray(this.value,tmp)>=3D0||jQuery.inAr=
ray(this.text,tmp)>=3D0);});if(!tmp.length)this.selectedIndex=3D-1;}else=0A=
this.value=3Dval;});},html:function(val){return =
val=3D=3Dundefined?(this.length?this[0].innerHTML:null):this.empty().appe=
nd(val);},replaceWith:function(val){return =
this.after(val).remove();},eq:function(i){return =
this.slice(i,i+1);},slice:function(){return =
this.pushStack(Array.prototype.slice.apply(this,arguments));},map:functio=
n(fn){return this.pushStack(jQuery.map(this,function(elem,i){return =
fn.call(elem,i,elem);}));},andSelf:function(){return =
this.add(this.prevObject);},domManip:function(args,table,dir,fn){var =
clone=3Dthis.length>1,a;return =
this.each(function(){if(!a){a=3DjQuery.clean(args,this.ownerDocument);if(=
dir<0)a.reverse();}var =
obj=3Dthis;if(table&&jQuery.nodeName(this,"table")&&jQuery.nodeName(a[0],=
"tr"))obj=3Dthis.getElementsByTagName("tbody")[0]||this.appendChild(docum=
ent.createElement("tbody"));jQuery.each(a,function(){var =
elem=3Dclone?this.cloneNode(true):this;if(!evalScript(0,elem))fn.call(obj=
,elem);});});}};function evalScript(i,elem){var =
script=3DjQuery.nodeName(elem,"script");if(script){if(elem.src)jQuery.aja=
x({url:elem.src,async:false,dataType:"script"});else=0A=
jQuery.globalEval(elem.text||elem.textContent||elem.innerHTML||"");if(ele=
m.parentNode)elem.parentNode.removeChild(elem);}else =
if(elem.nodeType=3D=3D1)jQuery("script",elem).each(evalScript);return =
script;}jQuery.extend=3DjQuery.fn.extend=3Dfunction(){var =
target=3Darguments[0]||{},a=3D1,al=3Darguments.length,deep=3Dfalse;if(tar=
get.constructor=3D=3DBoolean){deep=3Dtarget;target=3Darguments[1]||{};}if=
(al=3D=3D1){target=3Dthis;a=3D0;}var =
prop;for(;a<al;a++)if((prop=3Darguments[a])!=3Dnull)for(var i in =
prop){if(target=3D=3Dprop[i])continue;if(deep&&typeof =
prop[i]=3D=3D'object'&&target[i])jQuery.extend(target[i],prop[i]);else =
if(prop[i]!=3Dundefined)target[i]=3Dprop[i];}return target;};var =
expando=3D"jQuery"+(new =
Date()).getTime(),uuid=3D0,win=3D{};jQuery.extend({noConflict:function(de=
ep){window.$=3D_$;if(deep)window.jQuery=3D_jQuery;return =
jQuery;},isFunction:function(fn){return!!fn&&typeof =
fn!=3D"string"&&!fn.nodeName&&fn.constructor!=3DArray&&/function/i.test(f=
n+"");},isXMLDoc:function(elem){return =
elem.documentElement&&!elem.body||elem.tagName&&elem.ownerDocument&&!elem=
.ownerDocument.body;},globalEval:function(data){data=3DjQuery.trim(data);=
if(data){if(window.execScript)window.execScript(data);else =
if(jQuery.browser.safari)window.setTimeout(data,0);else=0A=
eval.call(window,data);}},nodeName:function(elem,name){return =
elem.nodeName&&elem.nodeName.toUpperCase()=3D=3Dname.toUpperCase();},cach=
e:{},data:function(elem,name,data){elem=3Delem=3D=3Dwindow?win:elem;var =
id=3Delem[expando];if(!id)id=3Delem[expando]=3D++uuid;if(name&&!jQuery.ca=
che[id])jQuery.cache[id]=3D{};if(data!=3Dundefined)jQuery.cache[id][name]=
=3Ddata;return =
name?jQuery.cache[id][name]:id;},removeData:function(elem,name){elem=3Del=
em=3D=3Dwindow?win:elem;var =
id=3Delem[expando];if(name){if(jQuery.cache[id]){delete =
jQuery.cache[id][name];name=3D"";for(name in =
jQuery.cache[id])break;if(!name)jQuery.removeData(elem);}}else{try{delete=
 =
elem[expando];}catch(e){if(elem.removeAttribute)elem.removeAttribute(expa=
ndo);}delete =
jQuery.cache[id];}},each:function(obj,fn,args){if(args){if(obj.length=3D=3D=
undefined)for(var i in obj)fn.apply(obj[i],args);else=0A=
for(var =
i=3D0,ol=3Dobj.length;i<ol;i++)if(fn.apply(obj[i],args)=3D=3D=3Dfalse)bre=
ak;}else{if(obj.length=3D=3Dundefined)for(var i in =
obj)fn.call(obj[i],i,obj[i]);else=0A=
for(var =
i=3D0,ol=3Dobj.length,val=3Dobj[0];i<ol&&fn.call(val,i,val)!=3D=3Dfalse;v=
al=3Dobj[++i]){}}return =
obj;},prop:function(elem,value,type,index,prop){if(jQuery.isFunction(valu=
e))value=3Dvalue.call(elem,[index]);var =
exclude=3D/z-?index|font-?weight|opacity|zoom|line-?height/i;return =
value&&value.constructor=3D=3DNumber&&type=3D=3D"curCSS"&&!exclude.test(p=
rop)?value+"px":value;},className:{add:function(elem,c){jQuery.each((c||"=
").split(/\s+/),function(i,cur){if(!jQuery.className.has(elem.className,c=
ur))elem.className+=3D(elem.className?" =
":"")+cur;});},remove:function(elem,c){elem.className=3Dc!=3Dundefined?jQ=
uery.grep(elem.className.split(/\s+/),function(cur){return!jQuery.classNa=
me.has(c,cur);}).join(" "):"";},has:function(t,c){return =
jQuery.inArray(c,(t.className||t).toString().split(/\s+/))>-1;}},swap:fun=
ction(e,o,f){for(var i in =
o){e.style["old"+i]=3De.style[i];e.style[i]=3Do[i];}f.apply(e,[]);for(var=
 i in =
o)e.style[i]=3De.style["old"+i];},css:function(e,p){if(p=3D=3D"height"||p=
=3D=3D"width"){var =
old=3D{},oHeight,oWidth,d=3D["Top","Bottom","Right","Left"];jQuery.each(d=
,function(){old["padding"+this]=3D0;old["border"+this+"Width"]=3D0;});jQu=
ery.swap(e,old,function(){if(jQuery(e).is(':visible')){oHeight=3De.offset=
Height;oWidth=3De.offsetWidth;}else{e=3DjQuery(e.cloneNode(true)).find(":=
radio").removeAttr("checked").end().css({visibility:"hidden",position:"ab=
solute",display:"block",right:"0",left:"0"}).appendTo(e.parentNode)[0];va=
r =
parPos=3DjQuery.css(e.parentNode,"position")||"static";if(parPos=3D=3D"st=
atic")e.parentNode.style.position=3D"relative";oHeight=3De.clientHeight;o=
Width=3De.clientWidth;if(parPos=3D=3D"static")e.parentNode.style.position=
=3D"static";e.parentNode.removeChild(e);}});return =
p=3D=3D"height"?oHeight:oWidth;}return =
jQuery.curCSS(e,p);},curCSS:function(elem,prop,force){var =
ret,stack=3D[],swap=3D[];function =
color(a){if(!jQuery.browser.safari)return false;var =
ret=3Ddocument.defaultView.getComputedStyle(a,null);return!ret||ret.getPr=
opertyValue("color")=3D=3D"";}if(prop=3D=3D"opacity"&&jQuery.browser.msie=
){ret=3DjQuery.attr(elem.style,"opacity");return =
ret=3D=3D""?"1":ret;}if(prop.match(/float/i))prop=3DstyleFloat;if(!force&=
&elem.style[prop])ret=3Delem.style[prop];else =
if(document.defaultView&&document.defaultView.getComputedStyle){if(prop.m=
atch(/float/i))prop=3D"float";prop=3Dprop.replace(/([A-Z])/g,"-$1").toLow=
erCase();var =
cur=3Ddocument.defaultView.getComputedStyle(elem,null);if(cur&&!color(ele=
m))ret=3Dcur.getPropertyValue(prop);else{for(var =
a=3Delem;a&&color(a);a=3Da.parentNode)stack.unshift(a);for(a=3D0;a<stack.=
length;a++)if(color(stack[a])){swap[a]=3Dstack[a].style.display;stack[a].=
style.display=3D"block";}ret=3Dprop=3D=3D"display"&&swap[stack.length-1]!=
=3Dnull?"none":document.defaultView.getComputedStyle(elem,null).getProper=
tyValue(prop)||"";for(a=3D0;a<swap.length;a++)if(swap[a]!=3Dnull)stack[a]=
.style.display=3Dswap[a];}if(prop=3D=3D"opacity"&&ret=3D=3D"")ret=3D"1";}=
else if(elem.currentStyle){var =
newProp=3Dprop.replace(/\-(\w)/g,function(m,c){return =
c.toUpperCase();});ret=3Delem.currentStyle[prop]||elem.currentStyle[newPr=
op];if(!/^\d+(px)?$/i.test(ret)&&/^\d/.test(ret)){var =
style=3Delem.style.left;var =
runtimeStyle=3Delem.runtimeStyle.left;elem.runtimeStyle.left=3Delem.curre=
ntStyle.left;elem.style.left=3Dret||0;ret=3Delem.style.pixelLeft+"px";ele=
m.style.left=3Dstyle;elem.runtimeStyle.left=3DruntimeStyle;}}return =
ret;},clean:function(a,doc){var =
r=3D[];doc=3Ddoc||document;jQuery.each(a,function(i,arg){if(!arg)return;i=
f(arg.constructor=3D=3DNumber)arg=3Darg.toString();if(typeof =
arg=3D=3D"string"){arg=3Darg.replace(/(<(\w+)[^>]*?)\/>/g,function(m,all,=
tag){return =
tag.match(/^(abbr|br|col|img|input|link|meta|param|hr|area)$/i)?m:all+"><=
/"+tag+">";});var =
s=3DjQuery.trim(arg).toLowerCase(),div=3Ddoc.createElement("div"),tb=3D[]=
;var =
wrap=3D!s.indexOf("<opt")&&[1,"<select>","</select>"]||!s.indexOf("<leg")=
&&[1,"<fieldset>","</fieldset>"]||s.match(/^<(thead|tbody|tfoot|colg|cap)=
/)&&[1,"<table>","</table>"]||!s.indexOf("<tr")&&[2,"<table><tbody>","</t=
body></table>"]||(!s.indexOf("<td")||!s.indexOf("<th"))&&[3,"<table><tbod=
y><tr>","</tr></tbody></table>"]||!s.indexOf("<col")&&[2,"<table><tbody><=
/tbody><colgroup>","</colgroup></table>"]||jQuery.browser.msie&&[1,"div<d=
iv>","</div>"]||[0,"",""];div.innerHTML=3Dwrap[1]+arg+wrap[2];while(wrap[=
0]--)div=3Ddiv.lastChild;if(jQuery.browser.msie){if(!s.indexOf("<table")&=
&s.indexOf("<tbody")<0)tb=3Ddiv.firstChild&&div.firstChild.childNodes;els=
e =
if(wrap[1]=3D=3D"<table>"&&s.indexOf("<tbody")<0)tb=3Ddiv.childNodes;for(=
var =
n=3Dtb.length-1;n>=3D0;--n)if(jQuery.nodeName(tb[n],"tbody")&&!tb[n].chil=
dNodes.length)tb[n].parentNode.removeChild(tb[n]);if(/^\s/.test(arg))div.=
insertBefore(doc.createTextNode(arg.match(/^\s*/)[0]),div.firstChild);}ar=
g=3DjQuery.makeArray(div.childNodes);}if(0=3D=3D=3Darg.length&&(!jQuery.n=
odeName(arg,"form")&&!jQuery.nodeName(arg,"select")))return;if(arg[0]=3D=3D=
undefined||jQuery.nodeName(arg,"form")||arg.options)r.push(arg);else=0A=
r=3DjQuery.merge(r,arg);});return r;},attr:function(elem,name,value){var =
fix=3DjQuery.isXMLDoc(elem)?{}:jQuery.props;if(name=3D=3D"selected"&&jQue=
ry.browser.safari)elem.parentNode.selectedIndex;if(fix[name]){if(value!=3D=
undefined)elem[fix[name]]=3Dvalue;return elem[fix[name]];}else =
if(jQuery.browser.msie&&name=3D=3D"style")return =
jQuery.attr(elem.style,"cssText",value);else =
if(value=3D=3Dundefined&&jQuery.browser.msie&&jQuery.nodeName(elem,"form"=
)&&(name=3D=3D"action"||name=3D=3D"method"))return =
elem.getAttributeNode(name).nodeValue;else =
if(elem.tagName){if(value!=3Dundefined){if(name=3D=3D"type"&&jQuery.nodeN=
ame(elem,"input")&&elem.parentNode)throw"type property can't be =
changed";elem.setAttribute(name,value);}if(jQuery.browser.msie&&/href|src=
/.test(name)&&!jQuery.isXMLDoc(elem))return =
elem.getAttribute(name,2);return =
elem.getAttribute(name);}else{if(name=3D=3D"opacity"&&jQuery.browser.msie=
){if(value!=3Dundefined){elem.zoom=3D1;elem.filter=3D(elem.filter||"").re=
place(/alpha\([^)]*\)/,"")+(parseFloat(value).toString()=3D=3D"NaN"?"":"a=
lpha(opacity=3D"+value*100+")");}return =
elem.filter?(parseFloat(elem.filter.match(/opacity=3D([^)]*)/)[1])/100).t=
oString():"";}name=3Dname.replace(/-([a-z])/ig,function(z,b){return =
b.toUpperCase();});if(value!=3Dundefined)elem[name]=3Dvalue;return =
elem[name];}},trim:function(t){return(t||"").replace(/^\s+|\s+$/g,"");},m=
akeArray:function(a){var r=3D[];if(typeof a!=3D"array")for(var =
i=3D0,al=3Da.length;i<al;i++)r.push(a[i]);else=0A=
r=3Da.slice(0);return r;},inArray:function(b,a){for(var =
i=3D0,al=3Da.length;i<al;i++)if(a[i]=3D=3Db)return =
i;return-1;},merge:function(first,second){if(jQuery.browser.msie){for(var=
 =
i=3D0;second[i];i++)if(second[i].nodeType!=3D8)first.push(second[i]);}els=
e=0A=
for(var i=3D0;second[i];i++)first.push(second[i]);return =
first;},unique:function(first){var r=3D[],done=3D{};try{for(var =
i=3D0,fl=3Dfirst.length;i<fl;i++){var =
id=3DjQuery.data(first[i]);if(!done[id]){done[id]=3Dtrue;r.push(first[i])=
;}}}catch(e){r=3Dfirst;}return r;},grep:function(elems,fn,inv){if(typeof =
fn=3D=3D"string")fn=3Deval("false||function(a,i){return "+fn+"}");var =
result=3D[];for(var =
i=3D0,el=3Delems.length;i<el;i++)if(!inv&&fn(elems[i],i)||inv&&!fn(elems[=
i],i))result.push(elems[i]);return =
result;},map:function(elems,fn){if(typeof =
fn=3D=3D"string")fn=3Deval("false||function(a){return "+fn+"}");var =
result=3D[];for(var i=3D0,el=3Delems.length;i<el;i++){var =
val=3Dfn(elems[i],i);if(val!=3D=3Dnull&&val!=3Dundefined){if(val.construc=
tor!=3DArray)val=3D[val];result=3Dresult.concat(val);}}return =
result;}});var =
userAgent=3Dnavigator.userAgent.toLowerCase();jQuery.browser=3D{version:(=
userAgent.match(/.+(?:rv|it|ra|ie)[\/: =
]([\d.]+)/)||[])[1],safari:/webkit/.test(userAgent),opera:/opera/.test(us=
erAgent),msie:/msie/.test(userAgent)&&!/opera/.test(userAgent),mozilla:/m=
ozilla/.test(userAgent)&&!/(compatible|webkit)/.test(userAgent)};var =
styleFloat=3DjQuery.browser.msie?"styleFloat":"cssFloat";jQuery.extend({b=
oxModel:!jQuery.browser.msie||document.compatMode=3D=3D"CSS1Compat",style=
Float:jQuery.browser.msie?"styleFloat":"cssFloat",props:{"for":"htmlFor",=
"class":"className","float":styleFloat,cssFloat:styleFloat,styleFloat:sty=
leFloat,innerHTML:"innerHTML",className:"className",value:"value",disable=
d:"disabled",checked:"checked",readonly:"readOnly",selected:"selected",ma=
xlength:"maxLength"}});jQuery.each({parent:"a.parentNode",parents:"jQuery=
.dir(a,'parentNode')",next:"jQuery.nth(a,2,'nextSibling')",prev:"jQuery.n=
th(a,2,'previousSibling')",nextAll:"jQuery.dir(a,'nextSibling')",prevAll:=
"jQuery.dir(a,'previousSibling')",siblings:"jQuery.sibling(a.parentNode.f=
irstChild,a)",children:"jQuery.sibling(a.firstChild)",contents:"jQuery.no=
deName(a,'iframe')?a.contentDocument||a.contentWindow.document:jQuery.mak=
eArray(a.childNodes)"},function(i,n){jQuery.fn[i]=3Dfunction(a){var =
ret=3DjQuery.map(this,n);if(a&&typeof =
a=3D=3D"string")ret=3DjQuery.multiFilter(a,ret);return =
this.pushStack(jQuery.unique(ret));};});jQuery.each({appendTo:"append",pr=
ependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"r=
eplaceWith"},function(i,n){jQuery.fn[i]=3Dfunction(){var =
a=3Darguments;return this.each(function(){for(var =
j=3D0,al=3Da.length;j<al;j++)jQuery(a[j])[n](this);});};});jQuery.each({r=
emoveAttr:function(key){jQuery.attr(this,key,"");this.removeAttribute(key=
);},addClass:function(c){jQuery.className.add(this,c);},removeClass:funct=
ion(c){jQuery.className.remove(this,c);},toggleClass:function(c){jQuery.c=
lassName[jQuery.className.has(this,c)?"remove":"add"](this,c);},remove:fu=
nction(a){if(!a||jQuery.filter(a,[this]).r.length){jQuery.removeData(this=
);this.parentNode.removeChild(this);}},empty:function(){jQuery("*",this).=
each(function(){jQuery.removeData(this);});while(this.firstChild)this.rem=
oveChild(this.firstChild);}},function(i,n){jQuery.fn[i]=3Dfunction(){retu=
rn =
this.each(n,arguments);};});jQuery.each(["Height","Width"],function(i,nam=
e){var n=3Dname.toLowerCase();jQuery.fn[n]=3Dfunction(h){return =
this[0]=3D=3Dwindow?jQuery.browser.safari&&self["inner"+name]||jQuery.box=
Model&&Math.max(document.documentElement["client"+name],document.body["cl=
ient"+name])||document.body["client"+name]:this[0]=3D=3Ddocument?Math.max=
(document.body["scroll"+name],document.body["offset"+name]):h=3D=3Dundefi=
ned?(this.length?jQuery.css(this[0],n):null):this.css(n,h.constructor=3D=3D=
String?h:h+"px");};});var =
chars=3DjQuery.browser.safari&&parseInt(jQuery.browser.version)<417?"(?:[=
\\w*_-]|\\\\.)":"(?:[\\w\u0128-\uFFFF*_-]|\\\\.)",quickChild=3Dnew =
RegExp("^>\\s*("+chars+"+)"),quickID=3Dnew =
RegExp("^("+chars+"+)(#)("+chars+"+)"),quickClass=3Dnew =
RegExp("^([#.]?)("+chars+"*)");jQuery.extend({expr:{"":"m[2]=3D=3D'*'||jQ=
uery.nodeName(a,m[2])","#":"a.getAttribute('id')=3D=3Dm[2]",":":{lt:"i<m[=
3]-0",gt:"i>m[3]-0",nth:"m[3]-0=3D=3Di",eq:"m[3]-0=3D=3Di",first:"i=3D=3D=
0",last:"i=3D=3Dr.length-1",even:"i%2=3D=3D0",odd:"i%2","first-child":"a.=
parentNode.getElementsByTagName('*')[0]=3D=3Da","last-child":"jQuery.nth(=
a.parentNode.lastChild,1,'previousSibling')=3D=3Da","only-child":"!jQuery=
.nth(a.parentNode.lastChild,2,'previousSibling')",parent:"a.firstChild",e=
mpty:"!a.firstChild",contains:"(a.textContent||a.innerText||jQuery(a).tex=
t()||'').indexOf(m[3])>=3D0",visible:'"hidden"!=3Da.type&&jQuery.css(a,"d=
isplay")!=3D"none"&&jQuery.css(a,"visibility")!=3D"hidden"',hidden:'"hidd=
en"=3D=3Da.type||jQuery.css(a,"display")=3D=3D"none"||jQuery.css(a,"visib=
ility")=3D=3D"hidden"',enabled:"!a.disabled",disabled:"a.disabled",checke=
d:"a.checked",selected:"a.selected||jQuery.attr(a,'selected')",text:"'tex=
t'=3D=3Da.type",radio:"'radio'=3D=3Da.type",checkbox:"'checkbox'=3D=3Da.t=
ype",file:"'file'=3D=3Da.type",password:"'password'=3D=3Da.type",submit:"=
'submit'=3D=3Da.type",image:"'image'=3D=3Da.type",reset:"'reset'=3D=3Da.t=
ype",button:'"button"=3D=3Da.type||jQuery.nodeName(a,"button")',input:"/i=
nput|select|textarea|button/i.test(a.nodeName)",has:"jQuery.find(m[3],a).=
length",header:"/h\\d/i.test(a.nodeName)",animated:"jQuery.grep(jQuery.ti=
mers,function(fn){return a=3D=3Dfn.elem;}).length"}},parse:[/^(\[) =
*@?([\w-]+) *([!*$^~=3D]*) *('?"?)(.*?)\4 =
*\]/,/^(:)([\w-]+)\("?'?(.*?(\(.*?\))?[^(]*?)"?'?\)/,new =
RegExp("^([:.#]*)("+chars+"+)")],multiFilter:function(expr,elems,not){var=
 old,cur=3D[];while(expr&&expr!=3Dold){old=3Dexpr;var =
f=3DjQuery.filter(expr,elems,not);expr=3Df.t.replace(/^\s*,\s*/,"");cur=3D=
not?elems=3Df.r:jQuery.merge(cur,f.r);}return =
cur;},find:function(t,context){if(typeof =
t!=3D"string")return[t];if(context&&!context.nodeType)context=3Dnull;cont=
ext=3Dcontext||document;var =
ret=3D[context],done=3D[],last;while(t&&last!=3Dt){var =
r=3D[];last=3Dt;t=3DjQuery.trim(t);var foundToken=3Dfalse;var =
re=3DquickChild;var m=3Dre.exec(t);if(m){var =
nodeName=3Dm[1].toUpperCase();for(var i=3D0;ret[i];i++)for(var =
c=3Dret[i].firstChild;c;c=3Dc.nextSibling)if(c.nodeType=3D=3D1&&(nodeName=
=3D=3D"*"||c.nodeName.toUpperCase()=3D=3DnodeName.toUpperCase()))r.push(c=
);ret=3Dr;t=3Dt.replace(re,"");if(t.indexOf(" =
")=3D=3D0)continue;foundToken=3Dtrue;}else{re=3D/^([>+~])\s*(\w*)/i;if((m=
=3Dre.exec(t))!=3Dnull){r=3D[];var =
nodeName=3Dm[2],merge=3D{};m=3Dm[1];for(var =
j=3D0,rl=3Dret.length;j<rl;j++){var =
n=3Dm=3D=3D"~"||m=3D=3D"+"?ret[j].nextSibling:ret[j].firstChild;for(;n;n=3D=
n.nextSibling)if(n.nodeType=3D=3D1){var =
id=3DjQuery.data(n);if(m=3D=3D"~"&&merge[id])break;if(!nodeName||n.nodeNa=
me.toUpperCase()=3D=3DnodeName.toUpperCase()){if(m=3D=3D"~")merge[id]=3Dt=
rue;r.push(n);}if(m=3D=3D"+")break;}}ret=3Dr;t=3DjQuery.trim(t.replace(re=
,""));foundToken=3Dtrue;}}if(t&&!foundToken){if(!t.indexOf(",")){if(conte=
xt=3D=3Dret[0])ret.shift();done=3DjQuery.merge(done,ret);r=3Dret=3D[conte=
xt];t=3D" "+t.substr(1,t.length);}else{var re2=3DquickID;var =
m=3Dre2.exec(t);if(m){m=3D[0,m[2],m[3],m[1]];}else{re2=3DquickClass;m=3Dr=
e2.exec(t);}m[2]=3Dm[2].replace(/\\/g,"");var =
elem=3Dret[ret.length-1];if(m[1]=3D=3D"#"&&elem&&elem.getElementById&&!jQ=
uery.isXMLDoc(elem)){var =
oid=3Delem.getElementById(m[2]);if((jQuery.browser.msie||jQuery.browser.o=
pera)&&oid&&typeof =
oid.id=3D=3D"string"&&oid.id!=3Dm[2])oid=3DjQuery('[@id=3D"'+m[2]+'"]',el=
em)[0];ret=3Dr=3Doid&&(!m[3]||jQuery.nodeName(oid,m[3]))?[oid]:[];}else{f=
or(var i=3D0;ret[i];i++){var =
tag=3Dm[1]=3D=3D"#"&&m[3]?m[3]:m[1]!=3D""||m[0]=3D=3D""?"*":m[2];if(tag=3D=
=3D"*"&&ret[i].nodeName.toLowerCase()=3D=3D"object")tag=3D"param";r=3DjQu=
ery.merge(r,ret[i].getElementsByTagName(tag));}if(m[1]=3D=3D".")r=3DjQuer=
y.classFilter(r,m[2]);if(m[1]=3D=3D"#"){var tmp=3D[];for(var =
i=3D0;r[i];i++)if(r[i].getAttribute("id")=3D=3Dm[2]){tmp=3D[r[i]];break;}=
r=3Dtmp;}ret=3Dr;}t=3Dt.replace(re2,"");}}if(t){var =
val=3DjQuery.filter(t,r);ret=3Dr=3Dval.r;t=3DjQuery.trim(val.t);}}if(t)re=
t=3D[];if(ret&&context=3D=3Dret[0])ret.shift();done=3DjQuery.merge(done,r=
et);return done;},classFilter:function(r,m,not){m=3D" "+m+" ";var =
tmp=3D[];for(var i=3D0;r[i];i++){var pass=3D(" "+r[i].className+" =
").indexOf(m)>=3D0;if(!not&&pass||not&&!pass)tmp.push(r[i]);}return =
tmp;},filter:function(t,r,not){var last;while(t&&t!=3Dlast){last=3Dt;var =
p=3DjQuery.parse,m;for(var =
i=3D0;p[i];i++){m=3Dp[i].exec(t);if(m){t=3Dt.substring(m[0].length);m[2]=3D=
m[2].replace(/\\/g,"");break;}}if(!m)break;if(m[1]=3D=3D":"&&m[2]=3D=3D"n=
ot")r=3DjQuery.filter(m[3],r,true).r;else =
if(m[1]=3D=3D".")r=3DjQuery.classFilter(r,m[2],not);else =
if(m[1]=3D=3D"["){var tmp=3D[],type=3Dm[3];for(var =
i=3D0,rl=3Dr.length;i<rl;i++){var =
a=3Dr[i],z=3Da[jQuery.props[m[2]]||m[2]];if(z=3D=3Dnull||/href|src|select=
ed/.test(m[2]))z=3DjQuery.attr(a,m[2])||'';if((type=3D=3D""&&!!z||type=3D=
=3D"=3D"&&z=3D=3Dm[5]||type=3D=3D"!=3D"&&z!=3Dm[5]||type=3D=3D"^=3D"&&z&&=
!z.indexOf(m[5])||type=3D=3D"$=3D"&&z.substr(z.length-m[5].length)=3D=3Dm=
[5]||(type=3D=3D"*=3D"||type=3D=3D"~=3D")&&z.indexOf(m[5])>=3D0)^not)tmp.=
push(a);}r=3Dtmp;}else if(m[1]=3D=3D":"&&m[2]=3D=3D"nth-child"){var =
merge=3D{},tmp=3D[],test=3D/(\d*)n\+?(\d*)/.exec(m[3]=3D=3D"even"&&"2n"||=
m[3]=3D=3D"odd"&&"2n+1"||!/\D/.test(m[3])&&"n+"+m[3]||m[3]),first=3D(test=
[1]||1)-0,last=3Dtest[2]-0;for(var i=3D0,rl=3Dr.length;i<rl;i++){var =
node=3Dr[i],parentNode=3Dnode.parentNode,id=3DjQuery.data(parentNode);if(=
!merge[id]){var c=3D1;for(var =
n=3DparentNode.firstChild;n;n=3Dn.nextSibling)if(n.nodeType=3D=3D1)n.node=
Index=3Dc++;merge[id]=3Dtrue;}var =
add=3Dfalse;if(first=3D=3D1){if(last=3D=3D0||node.nodeIndex=3D=3Dlast)add=
=3Dtrue;}else =
if((node.nodeIndex+last)%first=3D=3D0)add=3Dtrue;if(add^not)tmp.push(node=
);}r=3Dtmp;}else{var f=3DjQuery.expr[m[1]];if(typeof =
f!=3D"string")f=3DjQuery.expr[m[1]][m[2]];f=3Deval("false||function(a,i){=
return =
"+f+"}");r=3DjQuery.grep(r,f,not);}}return{r:r,t:t};},dir:function(elem,d=
ir){var matched=3D[];var =
cur=3Delem[dir];while(cur&&cur!=3Ddocument){if(cur.nodeType=3D=3D1)matche=
d.push(cur);cur=3Dcur[dir];}return =
matched;},nth:function(cur,result,dir,elem){result=3Dresult||1;var =
num=3D0;for(;cur;cur=3Dcur[dir])if(cur.nodeType=3D=3D1&&++num=3D=3Dresult=
)break;return cur;},sibling:function(n,elem){var =
r=3D[];for(;n;n=3Dn.nextSibling){if(n.nodeType=3D=3D1&&(!elem||n!=3Delem)=
)r.push(n);}return =
r;}});jQuery.event=3D{add:function(element,type,handler,data){if(jQuery.b=
rowser.msie&&element.setInterval!=3Dundefined)element=3Dwindow;if(!handle=
r.guid)handler.guid=3Dthis.guid++;if(data!=3Dundefined){var =
fn=3Dhandler;handler=3Dfunction(){return =
fn.apply(this,arguments);};handler.data=3Ddata;handler.guid=3Dfn.guid;}va=
r parts=3Dtype.split(".");type=3Dparts[0];handler.type=3Dparts[1];var =
events=3DjQuery.data(element,"events")||jQuery.data(element,"events",{});=
var handle=3DjQuery.data(element,"handle",function(){var val;if(typeof =
jQuery=3D=3D"undefined"||jQuery.event.triggered)return =
val;val=3DjQuery.event.handle.apply(element,arguments);return val;});var =
handlers=3Devents[type];if(!handlers){handlers=3Devents[type]=3D{};if(ele=
ment.addEventListener)element.addEventListener(type,handle,false);else=0A=
element.attachEvent("on"+type,handle);}handlers[handler.guid]=3Dhandler;t=
his.global[type]=3Dtrue;},guid:1,global:{},remove:function(element,type,h=
andler){var events=3DjQuery.data(element,"events"),ret,index;if(typeof =
type=3D=3D"string"){var =
parts=3Dtype.split(".");type=3Dparts[0];}if(events){if(type&&type.type){h=
andler=3Dtype.handler;type=3Dtype.type;}if(!type){for(type in =
events)this.remove(element,type);}else =
if(events[type]){if(handler)delete events[type][handler.guid];else=0A=
for(handler in =
events[type])if(!parts[1]||events[type][handler].type=3D=3Dparts[1])delet=
e events[type][handler];for(ret in =
events[type])break;if(!ret){if(element.removeEventListener)element.remove=
EventListener(type,jQuery.data(element,"handle"),false);else=0A=
element.detachEvent("on"+type,jQuery.data(element,"handle"));ret=3Dnull;d=
elete events[type];}}for(ret in =
events)break;if(!ret){jQuery.removeData(element,"events");jQuery.removeDa=
ta(element,"handle");}}},trigger:function(type,data,element,donative,extr=
a){data=3DjQuery.makeArray(data||[]);if(!element){if(this.global[type])jQ=
uery("*").add([window,document]).trigger(type,data);}else{var =
val,ret,fn=3DjQuery.isFunction(element[type]||null),evt=3D!data[0]||!data=
[0].preventDefault;if(evt)data.unshift(this.fix({type:type,target:element=
}));data[0].type=3Dtype;if(jQuery.isFunction(jQuery.data(element,"handle"=
)))val=3DjQuery.data(element,"handle").apply(element,data);if(!fn&&elemen=
t["on"+type]&&element["on"+type].apply(element,data)=3D=3D=3Dfalse)val=3D=
false;if(evt)data.shift();if(extra&&extra.apply(element,data)=3D=3D=3Dfal=
se)val=3Dfalse;if(fn&&donative!=3D=3Dfalse&&val!=3D=3Dfalse&&!(jQuery.nod=
eName(element,'a')&&type=3D=3D"click")){this.triggered=3Dtrue;element[typ=
e]();}this.triggered=3Dfalse;}return val;},handle:function(event){var =
val;event=3DjQuery.event.fix(event||window.event||{});var =
parts=3Devent.type.split(".");event.type=3Dparts[0];var =
c=3DjQuery.data(this,"events")&&jQuery.data(this,"events")[event.type],ar=
gs=3DArray.prototype.slice.call(arguments,1);args.unshift(event);for(var =
j in =
c){args[0].handler=3Dc[j];args[0].data=3Dc[j].data;if(!parts[1]||c[j].typ=
e=3D=3Dparts[1]){var =
tmp=3Dc[j].apply(this,args);if(val!=3D=3Dfalse)val=3Dtmp;if(tmp=3D=3D=3Df=
alse){event.preventDefault();event.stopPropagation();}}}if(jQuery.browser=
.msie)event.target=3Devent.preventDefault=3Devent.stopPropagation=3Devent=
.handler=3Devent.data=3Dnull;return val;},fix:function(event){var =
originalEvent=3Devent;event=3DjQuery.extend({},originalEvent);event.preve=
ntDefault=3Dfunction(){if(originalEvent.preventDefault)originalEvent.prev=
entDefault();originalEvent.returnValue=3Dfalse;};event.stopPropagation=3D=
function(){if(originalEvent.stopPropagation)originalEvent.stopPropagation=
();originalEvent.cancelBubble=3Dtrue;};if(!event.target&&event.srcElement=
)event.target=3Devent.srcElement;if(jQuery.browser.safari&&event.target.n=
odeType=3D=3D3)event.target=3DoriginalEvent.target.parentNode;if(!event.r=
elatedTarget&&event.fromElement)event.relatedTarget=3Devent.fromElement=3D=
=3Devent.target?event.toElement:event.fromElement;if(event.pageX=3D=3Dnul=
l&&event.clientX!=3Dnull){var =
e=3Ddocument.documentElement,b=3Ddocument.body;event.pageX=3Devent.client=
X+(e&&e.scrollLeft||b.scrollLeft||0);event.pageY=3Devent.clientY+(e&&e.sc=
rollTop||b.scrollTop||0);}if(!event.which&&(event.charCode||event.keyCode=
))event.which=3Devent.charCode||event.keyCode;if(!event.metaKey&&event.ct=
rlKey)event.metaKey=3Devent.ctrlKey;if(!event.which&&event.button)event.w=
hich=3D(event.button&1?1:(event.button&2?3:(event.button&4?2:0)));return =
event;}};jQuery.fn.extend({bind:function(type,data,fn){return =
type=3D=3D"unload"?this.one(type,data,fn):this.each(function(){jQuery.eve=
nt.add(this,type,fn||data,fn&&data);});},one:function(type,data,fn){retur=
n =
this.each(function(){jQuery.event.add(this,type,function(event){jQuery(th=
is).unbind(event);return(fn||data).apply(this,arguments);},fn&&data);});}=
,unbind:function(type,fn){return =
this.each(function(){jQuery.event.remove(this,type,fn);});},trigger:funct=
ion(type,data,fn){return =
this.each(function(){jQuery.event.trigger(type,data,this,true,fn);});},tr=
iggerHandler:function(type,data,fn){if(this[0])return =
jQuery.event.trigger(type,data,this[0],false,fn);},toggle:function(){var =
a=3Darguments;return =
this.click(function(e){this.lastToggle=3D0=3D=3Dthis.lastToggle?1:0;e.pre=
ventDefault();return =
a[this.lastToggle].apply(this,[e])||false;});},hover:function(f,g){functi=
on handleHover(e){var =
p=3De.relatedTarget;while(p&&p!=3Dthis)try{p=3Dp.parentNode;}catch(e){p=3D=
this;};if(p=3D=3Dthis)return =
false;return(e.type=3D=3D"mouseover"?f:g).apply(this,[e]);}return =
this.mouseover(handleHover).mouseout(handleHover);},ready:function(f){bin=
dReady();if(jQuery.isReady)f.apply(document,[jQuery]);else=0A=
jQuery.readyList.push(function(){return f.apply(this,[jQuery]);});return =
this;}});jQuery.extend({isReady:false,readyList:[],ready:function(){if(!j=
Query.isReady){jQuery.isReady=3Dtrue;if(jQuery.readyList){jQuery.each(jQu=
ery.readyList,function(){this.apply(document);});jQuery.readyList=3Dnull;=
}if(jQuery.browser.mozilla||jQuery.browser.opera)document.removeEventList=
ener("DOMContentLoaded",jQuery.ready,false);if(!window.frames.length)jQue=
ry(window).load(function(){jQuery("#__ie_init").remove();});}}});jQuery.e=
ach(("blur,focus,load,resize,scroll,unload,click,dblclick,"+"mousedown,mo=
useup,mousemove,mouseover,mouseout,change,select,"+"submit,keydown,keypre=
ss,keyup,error").split(","),function(i,o){jQuery.fn[o]=3Dfunction(f){retu=
rn f?this.bind(o,f):this.trigger(o);};});var readyBound=3Dfalse;function =
bindReady(){if(readyBound)return;readyBound=3Dtrue;if(jQuery.browser.mozi=
lla||jQuery.browser.opera)document.addEventListener("DOMContentLoaded",jQ=
uery.ready,false);else =
if(jQuery.browser.msie){document.write("<scr"+"ipt id=3D__ie_init =
defer=3Dtrue "+"src=3D//:><\/script>");var =
script=3Ddocument.getElementById("__ie_init");if(script)script.onreadysta=
techange=3Dfunction(){if(this.readyState!=3D"complete")return;jQuery.read=
y();};script=3Dnull;}else =
if(jQuery.browser.safari)jQuery.safariTimer=3DsetInterval(function(){if(d=
ocument.readyState=3D=3D"loaded"||document.readyState=3D=3D"complete"){cl=
earInterval(jQuery.safariTimer);jQuery.safariTimer=3Dnull;jQuery.ready();=
}},10);jQuery.event.add(window,"load",jQuery.ready);}jQuery.fn.extend({lo=
ad:function(url,params,callback){if(jQuery.isFunction(url))return =
this.bind("load",url);var off=3Durl.indexOf(" ");if(off>=3D0){var =
selector=3Durl.slice(off,url.length);url=3Durl.slice(0,off);}callback=3Dc=
allback||function(){};var =
type=3D"GET";if(params)if(jQuery.isFunction(params)){callback=3Dparams;pa=
rams=3Dnull;}else{params=3DjQuery.param(params);type=3D"POST";}var =
self=3Dthis;jQuery.ajax({url:url,type:type,data:params,complete:function(=
res,status){if(status=3D=3D"success"||status=3D=3D"notmodified")self.html=
(selector?jQuery("<div/>").append(res.responseText.replace(/<script(.|\s)=
*?\/script>/g,"")).find(selector):res.responseText);setTimeout(function()=
{self.each(callback,[res.responseText,status,res]);},13);}});return =
this;},serialize:function(){return =
jQuery.param(this.serializeArray());},serializeArray:function(){return =
this.map(function(){return =
jQuery.nodeName(this,"form")?jQuery.makeArray(this.elements):this;}).filt=
er(function(){return =
this.name&&!this.disabled&&(this.checked||/select|textarea/i.test(this.no=
deName)||/text|hidden|password/i.test(this.type));}).map(function(i,elem)=
{var val=3DjQuery(this).val();return =
val=3D=3Dnull?null:val.constructor=3D=3DArray?jQuery.map(val,function(val=
,i){return{name:elem.name,value:val};}):{name:elem.name,value:val};}).get=
();}});jQuery.each("ajaxStart,ajaxStop,ajaxComplete,ajaxError,ajaxSuccess=
,ajaxSend".split(","),function(i,o){jQuery.fn[o]=3Dfunction(f){return =
this.bind(o,f);};});var jsc=3D(new =
Date).getTime();jQuery.extend({get:function(url,data,callback,type){if(jQ=
uery.isFunction(data)){callback=3Ddata;data=3Dnull;}return =
jQuery.ajax({type:"GET",url:url,data:data,success:callback,dataType:type}=
);},getScript:function(url,callback){return =
jQuery.get(url,null,callback,"script");},getJSON:function(url,data,callba=
ck){return =
jQuery.get(url,data,callback,"json");},post:function(url,data,callback,ty=
pe){if(jQuery.isFunction(data)){callback=3Ddata;data=3D{};}return =
jQuery.ajax({type:"POST",url:url,data:data,success:callback,dataType:type=
});},ajaxSetup:function(settings){jQuery.extend(jQuery.ajaxSettings,setti=
ngs);},ajaxSettings:{global:true,type:"GET",timeout:0,contentType:"applic=
ation/x-www-form-urlencoded",processData:true,async:true,data:null},lastM=
odified:{},ajax:function(s){var =
jsonp,jsre=3D/=3D(\?|%3F)/g,status,data;s=3DjQuery.extend(true,s,jQuery.e=
xtend(true,{},jQuery.ajaxSettings,s));if(s.data&&s.processData&&typeof =
s.data!=3D"string")s.data=3DjQuery.param(s.data);if(s.dataType=3D=3D"json=
p"){if(s.type.toLowerCase()=3D=3D"get"){if(!s.url.match(jsre))s.url+=3D(s=
.url.match(/\?/)?"&":"?")+(s.jsonp||"callback")+"=3D?";}else =
if(!s.data||!s.data.match(jsre))s.data=3D(s.data?s.data+"&":"")+(s.jsonp|=
|"callback")+"=3D?";s.dataType=3D"json";}if(s.dataType=3D=3D"json"&&(s.da=
ta&&s.data.match(jsre)||s.url.match(jsre))){jsonp=3D"jsonp"+jsc++;if(s.da=
ta)s.data=3Ds.data.replace(jsre,"=3D"+jsonp);s.url=3Ds.url.replace(jsre,"=
=3D"+jsonp);s.dataType=3D"script";window[jsonp]=3Dfunction(tmp){data=3Dtm=
p;success();complete();window[jsonp]=3Dundefined;try{delete =
window[jsonp];}catch(e){}};}if(s.dataType=3D=3D"script"&&s.cache=3D=3Dnul=
l)s.cache=3Dfalse;if(s.cache=3D=3D=3Dfalse&&s.type.toLowerCase()=3D=3D"ge=
t")s.url+=3D(s.url.match(/\?/)?"&":"?")+"_=3D"+(new =
Date()).getTime();if(s.data&&s.type.toLowerCase()=3D=3D"get"){s.url+=3D(s=
.url.match(/\?/)?"&":"?")+s.data;s.data=3Dnull;}if(s.global&&!jQuery.acti=
ve++)jQuery.event.trigger("ajaxStart");if(!s.url.indexOf("http")&&s.dataT=
ype=3D=3D"script"){var =
head=3Ddocument.getElementsByTagName("head")[0];var =
script=3Ddocument.createElement("script");script.src=3Ds.url;if(!jsonp&&(=
s.success||s.complete)){var =
done=3Dfalse;script.onload=3Dscript.onreadystatechange=3Dfunction(){if(!d=
one&&(!this.readyState||this.readyState=3D=3D"loaded"||this.readyState=3D=
=3D"complete")){done=3Dtrue;success();complete();head.removeChild(script)=
;}};}head.appendChild(script);return;}var requestDone=3Dfalse;var =
xml=3Dwindow.ActiveXObject?new ActiveXObject("Microsoft.XMLHTTP"):new =
XMLHttpRequest();xml.open(s.type,s.url,s.async);if(s.data)xml.setRequestH=
eader("Content-Type",s.contentType);if(s.ifModified)xml.setRequestHeader(=
"If-Modified-Since",jQuery.lastModified[s.url]||"Thu, 01 Jan 1970 =
00:00:00 =
GMT");xml.setRequestHeader("X-Requested-With","XMLHttpRequest");if(s.befo=
reSend)s.beforeSend(xml);if(s.global)jQuery.event.trigger("ajaxSend",[xml=
,s]);var =
onreadystatechange=3Dfunction(isTimeout){if(!requestDone&&xml&&(xml.ready=
State=3D=3D4||isTimeout=3D=3D"timeout")){requestDone=3Dtrue;if(ival){clea=
rInterval(ival);ival=3Dnull;}status=3DisTimeout=3D=3D"timeout"&&"timeout"=
||!jQuery.httpSuccess(xml)&&"error"||s.ifModified&&jQuery.httpNotModified=
(xml,s.url)&&"notmodified"||"success";if(status=3D=3D"success"){try{data=3D=
jQuery.httpData(xml,s.dataType);}catch(e){status=3D"parsererror";}}if(sta=
tus=3D=3D"success"){var =
modRes;try{modRes=3Dxml.getResponseHeader("Last-Modified");}catch(e){}if(=
s.ifModified&&modRes)jQuery.lastModified[s.url]=3DmodRes;if(!jsonp)succes=
s();}else=0A=
jQuery.handleError(s,xml,status);complete();if(s.async)xml=3Dnull;}};if(s=
.async){var =
ival=3DsetInterval(onreadystatechange,13);if(s.timeout>0)setTimeout(funct=
ion(){if(xml){xml.abort();if(!requestDone)onreadystatechange("timeout");}=
},s.timeout);}try{xml.send(s.data);}catch(e){jQuery.handleError(s,xml,nul=
l,e);}if(!s.async)onreadystatechange();return xml;function =
success(){if(s.success)s.success(data,status);if(s.global)jQuery.event.tr=
igger("ajaxSuccess",[xml,s]);}function =
complete(){if(s.complete)s.complete(xml,status);if(s.global)jQuery.event.=
trigger("ajaxComplete",[xml,s]);if(s.global&&!--jQuery.active)jQuery.even=
t.trigger("ajaxStop");}},handleError:function(s,xml,status,e){if(s.error)=
s.error(xml,status,e);if(s.global)jQuery.event.trigger("ajaxError",[xml,s=
,e]);},active:0,httpSuccess:function(r){try{return!r.status&&location.pro=
tocol=3D=3D"file:"||(r.status>=3D200&&r.status<300)||r.status=3D=3D304||j=
Query.browser.safari&&r.status=3D=3Dundefined;}catch(e){}return =
false;},httpNotModified:function(xml,url){try{var =
xmlRes=3Dxml.getResponseHeader("Last-Modified");return =
xml.status=3D=3D304||xmlRes=3D=3DjQuery.lastModified[url]||jQuery.browser=
.safari&&xml.status=3D=3Dundefined;}catch(e){}return =
false;},httpData:function(r,type){var =
ct=3Dr.getResponseHeader("content-type");var =
xml=3Dtype=3D=3D"xml"||!type&&ct&&ct.indexOf("xml")>=3D0;var =
data=3Dxml?r.responseXML:r.responseText;if(xml&&data.documentElement.tagN=
ame=3D=3D"parsererror")throw"parsererror";if(type=3D=3D"script")jQuery.gl=
obalEval(data);if(type=3D=3D"json")data=3Deval("("+data+")");return =
data;},param:function(a){var =
s=3D[];if(a.constructor=3D=3DArray||a.jquery)jQuery.each(a,function(){s.p=
ush(encodeURIComponent(this.name)+"=3D"+encodeURIComponent(this.value));}=
);else=0A=
for(var j in =
a)if(a[j]&&a[j].constructor=3D=3DArray)jQuery.each(a[j],function(){s.push=
(encodeURIComponent(j)+"=3D"+encodeURIComponent(this));});else=0A=
s.push(encodeURIComponent(j)+"=3D"+encodeURIComponent(a[j]));return =
s.join("&").replace(/%20/g,"+");}});jQuery.fn.extend({show:function(speed=
,callback){return =
speed?this.animate({height:"show",width:"show",opacity:"show"},speed,call=
back):this.filter(":hidden").each(function(){this.style.display=3Dthis.ol=
dblock?this.oldblock:"";if(jQuery.css(this,"display")=3D=3D"none")this.st=
yle.display=3D"block";}).end();},hide:function(speed,callback){return =
speed?this.animate({height:"hide",width:"hide",opacity:"hide"},speed,call=
back):this.filter(":visible").each(function(){this.oldblock=3Dthis.oldblo=
ck||jQuery.css(this,"display");if(this.oldblock=3D=3D"none")this.oldblock=
=3D"block";this.style.display=3D"none";}).end();},_toggle:jQuery.fn.toggl=
e,toggle:function(fn,fn2){return =
jQuery.isFunction(fn)&&jQuery.isFunction(fn2)?this._toggle(fn,fn2):fn?thi=
s.animate({height:"toggle",width:"toggle",opacity:"toggle"},fn,fn2):this.=
each(function(){jQuery(this)[jQuery(this).is(":hidden")?"show":"hide"]();=
});},slideDown:function(speed,callback){return =
this.animate({height:"show"},speed,callback);},slideUp:function(speed,cal=
lback){return =
this.animate({height:"hide"},speed,callback);},slideToggle:function(speed=
,callback){return =
this.animate({height:"toggle"},speed,callback);},fadeIn:function(speed,ca=
llback){return =
this.animate({opacity:"show"},speed,callback);},fadeOut:function(speed,ca=
llback){return =
this.animate({opacity:"hide"},speed,callback);},fadeTo:function(speed,to,=
callback){return =
this.animate({opacity:to},speed,callback);},animate:function(prop,speed,e=
asing,callback){var opt=3DjQuery.speed(speed,easing,callback);return =
this[opt.queue=3D=3D=3Dfalse?"each":"queue"](function(){opt=3DjQuery.exte=
nd({},opt);var hidden=3DjQuery(this).is(":hidden"),self=3Dthis;for(var p =
in =
prop){if(prop[p]=3D=3D"hide"&&hidden||prop[p]=3D=3D"show"&&!hidden)return=
 =
jQuery.isFunction(opt.complete)&&opt.complete.apply(this);if(p=3D=3D"heig=
ht"||p=3D=3D"width"){opt.display=3DjQuery.css(this,"display");opt.overflo=
w=3Dthis.style.overflow;}}if(opt.overflow!=3Dnull)this.style.overflow=3D"=
hidden";opt.curAnim=3DjQuery.extend({},prop);jQuery.each(prop,function(na=
me,val){var e=3Dnew =
jQuery.fx(self,opt,name);if(/toggle|show|hide/.test(val))e[val=3D=3D"togg=
le"?hidden?"show":"hide":val](prop);else{var =
parts=3Dval.toString().match(/^([+-]=3D)?([\d+-.]+)(.*)$/),start=3De.cur(=
true)||0;if(parts){var =
end=3DparseFloat(parts[2]),unit=3Dparts[3]||"px";if(unit!=3D"px"){self.st=
yle[name]=3D(end||1)+unit;start=3D((end||1)/e.cur(true))*start;self.style=
[name]=3Dstart+unit;}if(parts[1])end=3D((parts[1]=3D=3D"-=3D"?-1:1)*end)+=
start;e.custom(start,end,unit);}else=0A=
e.custom(start,val,"");}});return =
true;});},queue:function(type,fn){if(jQuery.isFunction(type)){fn=3Dtype;t=
ype=3D"fx";}if(!type||(typeof type=3D=3D"string"&&!fn))return =
queue(this[0],type);return =
this.each(function(){if(fn.constructor=3D=3DArray)queue(this,type,fn);els=
e{queue(this,type).push(fn);if(queue(this,type).length=3D=3D1)fn.apply(th=
is);}});},stop:function(){var timers=3DjQuery.timers;return =
this.each(function(){for(var =
i=3D0;i<timers.length;i++)if(timers[i].elem=3D=3Dthis)timers.splice(i--,1=
);}).dequeue();}});var =
queue=3Dfunction(elem,type,array){if(!elem)return;var =
q=3DjQuery.data(elem,type+"queue");if(!q||array)q=3DjQuery.data(elem,type=
+"queue",array?jQuery.makeArray(array):[]);return =
q;};jQuery.fn.dequeue=3Dfunction(type){type=3Dtype||"fx";return =
this.each(function(){var =
q=3Dqueue(this,type);q.shift();if(q.length)q[0].apply(this);});};jQuery.e=
xtend({speed:function(speed,easing,fn){var =
opt=3Dspeed&&speed.constructor=3D=3DObject?speed:{complete:fn||!fn&&easin=
g||jQuery.isFunction(speed)&&speed,duration:speed,easing:fn&&easing||easi=
ng&&easing.constructor!=3DFunction&&easing};opt.duration=3D(opt.duration&=
&opt.duration.constructor=3D=3DNumber?opt.duration:{slow:600,fast:200}[op=
t.duration])||400;opt.old=3Dopt.complete;opt.complete=3Dfunction(){jQuery=
(this).dequeue();if(jQuery.isFunction(opt.old))opt.old.apply(this);};retu=
rn opt;},easing:{linear:function(p,n,firstNum,diff){return =
firstNum+diff*p;},swing:function(p,n,firstNum,diff){return((-Math.cos(p*M=
ath.PI)/2)+0.5)*diff+firstNum;}},timers:[],fx:function(elem,options,prop)=
{this.options=3Doptions;this.elem=3Delem;this.prop=3Dprop;if(!options.ori=
g)options.orig=3D{};}});jQuery.fx.prototype=3D{update:function(){if(this.=
options.step)this.options.step.apply(this.elem,[this.now,this]);(jQuery.f=
x.step[this.prop]||jQuery.fx.step._default)(this);if(this.prop=3D=3D"heig=
ht"||this.prop=3D=3D"width")this.elem.style.display=3D"block";},cur:funct=
ion(force){if(this.elem[this.prop]!=3Dnull&&this.elem.style[this.prop]=3D=
=3Dnull)return this.elem[this.prop];var =
r=3DparseFloat(jQuery.curCSS(this.elem,this.prop,force));return =
r&&r>-10000?r:parseFloat(jQuery.css(this.elem,this.prop))||0;},custom:fun=
ction(from,to,unit){this.startTime=3D(new =
Date()).getTime();this.start=3Dfrom;this.end=3Dto;this.unit=3Dunit||this.=
unit||"px";this.now=3Dthis.start;this.pos=3Dthis.state=3D0;this.update();=
var self=3Dthis;function t(){return =
self.step();}t.elem=3Dthis.elem;jQuery.timers.push(t);if(jQuery.timers.le=
ngth=3D=3D1){var timer=3DsetInterval(function(){var =
timers=3DjQuery.timers;for(var =
i=3D0;i<timers.length;i++)if(!timers[i]())timers.splice(i--,1);if(!timers=
.length)clearInterval(timer);},13);}},show:function(){this.options.orig[t=
his.prop]=3DjQuery.attr(this.elem.style,this.prop);this.options.show=3Dtr=
ue;this.custom(0,this.cur());if(this.prop=3D=3D"width"||this.prop=3D=3D"h=
eight")this.elem.style[this.prop]=3D"1px";jQuery(this.elem).show();},hide=
:function(){this.options.orig[this.prop]=3DjQuery.attr(this.elem.style,th=
is.prop);this.options.hide=3Dtrue;this.custom(this.cur(),0);},step:functi=
on(){var t=3D(new =
Date()).getTime();if(t>this.options.duration+this.startTime){this.now=3Dt=
his.end;this.pos=3Dthis.state=3D1;this.update();this.options.curAnim[this=
.prop]=3Dtrue;var done=3Dtrue;for(var i in =
this.options.curAnim)if(this.options.curAnim[i]!=3D=3Dtrue)done=3Dfalse;i=
f(done){if(this.options.display!=3Dnull){this.elem.style.overflow=3Dthis.=
options.overflow;this.elem.style.display=3Dthis.options.display;if(jQuery=
.css(this.elem,"display")=3D=3D"none")this.elem.style.display=3D"block";}=
if(this.options.hide)this.elem.style.display=3D"none";if(this.options.hid=
e||this.options.show)for(var p in =
this.options.curAnim)jQuery.attr(this.elem.style,p,this.options.orig[p]);=
}if(done&&jQuery.isFunction(this.options.complete))this.options.complete.=
apply(this.elem);return false;}else{var =
n=3Dt-this.startTime;this.state=3Dn/this.options.duration;this.pos=3DjQue=
ry.easing[this.options.easing||(jQuery.easing.swing?"swing":"linear")](th=
is.state,n,0,1,this.options.duration);this.now=3Dthis.start+((this.end-th=
is.start)*this.pos);this.update();}return =
true;}};jQuery.fx.step=3D{scrollLeft:function(fx){fx.elem.scrollLeft=3Dfx=
.now;},scrollTop:function(fx){fx.elem.scrollTop=3Dfx.now;},opacity:functi=
on(fx){jQuery.attr(fx.elem.style,"opacity",fx.now);},_default:function(fx=
){fx.elem.style[fx.prop]=3Dfx.now+fx.unit;}};jQuery.fn.offset=3Dfunction(=
){var =
left=3D0,top=3D0,elem=3Dthis[0],results;if(elem)with(jQuery.browser){var =
absolute=3DjQuery.css(elem,"position")=3D=3D"absolute",parent=3Delem.pare=
ntNode,offsetParent=3Delem.offsetParent,doc=3Delem.ownerDocument,safari2=3D=
safari&&parseInt(version)<522;if(elem.getBoundingClientRect){box=3Delem.g=
etBoundingClientRect();add(box.left+Math.max(doc.documentElement.scrollLe=
ft,doc.body.scrollLeft),box.top+Math.max(doc.documentElement.scrollTop,do=
c.body.scrollTop));if(msie){var =
border=3DjQuery("html").css("borderWidth");border=3D(border=3D=3D"medium"=
||jQuery.boxModel&&parseInt(version)>=3D7)&&2||border;add(-border,-border=
);}}else{add(elem.offsetLeft,elem.offsetTop);while(offsetParent){add(offs=
etParent.offsetLeft,offsetParent.offsetTop);if(mozilla&&/^t[d|h]$/i.test(=
parent.tagName)||!safari2)border(offsetParent);if(safari2&&!absolute&&jQu=
ery.css(offsetParent,"position")=3D=3D"absolute")absolute=3Dtrue;offsetPa=
rent=3DoffsetParent.offsetParent;}while(parent.tagName&&!/^body|html$/i.t=
est(parent.tagName)){if(!/^inline|table-row.*$/i.test(jQuery.css(parent,"=
display")))add(-parent.scrollLeft,-parent.scrollTop);if(mozilla&&jQuery.c=
ss(parent,"overflow")!=3D"visible")border(parent);parent=3Dparent.parentN=
ode;}if(safari2&&absolute)add(-doc.body.offsetLeft,-doc.body.offsetTop);}=
results=3D{top:top,left:left};}return results;function =
border(elem){add(jQuery.css(elem,"borderLeftWidth"),jQuery.css(elem,"bord=
erTopWidth"));}function =
add(l,t){left+=3DparseInt(l)||0;top+=3DparseInt(t)||0;}};})();
------=_NextPart_000_01AB_01C8B112.634FA1F0
Content-Type: application/octet-stream
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.nature.com/common/scripts/global.js

(function($) {
	$(document).ready(function () {

		// enables dropdown ads to display whilst maintaining .user-services =
visibility aat small resolutions
		// yes, it involves browser detection, and yes, that is truly =
horrible.
		if (jQuery.browser.mozilla) {
	=09
			var dropdownAd =3D false;
	=09
			// for each descendant of .leaderboard that isn't a <script>, =
determine if it's taller than standard leaderboard height
			$("#hdr .leaderboard *:not(script):not(.padder)").each(function() {
				if($(this).height() > 90) {
					dropdownAd =3D true;
				}
			});
	=09
			if (dropdownAd) {
				$("#hdr .leaderboard").css("overflow","visible");
				$("#hdr .leaderboard .padder").css("overflow","visible");
				$("#hdr .leaderboard").hover(function() {
					$("#hdr .leaderboard").css("overflow","visible");
					$("#hdr .leaderboard .padder").css("overflow","visible");
				},function() {
					$("#hdr .leaderboard").css("overflow","hidden");
					$("#hdr .leaderboard .padder").css("overflow","hidden");
				});		=09
			}
		}
	=09
	});
}) (jQuery);
------=_NextPart_000_01AB_01C8B112.634FA1F0--

